Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGRP,Agouti-related protein,42754,0.275953150063353,0.00485557703348897,0.266436219077714,0.285470081048991,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCN1,CCN family member 1,42569,0.358800212603822,0.00703102610711882,0.345019401433869,0.372581023773774,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CES1,Liver carboxylesterase 1,42661,0.324750536060824,0.00798434188214881,0.309101225971812,0.340399846149835,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LDLR,Low-density lipoprotein receptor,42644,0.403937940101489,0.00404694791126332,0.396005922195413,0.411869958007565,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LPL,Lipoprotein lipase,42636,-0.195794483897726,0.0045671738207754,-0.204746144586446,-0.186842823209006,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MFGE8,Lactadherin,42611,0.227810978019083,0.00410931844933924,0.219756713858378,0.235865242179788,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPY,Pro-neuropeptide Y,42721,0.343091101198496,0.00604764204874489,0.331237722782956,0.354944479614036,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,40483,0.291588855577819,0.00738425818830799,0.277115709528735,0.306062001626903,1.11253692926098e-308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,42611,0.12807771586286,0.00328327897238989,0.121642489076976,0.134512942648744,1.11253703639877e-308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GHR,Growth hormone receptor,40283,0.109052805338698,0.00278141275837721,0.103601236332278,0.114504374345117,1.11253719629856e-308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GCG,Pro-glucagon,42346,0.479947331589226,0.01252890684355,0.455390674175868,0.504503989002584,1.7643262142485e-304
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FURIN,Furin,42679,0.123530097227699,0.00323622059104203,0.117187104869257,0.129873089586141,8.033561852616e-303
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADIPOQ,Adiponectin,40539,-0.260409481753731,0.00681023504922062,-0.273757542450203,-0.247061421057258,5.02753063662524e-301
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGSF9,Protein turtle homolog A,40511,0.311280938618279,0.00816789124359594,0.295271871780831,0.327290005455727,4.17280769130457e-299
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,40532,0.082104630283257,0.00218613031501306,0.0778198148658314,0.0863894457006826,4.63049134745372e-291
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,42721,0.119961661294156,0.00326586301306831,0.113560569788542,0.12636275279977,1.20506635776735e-281
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42689,0.149206679070472,0.00422131225719858,0.140932907046362,0.157480451094581,8.2044110808313e-262
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRAP1,Proline-rich acidic protein 1,40527,0.143252899661117,0.0041302153818147,0.13515767751276,0.151348121809474,1.29734023913634e-250
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INHBC,Inhibin beta C chain,42611,0.141399095462216,0.00410599388562004,0.133351347446401,0.149446843478031,4.11958068007294e-249
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RARRES2,Retinoic acid receptor responder protein 2,42705,0.161711327885291,0.00470964743908611,0.152480418904683,0.1709422368659,8.56780660822678e-248
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTH,Parathyroid hormone,40182,0.280081565642283,0.00816466588708952,0.264078820503588,0.296084310780979,4.30728600213333e-245
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F7,Coagulation factor VII,42671,0.105150752847749,0.0031097426716483,0.0990556572113187,0.11124584848418,1.22445199674272e-240
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJB1,DnaJ homolog subfamily B member 1,42587,0.292878092429514,0.00866552338889724,0.275893666587275,0.309862518271752,2.25768210146522e-240
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMAD1,Mothers against decapentaplegic homolog 1,42346,0.273118194059015,0.00815015148035911,0.257143897157511,0.289092490960519,2.49335123758776e-236
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLTP,Phospholipid transfer protein,42752,-0.119637724336439,0.00360156713374581,-0.126696795918581,-0.112578652754297,1.09057438420608e-232
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRP1,Neuropilin-1,42705,-0.0924328141963062,0.00279107334513388,-0.0979033179527686,-0.0869623104398438,2.59420849027614e-231
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL27,C-C motif chemokine 27,42636,0.19569453306044,0.00592159582538069,0.184088205242693,0.207300860878186,2.43017946791055e-230
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL23,C-C motif chemokine 23,42676,0.138917527352633,0.00421854705723471,0.130649175120453,0.147185879584813,8.27643759134734e-229
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC39A5,Zinc transporter ZIP5,42594,0.176186687255756,0.00542010708909678,0.165563277361127,0.186810097150386,3.59061509426847e-223
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,42587,0.258792879175537,0.00798089302551467,0.243150328845529,0.274435429505546,3.98575399366581e-222
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42721,0.111704340500247,0.00346939176857753,0.104904332633835,0.118504348366659,3.25223173370485e-219
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DSG2,Desmoglein-2,42611,-0.0882613316917862,0.00274101276601479,-0.0936337167131752,-0.0828889466703972,3.42929426094367e-219
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,42477,0.481302723593541,0.0151128325141843,0.45168157186574,0.510923875321343,1.5012136849617e-214
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD4,T-cell surface glycoprotein CD4,42570,0.0993990270543401,0.00312741012842943,0.0932693032026184,0.105528750906062,8.8647691355582e-214
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,42587,0.331191729709528,0.0105229974973934,0.310566654614637,0.35181680480442,8.03099438493496e-210
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPR37,Prosaposin receptor GPR37,42357,0.215556220811062,0.00688196677000245,0.202067565941857,0.229044875680266,8.95040663145132e-208
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C9,Complement component C9,40532,-0.166453325188236,0.00532605497128299,-0.17689239293195,-0.156014257444521,9.4049700411784e-206
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTN3,Contactin-3,42611,0.0967988684632689,0.00315059600687719,0.0906237002897896,0.102974036636748,2.18344161751401e-200
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA5,Plasma serine protease inhibitor,40387,0.0965695655283585,0.00317030981056569,0.0903557582996497,0.102783372757067,7.43928426381639e-196
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPM,Carboxypeptidase M,42655,0.103312594464974,0.00340918336060981,0.0966305950781784,0.109994593851769,3.35894538707576e-195
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMPRSS15,Enteropeptidase,42587,0.278823637508184,0.009226247313958,0.260740192772826,0.296907082243541,3.85730412669745e-194
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42357,0.246663274896917,0.00820973042937373,0.230572203255345,0.26275434653849,6.99891273769942e-192
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,42771,-0.188270647994066,0.0062764920215362,-0.200572572356277,-0.175968723631855,1.80914900400796e-191
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,42770,-0.361991300228953,0.0121670724074525,-0.38583876214756,-0.338143838310347,1.72588965432458e-188
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GUSB,Beta-glucuronidase,42711,0.182239109868596,0.00613924411639297,0.170206191400466,0.194272028336726,1.20221597995234e-187
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APCS,Serum amyloid P-component,40419,0.102471016252798,0.00344265498041025,0.0957234124911937,0.109218620014402,1.88363261456369e-187
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL6,C-X-C motif chemokine 6,42754,0.226153277229934,0.00775079118895765,0.210961726499577,0.241344827960291,1.41391960079935e-181
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MXRA8,Matrix remodeling-associated protein 8,40283,-0.0920496270750762,0.0031450678647915,-0.0982139600900676,-0.0858852940600849,1.88392529650231e-181
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PROC,Vitamin K-dependent protein C,42663,0.0742358470122154,0.00254494379990187,0.0692477571644077,0.0792239368600231,1.92276875461192e-181
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRIP2,Cysteine-rich protein 2,42495,0.107976286183174,0.00371119681490621,0.100702340425958,0.115250231940391,1.76768435545127e-180
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TTR,Transthyretin,40424,0.0743098366101073,0.00254874453437385,0.0693142973227346,0.07930537589748,3.31676810363391e-180
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCHE,Cholinesterase,40346,0.0818840876858975,0.00281215712596732,0.0763722597190016,0.0873959156527934,1.01736576887488e-179
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,42587,0.202012984422512,0.00706527594800653,0.188165043564419,0.215860925280604,1.38758552234873e-174
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,42346,0.170884385775112,0.00599196934616208,0.159140125856634,0.18262864569359,1.2391506072648e-173
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42711,0.149782038859815,0.00525504420926475,0.139482152209656,0.160081925509974,1.40615339766625e-173
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42613,0.328397383134439,0.0115260672527266,0.305806291319094,0.350988474949783,2.04311082543731e-173
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA4,Kallistatin,40342,0.0685601822145655,0.00243816471979404,0.0637813793637692,0.0733389850653618,3.82225955503956e-168
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNCA,Alpha-synuclein,40283,0.326265277290498,0.0116362213634587,0.303458283418119,0.349072271162877,3.41405651703446e-167
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF21,Fibroblast growth factor 21,42689,0.330446415134754,0.0119059884826192,0.30711067770882,0.353782152560687,6.2677648550829e-165
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHMP6,Charged multivesicular body protein 6,40511,0.157470230576191,0.00566153486008599,0.146373622250422,0.168566838901959,9.43102865831704e-165
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PON3,Serum paraoxonase/lactonase 3,42676,-0.0801327845192855,0.00289347539050067,-0.0858039962846668,-0.0744615727539042,3.08736027796879e-164
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42495,0.203245623149968,0.00739951645773333,0.188742570892811,0.217748675407125,1.32921879679746e-161
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERP44,Endoplasmic reticulum resident protein 44,42569,0.0710452517446777,0.00259332373837823,0.0659623372174564,0.076128166271899,8.17588049244259e-161
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFP,Properdin,40539,0.0619242386809043,0.00226094163626063,0.0574927930738334,0.0663556842879751,5.56891524168812e-160
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD300LG,CMRF35-like molecule 9,42611,-0.106880479203022,0.00391310895873887,-0.114550172762151,-0.0992107856438942,6.65436088019289e-160
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AFM,Afamin,40539,0.0553098467263963,0.0020203534659842,0.0513499539330673,0.0592697395197253,7.65532788529162e-160
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G10,Group 10 secretory phospholipase A2,42495,-0.163079022122988,0.00599757051610827,-0.17483426033456,-0.151323783911416,1.72118070708626e-158
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,42238,0.05463616416718,0.00201016785595004,0.0506962351695179,0.0585760931648421,2.75575621135813e-158
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASGR1,Asialoglycoprotein receptor 1,42495,0.0841984957443156,0.00310451487170209,0.0781136465957795,0.0902833448928517,1.03264075242563e-157
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLAT,Tissue-type plasminogen activator,42760,0.138360409609675,0.00513735799348561,0.128291187942443,0.148429631276907,1.10247120293539e-155
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAMR1,Inactive serine protease PAMR1,42611,0.0732365290409664,0.00272253965416229,0.0679003513188084,0.0785727067631245,2.7730534648211e-155
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGR3,Anterior gradient protein 3,42326,0.163148728128987,0.0060937962511685,0.151204887476697,0.175092568781278,8.62496658857485e-154
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42357,0.150796348031956,0.0056364095951565,0.139748985225449,0.161843710838463,1.36641292819874e-153
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFH,Complement factor H,39956,0.0619954583019575,0.00231896625353007,0.0574502844450386,0.0665406321588765,1.68488602622344e-152
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHBG,Sex hormone-binding globulin,40532,-0.136727451805533,0.00512379339600769,-0.146770086861708,-0.126684816749358,3.3397303286794e-152
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSTA3,Glutathione S-transferase A3,42346,0.206611543104476,0.00777147516219953,0.191379451786565,0.221843634422387,9.73818190210317e-152
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SKAP1,Src kinase-associated phosphoprotein 1,42476,0.197990760427171,0.00750002708728459,0.183290707336093,0.212690813518249,9.98794269459283e-150
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUMB,Protein numb homolog,40199,0.219696930590811,0.0083384204555731,0.203353626497887,0.236040234683734,2.0661294458467e-148
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLI1,Friend leukemia integration 1 transcription factor,42346,0.292824466986924,0.0111833824913058,0.270905037303965,0.314743896669884,2.34172493618646e-147
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFI,Complement factor I,40539,0.0518241954264458,0.00198832433054409,0.0479270797385793,0.0557213111143122,1.68987820695981e-145
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINF1,Pigment epithelium-derived factor,40351,0.0704529996556568,0.00271165492502889,0.0651381560026001,0.0757678433087134,1.51145600562563e-144
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAT2,Linker for activation of T-cells family member 2,42587,0.323337638576605,0.0125590448557233,0.298721910659387,0.347953366493823,1.04374512193836e-142
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,42586,0.0497746654695313,0.00193479777002857,0.0459824618402753,0.0535668690987873,1.68055585400192e-142
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFPI,Tissue factor pathway inhibitor,42618,0.0811534314481198,0.00315616286284395,0.0749673522369457,0.0873395106592939,2.28945446357943e-142
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOS3,"Nitric oxide synthase, endothelial",42311,0.143481443242201,0.00558310219278996,0.132538562944333,0.15442432354007,3.80833696008606e-142
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHA1,Ephrin type-A receptor 1,42658,0.0864835142465268,0.00336810509427022,0.0798820282617571,0.0930850002312964,5.34451704740852e-142
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACY1,Aminoacylase-1,42636,0.158281594995629,0.00616549296272501,0.146197228788688,0.17036596120257,6.12141455485258e-142
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLA,Alpha-galactosidase A,40267,0.0973241110607387,0.00378659744273069,0.0899023800729866,0.104745842048491,1.48314137143046e-141
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENO3,Beta-enolase,40223,0.154042922086029,0.00599540711720957,0.142291924136298,0.16579392003576,1.90340421978432e-141
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMAD2,Mothers against decapentaplegic homolog 2,40451,0.180225411728915,0.0070353295874042,0.166436165737603,0.194014657720227,1.00724618938448e-140
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LATS1,Serine/threonine-protein kinase LATS1,40199,0.219430420730316,0.0085755041568826,0.202622432582826,0.236238408877805,2.49940801724395e-140
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPTL2,Angiopoietin-related protein 2,42640,0.104467230063063,0.00409432474967381,0.0964423535537023,0.112492106572424,2.83700586996907e-140
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL16,C-C motif chemokine 16,42794,0.135909408582731,0.00532950841222618,0.125463572094768,0.146355245070694,3.65397183042482e-140
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CKB,Creatine kinase B-type,40527,-0.156946629125829,0.00614264552242277,-0.168986214349777,-0.14490704390188,4.79344516547833e-140
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BPIFB1,BPI fold-containing family B member 1,42573,-0.161594741859501,0.00638218818399351,-0.174103830700128,-0.149085653018874,3.39358809416357e-138
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42689,-0.0967637027755345,0.00383126210840898,-0.104272976508016,-0.0892544290430529,1.47347000510486e-137
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DTYMK,Thymidylate kinase,40511,0.173974586303198,0.00690951663669467,0.160431933695276,0.187517238911119,3.6530973910917e-136
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOMO1,Nodal modulator 1,42611,0.0592715076495629,0.00236134960965954,0.0546432624146302,0.0638997528844956,6.51888527153087e-136
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40223,0.146287716542599,0.00581823077219947,0.134883984229088,0.15769144885611,1.06909036455677e-135
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,P4HB,Protein disulfide-isomerase,42563,0.0977418522521926,0.00390729934839224,0.0900835455293438,0.105400158975041,5.18979634610686e-135
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNAPIN,SNARE-associated protein Snapin,40482,0.146439875435463,0.00585718289853359,0.134959796954337,0.157919953916589,2.53456013953051e-134
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UPB1,Beta-ureidopropionase,40511,0.228270076870944,0.00915284281392349,0.210330504955654,0.246209648786234,1.07834468701362e-133
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40449,0.350198165929332,0.0140687961271859,0.322623325520048,0.377773006338616,3.50370818076009e-133
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,42794,-0.086136611745699,0.00348911806440411,-0.0929752831519311,-0.079297940339467,1.13665147077418e-131
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F9,Coagulation factor IX,42663,0.0454076821232963,0.00184478405360801,0.0417919053782246,0.049023458868368,6.81082061317376e-131
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSTA1,Glutathione S-transferase A1,42611,0.206972854666115,0.00841415202445335,0.190481116698187,0.223464592634044,1.01616968017994e-130
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTSS1,Protein MTSS 1,40449,0.278113394174961,0.0113723604584331,0.255823567676432,0.30040322067349,9.7825667638797e-129
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42346,0.169117646946167,0.0069379487894026,0.155519267318938,0.182716026573396,2.135907099194e-128
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40116,0.168463669353659,0.00691140187535255,0.154917321677968,0.18201001702935,7.92802883027248e-128
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGFR2,Fibroblast growth factor receptor 2,42679,0.055536651899019,0.00228899578682259,0.0510502201568467,0.0600230836411913,2.56823122204945e-127
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPIND1,Heparin cofactor 2,40516,0.0695473476213938,0.00286529559793406,0.0639313682494431,0.0751633269933446,6.5043519013084e-127
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,42733,0.0779257018592075,0.00321974144636626,0.0716150086243296,0.0842363950940854,1.0118395607545e-126
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42443,0.119746300863743,0.00495041819695382,0.110043481197713,0.129449120529772,1.57289342379209e-126
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBP5,Retinol-binding protein 5,42587,0.1379809691365,0.00570602038589129,0.126797169180153,0.149164769092847,1.75203103431783e-126
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL16,Pro-interleukin-16,42754,0.10157515394527,0.0042251420860694,0.0932938754565738,0.109856432433966,4.25940255732469e-125
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNAP29,Synaptosomal-associated protein 29,42679,0.223980662285792,0.00931743668478266,0.205718486383618,0.242242838187966,4.58439252802627e-125
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL13,C-X-C motif chemokine 13,42711,0.152984849303105,0.00641205351969067,0.140417224404511,0.165552474201699,2.84152782704685e-123
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KYNU,Kynureninase,42754,0.108401214133695,0.00454872785990233,0.0994857075282862,0.117316720739103,5.28346795509181e-123
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRP,Gastrin-releasing peptide,40223,0.136265121835667,0.00572838978848543,0.125037477850236,0.147492765821099,5.132386356876e-122
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLUL1,Clusterin-like protein 1,42621,-0.109076318664346,0.00459818971495976,-0.118088770505667,-0.100063866823025,6.82974069588194e-122
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FYB1,FYN-binding protein 1,42590,0.222182452893966,0.0093862571165335,0.20378538894556,0.240579516842372,2.18832600710832e-121
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EEF1D,Elongation factor 1-delta,40511,0.220914039057932,0.0093212219829967,0.202644443971258,0.239183634144605,3.13771480739348e-121
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SYAP1,Synapse-associated protein 1,40283,0.138046352856401,0.00584255765229659,0.1265949398579,0.149497765854903,1.83896088123334e-120
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YES1,Tyrosine-protein kinase Yes,42587,0.272927609905684,0.0115818017670536,0.250227278442259,0.295627941369109,2.42437984859126e-120
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SORT1,Sortilin,42613,0.0889144200612364,0.00378123412168885,0.0815032011827262,0.0963256389397465,7.53762188702976e-120
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42587,0.10489493335558,0.004462039572472,0.0961493357935353,0.113640530917626,8.79653876872745e-120
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HJV,Hemojuvelin,40482,0.106087198604752,0.00450556045788406,0.0972563001072996,0.114918097102205,1.03475853623455e-119
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPY30,Protein dpy-30 homolog,42651,0.144910557604782,0.00616790448648165,0.132821464811278,0.156999650398286,1.17655970930766e-119
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1RN,Interleukin-1 receptor antagonist protein,42585,0.130806356022063,0.00557319467134577,0.119882894466226,0.141729817577901,2.06251802253116e-119
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYH9,Myosin-9,40527,0.274572211361474,0.0116900259666083,0.251659760466922,0.297484662256027,3.72078630547231e-119
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42587,0.0955692529250539,0.00407669856220328,0.0875789237431355,0.103559582106972,3.86139432565283e-119
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ABL1,Tyrosine-protein kinase ABL1,42587,0.160066450579233,0.0068329317241854,0.146673904399829,0.173458996758636,5.67461251905939e-119
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAA80,N-alpha-acetyltransferase 80,40182,0.288040048480171,0.0123166284475685,0.263899456722937,0.312180640237406,4.38637628224816e-118
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDHR5,Cadherin-related family member 5,42636,0.0926031105855781,0.00396935603422624,0.0848231727584946,0.100383048412662,4.85308673323496e-118
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GH1,Somatotropin,42613,-0.409549372489205,0.0175854618297131,-0.444016877675443,-0.375081867302968,1.21300345190371e-117
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42587,0.079934715022376,0.00343718287768203,0.0731978365821192,0.0866715934626327,2.57893836689946e-117
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,42475,0.211192500972111,0.00910169403020006,0.193353180672919,0.229031821271303,8.66546140129984e-117
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CREG1,Protein CREG1,42445,0.0909776797026348,0.0039512423419878,0.0832332447123387,0.0987221146929309,4.6682722235984e-115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SARG,Specifically androgen-regulated gene protein,40456,0.255464064226684,0.011089978297867,0.233727706762865,0.277200421690503,9.00316681748204e-115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42594,0.225923249199838,0.00987968770804459,0.20655906129207,0.245287437107605,1.44248897193694e-113
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F11R,Junctional adhesion molecule A,42611,0.129786297361883,0.0056833544970662,0.118646922547633,0.140925672176132,2.85350280787547e-113
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MASP1,Mannan-binding lectin serine protease 1,42476,0.0548847992901446,0.00240442553766993,0.0501721252363116,0.0595974733439777,3.70556328240756e-113
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RTN4R,Reticulon-4 receptor,42721,0.0805740627946738,0.00353152396124665,0.0736522758306303,0.0874958497587172,4.31356643573692e-113
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,42760,0.0451435933935196,0.00197920024528194,0.041264360912767,0.0490228258742722,4.92602257323438e-113
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TJAP1,Tight junction-associated protein 1,42679,0.192198593703317,0.00842680592842217,0.17568205408361,0.208715133323025,5.18251159592591e-113
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AP1G2,AP-1 complex subunit gamma-like 2,40451,0.183935492409778,0.00807615939869516,0.168106219988335,0.19976476483122,2.72779810972396e-112
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD2AP,CD2-associated protein,42636,0.148054271733732,0.00651683692324517,0.135281271364171,0.160827272103292,3.73746160841446e-112
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,42679,0.0548527625547364,0.00241892683566804,0.050111665956827,0.0595938591526457,9.28767927558772e-112
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATRN,"Attractin, Isoform 2",40539,0.038906626824765,0.00171511381801702,0.0355450037414516,0.0422682499080783,1.87631631159839e-111
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KDR,Vascular endothelial growth factor receptor 2,42679,0.0572350725666076,0.00253343192549143,0.0522695459926444,0.0622005991405708,5.89377413276672e-111
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OXT,Oxytocin-neurophysin 1,42711,0.319476718074002,0.0141865055761966,0.291671167144657,0.347282269003348,2.80627838282691e-110
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40223,0.193985440668658,0.00859791494433186,0.177133527377768,0.210837353959548,3.13239000776898e-110
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BECN1,Beclin-1,40223,0.138146983311676,0.00612608314011128,0.126139860357058,0.150154106266294,3.99806826589076e-110
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SELPLG,P-selectin glycoprotein ligand 1,42594,0.0635395706325542,0.00282391650447433,0.0580046942837845,0.0690744469813239,4.43646208910378e-110
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,40462,0.196584685864862,0.00875332912339904,0.179428160783,0.213741210946724,2.60730674028879e-109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CES3,Carboxylesterase 3,42587,0.161932509209421,0.00722619787473361,0.147769161374944,0.176095857043899,3.22845246055337e-109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42587,0.222314979205625,0.00992909566368204,0.202853951704808,0.241776006706442,4.85231129778626e-109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM20A,Pseudokinase FAM20A,40511,0.0648608418262848,0.00289308298694901,0.0591903991718647,0.0705312844807048,5.89768376113427e-109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STC1,Stanniocalcin-1,42711,0.103708114675964,0.00463673556182725,0.0946201129747822,0.112796116377145,7.76223414536575e-109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,42370,0.127911388336577,0.00571988508641766,0.116700413567199,0.139122363105956,9.49776779182217e-109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGSF8,Immunoglobulin superfamily member 8,42636,0.0702462301231791,0.00314591356104363,0.0640802395435336,0.0764122207028246,1.77880514133228e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAB2,Stabilin-2,40527,0.0642365051242886,0.00287288854062482,0.0586056435846639,0.0698673666639132,2.11209906517875e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HEG1,Protein HEG homolog 1,40283,0.0617300042864995,0.00276143232763312,0.0563175969243386,0.0671424116486604,2.6493095030177e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJA2,DnaJ homolog subfamily A member 2,42721,0.185151399947104,0.008305947618421,0.168871742614998,0.201431057279209,3.91991522484036e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MLN,Promotilin,42594,0.202358882077678,0.00911794499261567,0.184487709892151,0.220230054263204,3.35398156022541e-107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMP4,Metalloproteinase inhibitor 4,42611,-0.0941031655069492,0.0042404266815957,-0.102414401802877,-0.0857919292110216,3.4495157919083e-107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXLNA,Alpha-taxilin,42495,0.199356613173287,0.00898574900130699,0.181744545130725,0.216968681215848,4.07772877195428e-107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLKB1,Plasma kallikrein,40293,0.0558492482099471,0.00252396435450849,0.0509022780751105,0.0607962183447837,3.32697823030388e-106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A4,Protein S100-A4,42679,0.128955359375951,0.00583938219313024,0.117510170277416,0.140400548474486,3.41896782093375e-106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAPK9,Mitogen-activated protein kinase 9,42594,0.0954442676856041,0.0043286851388232,0.0869600448135106,0.103928490557698,7.32895485777618e-106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YOD1,Ubiquitin thioesterase OTU1,40116,0.142871462512802,0.00649979155584795,0.13013187106334,0.155611053962264,8.04706476517738e-105
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPPC,C-type natriuretic peptide,42594,0.112850101065094,0.00515684778444595,0.10274267940758,0.122957522722608,2.47789845995966e-104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40302,0.251028945075515,0.011452089663883,0.228582849334304,0.273475040816726,2.67499864464823e-104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAXX,Protein PAXX,40283,0.101894743302833,0.00465379378652311,0.0927733074812472,0.111016179124418,4.55941797392536e-104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42495,0.119732384772249,0.00547832713775302,0.108994863582253,0.130469905962245,4.60916398229804e-104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F10,Coagulation factor X,40532,0.063596271710299,0.00290689016642905,0.0578987669840981,0.0692937764364999,5.87911784690604e-104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCTN1,Dynactin subunit 1,42721,0.144420236051257,0.00662942311132092,0.131426566753068,0.157413905349446,1.92435571763568e-103
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,42594,0.235080294049267,0.0108501401758439,0.213814019304613,0.256346568793921,2.42220337931845e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40465,0.178780110211038,0.00824619172865076,0.162617574422882,0.194942645999193,3.78076699706827e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,40283,0.184820973264221,0.00852514713571843,0.168111684878213,0.20153026165023,4.15140453979488e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40483,0.0885326249352249,0.00409312059955013,0.0805101085601067,0.0965551413103432,1.07944717211586e-101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AXIN1,Axin-1,42594,0.209588975506197,0.00971198341266829,0.190553488017367,0.228624462995027,1.45590099699205e-101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YTHDF3,YTH domain-containing family protein 3,42370,0.187772646270908,0.00870793099815753,0.17070510151452,0.204840191027297,2.22002496332852e-101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL17,C-X-C motif chemokine 17,42754,0.0898877260554501,0.0041716574556948,0.0817112774422883,0.0980641746686119,2.7831138945578e-101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HGF,Hepatocyte growth factor,42754,0.076950534640049,0.00357755211421948,0.0699385324961788,0.0839625367839192,6.14591426901491e-101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40449,0.0668416869043734,0.00311225213081198,0.0607416727279819,0.0729417010807649,2.59751572872341e-100
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40283,0.0476465006665648,0.0022182207086333,0.0432987880776435,0.0519942132554861,2.63022351662467e-100
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL18R1,Interleukin-18 receptor 1,42754,0.072654786444827,0.00339068925029133,0.066009035514256,0.079300537375398,3.35274915988114e-100
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCN2,Ficolin-2,42597,0.0902864798776459,0.00422004191260423,0.0820151977289416,0.0985577620263502,6.95280145589691e-100
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTSS2,Protein MTSS 2,40451,0.215622076430561,0.0100996533620438,0.195826755840955,0.235417397020167,3.59718805542817e-99
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSD,Cathepsin D,41747,0.0922139739346611,0.00433240873062988,0.0837224528226266,0.100705495046696,8.67491422040569e-99
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40482,0.211498669210002,0.00996601979427201,0.191965270413228,0.231032068006775,4.85439721204027e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AP3S2,AP-3 complex subunit sigma-2,40483,0.103522499090858,0.00487873179110469,0.0939601847802927,0.113084813401423,5.14258078887381e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDHR2,Cadherin-related family member 2,42587,0.153427954059961,0.00725531983739001,0.139207527178676,0.167648380941245,1.15326390471779e-97
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,42346,0.143106363474667,0.00677663471056156,0.129824159441967,0.156388567507368,2.246603166214e-97
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PROS1,Vitamin K-dependent protein S,40539,0.0566892367553586,0.00268334949485165,0.0514298717454494,0.0619486017652678,3.3504492076147e-97
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDGFC,Platelet-derived growth factor C,42346,0.0618824719297346,0.00293549483089274,0.0561289020611848,0.0676360417982844,4.77400438157446e-97
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,40223,0.155882924967512,0.00742044087742776,0.141338860847753,0.17042698908727,4.23376450919729e-96
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD63,CD63 antigen,42475,0.1097165444418,0.0052465282819137,0.0994333490092493,0.119999739874351,1.42740958544963e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,42346,0.154397704772414,0.00739929341204261,0.13989508968481,0.168900319860017,3.72600406384e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SORD,Sorbitol dehydrogenase,42658,0.143294964087375,0.00687013211441609,0.12982950514312,0.156760423031631,4.11538240230416e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42346,0.138227988993908,0.0066271447348028,0.125238785313695,0.151217192674122,4.44319166391922e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ISM1,Isthmin-1,42594,0.082578670537486,0.0039609400334951,0.0748152280718356,0.0903421130031364,5.06128743806212e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARF6,ADP-ribosylation factor 6,40449,0.229287679933315,0.0109825894562096,0.207761804599145,0.250813555267486,5.36198837371953e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,42689,0.0678939288078117,0.00326441219762459,0.0614956809004675,0.0742921767151559,1.3593970415666e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPY,Pancreatic prohormone,42600,0.221623217199176,0.0106618426717678,0.200726005562511,0.242520428835841,1.75777455774327e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP85,Centrosomal protein of 85 kDa,42346,0.136609895758611,0.00657340166475312,0.123726028495695,0.149493763021528,2.04748077597327e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KHK,Ketohexokinase,40223,0.133691606599656,0.00643901315893022,0.121071140808153,0.146312072391159,5.81780108280147e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA3F,Semaphorin-3F,42636,0.0578229958699908,0.0027920458192539,0.0523505860642532,0.0632954056757285,8.16730137171213e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42250,0.117495453591728,0.00567415282158676,0.106374114061418,0.128616793122038,9.51742857547307e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL22,C-C motif chemokine 22,42509,0.112762471842275,0.00545686501303479,0.102067016416727,0.123457927267823,2.10531540376733e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EHBP1,EH domain-binding protein 1,40511,0.157386822532766,0.00761188515297533,0.142467527632935,0.172306117432598,2.95200991370787e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TARBP2,RISC-loading complex subunit TARBP2,42311,0.165110122366972,0.008013752209447,0.149403168036456,0.180817076697488,7.50723722670669e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PYY,Peptide YY,40116,0.216702039610347,0.0105431613391795,0.196037443385555,0.237366635835139,3.89223022631974e-92
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,40483,0.225898879194478,0.0110029406783521,0.204333115464908,0.247464642924048,5.41463661178179e-92
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRSS8,Prostasin,42568,0.0885789750182505,0.00432159425694475,0.0801086502746388,0.0970492997618622,5.91022679410665e-92
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KAZN,Kazrin,40449,0.219380228157235,0.0106875231594373,0.198432682764738,0.240327773549732,5.93025401684745e-92
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CANT1,Soluble calcium-activated nucleotidase 1,42580,0.0432387370944216,0.00210974487351745,0.0391036371423274,0.0473738370465158,6.13996652692567e-92
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40283,0.10444560896602,0.00510120759412227,0.0944472420815408,0.1144439758505,1.75946559939742e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERBIN,Erbin,42587,0.213912165583958,0.0104673337851459,0.193396191365072,0.234428139802844,1.96667848632638e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCLY,Selenocysteine lyase,42674,0.0982351497894365,0.0048086982969983,0.0888101011273198,0.107660198451553,2.2381416581002e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADH1B,All-trans-retinol dehydrogenase,40283,0.156208440576258,0.00763915074078949,0.141235705124311,0.171181176028206,2.95763403961199e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,42594,0.217367211622578,0.0106483339398538,0.196496477100464,0.238237946144691,3.09409937050943e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,40511,0.140651362929106,0.00688139651642992,0.127163825756903,0.154138900101308,3.27747783659764e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EZR,Ezrin,42711,0.0501067951895802,0.00245561359799108,0.0452937925375176,0.0549197978416427,3.54799070752387e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IKBKG,NF-kappa-B essential modulator,42594,0.190664999689095,0.00935022384019875,0.172338560962305,0.208991438415884,4.76501710293858e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAMDC4,Apical endosomal glycoprotein,40451,0.115390621203099,0.00565073122248037,0.104315188007038,0.126466054399161,4.8535081652584e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40408,0.227982320165003,0.0111682707514115,0.206092509492236,0.249872130837769,5.66100571345364e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42679,0.0773885346413478,0.00379925659933146,0.0699419917066582,0.0848350775760375,7.24065914200572e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R9B,Neurabin-2,42754,0.195366315733387,0.00961894518158325,0.176513183177484,0.21421944828929,2.27895879751564e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,42346,0.103563983759194,0.0050981068324702,0.0935716943675524,0.113556273150836,2.33029891697925e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40511,0.154880331390965,0.00762322733389357,0.139938805816534,0.169821856965397,3.66027393732341e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFX1,Transcriptional repressor NF-X1,40116,0.141904376420096,0.0069863335964779,0.128211162570999,0.155597590269192,4.61651394655928e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCS1,Neuronal calcium sensor 1,42721,0.0602552579646742,0.00297795445741039,0.0544184672281498,0.0660920487011985,1.04415953549948e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF4B,Eukaryotic translation initiation factor 4B,42495,0.119572061097329,0.00591142482299195,0.107985668444264,0.131158453750393,1.24824704096097e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40116,0.153234483017248,0.00756344183936823,0.138410137012086,0.16805882902241,1.2745243167114e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LSP1,Lymphocyte-specific protein 1,42594,0.0823983356330801,0.00409553953603752,0.0743710781424466,0.0904255931237137,1.02130237466343e-88
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MVK,Mevalonate kinase,42370,0.165570863678543,0.00822899383044429,0.149442035770872,0.181699691586214,1.04517472316874e-88
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40449,0.0605142516003253,0.00301703152467408,0.0546008698119641,0.0664276333886865,5.91318352126193e-88
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLXNA4,Plexin-A4,42594,0.168837558094578,0.00843117731689012,0.152312450553473,0.185362665635682,6.36405180449651e-88
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP20,Centrosomal protein 20,42346,0.153925532942678,0.00769490906828494,0.13884351116884,0.169007554716517,1.02814596641437e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCR,Breakpoint cluster region protein,42594,0.187171253757427,0.00937036361181739,0.168805341078265,0.205537166436589,1.70341247068691e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGRN,Agrin,42676,0.0748251555558155,0.00374714700107412,0.0674807474337102,0.0821695636779208,1.89008391659863e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATG16L1,Autophagy-related protein 16-1,40449,0.173075057141945,0.00866670202707407,0.15608832116888,0.19006179311501,3.21704485277835e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40511,0.0605506686461849,0.00303590233097465,0.0546003000774746,0.0665010372148952,5.14439366291874e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNIP1,TNFAIP3-interacting protein 1,40483,0.181561809880183,0.00911016946552962,0.163705877727745,0.199417742032621,6.96898434993238e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDLIM7,PDZ and LIM domain protein 7,42676,0.251529135589827,0.0127050525544398,0.226627232583125,0.276431038596529,5.1834999156902e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DKK1,Dickkopf-related protein 1,42711,0.118999778323217,0.00603844672815794,0.107164422736027,0.130835133910406,2.94048786567919e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD6,T-cell differentiation antigen CD6,42746,0.106999951077063,0.00543661580326737,0.0963441841026587,0.117655718051467,4.77914993927274e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAB2,Disabled homolog 2,42721,0.220617729198241,0.011219934567251,0.198626657446429,0.242608800950053,6.82668804926908e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLA2,Src-like-adapter 2,40482,0.209857202514291,0.0106597552308432,0.188964082261838,0.230750322766744,7.34825096341759e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOST,Sclerostin,42613,0.0789132336731188,0.00401410916239189,0.0710455797148307,0.0867808876314069,7.53777841645591e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42570,0.212496923797006,0.0108111234802778,0.191307121775662,0.233686725818351,8.14120674497811e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC4A,C-type lectin domain family 4 member A,42594,-0.071351334046896,0.00363151180261286,-0.0784690971800172,-0.0642335709137748,9.36494746128545e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC1B,C-type lectin domain family 1 member B,42711,0.192387623899229,0.00979511386521052,0.173189200723416,0.211586047075042,1.0391602058713e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL10,C-X-C motif chemokine 10,42676,0.136790414807164,0.00696936670878891,0.123130456057938,0.150450373556391,1.36270545702576e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAT5B,Signal transducer and activator of transcription 5B,42587,0.275903057101042,0.0140766169269123,0.248312887924294,0.303493226277791,2.33664484797174e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TOP2B,DNA topoisomerase 2-beta,40199,0.160528296627009,0.00818099578882709,0.144493544880908,0.17656304837311,2.73759521410541e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BACH1,Transcription regulator protein BACH1,42594,0.147228976967941,0.0075171167523111,0.132495428133411,0.161962525802471,3.06411603292959e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAK4,Serine/threonine-protein kinase PAK 4,42311,0.122144381300757,0.00624667621365935,0.109900895921985,0.13438786667953,6.01006235000513e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NHLRC3,NHL repeat-containing protein 3,40013,0.0649631777345682,0.00331780097726885,0.0584602878191213,0.0714660676500151,6.41052076452283e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40483,0.139065084946969,0.00710656180158126,0.12513622381587,0.152993946078068,6.98069920535828e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42754,0.196892324149908,0.0100818346609666,0.177131928214413,0.216652720085403,8.70840917148953e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,42370,0.136890218285451,0.00701058975189595,0.123149462371735,0.150630974199167,9.98430005695096e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTBS,Di-N-acetylchitobiase,40383,0.0537967479599756,0.00275681522858684,0.0483933901119454,0.0592001058080058,2.0140022152958e-83
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL4A1,Collagen alpha-1(IV) chain,42636,-0.0801762475813453,0.00411815395486627,-0.0882478293328831,-0.0721046658298074,2.81102595001743e-83
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,40451,0.227420983441185,0.0116726281426244,0.204542632281641,0.250299334600729,3.54013491648042e-83
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RLN2,Prorelaxin H2,40257,0.100118608607284,0.00514219344064119,0.0900399094636271,0.110197307750941,4.79853651814778e-83
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTD,Biotinidase,40539,0.0411611523204979,0.00211988749797485,0.0370061728244672,0.0453161318165286,1.21485740168121e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUCB2,Nucleobindin-2,42683,0.0736143104230243,0.0038055402631227,0.0661554515073038,0.0810731693387448,2.96826313691536e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINF2,Alpha-2-antiplasmin,40317,0.0269863665968458,0.00139307488909294,0.0242559398142236,0.0297167933794679,3.00036025413862e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSIP1,PC4 and SFRS1-interacting protein,42594,0.128140224142858,0.00663123226557705,0.115143008902327,0.141137439383389,4.42126106714001e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HBEGF,Proheparin-binding EGF-like growth factor,42674,0.144673064192064,0.0074872044329306,0.12999814350352,0.159347984880608,4.44137500274152e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TANK,TRAF family member-associated NF-kappa-B activator,42370,0.138013259131482,0.00714356822808283,0.124011865404439,0.152014652858524,4.95819570021339e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSME1,Proteasome activator complex subunit 1,42480,0.0738495703294453,0.00382613923819275,0.0663503374225876,0.0813488032363031,6.89107182935556e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SRPK2,SRSF protein kinase 2,42594,0.165409389254788,0.00858290099379138,0.148586903306957,0.182231875202619,1.17182591512666e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNAP23,Synaptosomal-associated protein 23,42636,0.171108643738744,0.0089144790093102,0.153636264880496,0.188581022596992,4.97981309178939e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40277,0.0918926207817615,0.0047842268487535,0.0825155361582046,0.101269705405318,6.5749839326959e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCK2,Cytoplasmic protein NCK2,42676,0.206313229658189,0.0107603133740133,0.185223015445123,0.227403443871256,7.31581436326106e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FETUB,Fetuin-B,42663,0.0635317720884757,0.00331451300261378,0.0570353266033527,0.0700282175735987,8.17040909146447e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,40223,0.146776708245682,0.00765705000696142,0.131768890232037,0.161784526259326,1.36815316839663e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB11FIP3,Rab11 family-interacting protein 3,40511,0.210046349342727,0.0109691477196979,0.188546819812119,0.231545878873334,1.84161549885896e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFB1,Transforming growth factor beta-1 proprotein,42746,0.0749340633653925,0.00392222209946769,0.0672465080504359,0.0826216186803492,2.59990515596293e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42582,0.0532523919255053,0.0027917471675213,0.0477805674771635,0.058724216373847,4.68804333975324e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MCAM,Cell surface glycoprotein MUC18,42689,-0.0661411532456432,0.00346800100250299,-0.0729384352105491,-0.0593438712807374,4.87269573298951e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOXO1,Forkhead box protein O1,42594,0.166531754631036,0.00873789246044143,0.149405485408571,0.183658023853501,6.34341308008841e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDCD5,Programmed cell death protein 5,42711,0.112848510009916,0.00592743512431529,0.101230737166258,0.124466282853574,9.05335366612681e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRELD2,Protein disulfide isomerase CRELD2,42654,0.101633969890298,0.0053409662664092,0.0911656760081356,0.11210226377246,1.08498387190892e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ELN,Elastin,40511,0.0719807855465757,0.00377916119989683,0.0645736295947779,0.0793879414983735,1.22338276693992e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FN1,Fibronectin,40539,0.0522389452460598,0.00274520945310432,0.0468583347179754,0.0576195557741443,1.68354670485217e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IDUA,Alpha-L-iduronidase,42721,0.0907018669898841,0.00477882243691117,0.0813353750135382,0.10006835896623,2.6713437751128e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,40223,0.199829430529537,0.0105347144997809,0.179181390109966,0.220477470949107,5.56315296280276e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,40483,0.174912249990915,0.0092498065073637,0.156782629236482,0.193041870745347,1.53936454474224e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,42594,0.215646247025615,0.0114454598217169,0.19321314577505,0.23807934827618,3.542899201083e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OTUD7B,OTU domain-containing protein 7B,40482,0.120096876131741,0.0063706354528973,0.107610430644063,0.13258332161942,4.48045473052396e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPD52L2,Tumor protein D54,40283,0.207672731885971,0.0110219287941354,0.186069751449466,0.229275712322476,5.63279817893716e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42679,0.185034935842462,0.00984136559634729,0.165745859273622,0.204324012411303,7.21445947213272e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LEP,Leptin,42636,0.128654050063727,0.00684401135193726,0.11523978781393,0.142068312313524,7.77860961901307e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40482,0.161896212103545,0.00860475316753537,0.145030895895176,0.178761528311915,8.80397783792278e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUGP1,SURP and G-patch domain-containing protein 1,40449,0.0772767124353362,0.00411212913755013,0.0692169393257379,0.0853364855449344,1.33537719173403e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SELP,P-selectin,42689,0.10796702624049,0.00576684760288513,0.0966640049388355,0.119270047542145,3.10780356890386e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKT1S1,Proline-rich AKT1 substrate 1,42311,0.128371170267785,0.00685703329264914,0.114931385014193,0.141810955521378,3.36867379934122e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HCLS1,Hematopoietic lineage cell-specific protein,42754,0.105959777853155,0.00566864264666391,0.0948492382656938,0.117070317440616,5.29850722005856e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MINK1,Misshapen-like kinase 1,40483,0.178211686831374,0.00953915092514068,0.159514951018098,0.19690842264465,9.87827902321026e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LEFTY2,Left-right determination factor 2,42689,0.0962308006899723,0.00515742191390284,0.0861222537387227,0.106339347641222,9.88220191719798e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LBR,Delta(14)-sterol reductase LBR,42711,0.127822642688852,0.00685461169875057,0.114387603759301,0.141257681618403,1.20383775061122e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,40451,0.0997288450493891,0.00534835558669623,0.0892460680994644,0.110211621999314,1.89575702061261e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,42587,0.161931760742464,0.00870443630885892,0.144871065577101,0.178992455907828,2.753003363533e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMBP,Protein AMBP,42706,0.0402064613666294,0.00216209396377639,0.0359687571976277,0.0444441655356311,3.08342719070664e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DOK2,Docking protein 2,42636,0.230090664644694,0.0123840413290722,0.205817943639713,0.254363385649676,4.20583538977364e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAT,Linker for activation of T-cells family member 1,42754,0.143998505675003,0.00775819836719329,0.128792436875305,0.159204574474702,5.80679985907483e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCBP2,Poly(rC)-binding protein 2,40482,0.137520537556113,0.00741155513472823,0.122993889492046,0.152047185620181,9.90653045375579e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40449,0.207599893648603,0.0111911391953193,0.185665260825777,0.229534526471429,1.08255885692667e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40511,0.148576321195239,0.00801069877226636,0.132875351601597,0.164277290788881,1.12995321663681e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRELD1,Protein disulfide isomerase CRELD1,40283,0.0722762866496299,0.00389841924057667,0.0646353849380996,0.0799171883611601,1.35866465973114e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPL,N-acetylneuraminate lyase,40511,0.0869770687852031,0.00469481802396378,0.0777752254582341,0.0961789121121721,1.65199689412385e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGT1,Glutathione hydrolase 1 proenzyme,42590,0.0960163686293217,0.00518902480687908,0.0858458800078387,0.106186857250805,1.67667166743183e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RABEP1,Rab GTPase-binding effector protein 1,40283,0.148895416701612,0.00804003091416604,0.133136956109847,0.164653877293377,1.97087911373221e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP43,Centrosomal protein 43,42255,0.131298435303576,0.00711205848098648,0.117358800680842,0.145238069926309,3.80571641407681e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40451,0.135859634296639,0.00735425961613641,0.121445285449011,0.150273983144266,4.31583187816352e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40223,0.13049721175351,0.00706537302366143,0.116649080627134,0.144345342879886,4.85100282828802e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CMIP,C-Maf-inducing protein,40451,0.157434993867881,0.00852545418298772,0.140725103669225,0.174144884066537,4.90642908720775e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINH1,Serpin H1,40302,0.244995181559447,0.0132892167661003,0.21894831669789,0.271042046421003,8.82427600192557e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42495,0.179703299674634,0.00976450887748007,0.160564862274773,0.198841737074495,1.03492263455003e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLIN1,Perilipin-1,42311,0.0662724643386646,0.00360151870115662,0.0592134876843976,0.0733314409929315,1.11417298997748e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLSCR3,Phospholipid scramblase 3,40457,0.109915718506734,0.00597080586667637,0.0982129390080483,0.12161849800542,1.37801831594546e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42587,0.145069583668515,0.0078976536985299,0.129590182419397,0.160548984917634,1.91540436317399e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,METAP2,Methionine aminopeptidase 2,42689,0.107819530504317,0.00587386399092778,0.0963067570820983,0.119332303926535,2.37688588526401e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,40483,0.120155895364606,0.00654988883070489,0.107318113256424,0.132993677472787,4.31762664697872e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42657,0.193784258563971,0.0106071830218403,0.172994179841164,0.214574337286778,1.12860288904465e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AAMDC,Mth938 domain-containing protein,40223,0.100156248920149,0.00547836595104224,0.0894186516561067,0.110893846184192,1.39497994563469e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STK11,Serine/threonine-protein kinase STK11,42357,0.135915732384145,0.00745851853501451,0.121297036055517,0.150534428712773,2.69852976561882e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOA2,Apolipoprotein A-II,40532,-0.0925718825115647,0.00507565577187035,-0.102520167824431,-0.0826235971986988,2.84102232899441e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NSFL1C,NSFL1 cofactor p47,42711,0.121696100461989,0.0066841841162225,0.108595099594192,0.134797101329785,3.4217554104407e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SRP14,Signal recognition particle 14 kDa protein,42587,0.111165104634468,0.00611172623039388,0.0991861212228962,0.12314408804604,4.7811631871798e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HEXIM1,Protein HEXIM1,42594,0.151199287602627,0.00831557920312868,0.134900752364495,0.167497822840759,5.33067961146442e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCTN3,Tectonic-3,40511,0.0562764860067794,0.00309325272080395,0.0502137106740037,0.0623392613395552,6.3544377925615e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT18,"Keratin, type I cytoskeletal 18",42587,0.151200534819137,0.00832478941823716,0.134883947559392,0.167517122078882,7.61179937378465e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,42448,0.041025020386396,0.00226099023224992,0.0365934795311862,0.0454565612416059,1.06947216403027e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THOP1,Thimet oligopeptidase,42571,0.0577773860910257,0.00318555542511739,0.0515336974577956,0.0640210747242558,1.19775775902621e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNX15,Sorting nexin-15,40283,0.101279523773831,0.00559061021035369,0.090321927761538,0.112237119786124,2.61601912791787e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42357,0.175737066120187,0.00972073708538772,0.156684421432827,0.194789710807547,3.50165763596949e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAMBP,STAM-binding protein,42476,0.117766511986289,0.00651615843301823,0.104994841457573,0.130538182515005,3.7970462106769e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASAH2,Neutral ceramidase,42495,0.0998741898806459,0.00553072768697044,0.0890339636141839,0.110714416147108,4.93171111838149e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,40449,0.110730247268844,0.00612842100170915,0.0987185421054939,0.122741952432194,5.85882109119107e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AP3B1,AP-3 complex subunit beta-1,40449,0.142260225368945,0.00787431120508,0.126826575406988,0.157693875330901,6.06301961579497e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL18A1,Collagen alpha-1(XVIII) chain,42692,0.0452317845876561,0.00250717283729194,0.0403177258265639,0.0501458433487483,6.48586963607326e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42476,0.206606490401384,0.0114560100802163,0.18415271064416,0.229060270158608,7.4627083532694e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42636,-0.215150052657941,0.0119318296722056,-0.238536438815464,-0.191763666500418,7.71121660815432e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,USO1,General vesicular transport factor p115,42587,0.166963852197728,0.00926892839293617,0.148796752547573,0.185130951847883,1.07299490798309e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EGLN1,Egl nine homolog 1,42594,0.103126908091409,0.00572627466241464,0.0919034097530761,0.114350406429741,1.14747796327317e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJB6,DnaJ homolog subfamily B member 6,40183,0.155335962391108,0.00861600778900351,0.138448587124661,0.172223337657554,1.24144243096747e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSO,Cathepsin O,42754,0.0571534745840653,0.0031746097208861,0.0509312395311286,0.0633757096370021,1.24968077936206e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OGFR,Opioid growth factor receptor,42587,0.0604069536641331,0.00335696737531226,0.0538272976085211,0.0669866097197452,1.49430568709664e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VEGFC,Vascular endothelial growth factor C,42679,0.103041445187328,0.00572928772828264,0.0918120412398944,0.114270849134762,1.74271950493033e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NIT2,Omega-amidase NIT2,40462,0.135072404732518,0.00753149487777774,0.120310674772074,0.149834134692962,6.13616040923975e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SELE,E-selectin,42794,0.0938063690001385,0.00524175103575614,0.0835325369700565,0.104080201030221,8.20478329313297e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,42346,0.116046595664997,0.00648353635188844,0.103338864415296,0.128754326914699,8.33729803872119e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH2,Cadherin-2,42636,0.065631372789144,0.00366956435293307,0.0584390266573951,0.0728237189208928,1.010796910925e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PXN,Paxillin,42311,0.0942957435308196,0.00527767699216831,0.0839514966261697,0.104639990435469,1.46124420065903e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINE1,Plasminogen activator inhibitor 1,42794,0.121624506777049,0.00681233831537732,0.10827232367891,0.134976689875189,1.72558117435187e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGCC,Regulator of cell cycle RGCC,40482,0.138811251062172,0.00776795875193004,0.123586051908389,0.154036450215955,1.8890605285749e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNMBP,Dynamin-binding protein,42495,0.110441960014376,0.00618756244426966,0.0983143376236072,0.122569582405144,1.94614907434184e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40449,0.18877427194295,0.0105797787950408,0.16803790550467,0.20951063838123,3.03167782042116e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAS6,Growth arrest-specific protein 6,42718,-0.0466813187852663,0.00262039430060334,-0.0518172916144489,-0.0415453459560838,3.44365277089334e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP5,Fatty acid-binding protein 5,42678,0.124149936775678,0.00697945203795605,0.110470210781284,0.137829662770072,5.51618250947772e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCXR,L-xylulose reductase,42679,0.0964453450428605,0.00542534020824945,0.0858116782346915,0.107079011851029,6.6917059124088e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PHACTR2,Phosphatase and actin regulator 2,40482,0.207827584869971,0.0116784050772857,0.184937910918491,0.230717258821451,6.82538682577232e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SYTL4,Synaptotagmin-like protein 4,40511,0.135252284713832,0.00760168541776412,0.120352981295015,0.15015158813265,7.21064356449408e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GMPR,GMP reductase 1,42754,0.0905593605024362,0.00509649558260175,0.0805702291605368,0.100548491844336,7.6004043995335e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH2D1A,SH2 domain-containing protein 1A,42594,0.105995525203411,0.00596567313598681,0.0943028058568773,0.117688244549946,7.95313356053422e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTDH,Protein LYRIC,40199,0.172069130339361,0.00967588639635146,0.153104393002512,0.19103386767621,8.97537475572398e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1R2,Interleukin-1 receptor type 2,42600,0.0364687982833448,0.00205690005718359,0.032437274171265,0.0405003223954247,1.52821702675978e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGSF3,Immunoglobulin superfamily member 3,42587,0.066296255678496,0.00374042769797742,0.0589650173904603,0.0736274939665318,1.69132626429009e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEP1A,Meprin A subunit alpha,40449,0.132729711790021,0.00748088412169686,0.118067178911496,0.147392244668547,1.73284183373614e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40511,0.115566609074778,0.00651534314023024,0.102796536519927,0.128336681629629,1.8645871308633e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,40283,0.129631318406618,0.00731371721376936,0.11529643266763,0.143966204145606,2.44722294032791e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIT1,ARF GTPase-activating protein GIT1,40199,0.176864428993446,0.00998299176823768,0.1572977651277,0.196431092859192,2.84855686725663e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPB2,Carboxypeptidase B2,40516,0.0405908081214595,0.00229178609703737,0.0360989073712663,0.0450827088716528,2.93005130387816e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,40449,0.164828330532889,0.00930708772465109,0.146586438592573,0.183070222473205,3.04237822319935e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM5,Tripartite motif-containing protein 5,42594,0.155679566849141,0.00880222632759023,0.138427203247064,0.172931930451218,3.25970995303591e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PON2,Serum paraoxonase/arylesterase 2,42357,0.0637386210891039,0.00361533676703025,0.0566525610257246,0.0708246811524832,8.92013721040375e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH2B3,SH2B adapter protein 3,42346,0.176992714437675,0.0100444965701344,0.157305501160212,0.196679927715139,1.04722460583509e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,42357,0.16785694355067,0.00954169183473124,0.149155227554597,0.186558659546743,1.72228748636025e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL5,C-X-C motif chemokine 5,42605,0.205569599766736,0.0116915038047252,0.182654252309475,0.228484947223997,1.95081780741103e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAGK,N-acetyl-D-glucosamine kinase,40209,0.101154255244318,0.00574688283381572,0.0898903648900388,0.112418145598596,2.0611136857016e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ST13,Hsc70-interacting protein,40283,0.101812958669983,0.00581695456147757,0.0904117277294871,0.113214189610479,1.10422837315469e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGF,Placenta growth factor,42754,0.0480107273968876,0.00275120068021249,0.0426183740636711,0.0534030807301041,1.849268089244e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,42311,0.0921694262804709,0.00528350182578901,0.0818137627019245,0.102525089859017,2.17052436452907e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALDH1A1,Retinal dehydrogenase 1,42611,0.0963095825021901,0.00553601718541992,0.0854589888187671,0.107160176185613,4.73172655654143e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARSB,Arylsulfatase B,42587,0.0987047936373444,0.00567575311327415,0.087580317535327,0.109829269739362,5.28464053029991e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BID,BH3-interacting domain death agonist,42594,0.120499741672651,0.00693937180482102,0.106898572935202,0.1341009104101,8.22000530381054e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MME,Neprilysin,42587,0.145667239113527,0.00839165657512642,0.129219592226279,0.162114886000775,9.12298176532961e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYN,Tyrosine-protein kinase Lyn,42587,0.150125941735463,0.00865620912974898,0.133159771841155,0.167092111629771,1.18636190540979e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AZI2,5-azacytidine-induced protein 2,40482,0.0985585205238397,0.00567872596134364,0.0874282176396062,0.109688823408073,1.30251602492917e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42587,0.0793912135251302,0.00458423882361535,0.0704061054308441,0.0883763216194163,1.8104201028615e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NIT1,Deaminated glutathione amidase,40223,0.0849380066473672,0.00490105302265377,0.0753319427229659,0.0945440705717686,2.0890245595142e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLB1,Beta-galactosidase,42495,0.0740124906365604,0.00427643547364797,0.0656306771082103,0.0823943041649104,2.21654100829095e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,42594,0.0698368949259897,0.00403722990492107,0.0619239243123444,0.077749865539635,2.54397154769531e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SFRP4,Secreted frizzled-related protein 4,40283,0.0719017657477446,0.00416324836526075,0.0637417989518335,0.0800617325436557,5.69480502366131e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OPHN1,Oligophrenin-1,40483,0.19026726828671,0.0110214841630264,0.168665159327179,0.211869377246242,6.22129234505219e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SKAP2,Src kinase-associated phosphoprotein 2,42676,0.184992018529159,0.0107488490265071,0.163924274437205,0.206059762621113,1.11478810208892e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42651,0.103665625713418,0.00602721394251601,0.0918522863860869,0.11547896504075,1.34206397647046e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42636,0.0489694840586603,0.00285975935264576,0.0433643557274747,0.054574612389846,4.83481524254134e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOF,Apolipoprotein F,40532,-0.0421835181934799,0.0024625649899415,-0.0470101455737652,-0.0373568908131946,5.81414341809692e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDT5,ADP-sugar pyrophosphatase,42611,0.0892566330507066,0.00521585430601759,0.0790335586109121,0.099479707490501,5.8411387830976e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40482,0.136575208999263,0.00798673359318424,0.120921211156622,0.152229206841904,9.62934751606683e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACE2,Angiotensin-converting enzyme 2,42357,0.0947780904286906,0.00554872480615992,0.0839025898086172,0.105653591048764,1.02143841343241e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40482,0.140250981250113,0.00820503639862369,0.124169109908811,0.156332852591415,1.08212914791712e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,42611,0.0411417840058496,0.00240950746507024,0.0364191493743119,0.0458644186373873,1.10158074777115e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMN,Protein amnionless,42370,0.083198318797161,0.00487285097935022,0.0736475308776345,0.0927491067166874,1.15087037406713e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40030,0.0589184950655552,0.00345011380697895,0.0521562720038765,0.0656807181272339,1.5265773478862e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,42346,0.110386364242286,0.00647191532236885,0.0977014102104433,0.123071318274129,1.5508979461808e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40449,0.156451194261053,0.00916570402818593,0.138486414365808,0.174415974156297,1.62690632926857e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,42311,0.0507030786145276,0.00297576732882375,0.044870574650033,0.0565355825790221,2.08929341970984e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42711,-0.0831235929403638,0.00488002866361707,-0.0926884491210532,-0.0735587367596743,2.17691068261727e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNST,Consortin,42636,0.190635604870963,0.0111957067420027,0.168692019656638,0.212579190085289,2.4216065437333e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DLK1,Protein delta homolog 1,42794,0.0968885060808489,0.00569257987900715,0.0857310495179948,0.108045962643703,2.69342383144248e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,QDPR,Dihydropteridine reductase,42581,0.0745982944807942,0.00438837526676858,0.0659970789579277,0.0831995100036606,3.92303295703673e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYDGF,Myeloid-derived growth factor,40511,0.172138914767532,0.0101289722595445,0.152286129138825,0.19199170039624,5.57248108256752e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM13A,Protein FAM13A,40449,0.118005836718516,0.00694458585989592,0.10439444843312,0.131617225003912,5.83868793410484e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRAP,BRCA1-associated protein,40342,0.190867684055356,0.0112445650436246,0.168828336569852,0.21290703154086,8.04810934703506e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH3GLB2,Endophilin-B2,40483,0.116840918519715,0.00688537638388337,0.103345580807303,0.130336256232126,8.51882712502216e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC27,Cell division cycle protein 27 homolog,42346,0.105354673190983,0.00622192546066213,0.0931596992880855,0.117549647093881,1.21583591117527e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBPL,FK506-binding protein-like,40449,0.102418476691921,0.00604353219120667,0.0905731535971563,0.114263799786686,1.24701419909402e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EREG,Proepiregulin,42476,0.140584548144024,0.00831560686821454,0.124285958682323,0.156883137605724,1.86680209776025e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGBP1,Immunoglobulin-binding protein 1,40482,0.10650834849961,0.00629554909678265,0.0941690722699165,0.118847624729304,1.99761332854735e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MITD1,MIT domain-containing protein 1,42495,0.166943260642497,0.00988386898834881,0.147570877425334,0.186315643859661,2.41467452043506e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRKL,Crk-like protein,42636,0.1823466805309,0.0107968798413638,0.161184796041827,0.203508565019973,2.44285378641331e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,40199,0.155169751249604,0.00918688968891459,0.137163447459332,0.173176055039877,3.30434798674794e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STIP1,Stress-induced-phosphoprotein 1,42586,0.11255770045409,0.00667344639622885,0.0994777455174817,0.125637655390699,3.5572616122949e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL32,Interleukin-32,42594,-0.0773617307132608,0.00458722069628524,-0.0863526832779799,-0.0683707781485418,3.66679382288379e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAG1,Dystroglycan,42676,0.0798364093769117,0.00473714647493392,0.0705516022860412,0.0891212164677822,4.38577825152242e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IST1,IST1 homolog,40375,0.171705896999636,0.0101860175086041,0.151741302682772,0.191670491316501,5.56894057563751e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CMC1,COX assembly mitochondrial protein homolog,40511,0.157342242836174,0.00933575964817682,0.139044153925747,0.175640331746601,5.75793100813406e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42569,0.133048400622622,0.00790425704311761,0.117556056818111,0.148540744427132,6.25801518261205e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRHBP,Corticotropin-releasing factor-binding protein,42618,0.0477038927865169,0.00283443586527431,0.0421483984905793,0.0532593870824545,6.47450176482625e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GOLGA3,Golgin subfamily A member 3,40482,0.136176525452732,0.00808629812625971,0.120327381125263,0.152025669780201,7.20357795316962e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42587,0.0764624840909967,0.00454861867876898,0.0675471914806095,0.085377776701384,9.0528731551996e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VWA1,von Willebrand factor A domain-containing protein 1,42689,0.0716624764587114,0.00426376712338397,0.0633054928968788,0.080019460020544,9.36661614650854e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TAX1BP1,Tax1-binding protein 1,40483,0.109585534372323,0.00652633030313705,0.0967939269781745,0.122377141766472,1.61656130198054e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,40302,0.0914821614353029,0.00545295866595526,0.0807943624500306,0.102169960420575,2.11586309298239e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GMPR2,GMP reductase 2,40283,0.116527467284599,0.00694950985848322,0.102906427961972,0.130148506607226,2.4554097710583e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCN2,CCN family member 2,42624,0.0954087956797577,0.0056971789560049,0.0842423249259881,0.106575266433527,2.5640445638087e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL17,C-C motif chemokine 17,42604,0.158568839932357,0.00947118294050941,0.140005321368959,0.177132358495756,2.76394832623855e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEC31A,Protein transport protein Sec31A,40223,0.132637995724528,0.00791756882420537,0.117119560829085,0.14815643061997,3.18888796138859e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMOT,Angiomotin,40283,0.0670733447349195,0.00400592404505959,0.0592217336066027,0.0749249558632363,3.65074937298885e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ELOA,Elongin-A,42587,0.0925205989424256,0.00553793582360695,0.0816662447281559,0.103374953156695,4.96748689885183e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,40482,0.115815147421125,0.00692691450010754,0.102238395000914,0.129391899841335,5.24323327682162e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MUC13,Mucin-13,42311,0.0901672876506262,0.00540127830672278,0.0795807821694496,0.100753793131803,6.33585576807591e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMAD5,Mothers against decapentaplegic homolog 5,42587,0.0346165517668574,0.00207481696905264,0.0305499105075142,0.0386831930262006,7.19207802401245e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBCC,Tubulin-specific chaperone C,42495,0.137807928762631,0.00828079172448699,0.121577576982636,0.154038280542625,1.45148730106147e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL13,C-C motif chemokine 13,42734,0.118761696705613,0.0071432637511615,0.104760899753337,0.13276249365789,1.8449573647511e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42754,0.0439116942970814,0.00264279256978399,0.0387318208603047,0.049091567733858,2.16993751653051e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GASK1A,Golgi-associated kinase 1A,40116,0.0744915535685501,0.00447968967617262,0.0657113618032518,0.0832717453338485,2.44360562535805e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DBNL,Drebrin-like protein,42676,0.157110591983392,0.00946011334308656,0.138568769830942,0.175652414135841,2.4908930341213e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRAF2,TNF receptor-associated factor 2,42594,0.11913419180276,0.00717894071053423,0.105063468010113,0.133204915595407,3.09242736307702e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42346,0.0747911304956323,0.0045117095674302,0.0659481797434691,0.0836340812477954,4.24593462426459e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COMMD1,COMM domain-containing protein 1,40223,0.103525355276526,0.0062392777078634,0.0912963709691139,0.115754339583938,4.33103129505636e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42594,0.17181012002061,0.0103769990531036,0.151471201876527,0.192149038164693,5.75792882652843e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGAP45,Rho GTPase-activating protein 45,40283,0.140744905718874,0.00849987151971366,0.124085157540236,0.157404653897513,7.45921446972856e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL5,C-C motif chemokine 5,42689,0.170140555778824,0.0102894037688288,0.14997332439192,0.190307787165729,8.06664112169429e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAG4,BAG family molecular chaperone regulator 4,40199,0.0836071752661994,0.00506218124958258,0.0736853000170176,0.0935290505153813,1.50190910235621e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40449,0.0884025895193941,0.00535475265716373,0.0779072743113532,0.098897904727435,1.61774496560059e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,42594,0.134286350096863,0.00814396273355631,0.118324183139092,0.150248517054633,1.73173755683063e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40302,0.179231843181894,0.0108751900823947,0.1579164706204,0.200547215743387,2.61421559083251e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42346,0.131565094221842,0.00799092665405123,0.115902877979901,0.147227310463782,2.65316711966755e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,40116,0.105437934922773,0.00640069595369338,0.0928925708535344,0.117983298992012,3.05339583407195e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GOLM2,Protein GOLM2,42711,0.039221557656625,0.00238702678958542,0.0345429851490376,0.0439001301642124,4.37404173113363e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB27B,Ras-related protein Rab-27B,40511,0.13978146886553,0.00850431528171033,0.123113010913378,0.156449926817683,5.18200283327289e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS9,Galectin-9,42620,0.0547527107382609,0.00333692492891055,0.0482123378775962,0.0612930835989256,6.39962861898047e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GORASP2,Golgi reassembly-stacking protein 2,40449,0.0796183175640727,0.00485466474464628,0.0701031746645659,0.0891334604635794,9.35399400542033e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIAE,Sialate O-acetylesterase,42646,0.0776041202700715,0.00474146782210364,0.0683108433387483,0.0868973972013946,1.23697988009895e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHSG,Alpha-2-HS-glycoprotein,40532,0.0459461493051109,0.00280741564372181,0.0404436146434161,0.0514486839668056,1.60638461706113e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBXN1,UBX domain-containing protein 1,40283,0.11554727778777,0.00706217107595211,0.101705422478904,0.129389133096636,1.78913144592894e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADD1,Alpha-adducin,40283,0.12011463857974,0.00734891947970177,0.105710756399525,0.134518520759956,2.34601405347074e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUOM,Fucose mutarotase,40283,0.106936262230569,0.00654288552329109,0.0941122066049188,0.11976031785622,2.36985483440458e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GZMA,Granzyme A,42754,0.0598910149398468,0.00367965114175806,0.052678898702001,0.0671031311776926,5.26804016787633e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,40169,0.0828888954922815,0.00508816177951516,0.0729160984044318,0.0928616925801312,5.65409932974892e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DGKA,Diacylglycerol kinase alpha,40199,0.0917472327682146,0.00565275980842797,0.0806678235436958,0.102826641992733,1.46541024167448e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40283,0.0966972210066589,0.00596689223599184,0.0850021122241149,0.108392329789203,2.15190511810725e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAT2,Signal transducer and activator of transcription 2,40199,0.127281895130874,0.0078561832929109,0.111883775876769,0.142680014384979,2.32471886217306e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,42583,0.0552201382200917,0.00341313589130249,0.0485303918731388,0.0619098845670446,2.54425682643939e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42594,0.119196648426792,0.00736991445623801,0.104751616092565,0.133641680761018,2.76551855176268e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42346,0.0855315239105377,0.0052880212853817,0.0751670021911896,0.0958960456298858,2.7793995178882e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40451,0.0802404923509855,0.0049569539474759,0.0705248626139327,0.0899561220880383,2.80749944392537e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CES2,Cocaine esterase,42587,0.0917002104884687,0.00567924570443206,0.0805688889077819,0.102831532069156,4.24311241966299e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40482,0.179318622393032,0.0111130408582909,0.157537062310782,0.201100182475282,6.33544374647442e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42370,0.0770853322774496,0.00478281157821465,0.0677110215841489,0.0864596429707503,6.90678254324932e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMP3,Metalloproteinase inhibitor 3,42676,0.216875659571744,0.0134636027162551,0.190486998247884,0.243264320895604,7.72642817493501e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",40267,0.141312494509006,0.00876571975515351,0.124131683788905,0.158493305229107,8.24275787112231e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40482,0.10969980918804,0.00680973868318713,0.0963527213689928,0.123046897007086,9.65309774560775e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDHD2,Phospholipase DDHD2,40482,0.109054297040991,0.00677356509232821,0.0957781094600274,0.122330484621954,1.11758411157906e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIGYF2,GRB10-interacting GYF protein 2,40482,0.125117272130668,0.00777164411357241,0.109884849668066,0.14034969459327,1.13148798984221e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,42587,0.191813876267361,0.0119252547089525,0.168440377037814,0.215187375496908,1.13264372074604e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUS,RNA-binding protein FUS,42336,0.0661937240900741,0.0041190440928326,0.0581203976681222,0.074267050512026,1.45888124783107e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL3,C-C motif chemokine 3,42594,0.0957319376733356,0.00595794359509832,0.0840543682269429,0.107409507119728,1.4751506248509e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42587,0.145390092236001,0.0090743764383002,0.127604314416933,0.16317587005507,3.04892829695339e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASC3,Protein CASC3,40182,0.0695509069562643,0.00434164561782111,0.0610412815453349,0.0780605323671937,4.13284747033698e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HS1BP3,HCLS1-binding protein 3,40223,0.146537924991259,0.00914906701979512,0.128605753632461,0.164470096350058,4.29352034891997e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATXN2L,Ataxin-2-like protein,40482,0.0797647520148726,0.00498970906805241,0.0699849222414898,0.0895445817882553,6.74145567123213e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,42370,0.0992909618387132,0.00621765797044941,0.0871043522166323,0.111477571460794,7.15129888607602e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CIRBP,Cold-inducible RNA-binding protein,40449,0.156604241575325,0.00981151909988731,0.137373664139546,0.175834819011104,9.95406234153215e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17RB,Interleukin-17 receptor B,42416,-0.0883000783544844,0.00554020149257617,-0.0991588732799337,-0.0774412834290351,1.16137794738693e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS8,Galectin-8,42711,0.0985116346605266,0.00618507484770649,0.0863888879590219,0.110634381362031,1.33933854975021e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOD,Apolipoprotein D,40033,-0.072081557001889,0.00452107531576408,-0.0809428646207866,-0.0632202493829914,1.38840763275152e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42611,0.100270339636277,0.00629954942235092,0.0879232227684688,0.112617456504084,1.58675826257689e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40449,0.239670038132201,0.0150481517223687,0.210175660756359,0.269164415508044,1.70516709327974e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OGA,Protein O-GlcNAcase,40449,0.115236763120995,0.00723665595316089,0.1010529174528,0.12942060878919,1.7826012735789e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TWF2,Twinfilin-2,40527,0.136386590449674,0.00857380904308015,0.119581924725237,0.153191256174112,2.29149418127535e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDGFB,Platelet-derived growth factor subunit B,42676,0.140258551310359,0.00883539532917306,0.12294117646518,0.157575926155538,3.06761974138961e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FMNL1,Formin-like protein 1,42311,0.101639318706078,0.00640261570554274,0.0890901919232145,0.114188445488942,3.16633001733292e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WASHC3,WASH complex subunit 3,40483,0.122735784693846,0.00773660407113037,0.10757204071443,0.137899528673261,4.50963438277375e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COCH,Cochlin,40511,0.0769598452001671,0.00485336546142366,0.0674472488957767,0.0864724415045575,5.03488491696355e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATXN3,Ataxin-3,40483,0.102075545948716,0.00643794377707423,0.0894571761456501,0.114693915751781,5.18779306529731e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASE4,Ribonuclease 4,40169,0.0480260930406602,0.00302884668856742,0.042089553531068,0.0539626325502523,5.31766164153366e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42611,0.0740891694687631,0.00468161898603359,0.0649131962561373,0.083265142681389,6.63988677864289e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1S,Complement C1s subcomponent,40539,0.0341094067898522,0.00215454597876761,0.0298864966714677,0.0383323169082367,7.47849116183588e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSPA1A,Heat shock 70 kDa protein 1A,42658,0.114460770016424,0.0072363151299227,0.100277592361775,0.128643947671072,7.49146608573846e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDLIM5,PDZ and LIM domain protein 5,40482,0.190903303096695,0.0120630121623987,0.167259799258394,0.214546806934997,8.2477382489384e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RWDD1,RWD domain-containing protein 1,42711,0.102474576137991,0.0064995346620715,0.0897354882003307,0.115213664075651,1.65237906962087e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBC1D23,TBC1 domain family member 23,42587,0.145605616016535,0.00924752669303766,0.127480463698182,0.163730768334889,2.31678391975701e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40209,0.129963115177836,0.00825196793353831,0.113789258028101,0.146136972327571,2.77735790677905e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPART,Spartin,40283,0.124654868495007,0.00791602868325733,0.109139452275823,0.140170284714192,2.84743373905358e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD36,Platelet glycoprotein 4,40199,0.0730072846023605,0.00463683985444227,0.0639190784876536,0.0820954907170673,2.9717964688322e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNLR1,Interferon lambda receptor 1,42594,0.0593607945087614,0.00377460299120593,0.0519625726459977,0.066759016371525,3.10858893129177e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VAMP8,Vesicle-associated membrane protein 8,40199,0.143246060217606,0.00910224828144983,0.125405653585964,0.161086466849247,3.34298338536103e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PARP1,Poly [ADP-ribose] polymerase 1,42594,0.0946373416828409,0.00602831295748372,0.0828218482861728,0.106452835079509,4.76377903194265e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40451,0.133313228059385,0.00848534544109656,0.116681950994835,0.149944505123934,4.87826789029363e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLT4,Vascular endothelial growth factor receptor 3,42679,0.0536592466666734,0.00341855348682217,0.0469588818325019,0.0603596115008448,4.90436515570681e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDH9,Protocadherin-9,40449,0.0561068966733491,0.00357169837503763,0.0491063678582753,0.0631074254884228,5.05197117494477e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TALDO1,Transaldolase,40499,0.071461218610215,0.00455811332687586,0.0625273164895383,0.0803951207308917,8.09298926642967e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSNK2A1,Casein kinase II subunit alpha,40482,-0.0727039244772244,0.00464480547005695,-0.0818077431985361,-0.0636001057559128,1.19277395682684e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGA5,Integrin alpha-5,42611,0.0405444859795148,0.00259273081422177,0.0354627335836401,0.0456262383753894,1.22177072445262e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1RL2,Interleukin-1 receptor-like 2,42370,0.0625792008467774,0.00400291361828321,0.0547334901549423,0.0704249115386125,1.3327747533425e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IMPACT,Protein IMPACT,40483,0.0906451847456575,0.00579703198464943,0.0792830020557447,0.10200736743557,1.53128251922676e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLXNB3,Plexin-B3,42597,0.0756726310366924,0.00484440145316227,0.0661776041884943,0.0851676578848904,1.59243391088364e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPTL7,Angiopoietin-related protein 7,42721,0.0588386211832654,0.00377089241397138,0.0514476720518815,0.0662295703146493,2.05677256058048e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,40451,0.141443487287962,0.00906032571006732,0.12368524889623,0.159201725679694,2.26234519177413e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD5,T-cell surface glycoprotein CD5,42706,0.0582565890537697,0.00373920798501063,0.0509277414031488,0.0655854367043905,2.95297905088953e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",42676,0.176434944787189,0.0113334202140126,0.154221441167725,0.198648448406654,3.57330993657863e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42495,0.0701228788892572,0.0045146098774891,0.0612742435293786,0.0789715142491358,6.22411031917297e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F13B,Coagulation factor XIII B chain,40479,0.0417046795863184,0.00268356628185488,0.0364448896738828,0.0469644694987539,6.64010686868906e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TP53,Cellular tumor antigen p53,42346,0.0692296939046863,0.00445926322927959,0.0604895379752983,0.0779698498340743,7.06898372233384e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM24,Transcription intermediary factor 1-alpha,40287,0.104334882454066,0.00671593146521599,0.0911716567822428,0.11749810812589,7.36359874350666e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT5,"Keratin, type II cytoskeletal 5",42311,0.0825088623360904,0.00532440227449569,0.0720730338780789,0.092944690794102,1.09720886330016e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AP2B1,AP-2 complex subunit beta,40182,0.0775301070612681,0.00500702006054444,0.067716347742601,0.0873438663799352,1.62541811627644e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MFAP5,Microfibrillar-associated protein 5,42794,0.0657813761674229,0.004264129701353,0.057423681952771,0.0741390703820747,3.05706629291335e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MPHOSPH8,M-phase phosphoprotein 8,42357,0.12010096066835,0.00779181663271239,0.104829000068234,0.135372921268466,3.8516556447257e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TDRKH,Tudor and KH domain-containing protein,42311,0.134772145526632,0.00874527988304291,0.117631396955868,0.151912894097396,4.03933039556653e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNCG,Gamma-synuclein,42495,0.109826248408764,0.00713898925942564,0.0958338294602899,0.123818667357238,5.98433763507901e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GTPBP2,GTP-binding protein 2,40182,0.128701475934056,0.00835965301677133,0.112316556021184,0.145086395846928,6.24773028670293e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42654,0.134937346980216,0.00879468240947009,0.117699769457654,0.152174924502777,1.09978695954177e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42346,0.129503016691196,0.00845064785669379,0.112939746892076,0.146066286490316,1.48847070879372e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLOD4,Glyoxalase domain-containing protein 4,42602,0.0553685788836603,0.00361386691292669,0.048285399734324,0.0624517580329966,1.53828670032016e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIA1,Nucleolysin TIA-1 isoform p40,42190,0.191073207752655,0.0124857847736619,0.166601069596278,0.215545345909033,2.08110962981815e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42679,0.113639580548694,0.00743023620879693,0.0990763175794521,0.128202843517936,2.29767378685559e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40451,0.0604021113212149,0.00395260925998238,0.0526549971716495,0.0681492254707804,3.38480803713234e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOXJ3,Forkhead box protein J3,40199,0.069150618748307,0.0045275236699277,0.0602766723552487,0.0780245651413653,3.93373613616651e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,42594,0.163946958954241,0.0107448615984171,0.142887030221343,0.185006887687139,3.98124830908904e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DOK1,Docking protein 1,40483,0.214186519243236,0.0140490013285114,0.186650476639354,0.241722561847119,5.78430257877959e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DLG4,Disks large homolog 4,40483,0.110424322206544,0.00724706059848276,0.0962200834335178,0.12462856097957,6.57639076181549e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNPY4,Protein canopy homolog 4,42587,0.116346269516408,0.00765246798870804,0.10134743225854,0.131345106774275,9.02759527903419e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",42611,0.120107891696679,0.00790169410802578,0.104620571244949,0.13559521214841,9.49588821963655e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GHRL,Appetite-regulating hormone,42636,0.133599227970056,0.00880769091994854,0.116336153766957,0.150862302173155,1.52679497408867e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUSD1,Sushi domain-containing protein 1,42357,0.0773054365306171,0.00510194340684861,0.0673056274531938,0.0873052456080404,1.98962669901145e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJB2,DnaJ homolog subfamily B member 2,40283,0.0844237043636337,0.00557157168494775,0.0735034238611361,0.0953439848661313,2.37675112780332e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UROD,Uroporphyrinogen decarboxylase,40283,0.107872734373656,0.00712968328545613,0.0938985551341621,0.12184691361315,3.32307370457004e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YWHAQ,14-3-3 protein theta,40283,0.114862866757197,0.00760064934888425,0.0999655940333834,0.12976013948101,4.33363324532008e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP10,Stromelysin-2,42608,-0.0920518680902159,0.00609663919425491,-0.104001280910955,-0.0801024552694762,4.33432546657083e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TP53I3,Quinone oxidoreductase PIG3,40058,0.0830343014832769,0.00550204643524172,0.0722502904702032,0.0938183124963507,6.03767665425953e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DFFA,DNA fragmentation factor subunit alpha,42754,0.104167176285345,0.0069113486410821,0.090620932948824,0.117713419621866,6.40387978838063e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICA1,Islet cell autoantigen 1,42370,0.122697767378873,0.00814509356172472,0.106733383997892,0.138662150759853,7.40153408014228e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBM17,Splicing factor 45,40482,0.119104364692245,0.00790170340502655,0.103617026018393,0.134591703366097,7.57927984180935e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,40483,0.0577288220449457,0.00383541683569354,0.0502114050469863,0.065246239042905,1.046173445935e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R2,Protein phosphatase inhibitor 2,42636,0.122145613020399,0.00814045118141444,0.106190328704826,0.138100897335971,1.75022931955301e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,42620,0.0764913246166386,0.00510145305725851,0.0664924766244119,0.0864901726088653,2.05456710974719e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VEGFA,Vascular endothelial growth factor A,42716,0.0907987533052781,0.00606461572107892,0.0789121064919635,0.102685400118593,2.83257694107629e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",42357,0.142982379793773,0.00956031710852178,0.12424415826107,0.161720601326476,3.6827863341326e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDC,Nuclear migration protein nudC,42754,0.0959362785661735,0.00641557459186106,0.0833617523661258,0.108510804766221,3.69961597861615e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YJU2,Splicing factor YJU2,40451,0.0502860029942943,0.00336092150668079,0.0436985968412,0.0568734091473887,3.941275693816e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42587,0.0587333639376074,0.00392927270160729,0.0510319894424571,0.0664347384327577,4.08923173370409e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LPP,Lipoma-preferred partner,40116,0.101768150029808,0.0068183812954161,0.0884041226907927,0.115132177368824,6.96299844249638e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL3,C-X-C motif chemokine 3,42620,0.143790867867185,0.00964412890389451,0.124888375215551,0.162693360518818,7.14251090988778e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,40182,0.107428288734496,0.00720137983679644,0.0933135842543753,0.121542993214617,7.75869967428882e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40482,0.0746169201537355,0.00501973517184356,0.0647782392169221,0.0844556010905489,1.63991642890867e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40302,0.101341819004153,0.00681740517520815,0.0879797048607451,0.114703933147561,1.65751477069738e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAVS,Mitochondrial antiviral-signaling protein,42346,0.1394073274929,0.00939300336163151,0.120997040904103,0.157817614081698,1.97906043342078e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSZ,Cathepsin Z,42648,0.0494679988869669,0.00334236908516917,0.0429169554800353,0.0560190422938985,3.55254422182193e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL18,Interleukin-18,42566,0.0712477671973509,0.00481464845244158,0.0618110562305654,0.0806844781641364,3.68619132602677e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42346,0.129414588698607,0.00874520415248565,0.112273988559735,0.146555188837479,3.72888383287343e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL11,Eotaxin,42754,0.0562693544883453,0.00380557463323482,0.0488104282072051,0.0637282807694856,4.34542327236136e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHMP1A,Charged multivesicular body protein 1a,42495,0.120763817456579,0.00816932878882514,0.104751933030481,0.136775701882676,4.64793656529597e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXNDC5,Thioredoxin domain-containing protein 5,42711,0.102273696058966,0.00692069121448512,0.0887091412785749,0.115838250839357,4.90313461903609e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP6AP2,Renin receptor,42346,0.0618878269489819,0.00418919652079557,0.0536770017682226,0.0700986521297412,5.38481123488615e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF19,Fibroblast growth factor 19,42676,0.118786491729815,0.00804284719775976,0.103022511222206,0.134550472237424,5.58415708815052e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCGB3A2,Secretoglobin family 3A member 2,42654,-0.133299352264925,0.00902709659451408,-0.150992461590173,-0.115606242939677,5.81083885942961e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NT5E,5'-nucleotidase,42679,0.0866098415203459,0.00587100148733207,0.075102678605175,0.0981170044355167,7.16206292979153e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,40223,0.0487888148285774,0.00330963511174143,0.0423019300095642,0.0552756996475906,1.0143563455165e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GYS1,"Glycogen [starch] synthase, muscle",42357,0.140696070267029,0.00955733711580746,0.121963689520047,0.159428451014012,1.14697361622819e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,42711,0.0991382776009466,0.00673895785100792,0.085929920212971,0.112346634988922,1.29719850258559e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CETN3,Centrin-3,40449,0.115394551138954,0.00783911551419115,0.10002988473114,0.130759217546769,1.34901278304132e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMG3,Proteasome assembly chaperone 3,42594,0.0780401850216232,0.00531040038113783,0.0676318002745931,0.0884485697686534,1.6370349994983e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNM3,Dynamin-3,40482,0.0836131128929936,0.0056876104516861,0.0724653964076888,0.0947608293782983,1.7827217310714e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,42587,0.0854163724931766,0.00581776959781448,0.0740135440814602,0.096819200904893,1.99962649379693e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APPL2,DCC-interacting protein 13-beta,40283,0.168458473444769,0.0114825278109398,0.145952718935328,0.190964227954211,2.80541978859395e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,42346,0.0881745393880249,0.00602443388541511,0.0763666489726113,0.0999824298034385,3.94587556706011e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RTBDN,Retbindin,42587,0.0453748134271305,0.00310115621248492,0.03929654725066,0.0514530796036009,4.15100723009406e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VNN1,Pantetheinase,40532,0.110384685953184,0.00754406461943682,0.0955983192990875,0.12517105260728,4.80837509962051e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD244,Natural killer cell receptor 2B4,42754,0.0415485194730078,0.00284232836782382,0.0359775558720732,0.0471194830739425,5.01580311986096e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERMAP,Erythroid membrane-associated protein,40199,0.0679183400649761,0.00464376144942554,0.058816567624102,0.0770201125058501,5.42439560859986e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD207,C-type lectin domain family 4 member K,42365,0.0603493348417086,0.0041301737883763,0.0522541942164911,0.0684444754669262,5.60294070978376e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATG4A,Cysteine protease ATG4A,42346,0.0890105526072423,0.00610276961600903,0.0770491241598646,0.10097198105462,8.2285752257395e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40283,0.127389324057457,0.00873105788439376,0.110276450604045,0.144502197510869,8.95469412171519e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAX,Protein max,42311,0.158077901877323,0.010844703568593,0.13682228288288,0.179333520871765,9.35788013436573e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,42620,0.0854865066842236,0.0058664997572698,0.0739881671599748,0.0969848462084724,9.79559213911371e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBKS,Ribokinase,42317,0.0750480618516106,0.00515112897459029,0.0649518490614136,0.0851442746418075,1.03860088974018e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRSS2,Trypsin-2,42689,0.0843973943776064,0.00579538011390184,0.0730384493543588,0.095756339400854,1.11212764375708e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGAP25,Rho GTPase-activating protein 25,42346,0.0895711480511851,0.00615938184513258,0.0774987596347252,0.101643536467645,1.5292946162327e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUB1,NEDD8 ultimate buster 1,42594,0.125106267816986,0.00860506290595426,0.108240344521315,0.141972191112656,1.58453664542177e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HYOU1,Hypoxia up-regulated protein 1,42794,0.0348611146005822,0.00239797012961466,0.0301610931465375,0.039561136054627,1.58632684683564e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL7,C-C motif chemokine 7,42594,0.0892386002888795,0.00613892939012103,0.0772062986842423,0.101270901893517,1.63482099525166e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SULT2A1,Bile salt sulfotransferase,42594,0.0845374807331913,0.00582197830499332,0.0731264032554044,0.0959485582109782,2.06050860778193e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEXN,Nexilin,40532,0.103694858649555,0.0071378952009875,0.0897045840556193,0.11768513324349,2.16407643362258e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,A1BG,Alpha-1B-glycoprotein,40539,0.0256153798681738,0.00176333877811083,0.0221592358630766,0.029071523873271,2.18572588045084e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,40199,0.0855958112888214,0.00589651061163479,0.0740386504900172,0.0971529720876256,2.60919664505302e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40482,0.121066231425618,0.00834287845566014,0.104714189652524,0.137418273198712,2.7347897349478e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42295,0.0863368301292436,0.00595444833991364,0.0746661113830129,0.0980075488754743,2.83164426581479e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CST3,Cystatin-C,42659,0.0454360694336953,0.00313530415431841,0.0392908732912312,0.0515812655761593,3.09588799040796e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OTUD6B,Deubiquitinase OTUD6B,40449,0.0878354189844956,0.00606023025345483,0.0759573676877242,0.0997134702812671,3.52681728470485e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP4,"Fatty acid-binding protein, adipocyte",42794,0.0769894686882751,0.00531765180577101,0.066566871148964,0.0874120662275863,3.73540510444972e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM40,E3 ubiquitin ligase TRIM40,40182,0.10789179015566,0.00744747295035336,0.0932947431729678,0.122488837138353,3.97369712984264e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42307,0.116861788764885,0.00807417563905318,0.101036404512341,0.132687173017429,4.10797559621101e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRADD,Death domain-containing protein CRADD,42476,0.112156077993516,0.00775033630654534,0.0969654188326876,0.127346737154345,4.20715547028983e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MENT,Protein MENT,40283,-0.0348112640783539,0.00240548190721536,-0.0395260086164961,-0.0300965195402118,4.90630107917731e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ESYT2,Extended synaptotagmin-2,40483,0.123283001392964,0.00852114239984732,0.106581562289263,0.139984440496665,5.08697321713097e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKG1,cGMP-dependent protein kinase 1,40283,0.186189087471827,0.0128771594299086,0.160949854989206,0.211428319954448,5.88702282886339e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,42346,0.11302169649356,0.00783013597440887,0.0976746299837183,0.128368763003401,7.19039957229822e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA11,Annexin A11,42570,0.0996944387379379,0.00690997740008539,0.0861508830337706,0.113237994442105,7.79215056508243e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TADA3,Transcriptional adapter 3,40451,0.0591396533982596,0.00409841548100652,0.0511067590554868,0.0671725477410324,8.76889596591894e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RRAS,Ras-related protein R-Ras,40182,0.193881479566496,0.013437641636987,0.167543701958002,0.220219257174991,9.18744717357541e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPRY2,Protein sprouty homolog 2,42370,0.137283626872375,0.00953408304570927,0.118596824102784,0.155970429641965,1.18176814836185e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,42611,0.0845630807915967,0.00587642702625337,0.0730452838201401,0.0960808777630533,1.32459320812325e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40483,0.144877895247798,0.0100612548220702,0.12515783579654,0.164597954699055,1.34556597369544e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD226,CD226 antigen,40199,0.063294224835313,0.00439772121559436,0.0546746912527481,0.071913758417878,1.52430617663226e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RASSF2,Ras association domain-containing protein 2,42346,0.0847186608163593,0.00589388624187686,0.0731666437822806,0.0962706778504379,1.69544689914266e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42346,0.145993776475987,0.010170919907133,0.126058773458006,0.165928779493968,2.25118016042409e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42636,0.123268537056332,0.00859265878320133,0.106426925841258,0.140110148271407,2.48749682486697e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PARK7,Parkinson disease protein 7,42611,0.0769276267973196,0.00536612245952362,0.0664100267766533,0.0874452268179859,2.87108695178801e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIFBP,KIF-binding protein,42587,0.121135580374769,0.00845189574535071,0.104569864713882,0.137701296035657,3.01878633962837e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RILPL2,RILP-like protein 2,40511,0.143823264265347,0.0100289226860466,0.124166575800696,0.163479952729998,3.08760657598609e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP10,Caspase-10,42311,0.106152318551176,0.00740733468735137,0.0916339425639676,0.120670694538385,3.14143677141902e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RFC4,Replication factor C subunit 4,40451,0.0313878775354263,0.00219190821079484,0.0270917374422684,0.0356840176285841,4.17343408295741e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRC59,Leucine-rich repeat-containing protein 59,40511,0.072112752238478,0.00503646333023552,0.0622412841112164,0.0819842203657396,4.25733195043268e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40449,0.154965878017033,0.0108327299831834,0.133733727249993,0.176198028784072,5.12629213214413e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA4D,Semaphorin-4D,42711,0.0442412097105161,0.00309847204240592,0.0381682045074005,0.0503142149136317,6.43529759674439e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42495,0.115433965445976,0.0080849461050271,0.0995874710801225,0.131280459811829,6.58506416056508e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LEPR,Leptin receptor,42636,-0.0461942996946593,0.00323592084537794,-0.0525367045516001,-0.0398518948377186,6.73522071339045e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD99L2,CD99 antigen-like protein 2,42611,0.0359046982513122,0.00251648430900439,0.0309723890056636,0.0408370074969608,7.5168320693928e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MOCS2,Molybdopterin synthase catalytic subunit,40283,0.097813056823834,0.00685188222460554,0.0843833676636072,0.111242745984061,7.93175568288515e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CACYBP,Calcyclin-binding protein,40267,0.150688759654982,0.0105558669630197,0.129999260407463,0.1713782589025,7.94230975814434e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRAP2,GRB2-related adapter protein 2,42636,0.187275798660801,0.0131486432399456,0.161504457910508,0.213047139411094,1.06553177551589e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCT5,T-complex protein 1 subunit epsilon,42346,0.0678695833226341,0.00476547588711328,0.0585292505838921,0.0772099160613761,1.09952653823695e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPB1,Carboxypeptidase B,42794,0.0895875749903808,0.00629766048795768,0.0772441604339837,0.101930989546778,1.3505369577045e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42594,0.140766930439549,0.00989594241120216,0.121370883313593,0.160162977565505,1.3815187074043e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMED8,Protein TMED8,40449,0.150365740508607,0.010568731313325,0.12965102713449,0.171080453882724,1.53578648170662e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOXO3,Forkhead box protein O3,42346,0.139919205913606,0.00984607171129786,0.120620905359462,0.15921750646775,1.70766075916402e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,40482,0.136692597210826,0.00964891870290152,0.117780716553139,0.155604477868513,3.59132917348146e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40283,0.15196907354714,0.0107294774834227,0.130939297679632,0.172998849414649,3.80083724010996e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERP29,Endoplasmic reticulum resident protein 29,40283,0.172925746772663,0.012255048955071,0.148905850820724,0.196945642724602,7.97751065080603e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THPO,Thrombopoietin,42357,0.0568985972221337,0.00404303688598299,0.0489742449256071,0.0648229495186604,1.16862086807627e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42346,0.123208227217836,0.00875842001287706,0.106041723992597,0.140374730443075,1.26825727366246e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",42679,0.0882688356998303,0.00628057140609206,0.0759589157438899,0.100578755655771,1.49536429540845e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGL1,Fibrinogen-like protein 1,40532,-0.0959170113767152,0.00682301972895941,-0.109290130045476,-0.0825438927079548,1.6291280111457e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MIF,Macrophage migration inhibitory factor,42586,0.098498375866362,0.00701139021748973,0.0847560510400821,0.112240700692642,1.63212546573102e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RILP,Rab-interacting lysosomal protein,42674,0.0865803840297831,0.00617252842414025,0.0744822283184682,0.098678539741098,2.1938117613133e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PENK,Proenkephalin-A,40283,0.0477620527108496,0.00340312703939818,0.0410919237136292,0.05443218170807,2.28761466873173e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK10,Kallikrein-10,42636,0.0591637521846496,0.00421937143145776,0.0508937841789924,0.0674337201903068,2.34960824801929e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBCB,Tubulin-folding cofactor B,42495,0.144533288283253,0.010310402315945,0.124324899744001,0.164741676822506,2.49341581748448e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMAD3,Mothers against decapentaplegic homolog 3,40451,0.0751166723375823,0.00535721420163286,0.0646165325023819,0.0856168121727827,2.7101714689887e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPI,Glucose-6-phosphate isomerase,40532,0.0681753712465257,0.00486288859395653,0.0586441096023709,0.0777066328906805,2.77218923612839e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGCT,Gamma-glutamylcyclotransferase,40500,0.0691952289334629,0.00493977717903267,0.0595132656625589,0.0788771922043669,3.27002489548e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MGLL,Monoglyceride lipase,42654,0.124340515313183,0.00888684701697556,0.106922295159911,0.141758735466455,3.57971222958313e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42794,0.042482616841618,0.00303708040279969,0.0365299392521306,0.0484352944311054,3.73269369288915e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPC5,Glypican-5,42495,0.0816895404929192,0.00584586563802208,0.0702316438423959,0.0931474371434425,4.60793333670692e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42587,0.077198834746796,0.00552728818691684,0.066365349900439,0.088032319593153,5.05507406762059e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,42711,0.0667018839852443,0.00478205918597757,0.0573290479807282,0.0760747199897603,6.48640440314991e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINE2,Glia-derived nexin,40511,0.0927641011936973,0.00665840194678187,0.0797136333780048,0.10581456900939,9.31176422646166e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSC22D1,TSC22 domain family protein 1,40482,0.0941416063195095,0.0067576502150946,0.0808966118979241,0.107386600741095,9.43102176600211e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42459,0.0601829432253322,0.00432321595495181,0.0517094399536266,0.0686564464970377,9.60517087405033e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,40482,0.122648141556854,0.00880582070727946,0.105388732970586,0.139907550143122,9.83393633761066e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42587,0.0400911285753675,0.00288174204431909,0.0344429141685021,0.0457393429822329,1.07655958509951e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",40481,0.05729095141797,0.00411694098783006,0.0492217470818231,0.065360155754117,1.16275441692384e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42495,0.0846375835871637,0.00608993996338178,0.0727013012589354,0.0965738659153919,1.31512264439035e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,42636,0.0961786587527572,0.0069256996454509,0.0826042874476734,0.109753030057841,1.51322091593548e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF4E,Eukaryotic translation initiation factor 4E,40199,0.12987713469651,0.00934880208294636,0.111553482613935,0.148200786779084,1.64023520176789e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,42311,0.104909888783117,0.00757747499832324,0.0900580377864033,0.11976173977983,2.74976012073519e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ORM1,Alpha-1-acid glycoprotein 1,40483,0.0288876184529623,0.00208579473266314,0.0247994607769425,0.032975776128982,2.88356208193786e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,42794,0.0567073495036026,0.00410047559215632,0.0486704173429762,0.064744281664229,3.3187433444412e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42346,0.0931108243732174,0.00674548351752321,0.0798896766788719,0.106331972067563,4.8479428651728e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTF1,Cardiotrophin-1,42357,0.120086552201779,0.00870509796400425,0.103024560192331,0.137148544211227,5.43961304891574e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42638,0.0455203174662943,0.00330650299696839,0.0390395715922363,0.0520010633403524,7.86776770941625e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJB14,DnaJ homolog subfamily B member 14,40449,0.0902647399252828,0.00656541826306124,0.0773965201296827,0.103132959720883,1.14910258380283e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GET3,ATPase GET3,40511,0.0770561240215,0.00560899286268675,0.0660624980106339,0.088049750032366,1.32058526180742e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANG,Angiogenin,42618,0.0478006621438432,0.00348265795465284,0.0409746525527236,0.0546266717349628,1.38761022200671e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THTPA,Thiamine-triphosphatase,40436,0.125031837826218,0.00911503339500608,0.107166372372006,0.14289730328043,1.7618586198777e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,42794,-0.0469096124103882,0.00342379831856279,-0.0536202571147713,-0.0401989677060051,1.91447728598992e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATOX1,Copper transport protein ATOX1,42679,0.0987215359328427,0.00721495714236295,0.0845802199338113,0.112862851931874,2.46267040041273e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40223,0.108263752898102,0.00790923048779679,0.0927616611420201,0.123765844654184,2.6426394383673e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EHD3,EH domain-containing protein 3,40223,0.166205211992468,0.0121671961546642,0.142357507529326,0.19005291645561,3.86737806306758e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,40417,0.061627839965085,0.0045119685534248,0.0527843816003724,0.0704712983297976,3.88631873840264e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP2,Microtubule-associated protein 2,40483,0.0658217069773508,0.00482219289138009,0.0563702089102458,0.0752732050444558,4.36902237150582e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HAO1,Hydroxyacid oxidase 1,42721,0.176937252044996,0.0129717261037,0.151512668881744,0.202361835208248,4.38142628199924e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FEN1,Flap endonuclease 1,42346,0.0901702307857328,0.00661623666668755,0.0772024069190252,0.10313805465244,5.21846367547865e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD22,B-cell receptor CD22,42754,0.0617073983902178,0.00452851359539703,0.0528315117432396,0.070583285037196,5.27278299565508e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CIAPIN1,Anamorsin,42679,0.0875643012923996,0.00642744502728396,0.074966509038923,0.100162093545876,5.50371695922424e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42192,0.121208800402261,0.00890043021046784,0.103763957189744,0.138653643614778,6.04522257543605e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40283,0.0881461084743669,0.00647748682792689,0.0754502342916302,0.100841982657104,7.76659190687851e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTSL2,ADAMTS-like protein 2,40527,0.0482923008408146,0.00355019653890116,0.0413339156245683,0.0552506860570609,8.21129145594084e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACYP1,Acylphosphatase-1,40250,0.0923987869275072,0.00679482823471909,0.0790809235874577,0.105716650267557,8.86599092813109e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40199,0.0705656654479645,0.00519360638334255,0.0603861969366131,0.0807451339593159,1.03669038351697e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PF4,Platelet factor 4,40463,0.138291919183849,0.0101793311884481,0.11834043005449,0.158243408313207,1.03851710519677e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NACC1,Nucleus accumbens-associated protein 1,40451,0.0777054286220039,0.00572892888374233,0.0664767280098689,0.0889341292341389,1.39407281045713e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPA1,Carboxypeptidase A1,42794,0.0879126752458919,0.00648724224489903,0.0751976804458898,0.100627670045894,1.44220562448844e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WDR46,WD repeat-containing protein 46,40451,0.0506043289940649,0.00373294132543391,0.0432877639962145,0.0579208939919154,1.54240247869599e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40283,0.0842731431733685,0.00622077024580265,0.0720804334915953,0.0964658528551417,1.76205287462933e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINB1,Leukocyte elastase inhibitor,42569,0.124282242968969,0.00918828659138,0.106273201249864,0.142291284688074,2.05127259469604e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOA1,Apolipoprotein A-I,40539,-0.0388394905857772,0.00287020941711199,-0.0444651010433167,-0.0332138801282377,2.12149239279007e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CETN2,Centrin-2,42311,0.0942560336959786,0.0069702856402353,0.0805942738411174,0.10791779355084,2.17951996560598e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40302,0.0690016398584345,0.00510065284427887,0.0590043602836479,0.0789989194332211,2.2713426263185e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,40451,0.0590426104816779,0.00436869843644062,0.0504799615462543,0.0676052594171015,2.67914087004371e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM172A,Cotranscriptional regulator FAM172A,40223,0.0854293135226724,0.00632225818374322,0.0730376874825357,0.0978209395628091,2.8106581079523e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX4,Syntaxin-4,42587,0.083224384172506,0.00616431985484644,0.071142317257007,0.0953064510880051,2.87225113340174e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,40116,0.0933655123792236,0.00691506409996936,0.0798119867432837,0.106919038015164,3.26682741249337e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40511,0.101949666105298,0.00755284118141118,0.0871460973897323,0.116753234820864,3.33752857765701e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,40223,0.127755333975371,0.00949952378162369,0.109136267363389,0.146374400587353,6.58634068139412e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DYNLT1,Dynein light chain Tctex-type 1,40182,0.112523047997131,0.00836922381879748,0.0961193693122875,0.128926726681974,6.94156774171533e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42636,0.0879623101793161,0.00655094919339696,0.075122449760258,0.100802170598374,7.6565230048389e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EGF,Pro-epidermal growth factor,42597,0.14289841168651,0.0106447077633519,0.12203478447034,0.163762038902679,7.98819026312719e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JAM3,Junctional adhesion molecule C,40283,0.0705792454619322,0.00526537946936026,0.0602591017019861,0.0808993892218783,1.18019141113218e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40283,0.0417211816260521,0.00311321196570078,0.0356192861732786,0.0478230770788257,1.22920731824651e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40511,0.0845065776858295,0.00631205122856636,0.0721349572778394,0.0968781980938196,1.44317887521806e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42495,0.129433046382985,0.00967786806870297,0.110464424968327,0.148401667797643,1.56484375732285e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPTL3,Angiopoietin-related protein 3,42652,0.0496302050294084,0.00371125506604206,0.0423561450999659,0.0569042649588508,1.57972242538475e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PQBP1,Polyglutamine-binding protein 1,42346,0.0788770329297512,0.00591769082592665,0.067278358910935,0.0904757069485675,2.86345090418156e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C19orf12,Protein C19orf12,42311,0.0879915065623803,0.00660278147960052,0.0750500548623632,0.100932958262397,2.96801240757729e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,40290,0.0613827907243119,0.00460642105373061,0.0523542054589999,0.0704113759896239,3.34995636309204e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP2,Caspase-2,42594,0.0929917706654374,0.00698463474380981,0.0793018865675702,0.106681654763305,3.4650719387514e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,40451,0.0786117404707596,0.00590315628195778,0.0670415541581223,0.0901819267833968,3.71393891431593e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPARC,SPARC,42679,0.0966379203006585,0.00726197381566516,0.0824044516219548,0.110871388979362,3.7556093153852e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL10RB,Interleukin-10 receptor subunit beta,42676,0.0416292071693034,0.00312919593627386,0.0354959831342066,0.0477624312044001,3.95496424116302e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP7,Caspase-7,40483,0.115374641214784,0.00866796329907276,0.0983854331486016,0.132363849280967,4.03465006013133e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINB9,Serpin B9,42495,0.0453360666799952,0.00341119991059319,0.0386501148552325,0.0520220185047578,4.73999744110581e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIP,Gastric inhibitory polypeptide,40223,0.081091600658016,0.00609740620426835,0.06914068449765,0.0930425168183819,4.74648563814382e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEBPB,CCAAT/enhancer-binding protein beta,42357,0.0525156777165885,0.00395166680637381,0.0447704107760958,0.0602609446570812,4.82325558262477e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFASC,Neurofascin,42754,0.0400199257031053,0.00301687104514221,0.0341068584546266,0.0459329929515841,6.51560258307058e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,42676,0.0542856341726582,0.00409229957717663,0.046264727001392,0.0623065413439244,6.54238188621353e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VASP,Vasodilator-stimulated phosphoprotein,40532,0.0991351360639955,0.00747450833904896,0.0844850997194595,0.113785172408531,7.50185724647399e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COMT,Catechol O-methyltransferase,42214,0.114086978571739,0.00861568623290225,0.0972002335552509,0.130973723588228,9.09830406807358e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VAV3,Guanine nucleotide exchange factor VAV3,40136,0.136117806636677,0.010273583169835,0.115981583623801,0.156254029649554,9.21296433290629e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD69,Early activation antigen CD69,42585,0.119956078381537,0.00906997518178917,0.10217892702523,0.137733229737844,1.10674426537029e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42370,0.0730106563229716,0.00552366102297839,0.062184280717934,0.0838370319280093,1.23779196675734e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BOLA2_BOLA2B,BolA-like protein 2,40223,0.0744102140017476,0.00562788624004547,0.0633795569712585,0.0854408710322367,1.31546960933646e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JPT2,Jupiter microtubule associated homolog 2,40449,0.119147808267324,0.00901441425993973,0.101479556317842,0.136816060216806,1.37119490782554e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LACTB2,Endoribonuclease LACTB2,42636,0.0891168305631978,0.00674827598811533,0.0758902096264918,0.102343451499904,1.43116131780389e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ESM1,Endothelial cell-specific molecule 1,42618,-0.0471667799378113,0.00357222812208223,-0.0541683470570925,-0.0401652128185301,1.47267945536791e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HPSE,Heparanase,40408,0.128474135705308,0.00973333279941788,0.109396803418449,0.147551467992167,1.74124115703853e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJC9,DnaJ homolog subfamily C member 9,40449,0.104889174492427,0.00796257464645504,0.0892825281853751,0.120495820799479,2.45932091361875e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALCA,Calcitonin,42476,0.086534168260948,0.00657444621695201,0.0736482536757221,0.099420082846174,2.55172417555736e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXNDC9,Thioredoxin domain-containing protein 9,40483,0.0719490724262906,0.00546595349796978,0.0612358035702698,0.0826623412823113,2.78319294333562e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD74,HLA class II histocompatibility antigen gamma chain,42711,0.0485399006745627,0.00369178914827708,0.0413039939439396,0.0557758074051857,3.03913712985458e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD72,B-cell differentiation antigen CD72,40283,0.0606095608955848,0.00460815276691946,0.0515775814724226,0.0696415403187469,3.22739024294471e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LARP1,La-related protein 1,40451,0.0833598660112794,0.00635810565797489,0.0708979789216486,0.0958217531009102,5.50929352814924e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42673,-0.0442491054080157,0.00337738676304772,-0.0508687834635893,-0.0376294273524422,5.57916641135415e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40449,0.0869123384459152,0.00663887048858493,0.0739001522882887,0.0999245246035416,7.08456645692563e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STK24,Serine/threonine-protein kinase 24,42311,0.0833655920582253,0.00637465839249896,0.0708712616089273,0.0958599225075232,7.72873009938057e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42311,0.149970807591031,0.0114837906849275,0.127462577848573,0.172479037333488,9.80127397483182e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BPIFB2,BPI fold-containing family B member 2,40473,0.0934884314835126,0.00715700790590963,0.0794606959879297,0.107516166979095,1.02922703566817e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSPB1,Heat shock protein beta-1,42448,0.0916218291814182,0.00702147793090558,0.0778597324368433,0.105383925925993,1.11740584275274e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PMVK,Phosphomevalonate kinase,42303,0.146046537666383,0.0112005166512926,0.12409352502985,0.167999550302917,1.27178727892181e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB33A,Ras-related protein Rab-33A,40116,0.0889561681093633,0.00681859036844283,0.0755917309872154,0.102320605231511,1.29884477617856e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40482,0.0641848832102303,0.00492816652128946,0.0545256768285029,0.0738440895919576,1.69003778683119e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,XCL1,Lymphotactin,42721,0.0759437317233181,0.00583656582907905,0.0645040626983231,0.087383400748313,1.78601117282708e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BIN2,Bridging integrator 2,42611,0.121618831545656,0.00936467042136034,0.10326407751979,0.139973585571522,2.46858246295235e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDT,D-dopachrome decarboxylase,40527,0.0561248325481262,0.00431922324851123,0.0476591549810442,0.0645905101152082,2.47849587363645e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40223,0.0661668127266507,0.00509394813725619,0.0561826743776285,0.0761509510756728,2.68553037621123e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40511,0.120309325886016,0.00927074391453666,0.102138667813524,0.138479983958508,3.08281842376505e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40511,0.121453557914185,0.00936109275031911,0.10310581612356,0.139801299704811,3.204830402716e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MESD,LRP chaperone MESD,42611,0.161652804282355,0.0124698963121089,0.137211807510621,0.186093801054088,3.34368542621032e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MCEMP1,Mast cell-expressed membrane protein 1,40199,0.12245570860515,0.00945605302586247,0.10392184467446,0.140989572535841,4.45701240583912e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42495,0.0773816861371147,0.00598175474380509,0.0656574468392567,0.0891059254349727,4.76363685719623e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDNF,Cerebral dopamine neurotrophic factor,42587,0.0451527420478612,0.00349948823951165,0.0382937450984184,0.0520117389973041,7.30748003305627e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,40539,-0.0358531349968661,0.0027794859976999,-0.0413009275523579,-0.0304053424413743,8.38263517771374e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MICALL2,MICAL-like protein 2,40182,0.0923072052066353,0.00715534896105467,0.0782827212429681,0.106331689170302,8.41344839004446e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBCA,Tubulin-specific chaperone A,40283,0.113324416435142,0.00879040461376489,0.0960952233921628,0.130553609478121,9.33957104099212e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,40283,0.115153999113384,0.00893542038494034,0.0976405751589007,0.132667423067867,9.88834361921426e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40451,0.0460242140915141,0.00357272058513831,0.039021681744643,0.0530267464383852,1.04762459892435e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA3,Annexin A3,42681,0.0926444910247865,0.00720644203927248,0.0785198646278125,0.106769117421761,1.32676774096077e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DXO,Decapping and exoribonuclease protein,40483,0.060979190982327,0.00474262482372601,0.051683646327824,0.07027473563683,1.42837550316333e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42587,0.0454345589545075,0.00353655465230307,0.0385029118359935,0.0523662060730216,1.48723791637641e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CERT,Ceramide transfer protein,42311,0.0814403396682147,0.00634045913279135,0.0690130397679436,0.0938676395684857,1.55339370218044e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL2L1,Bcl-2-like protein 1,40483,0.132121727433257,0.010283023244535,0.111967001873969,0.152276452992546,1.60520433274909e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS1,Galectin-1,42636,0.0467592753695024,0.0036453898161826,0.0396143113297845,0.0539042394092203,1.91996797443369e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REEP4,Receptor expression-enhancing protein 4,40482,0.0825316233261259,0.00643071932606684,0.0699274134470349,0.0951358332052169,1.93237323350575e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL12A_IL12B,Interleukin-12,42587,0.109208241812921,0.00852225220040292,0.0925046275001313,0.125911856125711,2.25502174020525e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINB6,Serpin B6,42679,0.0768739675787137,0.00600233632392761,0.0651093883838156,0.0886385467736119,2.46122485039073e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,40283,0.0487203253376934,0.00380176108957439,0.0412688736021276,0.0561717770732592,2.4794015190302e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STXBP1,Syntaxin-binding protein 1,40482,0.10207873478439,0.00796988840404925,0.0864577535124538,0.117699716056327,2.68636517911151e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUOX,"Sulfite oxidase, mitochondrial",40482,0.0827596750340469,0.00646169415929881,0.0700947544818212,0.0954245955862725,2.6971124772253e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL7,Interleukin-7,42594,0.0842923179650645,0.0065933245647222,0.071369401818209,0.0972152341119201,3.30148373386104e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPBP,Platelet basic protein,40471,0.111521789626987,0.00873304513223186,0.0944050211678122,0.128638558086161,4.34998818630719e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42594,0.130988193721892,0.0102783965549714,0.110842536474148,0.151133850969636,5.51656049376097e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUGT1,Protein SGT1 homolog,42346,0.105814985451095,0.00831631674576316,0.0895150046293995,0.122114966272791,7.19415306851048e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42654,0.099942457629352,0.00786023445157809,0.0845363981042589,0.115348517154445,7.95354560636249e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GMFG,Glia maturation factor gamma,40511,0.0943301611795953,0.00741620665308168,0.0797943961395553,0.108865926219635,8.23263349002776e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,40449,0.0694988178403216,0.00546963868028314,0.0587783260269667,0.0802193096536766,9.75091028443107e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,42636,0.0494705086098781,0.00389588307907775,0.0418345777748857,0.0571064394448705,9.83985255688852e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MPI,Mannose-6-phosphate isomerase,42587,0.111223487571614,0.00875955343256954,0.0940547628437778,0.12839221229945,9.95195931486897e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL2,C-C motif chemokine 2,42475,0.070122387869231,0.00553110135177512,0.0592814292197517,0.0809633465187102,1.27881863299556e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDIA4,Protein disulfide-isomerase A4,40527,0.078781544569095,0.00621621494513888,0.0665977632766228,0.0909653258615672,1.46655287659797e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,POSTN,Periostin,40527,-0.0508219388357936,0.00401464452324602,-0.0586906421013558,-0.0429532355702314,1.75784869314835e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F12,Coagulation factor XII,40539,0.054542095207903,0.00431414110676414,0.0460863786386453,0.0629978117771607,2.16124708025499e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK13,Kallikrein-13,42381,0.0606517010106931,0.00480083473087514,0.0512420649381779,0.0700613370832084,2.23944791998936e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TTF2,Transcription termination factor 2,40182,0.0643667926797881,0.0050940336393133,0.0543824867467341,0.0743510986128422,2.39999422561405e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NBN,Nibrin,42370,0.0703272200148168,0.00556923368271412,0.0594115219966971,0.0812429180329365,2.40853827360659e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C3,Complement C3,39989,0.0617755856478709,0.00489168167638195,0.0521878895621623,0.0713632817335795,2.64772886077114e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,40302,0.0969279756072893,0.00767703847197349,0.0818809802022213,0.111974971012357,2.70424222906354e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DBI,Acyl-CoA-binding protein,42562,0.0999291263817379,0.00792134766692701,0.084403284954561,0.115454967808915,2.80322737915413e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLMAP,Sarcolemmal membrane-associated protein,40449,0.10818166419371,0.00857164952557325,0.091381231123586,0.124982097263833,2.85163294166037e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCTD,Deoxycytidylate deaminase,40283,0.123092338960346,0.0097559397181071,0.103970697112856,0.142213980807836,3.0119532041812e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL4,C-C motif chemokine 4,42642,0.0895420598389146,0.00710857772203749,0.0756092475037211,0.103474872174108,3.53950048475603e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOD1,Superoxide dismutase [Cu-Zn],42365,0.0628277847085587,0.00498926558573877,0.0530488241605108,0.0726067452566067,3.74614907419569e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42594,0.0801119539932346,0.00636972804672201,0.0676272870216594,0.0925966209648097,4.51751443624752e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,42656,0.121350171785498,0.00967312139157207,0.102390853858017,0.14030948971298,6.71443258562183e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDGFA,Platelet-derived growth factor subunit A,42794,0.0933539052725332,0.00744316050848695,0.0787653106758988,0.107942499869168,6.92514598402505e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSNAX,Translin-associated protein X,40116,0.0515339632032615,0.00410879336578591,0.0434807282063211,0.0595871982002019,7.72684108642474e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,40223,0.0953606393619824,0.00761015091713165,0.0804447435644043,0.11027653515956,8.88231168946118e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS3BP,Galectin-3-binding protein,40539,0.0398570608053297,0.00318598776784465,0.0336125247803542,0.0461015968303052,1.12983385520899e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40451,0.139805007079949,0.0111759927451076,0.117900061299538,0.161709952860359,1.14459000329224e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,42711,0.0410846982349073,0.00328703315276348,0.0346421132554909,0.0475272832143238,1.18963567191543e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42667,0.143846776955588,0.0115145149382386,0.12127832767664,0.166415226234535,1.2896246772622e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBC1D5,TBC1 domain family member 5,42594,0.101723614900513,0.00814383322776611,0.0857617017740913,0.117685528026934,1.32156215246211e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZNRD2,Protein ZNRD2,40449,0.090471194152678,0.00724319660272185,0.0762745288113432,0.104667859494013,1.4471515371313e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD274,Programmed cell death 1 ligand 1,42495,0.0454835578344793,0.00364368804862347,0.0383419292591773,0.0526251864097813,1.46529926466738e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX8,Syntaxin-8,42594,0.0620238389721855,0.0049695562698005,0.0522835086833765,0.0717641692609945,1.49850141476953e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAG6,Large proline-rich protein BAG6,42357,0.0460350582185584,0.00369516564423032,0.038792533555867,0.0532775828812499,1.99884287428812e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42594,0.0781198466919908,0.00627188170839027,0.0658269585435459,0.0904127348404357,2.04815216341704e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40199,0.103281220845899,0.0082935120902569,0.0870259371489957,0.119536504542803,2.32294734130528e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL8,C-C motif chemokine 8,42706,0.0781777416259332,0.00628427602275191,0.0658605606213394,0.0904949226305269,2.46792166258972e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASEH2A,Ribonuclease H2 subunit A,40482,0.0619910338995372,0.0049841908348562,0.0522220198632191,0.0717600479358554,2.78284539946236e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39940,0.137199677693491,0.0110464048254284,0.115548724235651,0.15885063115133,3.53433572611201e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FIS1,Mitochondrial fission 1 protein,42624,0.0967799186124738,0.00781484429721845,0.0814628237899256,0.112097013435022,4.94770958273183e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP3,Caspase-3,42794,0.111347061833639,0.00900034811994279,0.0937063795185509,0.128987744148727,5.75382550494708e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,40451,0.120925228525202,0.00977182273562245,0.101772455963382,0.140078001087022,6.0286102650202e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRGN,Neurogranin,40532,0.11655412896248,0.00942329526479997,0.0980844702434723,0.135023787681488,6.47906741838817e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SWAP70,Switch-associated protein 70,40449,0.0458656325979552,0.00370967590828671,0.0385946678177132,0.0531365973781971,6.91026261616863e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF23,Fibroblast growth factor 23,42711,0.0699970399328762,0.00566487663918209,0.0588938817200793,0.0811001981456731,6.94654074864155e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BMPER,BMP-binding endothelial regulator protein,40283,0.0298042695400783,0.00241427023816837,0.0250722998732683,0.0345362392068883,8.76363235256532e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMEM106A,Transmembrane protein 106A,40451,0.0898526869769813,0.00728029954394745,0.0755832998708443,0.104122074083118,9.03792196805069e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,40199,0.0682669215888582,0.00553614333455293,0.0574160806531345,0.0791177625245819,1.04328490977075e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC37,Hsp90 co-chaperone Cdc37,42679,0.106645508591748,0.00866095158181251,0.0896700434913958,0.123620973692101,1.17817195056868e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40511,0.124389688690502,0.0100967346845181,0.104600088708847,0.144179288672158,1.1814897030335e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRYBB1,Beta-crystallin B1,40511,0.0814575660883912,0.00662741120930401,0.0684678401181553,0.0944472920586271,1.67966459938227e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PKD2,Polycystin-2,40116,0.0745599625800172,0.00606670390988897,0.0626692229166348,0.0864507022433996,1.73099623443948e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42587,0.118609795327445,0.00966378563022419,0.0996687754922057,0.137550815162684,1.92141189118856e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLB,Beta-klotho,42311,-0.0952488277004003,0.00776347882656724,-0.110465246200472,-0.0800324092003286,2.05569656707993e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40223,0.0328171126685346,0.0026739409900183,0.0275761883280987,0.0380580370089705,2.12138716271842e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYO9B,Unconventional myosin-IXb,42370,0.0841523851010535,0.00686224492266022,0.0707023850526395,0.0976023851494676,2.20051324262419e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCN1,Ficolin-1,40515,0.0710363778577539,0.00579244430877708,0.0596831870125508,0.082389568702957,2.34512269568998e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F2,Prothrombin,40539,0.0189605346014145,0.00154760914985613,0.0159272206676965,0.0219938485351325,2.71542441506411e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40223,0.0582122170571995,0.0047534853733735,0.0488953857253874,0.0675290483890115,2.93694560282806e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TREH,Trehalase,40527,0.0944531755899516,0.00772752758585367,0.0793072215216784,0.109599129658225,3.84426125172712e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40511,0.0510348885412493,0.00417685849921681,0.0428482458827843,0.0592215311997142,4.06111225533328e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DIABLO,"Diablo homolog, mitochondrial",42603,0.137743101412326,0.0112920910524889,0.115610602949447,0.159875599875204,4.81391005869055e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BMP6,Bone morphogenetic protein 6,42342,0.0514353085941857,0.00421738691105871,0.0431692302485106,0.0597013869398608,4.98355999613179e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,40116,0.0875662558264188,0.00717810278327237,0.073497174371205,0.101635337281633,5.23025234742962e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFRA1,GDNF family receptor alpha-1,42689,0.0376191604644872,0.00309236796977646,0.0315581192437254,0.0436802016852491,7.16715265736809e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTRB1,Chymotrypsinogen B,42611,0.0733607368122128,0.00603497254885363,0.0615321906164596,0.0851892830079659,8.03328814635642e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEMIP2,Cell surface hyaluronidase,40199,0.0435848741319233,0.00358487455179472,0.0365585200104056,0.0506112282534409,8.56507282982945e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42754,0.0356026238491876,0.00293117038523049,0.0298575298941359,0.0413477178042394,8.9974241885732e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC4G,C-type lectin domain family 4 member G,42594,0.0418651575732818,0.00344767331610909,0.0351077178737079,0.0486225972728556,9.39693031177645e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42721,0.077285555480719,0.00637372249519323,0.0647930593901402,0.0897780515712977,1.15466845034152e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42754,0.0505125547920307,0.00416836617279759,0.0423425570933474,0.0586825524907139,1.26414701971438e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NTRK3,NT-3 growth factor receptor,42711,-0.0274662663491237,0.00226657008686526,-0.0319087437193796,-0.0230237889788678,1.26702366200513e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNAS,Neuroendocrine secretory protein 55,40482,0.108386221587887,0.00894185367296031,0.0908601883888844,0.125912254786889,1.31816538411608e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLO1,Lactoylglutathione lyase,42357,0.072967557639588,0.00602300057292866,0.0611624765166478,0.0847726387625282,1.33056947788334e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRI1,Methylthioribose-1-phosphate isomerase,40182,0.0867051289933952,0.00715855959107959,0.0726743521948792,0.100735905791911,1.49061104411786e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLF4,Krueppel-like factor 4,40136,0.0505050661628092,0.00417748185827613,0.0423172017205879,0.0586929306050304,1.95188609153735e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F2R,Proteinase-activated receptor 1,42654,0.0701934440247924,0.00581090129906145,0.0588040774786319,0.0815828105709528,2.01521287106388e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPT1,Angiopoietin-1,42554,0.10516660980647,0.00870652787255636,0.0881018151762591,0.12223140443668,2.03487060216414e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,42346,0.0655990470996524,0.00543200247406329,0.0549523222504883,0.0762457719488164,2.11404048580274e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHRDL2,Chordin-like protein 2,42636,0.0592846305435756,0.00491603997930436,0.0496491921841391,0.0689200689030122,2.57000383981096e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINC1,Antithrombin-III,40516,0.0184498171377883,0.00153125237343445,0.0154485624858568,0.0214510717897198,3.14012594470352e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BLNK,B-cell linker protein,40199,0.0511746328151347,0.00424950056530663,0.0428456117071337,0.0595036539231357,3.43310100049657e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDT16,U8 snoRNA-decapping enzyme,40429,0.108200147282817,0.00898781141232711,0.0905840369146555,0.125816257650978,3.56494068237973e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GP1BB,Platelet glycoprotein Ib beta chain,40116,0.0864676912633616,0.00718693155018085,0.0723813054250072,0.100554077101716,3.94254612232797e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCS,Copper chaperone for superoxide dismutase,42495,0.0593853061971919,0.00494360825492937,0.0496958340175303,0.0690747783768534,4.52720614635235e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKT2,RAC-beta serine/threonine-protein kinase,40482,0.156893578062793,0.0130547480549179,0.131306271875154,0.182480884250432,4.54081057349101e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLRD1,Natural killer cells antigen CD94,42754,0.0588025550830016,0.00489789450421018,0.0492026818547496,0.0684024283112536,4.87801561468649e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,40283,0.0477381706528882,0.00398576638584943,0.0399260685366233,0.0555502727691531,7.46210991863532e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAP18,Chromatin complexes subunit BAP18,40483,0.0841890779933279,0.00704577341367089,0.0703793621025329,0.0979987938841228,1.03614431275995e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,40116,0.0852985189744805,0.00714013684800932,0.0713038507523823,0.0992931871965788,1.08407186211949e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMSB10,Thymosin beta-10,42611,0.0916737989038685,0.00769352991169081,0.0765944802769545,0.106753117530783,1.43109537084795e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42346,0.0823682845717474,0.00691387463491043,0.0688170902873229,0.0959194788561718,1.48053405740759e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AIF1,Allograft inflammatory factor 1,42346,0.0645348604486519,0.00541856527329748,0.0539144725129889,0.075155248384315,1.54374490480496e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42658,0.0634227196576502,0.00532934796366896,0.0529771976488591,0.0738682416664414,1.7086209129025e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42676,0.14558644729049,0.0122391936407954,0.121597627754531,0.169575266826449,1.82396012431295e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH3BP1,SH3 domain-binding protein 1,40449,0.0591797561540345,0.00497557033837208,0.0494276382908252,0.0689318740172438,1.9870165129563e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGR,Tyrosine-protein kinase Fgr,42311,0.0706233073221935,0.00595217517373377,0.0589570439816753,0.0822895706627117,2.62773347104073e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LONP1,"Lon protease homolog, mitochondrial",40223,0.106984706699795,0.00902036852435508,0.0893047843920589,0.124664629007531,2.98586840969895e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,40223,-0.0748706902893502,0.00631354220502697,-0.0872452330112031,-0.0624961475674974,3.04281668686906e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNMA1,Paraneoplastic antigen Ma1,40223,0.0687971063205446,0.00580466338811351,0.0574199660798421,0.0801742465612471,3.29307923677259e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCG2,Secretogranin-2,42636,0.0421766732494235,0.00356305223304551,0.0351930908726543,0.0491602556261927,3.61991429898989e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OCLN,Occludin,40482,0.0554830281829157,0.004685541169536,0.0462993674906252,0.0646666888752063,3.69811062905406e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40449,0.0933264201023884,0.00788571057051417,0.0778704273841806,0.108782412820596,3.99499619676606e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HNMT,Histamine N-methyltransferase,42439,0.0589972085819694,0.00499539842534817,0.049206227668287,0.0687881894956519,4.99820873196152e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,42357,0.134226330049911,0.0113659846287676,0.111949000177527,0.156503659922296,5.05908721304587e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,40223,0.0536705412629068,0.00454265131262351,0.0447669446901647,0.0625741378356489,5.10378705795932e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G4A,Cytosolic phospholipase A2,42676,0.106206449428413,0.00899480791643024,0.0885766259122098,0.123836272944616,5.13137898624385e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40223,0.0646767706821148,0.00548857942210516,0.0539191550147887,0.0754343863494409,7.3365241011717e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42638,0.0317485926548175,0.00269605961079819,0.026464315817653,0.0370328694919819,7.44740746970866e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PKN3,Serine/threonine-protein kinase N3,40302,0.0915149327189191,0.00778993671448744,0.0762466567585237,0.106783208679315,1.11516191628916e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GDNF,Glial cell line-derived neurotrophic factor,42311,0.0466336235720292,0.00397601814932391,0.0388406279993544,0.0544266191447041,1.3060844749955e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42346,0.0736032527523688,0.00627727679200469,0.0612997902400396,0.085906715264698,1.35737268640405e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DTNB,Dystrobrevin beta,40430,0.0522080527149603,0.00445089291688435,0.0434843025978669,0.0609318028320536,1.37013629728691e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL11,C-X-C motif chemokine 11,42711,0.0971708879465492,0.00830027127692055,0.0809023562437849,0.113439419649313,1.66648837822789e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,42346,0.0899216342299631,0.00768450403673213,0.0748600063179681,0.104983262141958,1.7893463014095e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40482,0.0813984540302939,0.00695649555769712,0.0677637227372076,0.0950331853233803,1.91133196534826e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL12B,Interleukin-12 subunit beta,42754,0.0690688126055206,0.00590647656100024,0.0574921185459601,0.0806455066650811,1.94206155463676e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42594,0.109970249648235,0.00941191125959282,0.091522903579433,0.128417595717037,2.18054912930674e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEPTIN9,Septin-9,42587,0.034525815040464,0.00296219751874087,0.0287199079037319,0.0403317221771961,3.04505316009438e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGACT,Gamma-glutamylaminecyclotransferase,40511,0.0850911037859084,0.00729917237637745,0.0707847259282086,0.0993974816436082,3.16326910669979e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42794,0.0286212355511592,0.00245687850102689,0.0238057536891465,0.0334367174131719,3.24947883079814e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APP,Amyloid-beta precursor protein,42592,0.080417296016534,0.00690429255681215,0.0668848826051822,0.0939497094278858,3.34273589096252e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITPA,Inosine triphosphate pyrophosphatase,40116,0.0814450286825161,0.00699290982454191,0.067738925426414,0.0951511319386183,3.63991315681959e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40421,0.0365540049897828,0.00314585863118477,0.0303881220726607,0.042719887906905,4.92369357755837e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40223,0.117245163190246,0.0100907306346156,0.0974673311463994,0.137022995234093,4.99575498995784e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARSA,Arylsulfatase A,42611,0.0537536899973867,0.00463087892046723,0.0446771673132709,0.0628302126815024,5.29865348049916e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40482,0.119775901187734,0.0103148876825811,0.0995587213298754,0.139993081045593,5.37525292460634e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40223,0.122951213692346,0.0105903592097795,0.102194109641178,0.143708317743514,5.56686190861763e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RP2,Protein XRP2,42587,0.0506096702191949,0.00436462537880758,0.0420550044767321,0.0591643359616578,6.10872875205643e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AK2,"Adenylate kinase 2, mitochondrial",40483,0.127035590754847,0.0109643576933398,0.105545449675901,0.148525731833793,7.23302143036022e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLG,Plasminogen,40285,0.02582414161793,0.00223018962801866,0.0214529699470135,0.0301953132888466,7.88635964862139e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,42408,0.0578785259420296,0.00500175636418973,0.0480750834682177,0.0676819684158415,8.07681118243526e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42689,0.0513970674607726,0.00444826873393792,0.0426784607422543,0.0601156741792909,9.78446401756071e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40199,0.0651774733830753,0.00564591906240254,0.0541114720207663,0.0762434747453843,1.18585416134564e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,40182,0.0731870226937263,0.00634457173402491,0.0607516620950375,0.0856223832924151,1.31276954046887e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLAMF6,SLAM family member 6,42346,0.0466079052993837,0.00404453909468212,0.0386806086738068,0.0545352019249607,1.40569537913817e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCN4,CCN family member 4,42721,0.0480376811099607,0.00416972794256732,0.0398650143425287,0.0562103478773926,1.4429219620787e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINT2,Kunitz-type protease inhibitor 2,42676,0.0483281367982386,0.00420073049088711,0.0400947050360999,0.0565615685603773,1.73352463236001e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMOX2,Heme oxygenase 2,42311,0.0546074158642641,0.00475020869721758,0.0452970068177176,0.0639178249108105,1.93742191964993e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42594,0.0972486376406297,0.00846599805934766,0.0806552814443083,0.113841993836951,2.12867971758482e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40483,0.102151122085916,0.00890871424418859,0.0846900421673066,0.119612202004526,2.86062802747371e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPON2,Spondin-2,42562,-0.0427678832605522,0.00373568580736399,-0.0500898274429856,-0.0354459390781187,3.30929647109553e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFT20,Intraflagellar transport protein 20 homolog,40182,0.0512727170893889,0.00447627521260249,0.042499217672688,0.0600462165060898,3.31875872565489e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP170,Centrosomal protein of 170 kDa,40223,0.0919508347135083,0.00803081210899253,0.076210442979883,0.107691226447134,3.49123432797345e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SDC4,Syndecan-4,42636,0.0560773620654399,0.00490461768409276,0.0464643114046181,0.0656904127262617,3.91525834811834e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42311,0.0755768570063479,0.00661936007424397,0.0626029112608297,0.088550802751866,4.73780146004374e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB10,Ras-related protein Rab-10,40511,0.0634619116982948,0.00556125288183606,0.0525618560498962,0.0743619673466935,5.3471457394777e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,40483,0.0383575366890914,0.00336167121420109,0.0317686611092573,0.0449464122689256,5.42458011886596e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FNDC1,Fibronectin type III domain-containing protein 1,40483,0.0560545195945775,0.00491312187974911,0.0464248007102693,0.0656842384788858,5.49365217800488e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42579,0.0290885275683835,0.00255534613171257,0.0240800491502269,0.0340970059865401,6.94169791069777e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DBN1,Drebrin,40199,0.0592591178873028,0.00520313010028212,0.0490609828907498,0.0694572528838557,6.96216074287286e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,42297,0.0671216924546567,0.00589703087849389,0.0555635119328087,0.0786798729765047,7.07781039799844e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,42676,-0.024578646087382,0.00216028051489423,-0.0288127958965747,-0.0203444962781893,7.40393085415518e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCARB2,Lysosome membrane protein 2,42302,0.0415005453275716,0.00364916820481911,0.0343481756461261,0.0486529150090171,7.8991170435191e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMP1,Metalloproteinase inhibitor 1,42501,0.0346644375184296,0.00304938510995328,0.0286876427029212,0.0406412323339381,8.31305952356592e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BPIFA2,BPI fold-containing family A member 2,39838,-0.134093830977269,0.0117905648964388,-0.157203338174289,-0.110984323780249,8.46916116958841e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP3R1,Calcineurin subunit B type 1,42495,0.0472290658918715,0.00416680098592351,0.0390621359594614,0.0553959958242816,1.20926777477311e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJC21,DnaJ homolog subfamily C member 21,40483,0.0452189067301536,0.00398817487618557,0.0374020839728299,0.0530357294874773,1.22670114289455e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMTN,Smoothelin,40460,0.108704139961786,0.00959439562623947,0.0898991245343568,0.127509155389216,1.34799087998546e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCTN6,Dynactin subunit 6,42311,0.0844672745867678,0.00745945006526444,0.0698467524588495,0.0990877967146861,1.37670741033253e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,42760,0.0393094177014829,0.00347451607105171,0.0324993662022216,0.0461194692007443,1.52350481403524e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ABHD14B,Protein ABHD14B,42460,0.0670246351148183,0.00592839094107338,0.0554049888703144,0.0786442813593221,1.67768905771288e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',40483,0.0508618154508013,0.00450081831620937,0.042040211551031,0.0596834193505717,1.8761895717178e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSTB,Cystatin-B,42437,0.0500518211435602,0.00443204344670346,0.0413650159880214,0.058738626299099,1.93346002136017e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KITLG,Kit ligand,42636,-0.044116936030532,0.00390930439426198,-0.0517791726432855,-0.0364546994177785,2.10764317509331e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C2,Complement C2,42663,0.0269032966473219,0.0023851127977572,0.0222284755637177,0.031578117730926,2.23938018895724e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ING1,Inhibitor of growth protein 1,42292,0.0550693796636696,0.00490301243935213,0.0454594752825394,0.0646792840447997,3.86984927640144e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42495,0.0837933969799754,0.00747260595435049,0.0691470893094484,0.0984397046505024,4.73024826210845e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,42679,0.0385039755751594,0.00343817766359471,0.0317651473545138,0.045242803795805,5.53854547414485e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAD23B,UV excision repair protein RAD23 homolog B,42346,0.0544293229422261,0.00486110172493938,0.0449015635613449,0.0639570823231073,5.70830212793396e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPPB,Natriuretic peptides B,42357,-0.164855217876161,0.0147511321217796,-0.193767436834849,-0.135942998917473,7.22688666133026e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFNA4,Ephrin-A4,42475,0.0395331336621844,0.00354079296975617,0.0325931794414623,0.0464730878829065,8.12295327700647e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ABCA2,ATP-binding cassette sub-family A member 2,40116,0.0419610964585164,0.00376760183575823,0.0345765968604302,0.0493455960566025,1.17735659788564e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIPC3,PDZ domain-containing protein GIPC3,40449,0.112419538896802,0.0101086342326117,0.0926066158008827,0.132232461992721,1.39470828229451e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,40511,0.0329183647935588,0.00296020383719288,0.0271163652726608,0.0387203643144568,1.40508799143775e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC26,Anaphase-promoting complex subunit CDC26,40428,0.0800040395271441,0.007195118164101,0.0659016079255061,0.0941064711287821,1.42576181615076e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCOF1,Treacle protein,40511,0.0370110437317265,0.00335646911652453,0.0304323642633385,0.0435897232001146,3.94664458411232e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42594,0.137044256929396,0.0124350893427338,0.112671481817637,0.161417032041154,4.0073090545327e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42495,-0.137195301563048,0.0124773952018034,-0.161650996158582,-0.112739606967513,5.30148528735225e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40283,0.0479925784508763,0.00436589831925747,0.0394354177451317,0.056549739156621,5.78250448342632e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAP3,Cytosol aminopeptidase,42370,0.0553954028114153,0.00504675438198966,0.0455037642227156,0.065287041400115,6.55262095350222e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCARF1,Scavenger receptor class F member 1,42794,0.0477499188771991,0.00435255411454664,0.0392189128126876,0.0562809249417105,6.92977365141035e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,42664,0.13520036923429,0.0123418281670402,0.111010386026891,0.159390352441689,8.27002470379896e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSME2,Proteasome activator complex subunit 2,42441,0.041256555694694,0.00376790216323235,0.0338714674547586,0.0486416439346294,8.79107766541124e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLRX,Glutaredoxin-1,42546,0.0638125848451036,0.00583492329659829,0.052376135183771,0.0752490345064363,1.01296045501501e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFAT5,Nuclear factor of activated T-cells 5,40199,0.0985041897394028,0.0090098954336114,0.0808447946895245,0.116163584789281,1.1136054270215e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OPLAH,5-oxoprolinase,40223,0.0769983090037414,0.00704431860991506,0.0631914445283079,0.0908051734791749,1.14151046125177e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40189,0.04000213056434,0.00366348519990691,0.0328216995725224,0.0471825615561575,1.2939086171259e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42711,0.0652445571690499,0.00598807343872767,0.0535079332291436,0.0769811811089561,1.57175431152282e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PECAM1,Platelet endothelial cell adhesion molecule,42611,0.0340695677329042,0.00312879893740209,0.0279371218155961,0.0402020136502124,1.69447748075398e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL1,Growth-regulated alpha protein,42607,0.108205735479735,0.00994041528506576,0.0887225215210063,0.127688949438464,1.76212364069422e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPP1,Tripeptidyl-peptidase 1,42545,0.051055190950945,0.00469185995954155,0.0418591454302435,0.0602512364716464,1.83835660783636e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRLF1,Cytokine receptor-like factor 1,42676,0.0284788007137772,0.00261967477514441,0.0233442381544941,0.0336133632730602,2.05609127157434e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNX9,Sorting nexin-9,42636,0.0756399911169085,0.00696401625897152,0.0619905192493243,0.0892894629844927,2.28316773596316e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,42311,0.0586835916979428,0.00542718671257213,0.0480463057413015,0.0693208776545842,3.8922118275732e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL18,C-C motif chemokine 18,42477,0.0783662431619178,0.00725208116289468,0.0641521640826442,0.0925803222411913,4.17791603841751e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G15,Phospholipase A2 group XV,42679,0.0298967570880471,0.00277025120241346,0.0244670647313167,0.0353264494447775,4.8388500319911e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40199,0.0500651925852414,0.00463894805165741,0.0409728544039929,0.0591575307664899,5.10656225265991e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TREML2,Trem-like transcript 2 protein,42611,0.0390307877868755,0.00362327811679641,0.0319291626779546,0.0461324128957965,6.00067956338956e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GP5,Platelet glycoprotein V,40283,0.0405499007240723,0.00376418505642849,0.0331720980134724,0.0479277034346721,6.30449511313454e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,40511,0.0675239362036307,0.00626960884361714,0.0552355028701411,0.0798123695371203,6.43788472921818e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSS,Cathepsin S,39872,0.0273845588629131,0.00254513526951321,0.0223960937346672,0.032373023991159,7.33378050122067e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RPL14,60S ribosomal protein L14,40223,0.0449061358419483,0.00417679708683056,0.0367196135517604,0.0530926581321362,7.93184356857737e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMB1,Laminin subunit beta-1,40223,0.0340803085278305,0.00317059771138487,0.0278659370135162,0.0402946800421449,8.14517239618109e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EGFL7,Epidermal growth factor-like protein 7,42346,0.044547415045599,0.00414982582386869,0.0364137564308164,0.0526810736603817,9.02232212874338e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,40483,0.0364209104888497,0.00339482353356335,0.0297670563630655,0.0430747646146339,1.00757360034038e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SF3B4,Splicing factor 3B subunit 4,42587,0.0811149817019019,0.00757218641539694,0.0662734963277239,0.0959564670760799,1.14367810393472e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LPA,Apolipoprotein(a),40324,-0.203056108592101,0.0189556384009864,-0.240209159858034,-0.165903057326167,1.20325019699349e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F11,Coagulation factor XI,40383,0.0336105934555037,0.00313802791744,0.0274600587373214,0.0397611281736861,1.21997276110893e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FADD,FAS-associated death domain protein,42636,0.0839778208991686,0.0078504568901091,0.0685909253945548,0.0993647164037825,1.34223652540854e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,40980,-0.0354127015846106,0.00331205118271002,-0.0419043219027222,-0.028921081266499,1.46720515694418e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSR1,Macrophage scavenger receptor types I and II,42711,0.0511764767085878,0.00480099719436952,0.0417665222076235,0.060586431209552,2.00362666634065e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX58,Antiviral innate immune response receptor RIG-I,42346,0.0628212865183161,0.00589686700735487,0.0512634271839005,0.0743791458527316,2.15522930996857e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",40449,0.0973719068325769,0.00913756725963193,0.0794622750036983,0.115281538661456,2.17858847208392e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCRN1,Secernin-1,42594,0.0613127255550651,0.00575627580428405,0.0500304249786684,0.0725950261314619,2.18872848416067e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,POMC,Pro-opiomelanocortin,40223,0.0777287598945646,0.00729664841397028,0.0634273290031828,0.0920301907859463,2.27583849408919e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCF2,Neutrophil cytosol factor 2,42578,0.0919613843821158,0.00864012682747697,0.0750267358002609,0.108896032963971,2.38240687654068e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1RL,Complement C1r subcomponent-like protein,40519,0.0219980938788003,0.00206667775750194,0.0179474054740965,0.0260487822835041,2.4717179154297e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GP6,Platelet glycoprotein VI,42590,0.0961768620006358,0.00904346402214178,0.0784516725172379,0.113902051484034,2.60917454513593e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100P,Protein S100-P,42357,0.0603185008363572,0.00567420559063348,0.0491970578787156,0.0714399437939989,2.75339048911019e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INPP1,Inositol polyphosphate 1-phosphatase,42587,0.0584359086063969,0.00550501895391082,0.0476460714567317,0.0692257457560621,3.2250430234263e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MET,Hepatocyte growth factor receptor,42654,-0.0219624023672099,0.0020690503684203,-0.0260177410893137,-0.0179070636451061,3.23143332271329e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD164,Sialomucin core protein 24,42611,0.0302016280347509,0.00284897829850612,0.0246176305696789,0.0357856254998229,3.74639183154105e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,42618,0.0577220777449167,0.00545091303070047,0.0470382882047438,0.0684058672850896,4.22837714347609e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADM,Pro-adrenomedullin,42721,0.0295250677281504,0.00279684612172196,0.0240432493295753,0.0350068861267254,5.97624949162552e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LBP,Lipopolysaccharide-binding protein,42689,-0.0646253453378967,0.00612379685788116,-0.0766279871793437,-0.0526227034964496,6.19865702398274e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40449,0.0506747955702071,0.00480235346158279,0.0412621827855049,0.0600874083549094,6.564333151947e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MIA,Melanoma-derived growth regulatory protein,42679,0.0414285492765893,0.00393004417514377,0.0337256626933076,0.0491314358598711,7.01099546089884e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UMOD,Uromodulin,42764,-0.0606693862582784,0.00575593241553752,-0.071951013792732,-0.0493877587238249,7.08812595371521e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA9,Serpin A9,42538,0.0786441282950415,0.00747569419237438,0.0639917676779878,0.0932964889120953,8.81685335792292e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,40283,0.0414005728750751,0.00393403564147007,0.0336898630177937,0.0491112827323564,8.8867809640542e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX16,Syntaxin-16,42346,0.0633636633434289,0.00602924592138568,0.051546341337513,0.0751809853493448,9.88940809457602e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA2,Annexin A2,40054,0.0794486100211415,0.00756894695143998,0.0646134739963191,0.0942837460459638,1.1872552275405e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCRG1,Scrapie-responsive protein 1,40511,0.0312259352131102,0.00297789413424623,0.0253892627099876,0.0370626077162328,1.31377587237916e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42346,0.0633693436797036,0.00604753785196217,0.0515161694898577,0.0752225178695494,1.36721616194038e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NADK,NAD kinase,42636,0.0596957860945833,0.00569737808044285,0.0485289250569153,0.0708626471322513,1.37147694169999e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40116,0.03109962955036,0.00297117450382371,0.0252761275228655,0.0369231315778544,1.61495462474127e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MNDA,Myeloid cell nuclear differentiation antigen,42611,0.105838587392235,0.0101176512069066,0.0860079910266977,0.125669183757772,1.63918404646002e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA4,Carbonic anhydrase 4,42794,-0.0262850311580248,0.00251449120702706,-0.0312134339237979,-0.0213566283922518,1.76523356930572e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP3,Stromelysin-1,42611,-0.054977067383219,0.00526367298696926,-0.0652938664376787,-0.0446602683287592,1.94121884268241e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNF,Tumor necrosis factor,42339,0.0417985847509184,0.00400738563771426,0.0339441089009984,0.0496530606008383,2.26280263870748e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSPN,Persephin,42594,0.101008183185081,0.00971419503926479,0.0819683609081224,0.12004800546204,3.15793432788628e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMOTL2,Angiomotin-like protein 2,40404,0.0522906836103938,0.00503104830795058,0.0424298289268107,0.0621515382939769,3.45058542233224e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",42754,0.0713842627688145,0.00687206844643055,0.0579150086138106,0.0848535169238184,3.50982672684057e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSTN,Growth/differentiation factor 8,42357,0.0576735518973293,0.00555416543601609,0.0467873876427378,0.0685597161519209,3.67350800326211e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BDNF,Brain-derived neurotrophic factor,40527,0.0906881549302103,0.00873581909696676,0.0735659495001555,0.107810360360265,3.91402820897682e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASAH1,Acid ceramidase,40418,0.0494543867238028,0.00476521054596221,0.0401145740537169,0.0587941993938887,4.04656179354453e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSNL1,Visinin-like protein 1,40483,0.0414759242544603,0.00400223029320966,0.0336315528797694,0.0493202956291513,4.72096286803079e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPM1F,Protein phosphatase 1F,40511,0.0561526587309972,0.00541997068806596,0.0455295161823879,0.0667758012796064,4.86071040717639e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42476,0.0784808246883973,0.00758329906857127,0.0636175585139976,0.093344090862797,5.25376671475019e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40483,0.0885969450050444,0.00855829725252841,0.0718226823900887,0.10537120762,5.29229172214051e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42587,-0.0212271157733628,0.00205218540906145,-0.0252493991751233,-0.0172048323716024,5.55191218988969e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTA,Lymphotoxin-alpha,42594,0.0440403363066091,0.00425965977626374,0.0356914031451321,0.052389269468086,5.82996977055613e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40223,-0.0381502761023119,0.00368889882921321,-0.0453805178075698,-0.030920034397054,5.91999862504657e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP7,Matrilysin,42333,0.0543383836738703,0.00525711637704567,0.0440344355748608,0.0646423317728798,6.02548624301004e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FRMD4B,FERM domain-containing protein 4B,40116,0.0756193207522882,0.0073147949613345,0.0612823226280725,0.0899563188765038,6.18913870009315e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42495,0.0393115006974852,0.0038056512654063,0.0318524242172888,0.0467705771776815,6.41999060914113e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCAM2,Neural cell adhesion molecule 2,42611,-0.0292723777547274,0.00283471140319711,-0.0348284121049937,-0.023716343404461,6.63491365761512e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",40223,0.0693105855809665,0.00671756450040639,0.05614415916017,0.0824770120017631,7.59254602443603e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,42370,0.0707558812226958,0.00686299806529798,0.0573044050147118,0.0842073574306799,7.91027475357534e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,0.029927777284217,0.00290543991331583,0.0242331150541179,0.035622439514316,9.07427762634283e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPME1,Protein phosphatase methylesterase 1,42587,0.06389948056384,0.00621257318406103,0.0517228371230804,0.0760761240045996,1.01223311407911e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HPCAL1,Hippocalcin-like protein 1,42754,0.0773500541810745,0.0075345622645528,0.062582312142551,0.092117796219598,1.2336970288865e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40511,0.0787969993217157,0.00768901608238338,0.0637265278002443,0.0938674708431871,1.54637195493529e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RPE,Ribulose-phosphate 3-epimerase,40302,0.0744949517442925,0.00728790265735664,0.0602106625358735,0.0887792409527115,2.03268875274444e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCRIB,Protein scribble homolog,40223,0.0965870249867557,0.00946846501090369,0.0780288335653845,0.115145216408127,2.51839267919047e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB2B,Ras-related protein Rab-2B,40451,0.0642825541660315,0.00630662149583927,0.0519215760341865,0.0766435322978765,2.72023207830002e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APRT,Adenine phosphoribosyltransferase,42480,0.0502275490646615,0.00492946460659779,0.0405657984357299,0.0598892996935932,2.72029834516095e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAGED1,Melanoma-associated antigen D1,42346,0.0513090460219824,0.00503735617592406,0.0414358279171712,0.0611822641267935,2.82626412525165e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,42565,0.0458673696527379,0.00450945235705161,0.0370288430329168,0.0547058962725591,3.25971823304613e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42594,0.126743589877959,0.0124662927625965,0.10230965606327,0.151177523692648,3.4104598533387e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PARD3,Partitioning defective 3 homolog,40302,0.0787800650312933,0.00775332285454414,0.0635835522363868,0.0939765778261998,3.78183823339962e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MZT1,Mitotic-spindle organizing protein 1,42346,0.0545258063338197,0.00537814285841144,0.0439846463313333,0.0650669663363061,4.57416012958665e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA13,Carbonic anhydrase 13,42483,0.108307982980988,0.0106844201314922,0.0873665195232634,0.129249446438713,4.6302830113522e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NID1,Nidogen-1,42652,0.0404379890535948,0.00399452326115842,0.0326087234617243,0.0482672546454653,5.3046169027003e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOL1,Apolipoprotein L1,40532,0.061377199176348,0.00606375329485437,0.0494922427184335,0.0732621556342626,5.58062001717622e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPK1,Thiamin pyrophosphokinase 1,40511,0.0288739830694152,0.0028543827955673,0.0232793927901033,0.0344685733487271,5.95167348311124e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GBP1,Guanylate-binding protein 1,40466,0.0691670469760834,0.00684136080350414,0.0557579798012153,0.0825761141509516,6.30042419301824e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STXBP3,Syntaxin-binding protein 3,42346,0.0456287965601954,0.00451548877246677,0.0367784385661605,0.0544791545542302,6.42152787135395e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,42611,0.0324548860341173,0.00321357411224127,0.0261562807741244,0.0387534912941102,6.77201335323259e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINB8,Serpin B8,42754,0.0607116267822567,0.00601225753137247,0.0489276020207666,0.0724956515437467,6.85007265847926e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40449,0.123150065862878,0.0121910790064669,0.0992555510102028,0.147044580715553,6.8665989101017e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1R,Complement C1r subcomponent,40539,0.0204750109438754,0.00202721977234556,0.0165016601900781,0.0244483616976727,6.96631132784009e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAG3,BAG family molecular chaperone regulator 3,42475,0.0427122164632217,0.00423161854966824,0.034418244105872,0.0510061888205715,7.19003054296877e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TST,Thiosulfate sulfurtransferase,42277,0.0782920072718091,0.00775668006040652,0.0630889143534124,0.0934951001902059,7.21838119936953e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPMT,Thiopurine S-methyltransferase,42346,0.0765329609851442,0.00758799458507202,0.0616604915984031,0.0914054303718854,7.77368427728394e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,42706,0.0696523899007274,0.00691012518173871,0.0561085445445196,0.0831962352569353,8.24098735856064e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42638,0.037823102879941,0.00375382056899571,0.0304656145647095,0.0451805911951726,8.57718010578491e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,40511,0.0343692974529563,0.00341028294494441,0.0276851428808652,0.0410534520250473,8.69574809943575e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DYNLT3,Dynein light chain Tctex-type 3,40451,0.045579956187728,0.0045285879750079,0.0367039237567125,0.0544559886187435,9.94507772538985e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,40527,0.0244549357533037,0.00243032214644244,0.0196915043462765,0.0292183671603309,1.01842085314861e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDCP1,CUB domain-containing protein 1,42495,0.0568830315614934,0.00566543757634804,0.0457787739118512,0.0679872892111356,1.22969025528652e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSE,Cathepsin E,40283,0.0536868089920338,0.00534540370770936,0.0432098177249234,0.0641638002591441,1.23759876757095e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGA11,Integrin alpha-11,42594,-0.0355558761040742,0.00354357481760322,-0.0425012827465765,-0.0286104694615719,1.3103782731405e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,42570,0.0906434458355884,0.00903471502889483,0.0729354043789546,0.108351487292222,1.32547317838413e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42476,0.0995805980284517,0.00993576159777051,0.0801065052968214,0.119054690760082,1.47279535247712e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPPK1,Epiplakin,40223,0.0758811426010743,0.00757101945692214,0.0610419444655069,0.0907203407366417,1.52947030674818e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP2,"Fatty acid-binding protein, intestinal",42636,-0.0825771643925065,0.0082503825854852,-0.0987479142600576,-0.0664064145249555,1.68360357705279e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCTN2,Dynactin subunit 2,42587,0.0972802307182713,0.00975286416873313,0.0781646169475544,0.116395844488988,2.37677723546376e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,42346,0.0390364965378521,0.00391770588245833,0.0313577930082337,0.0467152000674704,2.64630719823059e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGAL,Integrin alpha-L,40199,0.0463841680807076,0.00465679534359018,0.0372568492072708,0.0555114869541444,2.84571869206301e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CORO1A,Coronin-1A,42353,0.0923740495777578,0.00928992331173418,0.0741657998867588,0.110582299268757,3.25155119754373e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40511,0.0314370378990189,0.00316505803108266,0.0252335241580969,0.0376405516399409,3.73763512999178e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42587,0.0259373894071883,0.0026141270223209,0.0208137004434393,0.0310610783709372,4.01303773767233e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA6,Carbonic anhydrase 6,42581,-0.0646922394795641,0.00652054218146496,-0.0774725021552354,-0.0519119768038928,4.0418305904585e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BLMH,Bleomycin hydrolase,42794,0.0323458905434478,0.00326076337266054,0.0259547943330332,0.0387369867538625,4.09363371016487e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARAF,Serine/threonine-protein kinase A-Raf,40302,0.0708989875098176,0.00715683059245635,0.0568715995486031,0.084926375471032,4.86101699472335e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC27A4,Long-chain fatty acid transport protein 4,42311,0.0687065269105884,0.0069399672340102,0.0551041911319284,0.0823088626892484,5.00700737890703e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA12,Serpin A12,42249,0.106761526309241,0.0107838787044334,0.0856251240485516,0.12789792856993,5.01231022843552e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TLR3,Toll-like receptor 3,42754,0.0629245782784973,0.00636335953866291,0.050452393582718,0.0753967629742766,5.58082484132247e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD84,SLAM family member 5,42594,0.032331453133175,0.00327015693781966,0.0259219455350484,0.0387409607313015,5.69105111670594e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DENR,Density-regulated protein,40199,0.0587575395495209,0.00594554846230416,0.0471042645634047,0.0704108145356371,6.17011215052743e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGS10,Regulator of G-protein signaling 10,40482,0.0610891302185754,0.00618390775145561,0.0489686710257224,0.0732095894114284,6.37683509801315e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD40LG,CD40 ligand,42754,0.079605740968561,0.00807074735654109,0.0637870761497405,0.0954244057873816,7.15495488809554e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPXM1,Probable carboxypeptidase X1,42679,0.0714155255520291,0.00724272099147867,0.0572197924087309,0.0856112586953273,7.39033033664292e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERI1,3'-5' exoribonuclease 1,40302,0.0354379444942694,0.00359388952505862,0.0283939210251545,0.0424819679633843,7.65335138200138e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APLP1,Amyloid-like protein 1,42636,-0.0530226359124341,0.00538140420227006,-0.0635701881488834,-0.0424750836759848,7.95411802342632e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,42711,0.0534211545731244,0.00542448893435058,0.0427891562617973,0.0640531528844516,8.33150788579582e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF2,Fibroblast growth factor 2,42594,0.0700599330317682,0.00713225795107783,0.0560807074476556,0.0840391586158807,1.06967461974279e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPDC1,Neural proliferation differentiation and control protein 1,42636,0.0355020509579539,0.00361574498388908,0.0284151907895313,0.0425889111263765,1.11456480902845e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42587,0.0701519254740354,0.00714697730722599,0.0561438499518724,0.0841600009961983,1.15018199475786e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HDGF,Hepatoma-derived growth factor,42700,0.0951032953483847,0.00969092466166732,0.0761090830115168,0.114097507685253,1.17090247914668e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40199,0.0448053239083136,0.00457201563016192,0.0358441732731963,0.053766474543431,1.39390872628773e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARFIP1,Arfaptin-1,40482,0.0697845498802792,0.00712187789385186,0.0558256692083296,0.0837434305522289,1.40420273202296e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40482,0.0936385824741621,0.00956673029271258,0.0748877911004454,0.112389373847879,1.55925045616959e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PVR,Poliovirus receptor,42711,0.0374279766397114,0.00382938191407833,0.0299223880881179,0.044933565191305,1.7300385476214e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENTR1,Endosome-associated-trafficking regulator 1,40223,0.059537644308348,0.00609652692191813,0.0475884515413884,0.0714868370753075,1.94552514101631e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UNC79,Protein unc-79 homolog,40080,0.0566732270153555,0.00580549539312519,0.0452944560448301,0.0680519979858809,2.0253600245581e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPC2,NPC intracellular cholesterol transporter 2,40367,0.0348084099383291,0.00357399723086814,0.0278033753658276,0.0418134445108307,2.51319434680148e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AK1,Adenylate kinase isoenzyme 1,42636,0.0639013694805519,0.00656496058480017,0.0510340467343435,0.0767686922267602,2.5660948304264e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,40428,0.0420588300092378,0.00432243371771683,0.0335868599225129,0.0505308000959628,2.74051610551489e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,40199,0.040911824404038,0.00420602390998071,0.0326680175404758,0.0491556312676002,2.84471452597334e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NGRN,Neugrin,40483,0.0234984711396393,0.00241784608327578,0.0187594928164188,0.0282374494628598,3.06533320582494e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,40511,0.0271247410661297,0.00279165314258789,0.0216531009066574,0.0325963812256019,3.13595637040672e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPR,Nucleoprotein TPR,40116,0.0491972052500351,0.0050690049574713,0.0392619555333913,0.0591324549666788,3.51110174665146e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD302,CD302 antigen,42587,0.0324311906691749,0.00334498297307247,0.0258750240419529,0.038987357296397,3.72704337967071e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRG2,Bone marrow proteoglycan,40527,-0.0535156315893023,0.00551978211321852,-0.0643344045312106,-0.042696858647394,3.85029375674163e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBP2,Retinol-binding protein 2,42587,-0.0780931735835981,0.00806002832476249,-0.0938908291001326,-0.0622955180670636,3.97129962813752e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40482,0.0586986537757644,0.00605723713216714,0.0468264689967168,0.070570838554812,4.02856101286406e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,42459,0.030080417933084,0.00311026821913622,0.023984292223577,0.036176543642591,4.72010283199416e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PALM2,Paralemmin-2,40483,0.0380269382568567,0.00393828090989904,0.0303079076734546,0.0457459688402588,5.65278062116349e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DHPS,Deoxyhypusine synthase,40451,0.040725682726705,0.00422017074153431,0.0324541480732978,0.0489972173801123,5.96355158962499e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BOLA1,BolA-like protein 1,40136,0.0544432064064642,0.00565592993716603,0.0433575837296188,0.0655288290833096,7.58933296252596e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLIT2,Slit homolog 2 protein,42311,0.0527200370906923,0.00547968859261854,0.0419798474491599,0.0634602267322246,7.69755543617941e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RANBP1,Ran-specific GTPase-activating protein,40223,0.052648912879632,0.00547062065431631,0.0419264963971721,0.063371329362092,7.71950265468142e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42594,0.0817404572513773,0.00849790128339783,0.0650845707359175,0.098396343766837,7.82725175232388e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL24,C-C motif chemokine 24,42654,0.0829518802422778,0.00862865545021596,0.0660397155598545,0.0998640449247011,8.23725649187815e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40283,0.0882222141467426,0.00918920385382421,0.0702113745932471,0.106233053700238,9.6519559487515e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACRBP,Acrosin-binding protein,40451,0.0392401788346324,0.00408791429965428,0.03122786680731,0.0472524908619548,9.7703022669356e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40527,0.0632131207314012,0.00659464771660026,0.0502876112068647,0.0761386302559377,1.11160296134035e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDA,Cytidine deaminase,40494,0.0468126097786854,0.00489323226165461,0.0372218745458424,0.0564033450115284,1.33108546585155e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FRZB,Secreted frizzled-related protein 3,42454,0.0248526265072038,0.00259925203161886,0.0197580925252308,0.0299471604891768,1.36299273676548e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTC,Probetacellulin,42346,0.0745132974718836,0.00779754968069989,0.0592301000977118,0.0897964948460554,1.43824044281776e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42357,0.0871874361998506,0.00913099354896691,0.0692906888438755,0.105084183555826,1.54486975168989e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM3B,Protein FAM3B,42587,0.0351412888142931,0.00368116464596171,0.0279262061082082,0.0423563715203781,1.57457780884762e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MATN2,Matrilin-2,42638,0.0294230137336604,0.00308654007865779,0.0233733951794911,0.0354726322878296,1.7918221213998e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FST,Follistatin,42654,0.0488071838187428,0.00512353905306346,0.0387650472747385,0.0588493203627472,1.90856270240935e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD83,CD83 antigen,42594,0.0350826783016412,0.00368818172587126,0.0278538421189336,0.0423115144843489,2.18082554023936e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA2,Carbonic anhydrase 2,42573,0.0688294800345958,0.00724007415869936,0.054638934683545,0.0830200253856465,2.29789564279248e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM3C,Protein FAM3C,42613,0.0308458603939833,0.00324537024485944,0.0244849347140588,0.0372067860739078,2.34475269928794e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C7orf50,Uncharacterized protein C7orf50,40483,0.0225743222090957,0.00237543109088427,0.0179184772709625,0.0272301671472288,2.44440572334876e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOC1,Apolipoprotein C-I,40516,0.0365718829489001,0.00384865925658383,0.0290285108059958,0.0441152550918044,2.46070511061997e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,40329,0.0553470760170746,0.00582456531309465,0.043930928003409,0.0667632240307401,2.47168845218141e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40223,0.0413116814632588,0.0043485036010702,0.0327886144051612,0.0498347485213564,2.52724735147318e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,40383,0.0589224981841323,0.00620888774509284,0.0467530782037504,0.0710919181645143,2.77709377378768e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,40482,0.0376545916742631,0.00397100768957904,0.0298714166026882,0.045437766745838,2.98188351171776e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCARA5,Scavenger receptor class A member 5,42711,0.0304672980156087,0.00321764306242019,0.0241607176132652,0.0367738784179523,3.29242258489129e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGA2,Integrin alpha-2,40283,0.0344478519285064,0.00364151969035487,0.0273104733354109,0.0415852305216019,3.70892482376508e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMS,Spermine synthase,40136,0.0629846473503399,0.00665961600887675,0.0499317999729414,0.0760374947277383,3.79091069343197e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,42679,-0.0236905336018697,0.00250589113286038,-0.0286020802222761,-0.0187789869814634,3.79411990093125e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL26,C-C motif chemokine 26,42594,0.0919319426203563,0.00973627390874645,0.0728488457592133,0.111015039481499,4.24466588688976e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRSF1,G-rich sequence factor 1,40014,0.0795797847860684,0.00842571967631154,0.0630653742204978,0.096094195351639,4.29013593136573e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IMMT,MICOS complex subunit MIC60,40451,0.0444589033392206,0.00471393300903678,0.0352195946415086,0.0536982120369327,4.8391557867723e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DSCAM,Down syndrome cell adhesion molecule,40482,0.035636501843893,0.00377889915736693,0.0282298594954538,0.0430431441923322,4.88229158252783e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRK5,G protein-coupled receptor kinase 5,42357,0.0499015330303929,0.0052933456285307,0.0395265755984727,0.060276490462313,4.90566405157995e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40173,0.0269651771125991,0.00286442859741164,0.0213508970616723,0.032579457163526,5.73925320951141e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNGR2,Interferon gamma receptor 2,42495,0.0510761478977612,0.00543403357083301,0.0404254420989285,0.0617268536965939,6.37708480399579e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HEPH,Hephaestin,40511,0.0259723733790393,0.00276506097820365,0.0205528538617601,0.0313918928963184,6.94262464745836e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTGES2,Prostaglandin E synthase 2,40102,0.0530639175640962,0.00567682598588868,0.0419373386317544,0.064190496496438,1.07267554302319e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTN,Pleiotrophin,42357,0.0481089706153877,0.00515794142225407,0.0379994054277697,0.0582185358030057,1.25882961660574e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,42587,0.0533283476906258,0.00572166329619617,0.0421138876300814,0.0645428077511703,1.33749121605365e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDH7,Protocadherin-7,40449,0.0352501465425147,0.00378793161471371,0.0278258005776759,0.0426744925073536,1.57397497893251e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRP2,Neuropilin-2,42611,-0.0278411259752026,0.0029969780104817,-0.0337152028757468,-0.0219670490746585,1.78162723020469e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTX3,Pentraxin-related protein PTX3,42594,-0.0474521977924319,0.00510846801965133,-0.0574647951109485,-0.0374396004739153,1.79536816724672e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DGKZ,Diacylglycerol kinase zeta,42370,0.0337873421205018,0.0036417826676504,0.026649448091907,0.0409252361490966,1.9985284678493e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALB2,Calretinin,42311,0.0309787537743319,0.0033432962247276,0.0244258931738658,0.037531614374798,2.23139447877925e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40451,0.05334519703295,0.00575933885591175,0.042056892875363,0.064633501190537,2.36118252832185e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPAG1,Sperm-associated antigen 1,40482,0.0553746988294881,0.00598252450745097,0.0436489507948842,0.067100446864092,2.50258013344635e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42357,0.0558519006884395,0.00603738443500679,0.0440186271958262,0.0676851741810528,2.56242854499189e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,40482,0.0511393090401867,0.0055286644245653,0.0403031267680387,0.0619754913123347,2.65158889553249e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFB103A_DEFB103B,Beta-defensin 103,40135,0.0411516715462029,0.0044561681743758,0.0324175819244263,0.0498857611679794,3.0656707222353e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DKK4,Dickkopf-related protein 4,42477,0.0446711843239041,0.00484046614252003,0.0351838706845649,0.0541584979632434,3.148402045174e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SFRP1,Secreted frizzled-related protein 1,42457,0.0425543074401803,0.00461194556992528,0.0335148941231268,0.0515937207572339,3.19968084763406e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,40449,0.108798272576444,0.011797427867539,0.0856753139560672,0.13192123119682,3.42794734476567e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGH,Gamma-glutamyl hydrolase,42437,0.0328504173579161,0.00356814946529102,0.0258568444059457,0.0398439903098864,3.86624453527035e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,40451,0.0648238106990793,0.00703969308928782,0.0510260122440752,0.0786216091540835,3.89730875639225e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL16,C-X-C motif chemokine 16,42778,0.0229142003638098,0.00249049787192217,0.0180328245348423,0.0277955761927772,4.06980593941908e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP8,Caspase-8,42674,0.0587410056944366,0.00638766449862116,0.0462211832771391,0.0712608281117341,4.25275330418765e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,40332,0.0546353305907571,0.00594374292904032,0.0429855944498381,0.0662850667316761,4.53643839836176e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTGDS,Prostaglandin-H2 D-isomerase,42555,0.0313167515022064,0.00340953860218997,0.024634055841914,0.0379994471624987,4.71181510668495e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FXN,"Frataxin, mitochondrial",42721,0.0699721643777333,0.00762204035876018,0.0550329652745633,0.0849113634809032,4.91714611140589e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENO2,Gamma-enolase,42711,0.0615953216408092,0.00671055657670298,0.0484426307504714,0.074748012531147,4.98026006827464e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAT,Catalase,40361,0.0519325388800038,0.00565944911908836,0.0408400186065906,0.063025059153417,5.24676013544211e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCDC134,Coiled-coil domain-containing protein 134,40451,0.0466447796897104,0.00508681382243511,0.0366746245977376,0.0566149347816832,5.56380168768791e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BGLAP,Osteocalcin,40527,0.0865557657923854,0.00945162163536183,0.0680305873870762,0.105080944197695,6.20534590926544e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTSL4,ADAMTS-like protein 4,40223,0.0227383844582923,0.00248301715619295,0.0178716708321542,0.0276050980844305,6.2441441263017e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42754,0.0396397477049621,0.00433290912323689,0.0311472458234178,0.0481322495865064,6.58363689662121e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGBL1,Integrin beta-like protein 1,40527,0.0372080341387824,0.00406600806081297,0.029238658339589,0.0451774099379758,6.6038354724645e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC5A,C-type lectin domain family 5 member A,42603,-0.0287850650357548,0.00314710679102632,-0.0349533943461664,-0.0226167357253432,6.71656396296232e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRSS27,Serine protease 27,42603,0.0384616964454019,0.00420636742879091,0.0302172162849717,0.0467061766058321,6.89377475386585e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CBLN4,Cerebellin-4,42721,0.0310111638444266,0.00339565091015964,0.0243556880605137,0.0376666396283395,7.62321194214512e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXN,Thioredoxin,40384,0.0424184253977471,0.00464424678165014,0.0333157017057128,0.0515211490897813,7.767217512138e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGA6,Integrin alpha-6,42594,0.048421872336966,0.00530636085835974,0.0380214050545809,0.0588223396193511,8.16624673605218e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42370,0.06811457829028,0.00746437421272596,0.0534844048333371,0.0827447517472229,8.18155321858073e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLSTN3,Calsyntenin-3,40483,0.0292397974650714,0.00320509332114486,0.0229578145556275,0.0355217803745154,8.5501463120284e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42370,0.041221034216059,0.00452131329917816,0.0323592601496698,0.0500828082824481,8.82382369578125e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUSD2,Sushi domain-containing protein 2,42611,-0.027453381690182,0.00301331229879611,-0.0333594737958224,-0.0215472895845416,9.33018939144185e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYOM3,Myomesin-3,40283,-0.0881624790655872,0.00967609864886145,-0.107127632417356,-0.0691973257138187,9.53052562899691e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPA2,Carboxypeptidase A2,42670,0.0625156029276078,0.0068863702261467,0.0490183172843603,0.0760128885708554,1.25564652924708e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOE,Apolipoprotein E,40539,0.0689250460626615,0.00759119825725682,0.0540462974784381,0.0838037946468849,1.26944842407459e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39983,0.0466618017196421,0.00514344117910275,0.0365806570086007,0.0567429464306835,1.36996570992662e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICAM1,Intercellular adhesion molecule 1,42595,0.02756466616188,0.00304205042447716,0.0216022473299048,0.0335270849938553,1.46666661271775e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40199,0.042616088157072,0.00470236041268487,0.0333994617482097,0.0518327145659343,1.48770786652423e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX7,Syntaxin-7,40199,0.0473102741294961,0.00522246232008747,0.0370742479821247,0.0575463002768676,1.53870761707638e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RARRES1,Retinoic acid receptor responder protein 1,42346,0.0311443389377922,0.00344403053705134,0.0243940390851716,0.0378946387904129,1.73548081276651e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFB,Complement factor B,40344,0.0305402494385571,0.00337748664480854,0.0239203756147324,0.0371601232623819,1.78734527977797e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADA,Adenosine deaminase,42754,0.0326341310346237,0.0036147433359897,0.0255492340960838,0.0397190279731635,1.97996882318725e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMIGO2,Amphoterin-induced protein 2,42587,0.0221010388347321,0.00245030986207175,0.0172984315050715,0.0269036461643928,2.13960768453644e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEP1B,Meprin A subunit beta,42636,0.11110256771967,0.0123208083156297,0.0869537834210358,0.135251352018304,2.18208722915241e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42683,0.028998293200704,0.00321891646518153,0.0226892169289483,0.0353073694724598,2.36147000884017e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40449,0.0744932312163168,0.00826949359571458,0.0582850237687162,0.0907014386639174,2.43161175193729e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD1C,T-cell surface glycoprotein CD1c,42679,0.0236761474723781,0.00262998625183634,0.0185213744187789,0.0288309205259773,2.50089893681797e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40199,0.033065014195654,0.0036735758897855,0.0258648054516744,0.0402652229396336,2.60937455003541e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNAP25,Synaptosomal-associated protein 25,40136,0.044495901086187,0.00494993479384644,0.034794028890248,0.054197773282126,2.8997918525477e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40116,0.0379626406035462,0.00422789094243884,0.0296759743563661,0.0462493068507263,3.17724903695947e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STK4,Serine/threonine-protein kinase 4,42636,0.0800724375738004,0.00892134092475904,0.0625866093612727,0.0975582657863281,3.19388917618667e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IMPA1,Inositol monophosphatase 1,42495,0.0564782697683416,0.00630318085221311,0.0441240352980039,0.0688325042386793,3.66482668630381e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGAP1,Rho GTPase-activating protein 1,42346,0.0422241639682446,0.00471443727166915,0.032983866915773,0.0514644610207161,3.80218126317248e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSR,"Glutathione reductase, mitochondrial",40490,0.0210251630019402,0.00234711921477433,0.0164248093409826,0.0256255166628979,3.82834620072762e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42587,0.0508416819872827,0.00569316512757681,0.0396830783372321,0.0620002856373332,4.79592229075426e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP6V1F,V-type proton ATPase subunit F,42292,0.0617878408861831,0.00692218662987131,0.0482203550916354,0.0753553266807309,4.99582738844833e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX6,Syntaxin-6,42346,0.0615171773770656,0.00690211822043685,0.0479890256650094,0.0750453290891218,5.62439123832581e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAA10,N-alpha-acetyltransferase 10,40116,0.0478404946757721,0.00537163090784337,0.0373120980963991,0.0583688912551451,6.12026618525612e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,42746,0.0487456190177799,0.00547822702144734,0.0380082940557431,0.0594829439798167,6.39520936097001e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL20,C-C motif chemokine 20,42754,0.0849171886022098,0.00956492103117762,0.0661699433811016,0.103664433823318,7.65334248887547e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSL,Cathepsin L1,42636,0.0229442037731066,0.00258857332760636,0.0178706000509981,0.0280178074952151,8.70707914259183e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSAP,Prosaposin,40440,0.0266823538237142,0.00302831274836114,0.0207468608369263,0.032617846810502,1.42261510289872e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP1,Interstitial collagenase,42136,0.0838303505658635,0.00952417817773019,0.0651629613375123,0.102497739794215,1.51507046925954e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CIT,Citron Rho-interacting kinase,40182,0.0416443401070959,0.00474319070399638,0.032347686327263,0.0509409938869288,1.87980524825911e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNM1,Dynamin-1,40449,0.10419237806811,0.0118835920611455,0.0809005376282649,0.127484218507955,2.08417431768741e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK7,Kallikrein-7,40009,0.0358393700423642,0.004089604811461,0.0278237446119006,0.0438549954728277,2.17497485166052e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC3B,Tetranectin,40269,0.0191891267727111,0.00219470336635913,0.0148875081746472,0.023490745370775,2.58868243379705e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42689,-0.0403669829468869,0.00463256351791828,-0.0494468074420067,-0.0312871584517671,3.27914558915197e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRL1,Fc receptor-like protein 1,42636,0.0427050105163432,0.00490659313130064,0.0330880879789939,0.0523219330536924,3.58597395956708e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CR1,Complement receptor type 1,40509,0.032837837578776,0.00377597730227416,0.0254369220663187,0.0402387530912333,3.89409082205954e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEK7,Serine/threonine-protein kinase Nek7,40302,0.0691618434432988,0.00796002013809313,0.0535602039726363,0.0847634829139614,4.18124121946375e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HPGDS,Hematopoietic prostaglandin D synthase,42346,0.0346136444717781,0.00400657664360043,0.0267607542503212,0.0424665346932349,6.3079184792901e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LY75,Lymphocyte antigen 75,42594,0.0351548621163385,0.00406963144916996,0.0271783844759653,0.0431313397567116,6.34298193539214e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLTA,Clathrin light chain A,42357,0.0429146061724611,0.0049692353507747,0.0331749048849427,0.0526543074599796,6.48253628753923e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSDE1,Cold shock domain-containing protein E1,40116,0.104966638588768,0.0121843691511492,0.0810852750525161,0.128848002125021,7.96587733496401e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPQ,Carboxypeptidase Q,40516,0.032138080903689,0.00373266789106597,0.0248220518371997,0.0394541099701783,8.27473864156231e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40302,0.0816057390862462,0.00949604648595187,0.0629934879737806,0.100217990198712,9.55113646219514e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,42587,0.0307999758138839,0.00358610361097073,0.0237712127363813,0.0378287388913865,9.75904903313442e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ESAM,Endothelial cell-selective adhesion molecule,42794,0.0290907520490091,0.003387706306327,0.0224508476886082,0.03573065640941,9.87520109511416e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42611,0.0348459828173769,0.00405918371844798,0.0268899827292189,0.042801982905535,1.01202575364851e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40283,0.0630838499943934,0.00735863780754857,0.0486609198915982,0.0775067800971886,1.14428940272288e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLITRK2,SLIT and NTRK-like protein 2,42721,0.0354853984031248,0.00414387887111004,0.0273633958157491,0.0436074009905005,1.21394383493824e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40302,0.0341189027961642,0.00399187033860124,0.0262948369325058,0.0419429686598226,1.42721408160918e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNLIP,Pancreatic triacylglycerol lipase,40532,0.0581168188244069,0.00681255433154238,0.0447642123345839,0.07146942531423,1.63723096931138e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFCAB2,Dynein regulatory complex protein 8,40302,0.0310795672477117,0.00364701744268234,0.0239314130600544,0.0382277214353691,1.77199835986539e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SDHB,Succinate dehydrogenase,40449,0.0590587355766728,0.00693394462067045,0.0454682041201588,0.0726492670331869,1.84006019837109e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40483,0.0417107548596996,0.00490685729796052,0.032093314555697,0.0513281951637022,2.12478760764863e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42722,0.0251778470403035,0.0029703381241804,0.0193559843169099,0.0309997097636971,2.56052742457433e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HLA_E,,42594,0.0272785154821374,0.00322071768808239,0.0209659088134959,0.0335911221507789,2.7144199233422e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42587,-0.0366241293603887,0.00433044204861195,-0.0451117957756681,-0.0281364629451093,3.01587585643911e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNX5,Sorting nexin-5,40223,0.0256863765434149,0.00303768051718112,0.01973252272974,0.0316402303570899,3.11768772162117e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PMM2,Phosphomannomutase 2,40116,0.0530849886955049,0.0062778840820103,0.0407803358947647,0.065389641496245,3.12249344988814e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DMD,Dystrophin,40223,0.0455056841692494,0.00538470403192904,0.0349516642666684,0.0560597040718303,3.25329787345854e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42495,0.0342821981723949,0.00405880388394791,0.026326942559857,0.0422374537849328,3.31406443684146e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMARCA2,Probable global transcription activator SNF2L2,42311,0.0640236286057228,0.00758268247119252,0.0491615709621854,0.0788856862492601,3.40383985909061e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,40223,0.0460288505153432,0.00545236041361111,0.0353422241046654,0.056715476926021,3.5095293109713e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40223,0.0805749655825128,0.00955176169098699,0.0618535126681783,0.0992964184968473,3.70544643410407e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIT,Mast/stem cell growth factor receptor Kit,42663,-0.0264648635645752,0.0031437142600311,-0.0326265435142361,-0.0203031836149142,4.20113204035865e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLXNB2,Plexin-B2,42743,0.0211716824461388,0.00251925085207012,0.0162339507760814,0.0261094141161962,4.74360125326486e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SBSN,Suprabasin,40511,-0.0307566471065115,0.00366112722011733,-0.0379324564579414,-0.0235808377550815,4.96041601733479e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,40449,0.043065603731487,0.00513562003179233,0.032999788469174,0.0531314189938,5.64429972701804e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TF,Serotransferrin,40539,0.0186611261267824,0.00222657231610591,0.0142970443872148,0.02302520786635,5.86111193290208e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL6R,Interleukin-6 receptor subunit alpha,42582,0.0297632968673997,0.00355507257595035,0.022795354618537,0.0367312391162623,6.21985337888727e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA4,Annexin A4,42584,0.0622912824317872,0.00744098436494075,0.0477069530765033,0.0768756117870711,6.25599791060949e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42495,0.0297299643930346,0.00355801595124879,0.022756253128587,0.0367036756574823,7.14072520222516e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNDP1,Beta-Ala-His dipeptidase,42689,0.040207328434579,0.00481431766281553,0.0307712658154606,0.0496433910536975,7.3852407937916e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WAS,Wiskott-Aldrich syndrome protein,42370,0.0578263223066401,0.0069278957383085,0.0442476466595555,0.0714049979537248,7.70275918949784e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD276,CD276 antigen,42618,-0.0320003942698965,0.00383444380660437,-0.039515904130841,-0.0244848844089519,7.77857518948641e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BGN,Biglycan,42328,-0.104736384742924,0.0125558417264973,-0.129345834526859,-0.0801269349589893,8.05216632536035e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD28,T-cell-specific surface glycoprotein CD28,42346,0.033053137235101,0.00396815001540372,0.0252755632049097,0.0408307112652923,8.90861625673642e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL6A3,Collagen alpha-3(VI) chain,42794,0.0329802098932597,0.00396457962137987,0.0252096338353551,0.0407507859511642,9.73204577624568e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZBP1,Z-DNA-binding protein 1,40199,0.0347075740045308,0.00418451622712362,0.0265059221993685,0.0429092258096931,1.2196154813658e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40482,0.0572822219573598,0.00691557103546164,0.043727702727855,0.0708367411868646,1.33565215026374e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NID2,Nidogen-2,42611,0.0638028488724883,0.00771186856733168,0.0486875864805182,0.0789181112644584,1.42467126970721e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAPK2,Death-associated protein kinase 2,40199,0.0468117609353157,0.00565752204196472,0.0357230177330649,0.0579005041375666,1.44168712362136e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,42558,0.0303320352316589,0.00367852220240089,0.0231221317149532,0.0375419387483647,1.79409091703376e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPT,Dermatopontin,42794,0.0217369061792079,0.00264084819652823,0.0165608437140126,0.0269129686444033,2.02390278102173e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NECTIN2,Nectin-2,42613,0.0270942432596838,0.00329253930843206,0.020640866215157,0.0335476203042107,2.06107648901344e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIMAP8,GTPase IMAP family member 8,40080,0.0453280003933868,0.00551244620570283,0.0345236058302093,0.0561323949565644,2.21312630032164e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HRG,Histidine-rich glycoprotein,40479,0.0265268596441122,0.00322640884156198,0.0202030983146507,0.0328506209735737,2.22413362030142e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFA,Protransforming growth factor alpha,42594,0.040667295322995,0.00495460202807709,0.0309562753479639,0.0503783152980261,2.4535094916972e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDZD2,PDZ domain-containing protein 2,40116,0.0518272518581878,0.00631419788376089,0.0394514240060164,0.0642030797103591,2.50079461699619e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSNK1D,Casein kinase I isoform delta,40199,0.0539266987553911,0.00657150592227076,0.0410465471477404,0.0668068503630417,2.53859774798631e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD300A,CMRF35-like molecule 8,40283,0.0267257320537415,0.00325802778143318,0.0203399976021325,0.0331114665053505,2.60247422623298e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFC1,Cryptic protein,42346,0.0406095844837576,0.00495191668056552,0.0309038277898492,0.0503153411776661,2.60855963854795e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MDK,Midkine,42638,0.043681572641303,0.00532781371843496,0.0332390577531705,0.0541240875294355,2.64706362771489e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCARF2,Scavenger receptor class F member 2,42711,-0.0259401766658837,0.00316407893373517,-0.0321417713760046,-0.0197385819557627,2.65561440686841e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42370,0.051003311431679,0.00622190871462916,0.0388083703510058,0.0631982525123521,2.68272901904125e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A12,Protein S100-A12,42434,0.0642534155443679,0.00785525543641089,0.0488571148890025,0.0796497161997332,3.10408878614709e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42594,0.0325180807354667,0.00400050320565153,0.0246770944523897,0.0403590670185437,4.7255294870184e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,42357,0.0357409472117741,0.00440177375937612,0.0271134706433969,0.0443684237801513,5.0880518871382e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP9,Caspase-9,40199,0.053021643176783,0.00653691004731763,0.0402092994840404,0.0658339868695255,5.54812052607892e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGMN,Legumain,42676,0.0301782854460906,0.00372229720144821,0.0228825829312521,0.0374739879609291,5.61324408543219e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,40527,-0.0281080074428175,0.00346666316551502,-0.034902667247227,-0.0213133476384081,5.6708586443902e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,42595,0.0274094066884151,0.0033825535114358,0.020779601806001,0.0340392115708293,5.81556869444179e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDIA3,Protein disulfide-isomerase A3,40283,0.020941666328691,0.00258495874791244,0.0158751471827826,0.0260081854745994,6.00466012178494e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",42587,0.0500658354747147,0.00618458892004044,0.0379440411914354,0.062187629757994,6.20473050617629e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA14,Carbonic anhydrase 14,42721,-0.0303978180023801,0.00375883764959778,-0.0377651397955917,-0.0230304962091684,6.63101438775362e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRSS22,Brain-specific serine protease 4,40199,0.0309026578994231,0.00382575746235554,0.0234041732732063,0.03840114252564,7.29909002856859e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CBLIF,Cobalamin binding intrinsic factor,42613,0.0682757937684068,0.00845518867058005,0.0517036239740699,0.0848479635627437,7.3186041789891e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD46,Membrane cofactor protein,42580,0.0243305737013335,0.00301871257568394,0.018413897052993,0.030247250349674,8.27846084929601e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,42490,0.0848788994487528,0.0105563217197094,0.0641885088781224,0.105569290019383,9.69371866395992e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40171,0.0330071473820665,0.00410658551569929,0.0249582397712959,0.0410560549928371,1.00996018100266e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COLEC12,Collectin-12,42618,0.0234699519127889,0.00292336927554113,0.0177401481327283,0.0291997556928495,1.06931263840551e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WFDC1,WAP four-disulfide core domain protein 1,40229,0.0472992681101771,0.00590073193050849,0.0357338335263805,0.0588647026939738,1.20424118486652e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTGR1,Prostaglandin reductase 1,40511,0.0701746197002159,0.00875512309801294,0.0530145784281105,0.0873346609723212,1.20689759275872e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPCAM,Epithelial cell adhesion molecule,42616,-0.0826626707650665,0.0103275310007308,-0.102904631526499,-0.0624207100036342,1.30172342964035e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,40449,0.0373556590237006,0.00466748807366872,0.0282073823993099,0.0465039356480913,1.32933283412399e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",42495,0.0490750226710784,0.00614305574616606,0.0370346334085929,0.0611154119335639,1.47534091721826e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42562,0.0563588746838401,0.00705804118183161,0.0425251139674501,0.07019263540023,1.51872364857355e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42636,0.0291089738720015,0.0036464435797171,0.021961944455756,0.036256003288247,1.54549767424778e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40223,0.0368675284188593,0.00462104452260642,0.0278102811545507,0.0459247756831678,1.63198449658103e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40199,0.0569330152477931,0.00715507483993029,0.0429090685615297,0.0709569619340564,1.9353021174507e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C7,Complement component C7,40251,-0.0273758520569807,0.00344593357868124,-0.0341298818711959,-0.0206218222427654,2.14065426154905e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAS2,Growth arrest-specific protein 2,40302,0.0437032920375385,0.00551274893167943,0.0328983041314468,0.0545082799436302,2.44644524450945e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMOX1,Heme oxygenase 1,42500,-0.0400070745574949,0.005049233966586,-0.0499035731320035,-0.0301105759829864,2.49400496184492e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHI3L1,Chitinase-3-like protein 1,42416,0.0681111198164816,0.00861258512287899,0.0512304529756388,0.0849917866573244,2.81494060353294e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIF22,Kinesin-like protein KIF22,40116,0.103279063836669,0.0130614983555654,0.0776785270597613,0.128879600613578,2.88746435383485e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDF1,Endothelial differentiation-related factor 1,40482,0.0553216360743047,0.00699729414097204,0.0416069395579995,0.0690363325906099,2.90175882228086e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL19,C-C motif chemokine 19,42711,0.108026952233704,0.0136811852415642,0.0812118291602387,0.13484207530717,3.10046890139885e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH5,Cadherin-5,42794,-0.0248504977853022,0.00314736437042587,-0.0310193319513369,-0.0186816636192675,3.10823156642862e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASET2,Ribonuclease T2,42749,0.0227915038835803,0.00288893904997242,0.0171291833456344,0.0284538244215263,3.27248125950348e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHCHD6,MICOS complex subunit MIC25,40451,0.0238185945751844,0.00301978060863314,0.0178998245822634,0.0297373645681053,3.3672017934266e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD248,Endosialin,40527,-0.0335633750366525,0.0042651331821466,-0.0419230360736598,-0.0252037139996451,3.8921685366018e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGF1R,Insulin-like growth factor 1 receptor,42587,0.0178549024966307,0.00227000259437612,0.0134056974116535,0.0223041075816079,3.95396399050861e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD300C,CMRF35-like molecule 6,42711,0.0295126210081517,0.00375371983621728,0.0221553301291658,0.0368699118871376,4.05807955867e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VEGFB,Vascular endothelial growth factor B,40199,0.0243012764435081,0.00309624930360241,0.0182326278084474,0.0303699250785688,4.5964340455267e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INSL5,Insulin-like peptide INSL5,40449,0.0808008568952311,0.0103065140861683,0.0606000892863412,0.101001624504121,4.92000692791632e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40182,0.0452194672946874,0.00577104563215136,0.0339082178556707,0.056530716733704,5.09736429617686e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL14,C-C motif chemokine 14,42618,0.032883565863938,0.00421003294703083,0.0246319012877576,0.0411352304401184,6.10476032281048e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL15,C-C motif chemokine 15,42794,0.0364576262507443,0.00467140087727827,0.0273016805312789,0.0456135719702097,6.41180153518078e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,40116,0.0373235159972124,0.0047867310313929,0.0279415231756823,0.0467055088187425,6.90051582517055e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS7_LGALS7B,Galectin-7,42524,0.0352690926947135,0.00452649605971352,0.026397160417675,0.044141024971752,7.09912994771354e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AZU1,Azurocidin,42216,0.0621857972095041,0.00798563888654163,0.0465339449918825,0.0778376494271257,7.36733872550664e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA1,Carbonic anhydrase 1,42362,0.0487269842535404,0.00628166534565922,0.0364149201760484,0.0610390483310325,9.33288883051571e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRDX6,Peroxiredoxin-6,42721,-0.0491095543958089,0.006334518707777,-0.0615252110630519,-0.036693897728566,9.63712021149886e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,42346,0.0422635812598737,0.00545844952937703,0.0315650201822947,0.0529621423374526,1.04356190569608e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AFP,Alpha-fetoprotein,42459,0.054095406879404,0.00699703758808476,0.0403812132067579,0.0678096005520501,1.14200906099644e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD93,Complement component C1q receptor,42141,-0.025954015486032,0.00336964963103555,-0.0325585287628617,-0.0193495022092023,1.43343931434244e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL7R,Interleukin-7 receptor subunit alpha,42611,-0.042313729220718,0.00549805229725924,-0.0530899117233462,-0.0315375467180899,1.50021447786311e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,42346,0.0420894976871479,0.00547049111841551,0.0313673350950535,0.0528116602792423,1.52837787774754e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,42370,0.0312858442652817,0.00406735771963432,0.0233138231347984,0.039257865395765,1.55195179111338e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,42346,0.0425654062360052,0.00553765362493457,0.0317116051311334,0.0534192073408769,1.61863743385627e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCN5,CCN family member 5,42611,0.0310010446461319,0.00403388171407504,0.0230946364865448,0.038907452805719,1.6338679918031e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40511,0.0421741690099259,0.00548761419886135,0.0314184451801577,0.0529298928396942,1.65200717416843e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINI2,Serpin I2,40449,0.0448181679486217,0.00585607488862099,0.0333402611669245,0.0562960747303188,2.1192324732816e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPTL4,Angiopoietin-related protein 4,42654,-0.0356998088905005,0.00468041279734971,-0.0448734179733059,-0.026526199807695,2.55396801148345e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C5,Complement C5,40539,0.0120050218409164,0.00157384505455478,0.00892028553398899,0.0150897581478437,2.57818241207657e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMA4,Laminin subunit alpha-4,42676,0.0263394580897187,0.0034572865135159,0.0195631765232275,0.0331157396562099,2.73644159660625e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL2A1,Collagen alpha-1(II) chain,40223,0.0643753180414462,0.00845275450729989,0.0478079192071384,0.080942716875754,2.83275548980999e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTUS1,Microtubule-associated tumor suppressor 1,40302,0.0449370074900632,0.00591038319808509,0.0333526564218164,0.05652135855831,3.12517662962711e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CENPF,Centromere protein F,40302,0.0433405166393778,0.00570782772886348,0.0321531742908054,0.0545278589879502,3.37197702120971e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEL1L,Protein sel-1 homolog 1,40223,0.0259124903210997,0.00341613377604184,0.0192168681200577,0.0326081125221417,3.58326780526027e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17D,Interleukin-17D,42370,0.0272973618291559,0.00360423666043534,0.0202330579747026,0.0343616656836091,3.86909663232672e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,42636,0.0341049060625425,0.00452963364966869,0.0252268241091919,0.0429829880158932,5.42651563240405e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LIPF,Gastric triacylglycerol lipase,40223,0.0490584867172239,0.00651914273574319,0.0362809669551673,0.0618360064792806,5.66965408769627e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC4D,C-type lectin domain family 4 member D,42594,0.0489114163807222,0.00650704587097143,0.0361576064736182,0.0616652262878262,5.97448133368863e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD80,T-lymphocyte activation antigen CD80,40511,0.0273718928123856,0.00364717344226722,0.0202234328655418,0.0345203527592293,6.60551056862439e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAP,Prolyl endopeptidase FAP,42794,0.021399993414105,0.00285326939571069,0.015807585398512,0.0269924014296979,6.7682254246771e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA7A,Semaphorin-7A,42760,0.0222726101324875,0.00297338644154377,0.0164447727070617,0.0281004475579133,7.27620108237198e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40451,0.0295233765767004,0.00394112319193884,0.0217987751205002,0.0372479780329005,7.34061404429865e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNAR1,Interferon alpha/beta receptor 1,40449,0.0200747005114867,0.00268590434684469,0.0148103279916711,0.0253390730313023,8.35031479627989e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGHMBP2,DNA-binding protein SMUBP-2,40116,0.0428780044493133,0.00574575053595071,0.0316163333988499,0.0541396754997767,9.13088493566822e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL8,Interleukin-8,42494,0.0542628162207081,0.00727993327178468,0.0399941470080101,0.0685314854334061,9.63256053562625e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDC,Aromatic-L-amino-acid decarboxylase,42613,-0.0369522687592967,0.00496384363955235,-0.0466814022928193,-0.0272231352257741,1.0340497829739e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGXT,Serine--pyruvate aminotransferase,42636,0.058441009812089,0.00786243666701602,0.0430306339447376,0.0738513856794404,1.12626648314661e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42636,0.0380993038104949,0.00513141163638176,0.0280417370031867,0.0481568706178032,1.19813394838794e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSC,Dipeptidyl peptidase 1,42616,0.0341441285453667,0.00459950976406967,0.0251290894077901,0.0431591676829433,1.2099601676508e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRYGD,Gamma-crystallin D,40483,0.0755558845328887,0.0101780488350302,0.0556069088162295,0.0955048602495478,1.22346535910243e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40483,0.0324795684327775,0.00437811668734987,0.0238984597255718,0.0410606771399833,1.2683914826439e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MARCO,Macrophage receptor MARCO,42636,0.020317870290502,0.00273955915287238,0.0149483343508721,0.0256874062301318,1.27479588125762e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC16A1,Monocarboxylate transporter 1,42311,0.0444972312266415,0.00600422803003594,0.032728944287771,0.0562655181655119,1.33039788593449e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TREML1,Trem-like transcript 1 protein,40532,0.0405520105083021,0.00547524278088291,0.0298205346577716,0.0512834863588326,1.38946351409563e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42619,0.0451697808453731,0.00611256599603196,0.0331891514931504,0.0571504101975957,1.5590105681611e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ELOB,Elongin-B,40116,0.0310150663755164,0.00419807078500393,0.0227868476369087,0.0392432851141241,1.60011719074154e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42587,0.0351053203250899,0.00476428000810372,0.0257673315092066,0.0444433091409732,1.82738529837128e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,42689,0.0527317917527159,0.00715704138693142,0.0387039906343303,0.0667595928711015,1.83510777663554e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42679,0.0216629789080165,0.0029450240200486,0.0158907318287213,0.0274352259873118,2.00756488570665e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,XRCC4,DNA repair protein XRCC4,42311,0.0282717193876178,0.00384738269722264,0.0207308493010614,0.0358125894741742,2.12616667833772e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C2orf69,UPF0565 protein C2orf69,40182,0.0469100262985497,0.00638626089483981,0.0343929549446637,0.0594270976524357,2.19579398075284e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHCY,Adenosylhomocysteinase,42636,0.0513724894537066,0.00700116264195259,0.0376502106754795,0.0650947682319336,2.2974068664649e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,42721,0.0408612085027251,0.00558388831903088,0.0299167873974246,0.0518056296080256,2.66474433367472e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42346,0.0364338907637688,0.00499046720461265,0.026652575042728,0.0462152064848096,3.02727219827023e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RCOR1,REST corepressor 1,42357,0.0336929654679906,0.00462735148712332,0.0246233565532289,0.0427625743827523,3.49488408059434e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SDK2,Protein sidekick-2,40283,0.0306950505746071,0.00422986691004291,0.022404511430923,0.0389855897182912,4.23017867450324e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40302,0.0552926393899214,0.00765652275113756,0.0402858547976918,0.070299423982151,5.47238497848985e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SV2A,Synaptic vesicle glycoprotein 2A,40182,0.0472513876854905,0.00655294326948679,0.0344076188772964,0.0600951564936846,5.93182765560217e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MCTS1,Malignant T-cell-amplified sequence 1,40449,0.0206000781963712,0.00286070407721176,0.0149930982050361,0.0262070581877062,6.35604229454525e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP6,Gastrotropin,42334,0.0441602606192791,0.00613579723683162,0.0321340980350892,0.0561864232034691,6.4821396777726e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLITRK6,SLIT and NTRK-like protein 6,42357,-0.0266762246552008,0.00371366464124915,-0.0339550073520492,-0.0193974419583525,7.17277658669373e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD209,CD209 antigen,42668,-0.0291376016529445,0.00406103459704876,-0.0370972294631601,-0.021177973842729,7.61297712198792e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42649,0.016082144262248,0.00224198067491942,0.011687862139406,0.0204764263850901,7.71029915146294e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42721,0.0199051590442277,0.00278389890982339,0.0144487171809738,0.0253616009074815,9.11646980850027e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRL2,Fc receptor-like protein 2,42681,0.0393528861667282,0.00550453713179973,0.0285639933884007,0.0501417789450557,9.17947183374105e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNLY,Granulysin,42611,0.0399580324149046,0.00559558630947343,0.0289906832483366,0.0509253815814725,9.743165655418e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40116,0.0279002603393184,0.00391605385324812,0.020224794786952,0.0355757258916847,1.10970974791246e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH15,Cadherin-15,42692,0.0463950455098033,0.00651601111266621,0.0336236637289775,0.0591664272906291,1.13253944573255e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,40199,0.0289288160860472,0.00406362693012143,0.0209641073030092,0.0368935248690852,1.15516534737374e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHL1,Neural cell adhesion molecule L1-like protein,42668,-0.0225979403349844,0.0031877871057718,-0.0288460030622971,-0.0163498776076717,1.41900435203705e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEPE,Matrix extracellular phosphoglycoprotein,42618,0.0190508647568392,0.00268977028977248,0.0137789149888852,0.0243228145247933,1.48401219423586e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GDF2,Growth/differentiation factor 2,42636,0.0264259977223407,0.00374545561530835,0.0190849047163363,0.033767090728345,1.80424953044917e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAM,Signal transducing adapter molecule 1,40451,0.0275989467089671,0.00391292036552563,0.0199296227925368,0.0352682706253973,1.8498861039038e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PER3,Period circadian protein homolog 3,40199,0.0908559406195172,0.0128817813299191,0.0656076492128757,0.116104232026159,1.85533122694188e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VWC2,Brorin,42456,0.0303236572350398,0.00430564585759635,0.021884591354151,0.0387627231159287,1.97749168394613e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OMD,Osteomodulin,42676,-0.0310890132250246,0.00441535199905343,-0.0397431031431693,-0.0224349233068798,1.99937927037339e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42611,0.039694106596484,0.00564560043286994,0.0286287297480589,0.0507594834449091,2.15009373840724e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRL3,Fc receptor-like protein 3,42370,0.041521978891147,0.00590882583977532,0.0299406802451874,0.0531032775371066,2.2122151026606e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,42587,0.0155913543356506,0.00221925439189461,0.0112416157275371,0.019941092943764,2.23619722844935e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MPO,Myeloperoxidase,42611,0.0341192647486863,0.00485687723354917,0.0245997853709299,0.0436387441264426,2.24485787528843e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,40527,0.0377619344170105,0.00537749251825834,0.0272220490812242,0.0483018197527968,2.30864533917495e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ROBO1,Roundabout homolog 1,42638,0.0179828987013076,0.00256264561499616,0.0129601132959151,0.0230056841067001,2.37002586352211e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CST5,Cystatin-D,42357,0.0418203510343468,0.00597059344429354,0.0301179878835315,0.0535227141851621,2.60121991608312e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCDC80,Coiled-coil domain-containing protein 80,42636,0.0275179150558378,0.00392991854633453,0.0198152747050221,0.0352205554066534,2.64019705158559e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RALY,RNA-binding protein Raly,40451,0.0346047483828425,0.00495881195583354,0.0248854769494088,0.0443240198162763,3.15253792689578e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42594,0.0310017075508466,0.00444578893392506,0.0222879612403534,0.0397154538613397,3.24159814765349e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENAH,Protein enabled homolog,42370,0.0343882773058373,0.00493659994151302,0.0247125414204718,0.0440640131912028,3.41600461655221e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSPAN1,Tetraspanin-1,42357,0.0493795681342339,0.00709422376552936,0.0354748895537963,0.0632842467146714,3.55053165909415e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASE3,Eosinophil cationic protein,42578,0.0795731642871282,0.011477254922142,0.0570777446397299,0.102068583934527,4.30539886839112e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOBR,Apolipoprotein B receptor,40223,-0.0309479211141906,0.00446444645254744,-0.0396982361611836,-0.0221976060671976,4.37843394861986e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPR15L,Protein GPR15L,40449,0.0441092675061531,0.0063638530289002,0.0316361155695087,0.0565824194427975,4.4003701146746e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FES,Tyrosine-protein kinase Fes/Fps,42346,0.0344103981908084,0.00496959172625772,0.0246699984073433,0.0441507979742736,4.58838268208483e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,42587,0.0587516345493605,0.0084862588882756,0.0421185671283403,0.0753847019703806,4.61836178620411e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRYM,Ketimine reductase mu-crystallin,40136,0.0549327815243782,0.00793453349356781,0.0393810958769853,0.0704844671717711,4.66114097627676e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJB8,DnaJ homolog subfamily B member 8,42357,0.0419989508206994,0.00607807446528369,0.0300859248687434,0.0539119767726554,5.07275194237609e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F3,Tissue factor,42636,-0.0196939771559948,0.00285417249766355,-0.0252881552514154,-0.0140997990605743,5.43064526120897e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CABP2,Calcium-binding protein 2,40182,0.0467238814249768,0.00677049059247495,0.0334537198637259,0.0599940429862277,5.44399251003853e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RABEPK,Rab9 effector protein with kelch motifs,42346,0.0414273307767462,0.0060104369202071,0.0296468744131403,0.0532077871403522,5.72933223748886e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICAM4,Intercellular adhesion molecule 4,42594,-0.0380205258142795,0.00551945392135272,-0.0488386555001308,-0.0272023961284282,5.89174029712857e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMBS,Porphobilinogen deaminase,42721,0.0310785847334326,0.00451258101583714,0.0222339259423918,0.0399232435244734,5.94571024961279e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42292,0.0347683639940222,0.00505795999194707,0.024854762409806,0.0446819655782385,6.52585096181753e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRDT,Bromodomain testis-specific protein,40116,0.0267789262403171,0.00389543478460623,0.0191438740624889,0.0344139784181453,6.5629306682963e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42346,0.0357454210659832,0.00520400983706462,0.0255455617853366,0.0459452803466299,6.76448648754699e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,42311,0.0450070286781821,0.00655885666037493,0.0321516696238473,0.057862387732517,7.09410691534682e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTB,Lymphotoxin-beta,40451,0.025706163882906,0.00375010672449155,0.0183559547029025,0.0330563730629094,7.51554257823104e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CR2,Complement receptor type 2,42689,0.0343273883398593,0.00501083527523125,0.0245061512004061,0.0441486254793126,7.67110976034077e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL15A1,Collagen alpha-1(XV) chain,40527,0.0200887156019202,0.00293194804481537,0.0143420974340821,0.0258353337697583,7.67804514361606e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SFTPD,Pulmonary surfactant-associated protein D,42636,0.048513567935372,0.007100047246307,0.0345974753326103,0.0624296605381337,8.6828085427326e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40199,0.0260366816840346,0.00381524675154835,0.0185587980509999,0.0335145653170694,9.29492767302394e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40080,0.0466597804767639,0.0068424770591966,0.0332485254407386,0.0600710355127893,9.64426292649469e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A11,Protein S100-A11,42531,0.0323112914403064,0.00475900670544373,0.0229836382976367,0.0416389445829761,1.1728226478243e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECI2,Enoyl-CoA delta isomerase 2,40116,0.0436926315865832,0.00644565958929058,0.0310591387915737,0.0563261243815927,1.27590879451701e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAST,Gastrin,40483,0.103125320031921,0.0152261890339221,0.0732819895254333,0.132968650538408,1.32504889939754e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH3,Cadherin-3,42711,0.026543304476789,0.00391977815927783,0.0188605392846044,0.0342260696689735,1.32595851564171e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40449,0.0307283334184676,0.00454139130925285,0.021827206452332,0.0396294603846032,1.38692607930487e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGAM,Integrin alpha-M,42611,-0.0223690962612389,0.00330703010644713,-0.0288508752698753,-0.0158873172526026,1.39694987266102e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,42587,-0.0187897351154335,0.00277913193241716,-0.0242368337029712,-0.0133426365278959,1.42712840298405e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40116,0.0472832695837748,0.00701187651590669,0.0335399916125977,0.0610265475549519,1.62633105305021e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TAFA5,Chemokine-like protein TAFA-5,42587,0.0271891529991213,0.0040340678097306,0.0192823800920493,0.0350959259061933,1.64999061188744e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,42754,0.0257589355613068,0.0038219304545794,0.0182679518703312,0.0332499192522824,1.6504687449212e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC4M,C-type lectin domain family 4 member M,40504,-0.0349072960058345,0.00517900674806439,-0.0450581492320407,-0.0247564427796283,1.65914471662597e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42721,0.0245354504898864,0.0036425597973708,0.0173960332870397,0.0316748676927332,1.69652220291589e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BSG,Basigin,42746,0.0152936569724845,0.00227173831131124,0.0108410498823145,0.0197462640626546,1.73916738229044e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCGB1A1,Uteroglobin,42646,0.0391086971031833,0.00582799923826325,0.0276858185961873,0.0505315756101793,2.01745946614944e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNX2,Sorting nexin-2,40451,0.0576359122001653,0.00858902208825481,0.0408014289071859,0.0744703954931447,2.03386638190471e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNC,Tenascin,42689,-0.0338115250813003,0.00505065837356472,-0.0437108154934871,-0.0239122346691134,2.24997465913775e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COPB2,Coatomer subunit beta',40116,0.0302930004641993,0.00454051136319187,0.0213935981923432,0.0391924027360554,2.65061139765295e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSHB,Thyrotropin subunit beta,42636,0.0552630035040031,0.00828852882309469,0.0390174870107375,0.0715085199972687,2.7052799231264e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRN,Progranulin,42552,0.0171030516975843,0.00256617200462715,0.0120733545685151,0.0221327488266536,2.75404855024121e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40199,0.0406293442723678,0.00612840358203728,0.0286176732515747,0.0526410152931609,3.52165326025979e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42706,0.020443101898634,0.00308430694886194,0.0143978602788646,0.0264883435184034,3.5293099966406e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TEK,Angiopoietin-1 receptor,42679,0.0152088999538312,0.0022947060227971,0.0107112761491489,0.0197065237585136,3.53628926375314e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,40199,0.0209072841921956,0.00315657646242981,0.0147203943258332,0.027094174058558,3.67384937330646e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THBD,Thrombomodulin,42636,0.0209009284360107,0.00315640947344741,0.0147143658680538,0.0270874910039677,3.68479220876279e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LACRT,Extracellular glycoprotein lacritin,40419,0.0357479211633593,0.00540164749533695,0.0251606920724989,0.0463351502542198,3.80760751187301e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAGA,Alpha-N-acetylgalactosaminidase,40166,0.0388500628289726,0.00587387556173492,0.0273372667279722,0.0503628589299731,3.91356303076188e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD300LF,CMRF35-like molecule 1,42721,0.042103350379184,0.00637083591959993,0.0296165119767682,0.0545901887815999,4.02059546638154e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALPP,"Alkaline phosphatase, placental type",42587,0.0695789764639578,0.0105395956192893,0.0489213690501507,0.0902365838777648,4.21858431687325e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42357,-0.0146893864263802,0.00223649737116611,-0.0190729212738658,-0.0103058515788947,5.29003928707638e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DKK3,Dickkopf-related protein 3,42794,-0.0206831443437811,0.00315567192302158,-0.0268682613129034,-0.0144980273746588,5.79280607044386e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PI3,Elafin,42446,0.0388953060595611,0.00594465137625189,0.0272437893621074,0.0505468227570148,6.25516052960159e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRELP,Prolargin,42618,0.0166586123192516,0.00254636373208078,0.0116677394043733,0.0216494852341299,6.28528259980698e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,42781,0.0406216029763963,0.00621097790834735,0.0284480862760355,0.0527951196767571,6.35959755468774e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MANSC1,MANSC domain-containing protein 1,42679,-0.0192027343531004,0.00293756863430822,-0.0249603688763445,-0.0134450998298563,6.5045766005016e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD101,Immunoglobulin superfamily member 2,40449,0.0297709771191256,0.00456066656894928,0.0208320706439851,0.0387098835942662,6.96271804847519e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPM3,Tropomyosin alpha-3 chain,40116,-0.0300030217922139,0.00459681745132933,-0.0390127839968194,-0.0209932595876084,7.01147687491485e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECE1,Endothelin-converting enzyme 1,42311,0.0241870501016836,0.00371872142420602,0.0168983561102398,0.0314757440931274,8.09783520451883e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FSTL3,Follistatin-related protein 3,42574,0.0230140733924206,0.00353994902652743,0.0160757733004268,0.0299523734844143,8.24850242748917e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,42311,0.0572074592437559,0.00881391166712815,0.0399321923761847,0.074482726111327,8.85783705338979e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYL3,Myosin light chain 3,40223,-0.0498935565770586,0.00768922480742596,-0.0649644371996135,-0.0348226759545038,9.02534150728046e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASS1,Argininosuccinate synthase,40116,0.0527540140235881,0.00813546555742017,0.0368085015310445,0.0686995265161316,9.2901399171104e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIMAP7,GTPase IMAP family member 7,40283,-0.0215887690867817,0.00333289271273072,-0.0281212388037339,-0.0150562993698295,9.72106739249249e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP12,Macrophage metalloelastase,42592,0.0379020674500149,0.00586230994794762,0.0264119399520376,0.0493921949479922,1.04546670540627e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40449,0.0688905681979629,0.01065415862415,0.0480084172946289,0.0897727191012969,1.04746833419134e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42587,0.0267518977865858,0.00413971303399515,0.0186380602399553,0.0348657353332163,1.06721693775225e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,40223,0.0218968274835707,0.00339499839508603,0.0152426306292021,0.0285510243379393,1.1673699681067e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42292,0.0316223929477853,0.00490451403815198,0.0220095454330074,0.0412352404625632,1.17614606926133e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA7,Thyroxine-binding globulin,40539,0.0124584186403656,0.00193282429345794,0.00867008302518803,0.0162467542555432,1.19729364225764e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGMB,RGM domain family member B,42711,0.0191347228235657,0.00297734381911753,0.0132991289380953,0.024970316709036,1.34711063406222e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACTN2,Alpha-actinin-2,40116,-0.0400881897378093,0.00623837236812674,-0.0523153995793377,-0.0278609798962808,1.36402351440039e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFYA,Nuclear transcription factor Y subunit alpha,40116,0.0262754987408039,0.00409677250713378,0.0182458246268217,0.0343051728547861,1.47892383302669e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENSA,Alpha-endosulfine,40451,0.0356468455721817,0.00555883141326013,0.0247515360021918,0.0465421551421715,1.48738220617654e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RHOC,Rho-related GTP-binding protein RhoC,42443,0.0768395868822098,0.0119984449332719,0.0533226348129969,0.100356538951423,1.5633607589609e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLRK1,NKG2-D type II integral membrane protein,40483,0.0327406639062242,0.00511431042653716,0.0227166154702114,0.0427647123422371,1.59672846274287e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AOC3,Membrane primary amine oxidase,42689,-0.0201949413953077,0.0031604209277859,-0.0263893664137681,-0.0140005163768474,1.71387128683796e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,42679,0.0650878106396967,0.0101872797529144,0.0451207423239844,0.085054878955409,1.72318227081109e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,42754,0.0231015968839904,0.00362158231119822,0.0160032955540419,0.0301998982139389,1.8419263286217e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNG,Interferon gamma,42370,0.0754204301419601,0.0118252759122796,0.0522428893538921,0.0985979709300282,1.85529155381489e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,42590,0.0554446376047211,0.00869353482936211,0.0384053093391713,0.0724839658702708,1.85687683268172e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42689,0.0288263084877434,0.00452220355285265,0.0199627895241522,0.0376898274513346,1.89662896399763e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKD2,Serine/threonine-protein kinase D2,40116,0.030517563101239,0.00478689371874284,0.021135251412503,0.039899874789975,1.90056008252562e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,42292,0.0286098099931613,0.00449744720429151,0.0197948134727499,0.0374248065135727,2.06647303203665e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPARCL1,SPARC-like protein 1,42644,-0.0183653676264017,0.00289513766018011,-0.0240398374403547,-0.0126908978124487,2.31762211262677e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42370,0.0285988929992116,0.00450926537717282,0.0197607328599529,0.0374370531384703,2.33828942325273e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PON1,Serum paraoxonase/arylesterase 1,40532,-0.018136384787866,0.00285966083933518,-0.0237413200329629,-0.012531449542769,2.35208489173739e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,42794,0.0105707153963567,0.00166796468918672,0.00730150460555072,0.0138399261871627,2.4089896544007e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40449,0.0271091640109024,0.0042787956555868,0.0187227245259522,0.0354956034958525,2.45286976310281e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDCD1,Programmed cell death protein 1,42689,0.0298478947589009,0.00471234830365268,0.0206116920837417,0.0390840974340602,2.46503488887244e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,42676,0.0185330823619501,0.00293147486693974,0.0127873916227483,0.024278773101152,2.66161410232141e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CX3CL1,Fractalkine,42495,-0.0227581178449608,0.00360182935382117,-0.0298177033784503,-0.0156985323114714,2.72553856987756e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASGR2,Asialoglycoprotein receptor 2,40532,0.0178023805497145,0.00281818132201017,0.0122787451585746,0.0233260159408544,2.76722421790818e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42638,-0.0225565222956466,0.00357410234798023,-0.0295617628976879,-0.0155512816936054,2.85753069839701e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40482,0.031661510390607,0.00501724568524469,0.0218277088475274,0.0414953119336866,2.88489038106945e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40223,0.0320318413791295,0.00508864379131371,0.0220580995481547,0.0420055832101044,3.19549481929087e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIRPB1,Signal-regulatory protein beta-1,42600,0.0316984943165891,0.00503726089817741,0.0218254629561614,0.0415715256770168,3.21484720429199e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCAM,Basal cell adhesion molecule,42611,-0.0162136954253685,0.00257777146663824,-0.0212661274999795,-0.0111612633507576,3.27717029747597e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYAR,Cell growth-regulating nucleolar protein,42346,0.0357245060035629,0.0056862424630948,0.0245794707758971,0.0468695412312287,3.43407187098578e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASE6,Ribonuclease K6,40468,0.0223586676800916,0.00356159830799574,0.0153779349964199,0.0293394003637632,3.56230405714522e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFIC,Nuclear factor 1 C-type,40482,0.0312223553824251,0.00497385220754704,0.0214736050556329,0.0409711057092172,3.57145984197621e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40116,0.0548878186491794,0.00876688142966217,0.0377047310470416,0.0720709062513173,3.97350496876479e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,42311,0.0273820128925157,0.00437991997305283,0.0187973697453322,0.0359666560396993,4.18553423184439e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,42357,0.0352788899531257,0.00564405075108389,0.0242165504810013,0.0463412294252501,4.21410992056526e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BOC,Brother of CDO,42357,-0.0153080654429846,0.00245009637708859,-0.0201102543420782,-0.010505876543891,4.28706016013859e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFBR2,TGF-beta receptor type-2,42679,0.0233663394023726,0.00375242651035989,0.0160115834420672,0.030721095362678,4.8957620672652e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GZMH,Granzyme H,42357,0.0504694240472637,0.00811363068815072,0.0345667078984883,0.0663721401960391,5.11146954783111e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPP1,Osteopontin,42771,-0.0306237744868284,0.00494383270613347,-0.04031368659085,-0.0209338623828068,6.02195683753358e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40449,-0.0230333189454198,0.00371887891329143,-0.030322321615471,-0.0157443162753686,6.08497755615173e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMPD3,AMP deaminase 3,40483,0.045884735752567,0.0074132414721897,0.0313547824670752,0.0604146890380588,6.24237810701301e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAPG,Macrophage-capping protein,42461,0.0377995602930091,0.00611734545162872,0.0258095632078168,0.0497895573782014,6.63631745223116e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL21,C-C motif chemokine 21,42676,0.0272265285452847,0.00441331259586949,0.0185764358573805,0.0358766212331889,7.06077271634667e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB44,Ras-related protein Rab-44,40451,0.0270620683816555,0.00439376879684602,0.0184502815398373,0.0356738552234737,7.56116264724835e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42721,0.0220349107664312,0.00357993029418588,0.0150182473898269,0.0290515741430355,7.71387880996569e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42681,0.0193314804094585,0.00314184647068952,0.0131734613269071,0.02548949949201,7.82294810951043e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGR2,Anterior gradient protein 2 homolog,42215,0.064821684285312,0.010595480286422,0.0440545429239249,0.085588825646699,9.75580591594456e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDCD6,Programmed cell death protein 6,42636,-0.0450444247452625,0.00736799876090803,-0.0594857023166423,-0.0306031471738828,1.00153448931064e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,40199,0.0235772323552366,0.0038781770716425,0.0159760052948173,0.0311784594156559,1.24584465454802e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPP7,Dipeptidyl peptidase 2,42551,0.038207166142981,0.00629350658917597,0.0258718932281961,0.0505424390577659,1.30653125813304e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXADR,Coxsackievirus and adenovirus receptor,42594,0.0328600577920683,0.00542538990943334,0.022226293569579,0.0434938220145577,1.42644916558566e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYZL2,Lysozyme-like protein 2,40080,0.022855261639298,0.00377427721177598,0.0154576783042171,0.0302528449743789,1.44572544915605e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MDM1,Nuclear protein MDM1,40182,0.0198779605356651,0.00328382329558472,0.0134416668763191,0.0263142541950112,1.46543242025154e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42587,0.0352705364281375,0.00583550427486691,0.0238329480493984,0.0467081248068767,1.5420970532396e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40182,0.0343145628142994,0.00572352491174971,0.0230964539872699,0.0455326716413288,2.09423129101295e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VCAM1,Vascular cell adhesion protein 1,42663,-0.0175126320925724,0.00292338952239789,-0.0232424755564723,-0.0117827886286726,2.14500277581695e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PALM,Paralemmin-1,40384,0.0197754952630347,0.00330082444489788,0.0133058793510348,0.0262451111750345,2.14868940066785e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,42794,-0.0155035796716034,0.00259627906377701,-0.0205922866366063,-0.0104148727066004,2.41000630715896e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBC1D17,TBC1 domain family member 17,42311,0.0282899936275491,0.00474044310529292,0.0189987251411749,0.0375812621139232,2.46684961501068e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VEGFD,Vascular endothelial growth factor D,42734,-0.0224810626346848,0.00377312620254986,-0.0298763899916825,-0.0150857352776871,2.61353347190318e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1RAP,Interleukin-1 receptor accessory protein,42611,-0.0279361996319787,0.00469059223873828,-0.0371297604199057,-0.0187426388440517,2.65287159320806e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB6,Integrin beta-6,42370,0.0194049437230467,0.00326972325697696,0.0129962861393719,0.0258136013067216,3.01713945322534e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRH,Corticoliberin,42322,0.0533743816363866,0.00899362630250664,0.0357468740834736,0.0710018891892996,3.01825816511582e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDI2,Protein DDI1 homolog 2,40283,0.0486897878991167,0.00820417844332477,0.0326095981502001,0.0647699776480332,3.03088315270596e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL1A1,Collagen alpha-1(I) chain,42794,-0.0155269157601556,0.00262318600776732,-0.0206683603353796,-0.0103854711849317,3.31491998161743e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ROBO2,Roundabout homolog 2,42711,0.0144421473067002,0.00244799776103143,0.00964407169507863,0.0192402229183218,3.73155208459242e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C4BPB,C4b-binding protein beta chain,42679,0.0248370155387162,0.00421175506497458,0.0165819756113661,0.0330920554660664,3.78869004430584e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRDX1,Peroxiredoxin-1,42261,-0.0552348682641157,0.00937261431236389,-0.0736051923163489,-0.0368645442118825,3.88078699302002e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTN4,Contactin-4,42611,-0.0148062405014424,0.00251575096705562,-0.0197371123968714,-0.00987536860601337,4.06532999064244e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,40482,0.0253217205585084,0.00430669741070383,0.0168805936335289,0.033762847483488,4.22868251174694e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDIA5,Protein disulfide-isomerase A5,40080,0.0378010295406974,0.00643005490109505,0.0251981219345512,0.0504039371468437,4.25375761348062e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSPB6,Heat shock protein beta-6,42721,0.0242212094522465,0.00412479734929811,0.0161366066476223,0.0323058122568708,4.40415028276563e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BLVRB,Flavin reductase,42611,0.0402488635469517,0.0068723019964501,0.0267791516339095,0.0537185754599939,4.83273670842244e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40199,0.0265887994225318,0.00454145634496891,0.0176875449863927,0.0354900538586709,4.91568325460641e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYOM2,Myomesin-2,40116,-0.0308834844298787,0.00528810560465198,-0.0412481714149966,-0.0205187974447609,5.3631465419077e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCN4B,Sodium channel subunit beta-4,40223,0.0269071065149096,0.00461234409655374,0.0178669120856642,0.0359473009441549,5.5729997111216e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAX,Apoptosis regulator BAX,42292,0.0541052290404006,0.00927696829816195,0.0359223711760031,0.072288086904798,5.5988874840592e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42587,0.0214791868655234,0.00368828026642955,0.0142501575433215,0.0287082161877254,5.89034049744751e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42357,-0.0189029378468592,0.00324774910041536,-0.0252685260836734,-0.0125373496100451,6.01034595807302e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,40223,-0.0143920152526401,0.00247363350121924,-0.0192403369150298,-0.00954369359025038,6.11509999639642e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VGF,Neurosecretory protein VGF,40482,0.019183909714747,0.00330387923564712,0.0127083064128787,0.0256595130166154,6.5519528548822e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,QPCT,Glutaminyl-peptide cyclotransferase,42681,0.0165405605089319,0.00285438272009701,0.0109459703775418,0.022135150640322,6.99332461236567e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PODXL,Podocalyxin,42587,0.00917265255601875,0.00159794172828951,0.0060406867685713,0.0123046183434662,9.65622938154549e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL18BP,Interleukin-18-binding protein,42689,0.0193810542046157,0.00338131785339621,0.0127536712119591,0.0260084371972722,1.01492966895955e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,40451,0.0396950000910173,0.00692958063725165,0.0261130220420041,0.0532769781400306,1.04016640968457e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPM1A,Protein phosphatase 1A,42346,0.0190193577445965,0.00333309608829447,0.0124864894115393,0.0255522260776536,1.18008855257293e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIL1,Nucleotide exchange factor SIL1,40223,0.0185191512062752,0.00324564332251231,0.0121576902941511,0.0248806121183993,1.18746682337047e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPO,Erythropoietin,42594,0.0440850550792805,0.0077375641775444,0.0289194292912935,0.0592506808672675,1.24108507366969e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INSR,Insulin receptor,40199,0.0103377826411063,0.0018205999247329,0.00676940678862985,0.0139061584935828,1.39544020323605e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42778,0.0169840732020312,0.00299239635409646,0.0111189763480022,0.0228491700560603,1.40910932594421e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSH,Pro-cathepsin H,42332,0.0440404600197258,0.00778906237686177,0.0287738977610767,0.0593070222783749,1.59889878195239e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CBS,Cystathionine beta-synthase,40223,0.0304056143507449,0.00537861478107306,0.0198635293798417,0.040947699321648,1.61534012836606e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,40451,0.027033172373249,0.00478809227572682,0.0176485115128245,0.0364178332336736,1.68280395701031e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,40451,0.0198053795920724,0.00350842073414241,0.0129288749531532,0.0266818842309915,1.69081141401329e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40223,0.016718027225347,0.00296253458155497,0.0109114594454992,0.0225245950051947,1.71085109528374e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KEL,Kell blood group glycoprotein,42311,0.0213819723926304,0.00379344219596623,0.0139468256885365,0.0288171190967242,1.77054100893688e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPRR3,Small proline-rich protein 3,40483,0.0413191020798961,0.007342075518474,0.0269286340636871,0.0557095700961051,1.86965920003708e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42594,0.0207763035964776,0.00369422378196061,0.0135356249838348,0.0280169822091204,1.90319958770149e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL2L15,Bcl-2-like protein 15,40199,0.0331590083609833,0.00589643808236629,0.0216019897195453,0.0447160270024212,1.9161670207022e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA1,Annexin A1,40235,0.0244572862583392,0.00435207902460292,0.0159272113701174,0.0329873611465609,1.95950023663264e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEZ6L2,Seizure 6-like protein 2,42587,-0.013935662409865,0.00248487156120268,-0.0188060106698222,-0.0090653141499077,2.08484347748149e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTPN,Myotrophin,42357,0.0194719815980532,0.00347217950446843,0.0126665097692951,0.0262774534268113,2.08799276475189e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,B2M,Beta-2-microglobulin,40539,0.0184113447637944,0.00328680286002815,0.0119692111581392,0.0248534783694495,2.17331753929538e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40511,0.0195263985187416,0.00348623419992457,0.0126933794868894,0.0263594175505937,2.18091613412903e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASE1,Ribonuclease pancreatic,40532,0.0154925697275595,0.00276663544514832,0.0100699642550688,0.0209151752000502,2.19609563409767e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFHR2,Complement factor H-related protein 2,40451,0.0338874332435218,0.00605565286840599,0.0220183536214461,0.0457565128655976,2.24481936096332e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,40532,0.0237362745342006,0.00425419086856569,0.0153980604318118,0.0320744886365893,2.46739458575871e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS3,Galectin-3,42669,0.0174333102457402,0.00312709201023298,0.0113042099056836,0.0235624105857969,2.52391249246792e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ULBP2,UL16-binding protein 2,42495,0.0232346391747814,0.00418306476352655,0.0150358322382693,0.0314334461112934,2.83824993539164e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHISA5,Protein shisa-5,40527,0.0161563277083988,0.0029160422148552,0.0104408849672826,0.021871770449515,3.08346754551761e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF1,Macrophage colony-stimulating factor 1,42676,0.0161248884570527,0.00291146257288884,0.0104184218141905,0.0218313550999148,3.10933392110784e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GBP4,Guanylate-binding protein 4,42311,0.0283775167317488,0.00516513433491454,0.0182538534353163,0.0385011800281813,4.00138488519338e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTN1,Contactin-1,42794,-0.0159534057194835,0.00291212858870423,-0.0216611777533437,-0.0102456336856232,4.3715712277055e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPTL1,Angiopoietin-related protein 1,42439,0.0166353891348556,0.00304158036342381,0.0106738916225449,0.0225968866471662,4.59949555509417e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,40483,0.0216331340462222,0.00395701834607412,0.0138773780879169,0.0293888900045275,4.67377907082453e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOLR2,Folate receptor beta,42711,-0.0169217691725847,0.00309589471240477,-0.022989722808898,-0.0108538155362713,4.68798837160071e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PIGR,Polymeric immunoglobulin receptor,42464,0.0204608021505016,0.00374392202221372,0.0131227149869627,0.0277988893140405,4.71072210151098e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40080,-0.0176388303306981,0.00322795383692884,-0.0239656198510786,-0.0113120408103176,4.74707618349156e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LY9,T-lymphocyte surface antigen Ly-9,42443,0.017536303922922,0.00321009375102893,0.0112445201709053,0.0238280876749387,4.76972025638991e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PADI4,Protein-arginine deiminase type-4,42292,0.0410470894299053,0.00751712620720482,0.0263135220637838,0.0557806567960267,4.83515300602582e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GZMB,Granzyme B,42594,0.0379331480981563,0.00694946620176524,0.0243121943426964,0.0515541018536162,4.8891912476955e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPING1,Plasma protease C1 inhibitor,40516,0.0104522340416425,0.00191554580817149,0.00669776425762634,0.0142067038256586,4.95750468025678e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPL,Periplakin,40199,0.0190368983722638,0.00349114979145658,0.012194244781009,0.0258795519635187,5.0625187124911e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,42370,0.0226379308521044,0.00415312540696566,0.0144978050544517,0.0307780566497571,5.10409343523792e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42346,0.044074498426742,0.00809240764435848,0.0282133794437994,0.0599356174096847,5.23228756374209e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL9,C-X-C motif chemokine 9,42676,0.0384894598403447,0.00708656826985717,0.0245997860314246,0.0523791336492647,5.69068987197879e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNU13,NHP2-like protein 1,40116,0.0360926953479044,0.00664627572511095,0.023065994926687,0.0491193957691219,5.73959380577064e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCT,Secretin,40182,0.0284534944550123,0.00524274855132892,0.0181777072944076,0.038729281615617,5.84581719345627e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42594,-0.0223597468854412,0.00412385115343558,-0.0304424951461749,-0.0142769986247075,5.99389058906769e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40539,0.0145164768104481,0.00267793112415681,0.00926773180710079,0.0197652218137955,6.05545200311171e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF16,Fibroblast growth factor 16,40199,0.0269079397030509,0.00496546446459273,0.0171756293524492,0.0366402500536527,6.11912040180967e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LUZP2,Leucine zipper protein 2,40451,0.0260729074403715,0.004816709400708,0.0166321570149839,0.0355136578657592,6.32451370465423e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PVALB,Parvalbumin alpha,42654,0.0621109196488553,0.0114844311603688,0.0396014345745324,0.0846204047231783,6.47230192979405e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD59,CD59 glycoprotein,42130,0.014155467518526,0.00261923928891298,0.00902175851225658,0.0192891765247954,6.61714402292674e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SRPX,Sushi repeat-containing protein SRPX,40511,-0.0209372169343058,0.00387527956127285,-0.0285327648744006,-0.013341668994211,6.69518655465213e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40199,0.0196796571614691,0.00364826466061613,0.0125290584266615,0.0268302558962767,7.02351411858492e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH1,Cadherin-1,42188,0.0223696209930957,0.00416761521574104,0.0142010951702432,0.0305381468159481,8.1213189375999e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AFAP1,Actin filament-associated protein 1,40283,0.0466654723511914,0.00869767802639744,0.0296180234194524,0.0637129212829304,8.24508573315445e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42754,0.0200292630656481,0.00373447138262986,0.0127096991556935,0.0273488269756026,8.3034979400716e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGER,Advanced glycosylation end product-specific receptor,42587,0.0235435598338957,0.00439295175687779,0.0149333743904152,0.0321537452773762,8.48851800025627e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,42346,0.032361879827268,0.00604051027257047,0.0205224796930299,0.0442012799615062,8.58155266916603e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LIF,Leukemia inhibitory factor,42311,0.0287190040292983,0.00538082591818314,0.0181725852296593,0.0392654228289372,9.59194176151618e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DSG3,Desmoglein-3,42651,0.0195891409001562,0.00367861817009135,0.0123790492867771,0.0267992325135352,1.02500208640871e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAA4,Serum amyloid A-4 protein,40539,0.0180516012293013,0.00339207050281295,0.0114031430437879,0.0247000594148147,1.04757411196083e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA1,Alpha-1-antitrypsin,40327,-0.00455207975578487,0.000857678216460648,-0.00623312906004774,-0.002871030451522,1.13309067951207e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",42676,0.0156573471726416,0.00295673890986896,0.00986213890929845,0.0214525554359848,1.20569824121192e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD300E,CMRF35-like molecule 2,42677,0.0239333711785688,0.00452462084825774,0.0150651143159836,0.0328016280411539,1.24510744195227e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40223,0.020510670959518,0.00387889672036136,0.0129080333876098,0.0281133085314263,1.26191508835866e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX3,Syntaxin-3,40483,0.021503156368502,0.00406794145610231,0.0135299911145414,0.0294763216224625,1.27348739753794e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NECTIN1,Nectin-1,40199,0.0180962735917377,0.00343031569087918,0.0113728548376145,0.0248196923458609,1.34985055740778e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42654,0.0486134065885369,0.00923338138617998,0.0305159790716241,0.0667108341054497,1.42375040513686e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARG1,Arginase-1,42488,0.0284486597727248,0.00541638191240338,0.0178325512244142,0.0390647683210354,1.52499445208585e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLYR1,Putative oxidoreductase GLYR1,40451,0.0322680794598064,0.00616599541367485,0.0201827284490037,0.0443534304706091,1.69568446461154e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRTAP,Cartilage-associated protein,40182,0.0262751387860973,0.00503045337324169,0.0164154501745436,0.036134827397651,1.79060074715693e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40199,0.0183097363816496,0.0035100220765564,0.0114300931115991,0.0251893796517002,1.85733074265433e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40482,0.0234049037965083,0.00449538437790344,0.0145939504158176,0.0322158571771991,1.95893124641633e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGAP5,Rho GTPase-activating protein 5,40080,0.0435796544207308,0.00837403244034813,0.0271665508376484,0.0599927580038131,1.98443033831692e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPTLC1,Serine palmitoyltransferase 1,40483,0.0210997335264282,0.00405709092754498,0.0131478353084401,0.0290516317444164,2.02009379819096e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,42636,-0.0157364265058514,0.00302615696617136,-0.0216676941595473,-0.00980515885215556,2.02066410865788e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40527,-0.0215725364723725,0.00415077547885224,-0.0297080564109229,-0.0134370165338222,2.05797651146289e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDH1,Protocadherin-1,42721,0.0117877932557842,0.00227210016704388,0.00733447692837816,0.0162411095831902,2.15567084960617e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL9A2,Collagen alpha-2(IX) chain,40302,0.0243326646643045,0.00469404944099994,0.0151323277599447,0.0335330015686644,2.21317709727484e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRL6,Fc receptor-like protein 6,42594,0.0380280584583288,0.00733909493070987,0.0236434323941375,0.0524126845225202,2.23217173438973e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GC,Vitamin D-binding protein,40539,0.0140288787401914,0.00270900988871532,0.0087192193583094,0.0193385381220735,2.27387191173879e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA7,Carbonic anhydrase 7,40302,-0.0190919859726823,0.00369635151649053,-0.0263368349450037,-0.0118471370003608,2.44487224166792e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",42311,0.015154031932226,0.002936690135761,0.00939811926613441,0.0209099445983175,2.50231754633624e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PROCR,Endothelial protein C receptor,40116,-0.0189022461036793,0.00366700062285141,-0.026089567324468,-0.0117149248828905,2.58494309329774e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOB,Apolipoprotein B-100,40532,0.0120175882274817,0.00233623957040985,0.00743855866947841,0.016596617785485,2.73458805042853e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RPA2,Replication protein A 32 kDa subunit,40199,0.0170823908583432,0.00332282689532444,0.0105696501435073,0.0235951315731791,2.78089065663973e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42676,0.0148466177962714,0.00289258899466249,0.00917714336673292,0.0205160922258099,2.89680363592586e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICOSLG,ICOS ligand,42587,0.0103894253840338,0.00202571897410925,0.00641901619477962,0.0143598345732879,2.95729812022127e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA12,Carbonic anhydrase 12,42587,-0.0177552441858805,0.00346524956401404,-0.024547133331348,-0.010963355040413,3.03604379251904e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CILP,Cartilage intermediate layer protein 1,40527,0.0295368630751118,0.00578299356387224,0.0182021956899222,0.0408715304603014,3.31686919430673e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42611,0.0172571414007571,0.00337961969111064,0.0106330868061803,0.023881195995334,3.33138796115455e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCGB3A1,Secretoglobin family 3A member 1,40283,-0.0142981499321765,0.00280023421499069,-0.0197866089935583,-0.00880969087079478,3.34412571014983e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40223,0.0369860250632824,0.00725007102940165,0.0227758858456551,0.0511961642809096,3.42627703501009e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MUC16,Mucin-16,42587,0.102449388051787,0.0200925815871954,0.0630679281408841,0.14183084796269,3.46357290049438e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PZP,Pregnancy zone protein,40539,0.0271938553880576,0.00533687130144235,0.0167335876372306,0.0376541231388846,3.53477525867321e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PROK1,Prokineticin-1,42594,0.029475971091146,0.00578740755851396,0.0181326522764586,0.0408192899058333,3.56999103876646e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIF1C,Kinesin-like protein KIF1C,40116,0.0191915092836213,0.00376890347385486,0.0118044584748658,0.0265785600923768,3.60085099874441e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SATB1,DNA-binding protein SATB1,40482,0.0156023572257983,0.00307044910358384,0.00958427698277402,0.0216204374688227,3.80540787083708e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,40182,0.0405071297852108,0.00798678423764099,0.0248530326794344,0.0561612268909871,4.00563327553232e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WFDC2,WAP four-disulfide core domain protein 2,41948,0.0232359818743363,0.00458554124243553,0.0142483210391626,0.0322236427095099,4.0929979992999e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATXN2,Ataxin-2,40136,0.0586875732904707,0.0115823761359546,0.0359861160639997,0.0813890305169416,4.10791856614367e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42746,0.0213854280693921,0.0042247381267769,0.0131049413409094,0.0296659147978748,4.20423546681298e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECM1,Extracellular matrix protein 1,40269,0.0197838863267298,0.00391371883035486,0.0121129974192343,0.0274547752342253,4.37245696134764e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,40451,0.0212666682235486,0.00420870728713825,0.0130176019407576,0.0295157345063395,4.41711111803628e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSB,Cathepsin B,42659,-0.0283717851022222,0.00562148150493451,-0.0393898888518938,-0.0173536813525505,4.54585831230801e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLGN,Calmegin,40182,0.0246139357107938,0.00487672870993817,0.015055547439315,0.0341723239822726,4.55455524965481e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRUNE2,Protein prune homolog 2,40302,0.0158761239396859,0.00315509167346329,0.00969214425969785,0.022060103619674,4.93227900619964e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL5RA,Interleukin-5 receptor subunit alpha,42594,-0.0304106913564931,0.00604662747458639,-0.0422620812066824,-0.0185593015063037,4.98473761406323e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DUSP3,Dual specificity protein phosphatase 3,42311,0.0450066321111189,0.00895311566764068,0.0274585254025432,0.0625547388196947,5.04983361326553e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,42475,0.0140082820017416,0.00279308879402845,0.00853382796544588,0.0194827360380374,5.36239787815029e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LCP1,Plastin-2,40527,0.0251687565631154,0.00502628562524965,0.015317236737626,0.0350202763886047,5.59927237827649e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,40116,0.0526739053728008,0.010537314859096,0.0320207682489727,0.0733270424966289,5.85839252135683e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A14,Protein S100-A14,40482,0.0286904225232669,0.00574739391868772,0.017425530442639,0.0399553146038949,6.06803952924908e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1B,Interleukin-1 beta,42293,0.0295750884515232,0.00595582791164031,0.0179016657447081,0.0412485111583382,6.93018529908444e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLASP1,CLIP-associating protein 1,40080,0.0377462138014249,0.00762577961886421,0.022799685748451,0.0526927418543987,7.53962706265102e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB37,Ras-related protein Rab-37,42370,0.0418423389555433,0.0084676580358702,0.0252457292052377,0.0584389487058489,7.85044148476424e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM26,Tripartite motif-containing protein 26,40080,0.0291634063233761,0.00590208073077289,0.0175953280910612,0.0407314845556909,7.87956297984785e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TDO2,"Tryptophan 2,3-dioxygenase",40182,0.0200688554637871,0.00406185172426133,0.0121076260842349,0.0280300848433393,7.89435624735976e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OSM,Oncostatin-M,42534,0.0361503940759832,0.00732304514973603,0.0217972255825006,0.0505035625694658,8.04881483703937e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GBA,Lysosomal acid glucosylceramidase,40182,0.0287370531687191,0.00582080674894992,0.0173282719407772,0.0401458343966609,8.05183253244572e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LMNB2,Lamin-B2,40483,0.0148269825526992,0.00300434939889436,0.00893845773086628,0.0207155073745322,8.12234934515838e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,42346,0.0204485306081414,0.0041439844504415,0.012326321085276,0.0285707401310067,8.13360336698659e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42495,0.0553299162016422,0.0112260185366176,0.0333269198698717,0.0773329125334127,8.3766799393294e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,42351,0.0283409896233257,0.00575661346621553,0.0170580272295432,0.0396239520171081,8.61706410561589e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40449,0.0263382885761037,0.00535112630785869,0.0158500810127007,0.0368264961395068,8.68748571464382e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REG4,Regenerating islet-derived protein 4,42638,0.0270790312093994,0.00550815388983494,0.0162830495853229,0.0378750128334759,8.9294530242331e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSTT2B,Glutathione S-transferase theta-2B,40483,0.12353700720049,0.0251285673780647,0.0742850151394834,0.172788999261497,8.94826655974364e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TK1,"Thymidine kinase, cytosolic",40302,0.023419072512866,0.00476394134738643,0.0140817474719886,0.0327563975537434,8.96376156223434e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD48,CD48 antigen,42654,0.0159513236936707,0.00324567722164188,0.00958979633925261,0.0223128510480888,8.99946227404022e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL25,C-C motif chemokine 25,42754,0.0246110181747655,0.0050112199580311,0.0147890270570245,0.0344330092925064,9.15836837600559e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOM,Apolipoprotein M,42663,0.0144076072202834,0.00294948670833203,0.00862661327195261,0.0201886011686142,1.04731901635971e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A13,Protein S100-A13,40199,0.0182213579722797,0.00373114169014128,0.0109083202596028,0.0255343956849567,1.0563804822991e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK6,Kallikrein-6,42656,0.01619994835609,0.00331928272737939,0.00969415421042642,0.0227057425017536,1.06998938311931e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC10A,C-type lectin domain family 10 member A,42495,-0.0185232612971528,0.00381296113389001,-0.0259966651195773,-0.0110498574747284,1.19944830298034e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42346,0.0222313966606222,0.00457949595276763,0.0132555845931976,0.0312072087280467,1.2204632039981e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EGFLAM,Pikachurin,40449,0.0157372973526899,0.00324733060420067,0.00937252936845656,0.0221020653369232,1.27512048560945e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD99,CD99 antigen,42611,-0.0102003947597861,0.00211444322776216,-0.0143447034861999,-0.00605608603337228,1.42146021294929e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,40449,0.0282961409311006,0.00588524522662047,0.0167610602869245,0.0398312215752767,1.54436882429741e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CKAP4,Cytoskeleton-associated protein 4,42713,0.014545517231357,0.00302785704651517,0.00861091742018727,0.0204801170425267,1.57276128275665e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX5,Syntaxin-5,40199,0.0206666574258304,0.00430585176442609,0.0122271879675553,0.0291061268841055,1.61019621289444e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OLFM4,Olfactomedin-4,39870,0.0619994743415209,0.0129280670463699,0.0366604629306358,0.087338485752406,1.64277349316395e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCC,Netrin receptor DCC,40182,0.0116574113305864,0.00243425174704961,0.00688627790636921,0.0164285447548037,1.69880132713641e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40199,0.0223639302888987,0.00468029690074957,0.0131905483634296,0.0315373122143679,1.79056204282371e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,40302,0.0220721566306759,0.00462038903754145,0.0130161941170947,0.0311281191442572,1.80098343276118e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UROS,Uroporphyrinogen-III synthase,40182,0.0340288117985612,0.00712511818602854,0.0200635801539453,0.0479940434431772,1.81222440085219e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40482,-0.0195350338719635,0.00409591392433846,-0.0275630251636669,-0.0115070425802602,1.8709148723358e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STC2,Stanniocalcin-2,42591,0.0124126349636351,0.0026029049992102,0.00731094116518308,0.017514328762087,1.87312984630275e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL24A1,Collagen alpha-1(XXIV) chain,40449,0.0277513644847032,0.00583686947970459,0.0163111003044822,0.0391916286649242,2.0141002416464e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRL,Prolactin,42711,-0.0371946282835772,0.00783080715612146,-0.0525430103095753,-0.0218462462575791,2.05728387132997e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,42346,0.0204592976657639,0.00430944430361086,0.0120127868306866,0.0289058085008412,2.08067362591732e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPR1,Atrial natriuretic peptide receptor 1,40116,-0.0204284979998557,0.00430886362777779,-0.0288738707103002,-0.0119831252894113,2.1531054896351e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEDD9,Enhancer of filamentation 1,40199,0.0165436617302627,0.00349232818747192,0.0096986984828177,0.0233886249777076,2.19461260623396e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOSB,Protein fosB,42311,0.0189949430643157,0.00401363961853727,0.0111282094119827,0.0268616767166487,2.23979078399472e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEPTIN8,Septin-8,40470,0.0160755317314597,0.00340114461507387,0.00940928828591492,0.0227417751770045,2.31178580687207e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LMOD1,Leiomodin-1,40482,-0.0176809670042215,0.00374801431354155,-0.025027075058763,-0.0103348589496801,2.41716114252824e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLIC5,Chloride intracellular channel protein 5,40182,-0.0156268446264468,0.00332321248449935,-0.0221403410960655,-0.00911334815682807,2.60338865138083e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40182,0.0529878178694051,0.011285549917217,0.0308681400316597,0.0751074957071504,2.69580098497211e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42495,0.0149069800438991,0.00317950960562861,0.00867514121686703,0.0211388188709312,2.780129545902e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLU,Clusterin,40539,0.0154851621509923,0.00330378860645572,0.00900973648233909,0.0219605878196455,2.80339617888976e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PFDN2,Prefoldin subunit 2,42311,0.0271430527268518,0.0057941256021299,0.0157865665466772,0.0384995389070264,2.83349462780917e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RPS10,40S ribosomal protein S10,40116,-0.019992982950481,0.00427459981033798,-0.0283711985787434,-0.0116147673222185,2.94365612268376e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VIT,Vitrin,40511,0.0188822553326614,0.0040376591051017,0.0109684434866621,0.0267960671786607,2.95137477156061e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42495,0.0221743386125026,0.00474361616434514,0.0128768509303861,0.0314718262946191,2.97471101507064e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUCA1,Tissue alpha-L-fucosidase,42721,0.0411372567436856,0.00880238841862734,0.023884575443176,0.0583899380441952,2.99082754239883e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB39B,Ras-related protein Rab-39B,40116,0.0452072140040608,0.00969100163600821,0.0262128507974847,0.0642015772106369,3.12486461976077e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRC38,Leucine-rich repeat-containing protein 38,40182,0.0236601918906097,0.00507861702615929,0.0137061025193375,0.0336142812618819,3.21814068621826e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRDX2,Peroxiredoxin-2,40333,0.0304524450532932,0.00654751512145119,0.0176193154152488,0.0432855746913375,3.34142583878553e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK8,Kallikrein-8,42154,0.0181987180622676,0.0039178749887549,0.010519683084308,0.0258777530402272,3.43341405905548e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD14,Monocyte differentiation antigen CD14,42416,0.0202712116502054,0.00436847880234367,0.0117089931976118,0.028833430102799,3.5118262368276e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPC1,Glypican-1,42721,0.0145081405574248,0.00312874169994931,0.00837580682552414,0.0206404742893254,3.56720095321801e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THBS4,Thrombospondin-4,42652,0.022196078183132,0.00478758921259662,0.0128124033264426,0.0315797530398214,3.5826063750124e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MOG,Myelin-oligodendrocyte glycoprotein,42721,0.0164406655737876,0.00355460140755154,0.00947364681498656,0.0234076843325886,3.7774502596336e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QA,Complement C1q subcomponent subunit A,42701,-0.0106421124859726,0.00230504000314187,-0.0151599908921307,-0.00612423407981455,3.93127376840947e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42618,0.0193103368996657,0.00419392290839711,0.0110902479992073,0.027530425800124,4.17530971001583e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHGA,Chromogranin-A,40527,-0.0470991716974475,0.0102634012399416,-0.067215438127733,-0.026982905267162,4.5006915343811e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSPA2,Heat shock-related 70 kDa protein 2,40451,0.0164766488007989,0.00359839599201696,0.0094237926564457,0.0235295049451522,4.7246849789784e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AREG,Amphiregulin,42587,0.0203964536916629,0.00445696743767145,0.0116607975138269,0.0291321098694989,4.77507535458542e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,42346,0.0143023424329208,0.00313781542517348,0.00815222419958083,0.0204524606662609,5.20942445692592e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VIM,Vimentin,42357,0.055184915967417,0.0121250123485093,0.0314198917643388,0.0789499401704953,5.37855029413057e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BST2,Bone marrow stromal antigen 2,42711,0.0241675642472119,0.0053488226112025,0.013683871929255,0.0346512565651688,6.28677629081612e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD7,T-cell antigen CD7,40166,0.0211645754925169,0.00468733635744349,0.0119773962319276,0.0303517547531061,6.38962688306976e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHB6,Ephrin type-B receptor 6,42476,0.0158666743682278,0.00351784353690515,0.0089717010358937,0.0227616477005619,6.52781387628834e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMG4,Proteasome assembly chaperone 4,40199,0.0269385698265314,0.00597305023010546,0.0152313913755247,0.0386457482775381,6.54925606932211e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATXN10,Ataxin-10,42311,0.0340459898091656,0.00755528058646945,0.0192376398596854,0.0488543397586457,6.6553685683409e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICAM5,Intercellular adhesion molecule 5,42636,0.0216130859557688,0.00480003178116566,0.0122050236646841,0.0310211482468535,6.76611526958285e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NXPH1,Neurexophilin-1,42311,0.0183304967002614,0.0040724015790121,0.0103485896053977,0.0263124037951251,6.8168237910473e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRD1,Bromodomain-containing protein 1,40302,-0.0144377414335183,0.00321151851696722,-0.020732317726774,-0.00814316514026256,7.00725287085083e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP1,Caspase-1,42311,0.032493766054393,0.00723289788552074,0.0183172861987724,0.0466702459100137,7.09948367606973e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,XG,Glycoprotein Xg,42734,0.0162047944203307,0.00360824240790226,0.00913263930084227,0.0232769495398191,7.14591988453406e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LEO1,RNA polymerase-associated protein LEO1,40482,0.0152666077570639,0.00341047013592801,0.00858208629064496,0.0219511292234828,7.66584025747278e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,42587,-0.0158400463089687,0.00355013867098835,-0.0227983181041059,-0.00888177451383158,8.1932645436582e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,42794,-0.0135149721112443,0.00303054251644533,-0.0194548354434771,-0.00757510877901141,8.2775242359071e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPEP1,Dipeptidase 1,42476,-0.0231988447792464,0.00523092772008759,-0.033451463110618,-0.0129462264478747,9.28382468412783e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPOCK1,Testican-1,42495,0.0119240494185481,0.00269606727201168,0.00663975756540521,0.017208341271691,9.82229904708548e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DLL4,Delta-like protein 4,40223,0.0396903486084723,0.0089959861065491,0.022058215839636,0.0573224813773085,1.03388957160006e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,40182,0.0297862115276523,0.00675407915805289,0.0165482163778687,0.043024206677436,1.04302073275469e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40451,0.0304376511278639,0.00691312771969009,0.0168879207972713,0.0439873814584565,1.07809985728447e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX25,ATP-dependent RNA helicase DDX25,40182,-0.0174767464810346,0.0039819817380236,-0.0252814306875608,-0.00967206227450831,1.14958897438416e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOD3,Extracellular superoxide dismutase,40532,-0.0268320527592346,0.00611923419942505,-0.0388257517901077,-0.0148383537283615,1.17100666294145e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRC25,Leucine-rich repeat-containing protein 25,42587,0.0179567683266986,0.00410686479347823,0.00990731333148124,0.0260062233219159,1.23827276214376e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPHS1,Nephrin,40199,0.0154105306295399,0.00352545523869365,0.00850063836170033,0.0223204228973795,1.24689753169721e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GUCA2A,Guanylin,42563,-0.0166469742206339,0.0038125299146036,-0.024119532853257,-0.00917441558801086,1.27269337564035e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PMS1,PMS1 protein homolog 1,40182,0.0238445605494596,0.00546117746350214,0.0131406527209954,0.0345484683779238,1.27587197251579e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EBI3_IL27,Interleukin-27,42689,-0.0140913994247031,0.00322983895060492,-0.0204218837678888,-0.00776091508151749,1.29314512331275e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40116,0.0224686340555337,0.00515404455369983,0.0123667067302821,0.0325705613807854,1.31602424547115e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCGB2A2,Mammaglobin-A,40116,-0.01454474904236,0.00333790884470729,-0.0210870503779863,-0.00800244770673369,1.32792761806453e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HGFAC,Hepatocyte growth factor activator,40428,0.0126209487010804,0.00290476047447047,0.00692761817111831,0.0183142792310426,1.40551055636855e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHRDL1,Chordin-like protein 1,42654,0.0146930251957418,0.00338267767836422,0.00806297694614793,0.0213230734453357,1.41187536329738e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42611,0.0161605042767491,0.00372130648925048,0.00886674355781814,0.02345426499568,1.41777214023082e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERC2,ERC protein 2,40182,0.0345715393212836,0.00797152612683291,0.0189473481126911,0.0501957305298761,1.45809435262883e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCAM1,Neural cell adhesion molecule 1,42689,-0.0136835615292189,0.00316461825806859,-0.0198862133150334,-0.00748090974340448,1.54379442327621e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FMR1,Synaptic functional regulator FMR1,42346,0.0160088363713055,0.00371320532056284,0.00873095394300234,0.0232867187996087,1.63460371332531e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VCAN,Versican core protein,42711,-0.0137745202552992,0.00319869037898416,-0.0200439533981082,-0.00750508711249025,1.6717858362656e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALCAM,CD166 antigen,42794,0.00883723273090229,0.00205692687285616,0.00480565606010423,0.0128688094017004,1.74856843911617e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAFB2,Scaffold attachment factor B2,40482,0.0123565519247004,0.00288071724654023,0.00671034612148152,0.0180027577279192,1.80646570777639e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTRL,Chymotrypsin-like protease CTRL-1,40483,-0.0317872964663236,0.00741452579648639,-0.0463197670274369,-0.0172548259052103,1.82470774602777e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLAMF8,SLAM family member 8,42346,0.0248465330868533,0.00579776555862604,0.0134829125919463,0.0362101535817604,1.83596257323059e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MST1,Hepatocyte growth factor-like protein,40370,0.0292859499414249,0.00685637789246769,0.0158474492721883,0.0427244506106616,1.95905462192106e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DGCR6,Protein DGCR6,40136,0.019860426463733,0.00465041790296383,0.0107456073739239,0.0289752455535421,1.96527306193056e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C9orf40,Uncharacterized protein C9orf40,40449,0.0362906686794799,0.00851844523145303,0.0195945160258319,0.0529868213331278,2.05863061226662e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSN,Gelsolin,40488,-0.00864412018876013,0.00203211956803845,-0.0126270745421155,-0.00466116583540476,2.11917682164658e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF5,Fibroblast growth factor 5,42370,-0.0147116706445613,0.00346443025946102,-0.0215019539531049,-0.00792138733601767,2.18634138260775e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC6A,C-type lectin domain family 6 member A,42346,0.0210587839989171,0.00498330183925721,0.0112915123939729,0.0308260556038612,2.39625086963074e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPE,Carboxypeptidase E,42588,-0.0170438495272359,0.00404201931137998,-0.0249662073775407,-0.00912149167693117,2.49568021351954e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,40116,0.0162410363855228,0.00385241355416408,0.00869030581936121,0.0237917669516844,2.50889360287524e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40116,-0.0143475515874748,0.00341017516614221,-0.0210314949131136,-0.00766360826183608,2.60531410419238e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLPS,Colipase,42590,0.0320709747173876,0.00762676670970211,0.0171225119663715,0.0470194374684037,2.62714551312587e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFHR5,Complement factor H-related protein 5,40382,0.018607084160462,0.00442713896065873,0.00992989179757086,0.0272842765233531,2.65494914321775e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THBS2,Thrombospondin-2,42611,0.0170726715587137,0.00406283943508813,0.00910950626594101,0.0250358368514865,2.66099482429362e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,QSOX1,Sulfhydryl oxidase 1,40342,0.0190753999694502,0.00454504683319259,0.0101671081763927,0.0279836917625076,2.72614158565388e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGT5,Glutathione hydrolase 5 proenzyme,42495,0.0103525582653205,0.00247016388537954,0.00551103704997661,0.0151940794806644,2.79471643148905e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1RL1,Interleukin-1 receptor-like 1,42760,-0.0200729897341058,0.00479088161085995,-0.0294631176913913,-0.0106828617768203,2.80927461070676e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,42370,0.0189474948195227,0.00452280226966252,0.0100828023709842,0.0278121872680613,2.81605962392943e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JAM2,Junctional adhesion molecule B,42711,0.0124576256196292,0.00297514021976471,0.00662635078889037,0.018288900450368,2.84156537716132e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CREBZF,CREB/ATF bZIP transcription factor,40080,-0.0114846897314465,0.0027463573003416,-0.016867550040116,-0.00610182942277694,2.91488398774402e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSF,Cathepsin F,42679,0.0172646328121151,0.00414352586862689,0.00914332210960635,0.0253859435146238,3.11031677635863e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD109,CD109 antigen,42611,-0.0146598299542894,0.00352128659645911,-0.0215615516833493,-0.00775810822522959,3.15774277289e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40527,-0.0118445181768563,0.00284662474134023,-0.0174239026698832,-0.0062651336838295,3.19336909450826e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40451,0.0193508498198196,0.00465586645056515,0.0102253515767119,0.0284763480629273,3.25936651227836e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40223,0.0145074216886983,0.0035152403136569,0.00761755067393075,0.0213972927034658,3.70217104045524e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40449,0.00931033708765313,0.00225669598958355,0.00488721294806938,0.0137334612272369,3.72349613995868e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VAMP5,Vesicle-associated membrane protein 5,42357,0.0239155190694941,0.00580422016106718,0.0125392475538024,0.0352917905851857,3.80583838220409e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSBP1,Heat shock factor-binding protein 1,40223,0.0408415905118903,0.00991182155829418,0.0214144202576337,0.0602687607661469,3.80825603966733e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT8,"Keratin, type II cytoskeletal 8",40136,0.0350461300331601,0.00850963738010154,0.018367240768161,0.0517250192981591,3.84309257410373e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF3,Granulocyte colony-stimulating factor,42370,0.021032205132381,0.00511995841995213,0.0109970866292749,0.0310673236354872,4.01710467422197e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDRG1,p53 and DNA damage-regulated protein 1,40182,0.0220905141887774,0.00538269069476079,0.0115404404270463,0.0326405879505086,4.09016892836411e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK11,Kallikrein-11,42543,0.0140709549892713,0.0034292372455935,0.00734964998790809,0.0207922599906346,4.0983874735226e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP13,Collagenase 3,42311,-0.0142384451885837,0.00349206924337045,-0.0210829009055897,-0.00739398947157759,4.58175135626878e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GBP2,Guanylate-binding protein 2,42370,0.0259304429520545,0.00636422310218661,0.0134565656717687,0.0384043202323402,4.64017646575095e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42611,0.0101059335090065,0.00248452603028817,0.00523626248964167,0.0149756045283713,4.77816309310591e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMPRSS11D,Transmembrane protease serine 11D,40470,0.0174206856844955,0.00429687014857325,0.00899882019329197,0.0258425511756991,5.06283762079719e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNPEP,Aspartyl aminopeptidase,40483,0.0242333994776323,0.00598750283469653,0.0124978939216271,0.0359689050336375,5.21506858545265e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YAP1,Transcriptional coactivator YAP1,40483,0.0121753763966218,0.00301559939396184,0.00626480158445657,0.018085951208787,5.43889653520432e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40483,0.0230220468997127,0.00570310383061977,0.011843963391698,0.0342001304077275,5.45529021360604e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RSPO1,R-spondin-1,42495,0.0142995712814887,0.00355230274420567,0.00733705790284558,0.0212620846601318,5.7184799144335e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDH17,Protocadherin-17,42636,0.0156923507722932,0.00389850457410316,0.008051281807051,0.0233334197375354,5.72334456020957e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ART3,Ecto-ADP-ribosyltransferase 3,42689,-0.0150870329644626,0.00376803282405434,-0.0224723772996091,-0.00770168862931606,6.26257455759957e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL34,Interleukin-34,42292,0.0153196379370593,0.00382852577704131,0.00781572741405835,0.0228235484600603,6.33030791224783e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRTN,Neurturin,42370,0.0206005638113681,0.00515912605159888,0.0104886767502343,0.0307124508725019,6.55873050187699e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRTG,Protogenin,42721,0.0103991558758446,0.00260564411368438,0.00529209341302323,0.015506218338666,6.61391379521138e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,40302,0.0282862789677759,0.00708820972055145,0.0143933879154951,0.0421791700200568,6.63270232811245e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40223,0.0270937888173401,0.00679254179889226,0.0137804068915112,0.0404071707431689,6.68498370946343e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42611,0.0179664620494463,0.00450571584026646,0.00913525900252406,0.0267976650963686,6.71321731445682e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPTX2,Neuronal pentraxin-2,40527,-0.013730474659455,0.00344482954017129,-0.0204823405581907,-0.00697860876071923,6.7668630793665e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD5L,CD5 antigen-like,40479,0.0199283381228821,0.00500253690260958,0.0101233657937674,0.0297333104519969,6.82921341621553e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NTRK2,BDNF/NT-3 growth factors receptor,42636,0.0106520304487671,0.00267762883678389,0.00540387792867067,0.0159001829688635,6.98154484852267e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CST7,Cystatin-F,42642,0.0389598209654589,0.00980719001750114,0.0197377285311566,0.0581819133997611,7.14698513548996e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NDRG1,Protein NDRG1,42311,0.0270246481643176,0.00681813675859325,0.0136611001174748,0.0403881962111604,7.42064049638271e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,40451,0.011935960279301,0.00302415433591078,0.00600861778091586,0.0178633027776861,7.96591184037345e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAG3,Lymphocyte activation gene 3 protein,42587,-0.0169606569529415,0.00429932785259393,-0.0253873395440256,-0.0085339743618574,8.02217756951433e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFBR3,Transforming growth factor beta receptor type 3,42794,-0.0130801652254052,0.00331793231310812,-0.0195833125590971,-0.00657701789171325,8.11202894845322e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42370,0.0152922079759841,0.00388758917183435,0.00767253319918882,0.0229118827527795,8.41131734648044e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL14,C-X-C motif chemokine 14,42370,0.0232779238132696,0.00591847200957321,0.0116777186745061,0.0348781289520331,8.42881321214538e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40482,0.0298205244505778,0.00759932480967574,0.0149258478236134,0.0447152010775423,8.75702660903288e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MKI67,Proliferation marker protein Ki-67,40199,0.0159456229906064,0.00406389895155122,0.00798038104556601,0.0239108649356468,8.77204637906471e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40223,0.0313793027024464,0.00800374518571976,0.0156919621384357,0.0470666432664572,8.887152663253e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINI1,Neuroserpin,40267,0.0123831566072281,0.00316795285607897,0.00617396900931334,0.0185923442051429,9.32764130666616e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,42705,-0.00824087640265139,0.00211518071281866,-0.012386630599776,-0.00409512220552681,9.82405121652746e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42545,0.0115347863560985,0.00296148605221145,0.00573027369376408,0.0173392990184329,9.87050762397319e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLSTN2,Calsyntenin-2,42754,-0.0161379951133303,0.00415147681670871,-0.0242748896740793,-0.00800110055258121,0.000101852366765354
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF5,Eukaryotic translation initiation factor 5,40116,0.0178568848444071,0.00462554735622392,0.00879081202620824,0.026922957662606,0.000113811462939081
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YY1,Transcriptional repressor protein YY1,40199,0.0114211567104065,0.00295894529899247,0.00562162392438128,0.0172206894964318,0.000114093858916799
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGSF21,Immunoglobulin superfamily member 21,40223,0.0160202946674002,0.00415434190599395,0.00787778453165205,0.0241628048031483,0.000115781180252393
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGT,Angiotensinogen,40532,0.00964185615915717,0.0025022519749263,0.00473744228830163,0.0145462700300127,0.000117192475014256
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42357,0.0197103917262883,0.0051266653053647,0.00966212772777351,0.0297586557248031,0.000121277603532324
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNPY2,Protein canopy homolog 2,42357,0.024820248006306,0.00645761980721707,0.0121633131841606,0.0374771828284515,0.000121832548887823
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RSPO3,R-spondin-3,42721,0.0119466438611918,0.00311280541245618,0.00584554525277766,0.0180477424696059,0.000124654244017437
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAPRT,Nicotinate phosphoribosyltransferase,40483,0.0135967159796837,0.003552871723807,0.00663308740102193,0.0205603445583454,0.000130432777571639
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD160,CD160 antigen,42754,0.0196201397523576,0.00513468942903016,0.00955614847145847,0.0296841310332567,0.00013345313824127
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL6,Interleukin-6,42587,0.030720939087286,0.00805122915752746,0.0149405299385322,0.0465013482360398,0.00013641721695788
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RCC1,Regulator of chromosome condensation,40451,0.0209880801828619,0.00550544526037812,0.0101974074725208,0.031778752893203,0.000138447164936666
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPP4,Dipeptidyl peptidase 4,42441,0.0112478737200566,0.00295125702881966,0.00546340994357009,0.0170323374965431,0.000138911426166462
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PREB,Prolactin regulatory element-binding protein,42370,0.011775443926306,0.00308992266339656,0.00571919550604876,0.0178316923465633,0.000139081015863714
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBPMS,RNA-binding protein with multiple splicing,40199,0.025385225484991,0.00669906648738462,0.0122550551697172,0.0385153958002649,0.000151836536360943
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",42636,0.0289241775009593,0.00764180374712051,0.0139462421566031,0.0439021128453155,0.000154380429176158
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGA4,Pepsin A-4,40532,0.0319644176983696,0.00845417616541856,0.0153942324141492,0.0485346029825899,0.000157062557532505
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFNA1,Ephrin-A1,42590,0.0119848923725491,0.003172223850679,0.00576733362521822,0.0182024511198799,0.00015873102462629
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ROBO4,Roundabout homolog 4,40223,-0.00718420989856454,0.00191028114042055,-0.0109283609337888,-0.00344005886334026,0.000170237784457886
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLAMF7,SLAM family member 7,42594,-0.0233944136761916,0.00623303337905427,-0.035611159099138,-0.0111776682532452,0.000175262102924794
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40527,0.0145438311812077,0.00387749135383886,0.00694394812768353,0.0221437142347319,0.00017712445964452
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CYTL1,Cytokine-like protein 1,40527,0.010040937643431,0.0026816731420053,0.00478485828510059,0.0152970170017614,0.000181806420499206
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCN3,CCN family member 3,42779,0.0138753155217781,0.00371515401549527,0.00659361365140741,0.0211570173921489,0.000188640828437311
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSH3,Protein phosphatase Slingshot homolog 3,40080,0.0113476253747517,0.0030387305011992,0.00539171359240131,0.0173035371571022,0.000189174932969208
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHNAK2,Protein AHNAK2,40223,0.0118143696873997,0.00317112801474667,0.00559895877849619,0.0180297805963032,0.000195819888700991
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALB1,Calbindin,42587,0.0177393195297193,0.00477686141775704,0.00837667115091552,0.0271019679085231,0.000205166628421989
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SDC1,Syndecan-1,42636,0.0157947801773466,0.00425647042468408,0.0074520981449658,0.0241374622097274,0.000207463503832953
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OGN,Mimecan,42611,0.0171716986213329,0.00463978051091649,0.00807772881993653,0.0262656684227292,0.000215634126208304
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42570,0.0708774457951202,0.0191748036263912,0.0332948306873936,0.108460060902847,0.00021956510955635
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,42636,-0.0104501272275561,0.00283215909671345,-0.0160011590571144,-0.00489909539799773,0.00022530804813643
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REG3G,Regenerating islet-derived protein 3-gamma,40451,0.0158260915426943,0.00429995401575478,0.00739818167181496,0.0242540014135737,0.000233840609365734
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDK1,Cyclin-dependent kinase 1,40080,0.0142242926592917,0.00387156228563303,0.00663603057945097,0.0218125547391324,0.000239886480459483
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL10RA,Interleukin-10 receptor subunit alpha,42370,0.0223238778689231,0.00608226129740699,0.0104026457260054,0.0342451100118407,0.000243198297238655
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",40527,0.0157929288612792,0.0043041426279523,0.00735680931049266,0.0242290484120657,0.000244388996348196
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40116,-0.015015295981086,0.00409697785443849,-0.0230453725757854,-0.00698521938638653,0.000248540764215117
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD200,OX-2 membrane glycoprotein,42594,-0.0105403735460268,0.00287637255199836,-0.0161780637479435,-0.00490268334410997,0.00024881015957237
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42311,0.0114160533769088,0.00314998181096295,0.00524208902742142,0.0175900177263962,0.000290992984419433
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL31RA,Interleukin-31 receptor subunit alpha,40145,0.0145640273888584,0.00402177914825663,0.00668134025827541,0.0224467145194414,0.000294462269575663
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIPC2,PDZ domain-containing protein GIPC2,40483,0.0117264860530554,0.00324745697528044,0.00536147038150571,0.018091501724605,0.000306370519710311
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VWF,von Willebrand factor,42794,-0.0271176011556483,0.00752166944179848,-0.0418600732615733,-0.0123751290497233,0.000312951509684423
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL28,C-C motif chemokine 28,42538,0.0221234165864267,0.0061523453609374,0.0100648196789894,0.034182013493864,0.000324398884075741
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLIN3,Perilipin-3,42636,0.0157677842712589,0.00440081070207709,0.0071421952951878,0.02439337324733,0.000340966528170269
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK4,Kallikrein-4,42721,-0.023853196805608,0.0066581466928125,-0.0369031643235205,-0.0108032292876955,0.000341440867961156
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CENPJ,Centromere protein J,40302,0.0265634535172081,0.00744097552155636,0.0119791414949577,0.0411477655394586,0.000358640614756231
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,40136,-0.0121674027997561,0.00340956948642791,-0.0188501589931548,-0.0054846466063574,0.000360424463468556
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFRA2,GDNF family receptor alpha-2,42587,0.00793658742698395,0.00223057038537139,0.00356466947165602,0.0123085053823119,0.000374841732189292
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40511,0.0105936205644759,0.00297727654804173,0.0047581585303141,0.0164290825986377,0.000374992909770712
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSAP,Gamma-secretase-activating protein,42346,0.0318642756754801,0.00897395800491179,0.014275317985853,0.0494532333651072,0.000385477979426415
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,40302,0.0321346289796197,0.00906881368602306,0.0143597541550145,0.0499095038042249,0.00039659238683222
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP3,"Fatty acid-binding protein, heart",40511,0.0194319125360934,0.00549945725916183,0.00865297630813619,0.0302108487640506,0.00041185000427337
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC14A,C-type lectin domain family 14 member A,42611,-0.0123263827102652,0.00349262410139617,-0.0191719259490016,-0.00548083947152866,0.000418116575129713
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42711,0.0263381708259643,0.00746805923798947,0.011700774719505,0.0409755669324237,0.000422046767720896
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALPI,Intestinal-type alkaline phosphatase,40199,0.0463709158098683,0.0131593133894269,0.0205786615665915,0.072163170053145,0.000427116166504407
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRLB,Fc receptor-like B,42346,0.0239882259824426,0.00681000858847905,0.0106406091490237,0.0373358428158616,0.000428953462701
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40116,0.0165287927677606,0.00469625486575637,0.00732413323087808,0.0257334523046431,0.00043400840610503
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNMA2,Paraneoplastic antigen Ma2,40136,0.0163872417685555,0.00466426809865979,0.00724527629518233,0.0255292072419287,0.000444267779300488
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDH12,Protocadherin-12,40482,0.00946963862247867,0.00270604989534011,0.00416578082761206,0.0147734964173453,0.000468047424514131
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,40457,0.013795462413159,0.0039775303653867,0.00599950289700109,0.021591421929317,0.000525624397711495
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40449,-0.0256093493118828,0.00739239977941983,-0.0400984528795457,-0.01112024574422,0.000533630769750323
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRCAM,Neuronal cell adhesion molecule,42636,0.0105270772433102,0.00304279445788436,0.00456320010585684,0.0164909543807635,0.000542507059328836
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,42711,0.00841914942004162,0.00243805705200655,0.00364055759810878,0.0131977412419745,0.000555632148370919
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJA4,DnaJ homolog subfamily A member 4,40483,0.025603433495152,0.00741564224790951,0.0110687746892494,0.0401380923010547,0.000557195016838418
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA11,Serpin A11,42794,-0.0147507902182248,0.00427970220856529,-0.0231390065470128,-0.00636257388943686,0.000569223136869096
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40080,0.0209310938514069,0.0061000312112383,0.00897503267737982,0.032887155025434,0.000602906960767838
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,42607,0.00798292342697044,0.00233174306007735,0.00341270702921884,0.012553139824722,0.000619853931904814
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EP300,Histone acetyltransferase p300,40199,0.0111081514884783,0.00324963894939809,0.00473885914765809,0.0174774438292986,0.00063248316877368
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INSL3,Insulin-like 3,40483,0.0280284431519414,0.00820301217464874,0.0119505392896299,0.0441063470142529,0.000635741251746642
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FDX2,"Ferredoxin-2, mitochondrial",40116,0.0202400742492386,0.00592857036759636,0.00862007632874977,0.0318600721697275,0.000642517898444503
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSPAN8,Tetraspanin-8,40449,0.0366569946199921,0.010740618755583,0.0156053818590495,0.0577086073809347,0.000644944908731693
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JUN,Transcription factor AP-1,42370,0.017123362154717,0.00502186788634569,0.00728050109747943,0.0269662232119545,0.000652150862168464
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42370,0.0202966836927112,0.00595926936982499,0.0086165157278542,0.0319768516575681,0.000661428615195289
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40065,0.0313733849300078,0.00921204684373749,0.0133177731162824,0.0494289967437333,0.000662356120059142
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL2,Apoptosis regulator Bcl-2,40449,0.020400487061597,0.00599770144646875,0.0086449922265183,0.0321559818966758,0.000672787095533526
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLNS1A,Methylosome subunit pICln,40182,0.011910412957759,0.00350567180049434,0.00503929622879012,0.0187815296867279,0.000682534413849275
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40116,0.0186656288901722,0.00550550038554113,0.00787484813451163,0.0294564096458328,0.000700480459819077
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,40527,0.0225503449464476,0.00665190203417434,0.00951261695946587,0.0355880729334293,0.000701157939166391
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RETN,Resistin,42598,0.0153889107749815,0.00454617225375309,0.00647841315762548,0.0242994083923376,0.000713756649261489
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPESP1,Sperm equatorial segment protein 1,40511,0.0112765880552232,0.00333123231609644,0.00474737271567413,0.0178058033947722,0.000713914717824918
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42618,0.0103538433416384,0.00307082056352702,0.00433503503712542,0.0163726516461513,0.000749203502866952
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSTP1,Glutathione S-transferase P,42237,-0.0247149552974858,0.00734553613672892,-0.0391122061254745,-0.0103177044694971,0.00076869385666029
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40223,-0.00740148608182541,0.00220406144393291,-0.0117214465119339,-0.0030815256517169,0.000787422908360513
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40539,-0.00694603019306141,0.00207253956314436,-0.0110082077368244,-0.00288385264929847,0.000806496436394151
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,42636,0.0203869849016503,0.00609685384710661,0.0084371513613213,0.0323368184419792,0.000828492105769551
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LMNB1,Lamin-B1,40434,0.020886617888768,0.00626401897749262,0.00860914069288249,0.0331640950846535,0.000857663821280616
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLC,Galectin-10,42611,-0.0228939666837986,0.00689538565201504,-0.036408922561748,-0.00937901080584908,0.000901972090716474
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1R1,Interleukin-1 receptor type 1,42590,-0.00817828139072594,0.00246706756837763,-0.0130137338247461,-0.00334282895670579,0.000918928199673055
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHRM1,Muscarinic acetylcholine receptor M1,40182,-0.0129583148283019,0.00390884126256185,-0.0206196437029231,-0.00529698595368068,0.000918973387936688
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAPK13,Mitogen-activated protein kinase 13,40080,0.0145372896872176,0.00439083387184282,0.00593125529840567,0.0231433240760295,0.000933234338604316
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCR1,Natural cytotoxicity triggering receptor 1,42566,0.0134004324139547,0.00405663588378916,0.005449426081728,0.0213514387461815,0.000957926152883255
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40199,0.0107649423946748,0.00325985114227512,0.00437563415581552,0.017154250633534,0.000962078290565879
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CST6,Cystatin-M,42332,0.0174873332823079,0.00531198165806353,0.00707584923250334,0.0278988173321124,0.000997207857800704
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,40483,0.0186631782161878,0.0056732274966346,0.00754365232278394,0.0297827041095916,0.00100603902043554
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFRAL,GDNF family receptor alpha-like,40109,-0.0216819264490996,0.00659236560263153,-0.0346029630302574,-0.0087608898679418,0.00100882111727058
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC12A2,Solute carrier family 12 member 2,40116,-0.009395067668302,0.00286113328240243,-0.0150028889018108,-0.00378724643479324,0.00102780690999961
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCAR,Immunoglobulin alpha Fc receptor,42594,0.016772181143663,0.00511186726453562,0.00675292130517321,0.0267914409821528,0.00103693663177654
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42173,-0.0295080285550508,0.00899953762203991,-0.047147122294249,-0.0118689348158525,0.00104509670590411
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PKD1,Polycystin-1,40511,0.00922278810799138,0.00281348326295561,0.00370836091259839,0.0147372153033844,0.00104835622676985
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G1B,Phospholipase A2,42782,-0.0156226467438819,0.00477479327698777,-0.0249812415667779,-0.00626405192098588,0.00107093742732341
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COMMD9,COMM domain-containing protein 9,40451,0.0135659374366738,0.00416481270090577,0.00540290454289848,0.0217289703304491,0.00112820803597966
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFB2,Transforming growth factor beta-2 proprotein,40451,0.0178173374177008,0.00547017241183309,0.00709579949050794,0.0285388753448937,0.00112858172858049
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,42311,0.0508948734217192,0.0156319804894324,0.0202561916624317,0.0815335551810068,0.00113353315112828
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,42737,0.0106164011152889,0.0032633816616646,0.00422017305842623,0.0170126291721515,0.00114396673634509
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEZ6,Seizure protein 6 homolog,40182,-0.010728658214329,0.00329810142410751,-0.0171929370055797,-0.00426437942307824,0.00114546316752456
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42618,0.0253807327671502,0.00781471678773475,0.0100638878631901,0.0406975776711103,0.00116581675274216
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRK1,Protein BRICK1,42311,0.0152587371053476,0.00470341343393633,0.00604004677483245,0.0244774274358628,0.0011808267018991
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP6V1D,V-type proton ATPase subunit D,42587,0.00888357954145321,0.00273848972911385,0.00351613967239006,0.0142510194105164,0.00118164978738392
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MILR1,Allergin-1,42370,-0.0174680879186854,0.00540000150960678,-0.0280520908775146,-0.00688408495985608,0.00122015250220033
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,40199,0.0120162831115921,0.00372089864546671,0.00472332176647731,0.0193092444567068,0.00124412782768372
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EXTL1,Exostosin-like 1,40116,0.016020397315215,0.00497176486614366,0.00627573817757346,0.0257650564528566,0.00127549686438747
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIF20B,Kinesin-like protein KIF20B,40136,0.0264529380651321,0.00821827815517897,0.0103451128809813,0.0425607632492828,0.00129106651035872
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G2A,"Phospholipase A2, membrane associated",42602,-0.019149860679016,0.00596921722606585,-0.0308495264421051,-0.00745019491592695,0.00133927897328578
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMP2,Metalloproteinase inhibitor 2,40511,-0.00934822403758812,0.00292070791107226,-0.0150728115432898,-0.00362363653188649,0.00137486732890599
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WIF1,Wnt inhibitory factor 1,42721,-0.011552051416833,0.00361074835747598,-0.0186291181974859,-0.00447498463618004,0.00138055007860401
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40199,0.0279586533376998,0.00874004747286028,0.0108281602908936,0.0450891463845059,0.00138337590831268
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NLGN2,Neuroligin-2,40136,-0.0161330052298939,0.0050484607092093,-0.0260279882199441,-0.0062380222398437,0.00139922760403843
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DSC2,Desmocollin-2,42488,-0.0118442485334785,0.00370963345480174,-0.0191151301048899,-0.00457336696206707,0.00141211419249325
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42495,0.0230519082339377,0.00722221473199454,0.00889636735922836,0.0372074491086469,0.00141715000948808
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,40182,0.0281385350930407,0.00883521141905508,0.0108215207116927,0.0454555494743886,0.00145249816918263
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,40080,0.0197618831875153,0.00620706375405947,0.00759603822955878,0.0319277281454719,0.00145778085109153
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC1,Sialoadhesin,42676,0.0143954821504986,0.00452289354966264,0.00553061079315985,0.0232603535078374,0.00146187590284007
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHA4,Ephrin type-A receptor 4,40283,0.00969104887936529,0.00305800456616761,0.00369735992967678,0.0156847378290538,0.0015333985944659
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42638,0.0115578952046644,0.00364802363993293,0.00440776887039588,0.018708021538933,0.00153696446185606
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REG3A,Regenerating islet-derived protein 3-alpha,42794,-0.0216884932449495,0.00684900505978783,-0.0351125431621336,-0.00826444332776534,0.0015453928837842
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPA4,Carboxypeptidase A4,40060,0.0146385600300079,0.00463853104078214,0.00554703919007491,0.0237300808699409,0.00160461907615666
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40482,0.0162992422037702,0.00518666900868491,0.00613337094674781,0.0264651134607927,0.00167930225269503
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSLN,Mesothelin,42553,0.0195887300835027,0.00624251198863596,0.00735340658577619,0.0318240535812292,0.00170500146351013
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,40199,0.00799217272066495,0.00255409583764852,0.00298614487887385,0.0129982005624561,0.00175765278049485
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSV,Cathepsin L2,42677,0.0136882715090342,0.00438473522759703,0.00509419046294399,0.0222823525551243,0.00180128268240273
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,42572,0.0111866893334928,0.00358417692721045,0.00416170255616033,0.0182116761108253,0.00180540777628351
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40255,-0.015783699753189,0.00507302226354143,-0.0257268233897302,-0.00584057611664775,0.00186739026207574
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK14,Kallikrein-14,42721,-0.0153472610837221,0.00493822017684864,-0.0250261726303455,-0.00566834953709879,0.00188842541062941
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CST1,Cystatin-SN,39042,0.0358677779160077,0.0115553283666339,0.0132193343174052,0.0585162215146102,0.00191462360939365
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ELAVL4,ELAV-like protein 4,40136,0.0276639494112176,0.00892123705632143,0.0101783247808276,0.0451495740416076,0.00193417556784146
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42311,0.0171748318577242,0.00554202155313674,0.0063124696135762,0.0280371941018722,0.0019457306081927
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM171B,Protein FAM171B,40451,0.00858556520711767,0.00277196586442264,0.0031525121128493,0.014018618301386,0.00195783173159951
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIAA1549L,UPF0606 protein KIAA1549L,40302,-0.00939708082125321,0.00304296860206218,-0.0153612992812951,-0.00343286236121132,0.00201917447541537
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,42594,0.02240525283093,0.00727078331487775,0.00815451753376962,0.0366559881280904,0.00206346326232942
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC12A,C-type lectin domain family 12 member A,40199,0.00669218664380175,0.00217360996021958,0.00243191112177138,0.0109524621658321,0.00208323249411195
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXNL1,Thioredoxin-like protein 1,40124,0.0318736624775505,0.0103551833027913,0.0115775032040796,0.0521698217510214,0.00208883324455352
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA6C,Semaphorin-6C,40199,0.00844407669537064,0.00275541324023293,0.00304346674451411,0.0138446866462272,0.00218531923178369
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TG,Thyroglobulin,40451,-0.0369449627207576,0.0120865405295062,-0.0606345821585897,-0.0132553432829255,0.00224310520921423
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRISP3,Cysteine-rich secretory protein 3,40439,-0.00868126086394096,0.00286072545749836,-0.0142882827606377,-0.00307423896724418,0.00241376294190165
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HEPACAM2,HEPACAM family member 2,40483,-0.0133591419841531,0.00442065770851899,-0.0220236310928503,-0.00469465287545591,0.00251689499701096
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DSG4,Desmoglein-4,42543,0.0158403235778432,0.00524452965244641,0.00556104545904821,0.0261196016966382,0.00252958996404342
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIAA1549,UPF0606 protein KIAA1549,40302,0.0224306105658559,0.00743634651498863,0.00785537139647821,0.0370058497352336,0.00256418103826819
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40483,0.0202773720528244,0.00672643336600343,0.00709356265545771,0.0334611814501911,0.00257906919997601
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNXB,Tenascin-X,42611,-0.00814535683094847,0.00270288639351486,-0.0134430141622376,-0.00284769949965936,0.00258669284793274
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,40302,0.0181241202814899,0.00601897940670858,0.00632692064434111,0.0299213199186387,0.00260835343645702
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40451,0.0157891551170635,0.00524481455669978,0.00550931858593193,0.0260689916481951,0.00261455010414984
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REN,Renin,42636,-0.0269490720394959,0.00895571891609384,-0.0445022811150399,-0.00939586296395202,0.00262468086586406
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHX2,Bifunctional epoxide hydrolase 2,42357,0.0195974649317843,0.00651561224908465,0.00682686492357844,0.0323680649399902,0.00263669202341499
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GM2A,Ganglioside GM2 activator,40269,0.0129112211453145,0.00429355048745047,0.00449586218991161,0.0213265801007175,0.00264327528005164
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALCB,Calcitonin gene-related peptide 2,40483,0.012876161111524,0.00430319524423629,0.00444189843282087,0.0213104237902271,0.00277543882724756
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NTF4,Neurotrophin-4,42346,0.0122424247384946,0.00409207718555552,0.0042219534548058,0.0202628960221834,0.00277908182959429
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNX18,Sorting nexin-18,40449,0.0137346259593794,0.0045958795159321,0.00472670210815244,0.0227425498106063,0.00280987629854911
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LXN,Latexin,42461,-0.021150610637414,0.00709596307885163,-0.0350586982719632,-0.00724252300286481,0.00288155227829852
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS4,Galectin-4,42618,0.0176336787387061,0.00591661024657632,0.00603712265541651,0.0292302348219957,0.00288417666423511
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NMRK2,Nicotinamide riboside kinase 2,40080,-0.0132966545726824,0.00446135214587577,-0.0220409047785989,-0.0045524043667659,0.00288499768942508
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKAP12,A-kinase anchor protein 12,40283,-0.00687353261679206,0.00231179605191192,-0.0114046528785394,-0.00234241235504469,0.00295304212245647
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA4C,Semaphorin-4C,42587,-0.00861393614828232,0.00291361412693832,-0.0143246198370814,-0.00290325245948321,0.00311751740911094
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD55,Complement decay-accelerating factor,42201,0.00841356945058446,0.00285575831351986,0.00281628315608554,0.0140108557450834,0.00322298677254065
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40223,-0.00792650204548887,0.00269115899915345,-0.0132011736838296,-0.00265183040714811,0.00323225841220662
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40302,0.0162369755328325,0.00552251277862382,0.00541285048672986,0.0270611005789352,0.00328737229972875
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHB4,Ephrin type-B receptor 4,42794,-0.00811054269876952,0.00276356296338746,-0.0135271261070089,-0.00269395929053009,0.00334305933617496
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFF2,Trefoil factor 2,42654,0.017882116607629,0.00609696500599192,0.00593206519588485,0.0298321680193732,0.00336319779649984
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40451,0.0143755190794894,0.00490131266773349,0.00476894625073173,0.023982091908247,0.0033638739578956
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRR5,Proline-rich protein 5,40199,0.014672172825093,0.00501817947487228,0.00483654105434332,0.0245078045958427,0.0034648733206944
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCN2B,Sodium channel subunit beta-2,40182,-0.00891067257428231,0.00306292738028072,-0.0149140102396325,-0.00290733490893209,0.00363079790048605
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYOC,Myocilin,42611,-0.0135848067507069,0.00467995724636962,-0.0227575229535913,-0.00441209054782242,0.00370488792227449
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNW1,Interferon omega-1,40116,-0.0112276361173582,0.0038724414810688,-0.018817621420253,-0.00363765081446331,0.00374659678895247
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPSAB1,Tryptase alpha/beta-1,42741,0.0158927887626326,0.0054871334839582,0.00513800713407452,0.0266475703911907,0.00378106646835536
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DKKL1,Dickkopf-like protein 1,42587,-0.0266457178380759,0.00920998158419832,-0.0446972817431046,-0.00859415393304721,0.00382032401312078
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,42346,0.0171487420427585,0.00593714415078099,0.00551193950722776,0.0287855445782892,0.00387860741219795
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40302,0.0196608852456071,0.00684546721713836,0.00624376950001592,0.0330780009911983,0.00408522154690264
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UNG,Uracil-DNA glycosylase,40451,0.0102788412381087,0.00358067606880968,0.0032607161432417,0.0172969663329757,0.00410402083131368
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSAPL1,Proactivator polypeptide-like 1,40449,-0.0153636089081224,0.00535760343024932,-0.0258645116314111,-0.00486270618483373,0.00414330834226672
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REG1A,Lithostathine-1-alpha,42575,-0.0156768385809832,0.00546721317418089,-0.0263925764023778,-0.00496110075958868,0.00414469676729841
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP112,Centrosomal protein of 112 kDa,40116,0.0135098574455935,0.00471285562319724,0.00427266042412695,0.0227470544670601,0.0041570427347362
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENO1,Alpha-enolase,42588,0.0235337073445887,0.00822856488194973,0.00740572017596726,0.0396616945132102,0.00424293953126515
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LEG1,Protein LEG1 homolog,39926,-0.0209594632735701,0.00735034033282087,-0.035366130325899,-0.00655279622124119,0.00435971405937459
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHA2,Ephrin type-A receptor 2,42125,0.0100475316748727,0.00353396699896589,0.00312095635689958,0.0169741069928459,0.00447426951997763
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40116,-0.00620497697869755,0.00218259298672084,-0.0104828592326704,-0.0019270947247247,0.00447826626284163
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDA1,DET1- and DDB1-associated protein 1,40116,0.012019273069131,0.00422961643642759,0.00372922485373289,0.020309321284529,0.00449577445791955
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,42346,0.0150839375424934,0.00531211471560201,0.00467219269991343,0.0254956823850733,0.00452485860551735
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GUK1,Guanylate kinase,40116,-0.0114463406410104,0.00403623608189727,-0.0193573633615291,-0.00353531792049176,0.00457815247258886
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CGA,Glycoprotein hormones alpha chain,42611,-0.0186870146980999,0.00659778024912629,-0.0316186639863874,-0.0057553654098124,0.00462806449904602
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEO1,Neogenin,40482,0.00659644951571075,0.00233165010592475,0.00202641530809823,0.0111664837233233,0.00467627986619752
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGMA,Repulsive guidance molecule A,42711,-0.00943626756633051,0.00335373193361384,-0.0160095821562136,-0.00286295297644739,0.00490514429436142
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH6,Cadherin-6,42636,-0.0113931044663947,0.00405315697178264,-0.0193372921310887,-0.00344891680170071,0.00494713684335913
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLT1,Vascular endothelial growth factor receptor 1,42559,0.00636690140372441,0.00226573461905279,0.00192606155038094,0.0108077412570679,0.00496007810525633
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PKLR,Pyruvate kinase PKLR,42636,0.0191500804846097,0.00682733752977027,0.00576849892625994,0.0325316620429594,0.0050402585983234
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPON1,Spondin-1,42638,0.00994564774664333,0.00355005195903498,0.00298754590693477,0.0169037495863519,0.0050930460704346
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40136,0.00953852905101319,0.00340588394016399,0.00286299652829177,0.0162140615737346,0.00510966822095637
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRXN3,Neurexin-3,40182,0.0104456993210376,0.00373738504228722,0.00312042463815462,0.0177709740039205,0.00520022658019332
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCG3,Secretogranin-3,42638,-0.00998322526599847,0.00357877203519498,-0.0169976184549806,-0.00296883207701632,0.0052852808632601
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYBPC1,"Myosin-binding protein C, slow-type",40511,-0.0208604483671581,0.00751880539480715,-0.0355973069409801,-0.00612358979333613,0.00553880783131969
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRG3,Proteoglycan 3,40527,-0.0144790950579725,0.00522642869319121,-0.0247228952966273,-0.00423529481931777,0.0056085350616583
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYOM1,Myomesin-1,40136,0.0139772922941453,0.00505615527992886,0.00406722794548475,0.0238873566428059,0.00571210672391377
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACE,Angiotensin-converting enzyme,40532,-0.00770310861205097,0.00281349018600984,-0.0132175493766302,-0.00218866784747169,0.00619257412927098
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40116,-0.0116866546401117,0.00428546146052818,-0.020086159102747,-0.00328715017747649,0.00640059742517656
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDN1,Endothelin-1,40223,0.00870671670352399,0.00319324935519892,0.0024479479673341,0.0149654854397139,0.00640914935935563
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AIDA,"Axin interactor, dorsalization-associated protein",40182,0.0240871544436962,0.00883845337450074,0.00676378582967479,0.0414105230577177,0.0064351032047584
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TTN,Titin,40116,-0.0187842713676571,0.00689508603353882,-0.0322986399933932,-0.00526990274192103,0.00645407818964331
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACHE,Acetylcholinesterase,40283,0.00950050295995589,0.00348834759743119,0.00266334166899076,0.016337664250921,0.00646959779793987
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NMI,N-myc-interactor,40421,0.0205436379256118,0.00754662053362398,0.00575226167970878,0.0353350141715148,0.00649430451342545
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40199,0.0100724336860215,0.00370554745037046,0.00280956068329536,0.0173353066887476,0.00657401677871511
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",40080,0.026290514141359,0.00970999273337918,0.00725892838393584,0.0453220998987822,0.00678829774614821
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL19,Interleukin-19,42261,0.0204861643711104,0.00757355141512633,0.00564200359746282,0.035330325144758,0.00684008598089761
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFPI2,Tissue factor pathway inhibitor 2,42635,0.0106570174369391,0.00394087162580241,0.00293290905036643,0.0183811258235119,0.00685493668066929
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBP7,Retinoid-binding protein 7,40449,0.0169907915319992,0.00629349132065429,0.00465554854351681,0.0293260345204816,0.00694973430515195
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,40182,0.00852445726536179,0.00316226547508671,0.00232641693419184,0.0147224975965317,0.00703519620689618
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNL1,Interferon lambda-1,42311,0.0129107806923116,0.00479626760357008,0.00351009618931425,0.0223114651953089,0.00711493770549136
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AIF1L,Allograft inflammatory factor 1-like,40223,0.015723919391339,0.00584353403560431,0.00427059268155454,0.0271772461011234,0.00713832839099254
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCN2,Transcobalamin-2,42771,-0.00867911684323609,0.0032316536988618,-0.0150131580930052,-0.00234507559346697,0.00724751290409383
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP1B4,Protein ATP1B4,40080,-0.0119283621383997,0.00444323957667166,-0.0206371117086762,-0.00321961256812327,0.00727246001121855
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JCHAIN,Immunoglobulin J chain,42370,-0.0176283363691064,0.00656925317125056,-0.0305040725847575,-0.00475260015345525,0.00729554310853593
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTO1,Protein LTO1 homolog,42370,0.0118490453681857,0.00441589333341262,0.00319389443469698,0.0205041963016745,0.0072996590197863
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RRP15,RRP15-like protein,40136,-0.0258830533285786,0.00964787822200416,-0.0447928946437068,-0.00697321201345049,0.00731245726936038
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFHR4,Complement factor H-related protein 4,40509,0.0209383580253388,0.00781700193620048,0.00561703423038586,0.0362596818202918,0.00740449394555236
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTR,Methionine synthase,40116,0.0185689189717394,0.00697172676287843,0.00490433451649768,0.0322335034269811,0.00774549573129246
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TOP1,DNA topoisomerase 1,40449,0.0313490552416189,0.0117717881337535,0.00827635049946203,0.0544217599837757,0.00775422801994405
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BABAM1,BRISC and BRCA1-A complex member 1,40199,0.00812482985548593,0.00305425615019606,0.00213848780110164,0.0141111719098702,0.00782152534138405
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP164,Centrosomal protein of 164 kDa,42370,0.018404715175922,0.00692309991916248,0.00483543933436358,0.0319739910174805,0.00785958142461012
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMPRSS5,Transmembrane protease serine 5,42438,-0.0105974346684894,0.003988902135645,-0.0184156828543536,-0.00277918648262525,0.00789972839015246
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NELL2,Protein kinase C-binding protein NELL2,42676,0.0080543476540737,0.00303326640317933,0.00210914550384221,0.0139995498043052,0.00793221086178846
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGLYRP1,Peptidoglycan recognition protein 1,42737,0.0118034142785151,0.00446021343521175,0.00306139594550007,0.0205454326115301,0.00814527224721369
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40116,-0.0107722927557674,0.0040822513508977,-0.0187735054035269,-0.00277108010800789,0.00833152420057532
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAD51,DNA repair protein RAD51 homolog 1,40302,0.0150309466437363,0.00570480823037002,0.00384952251221105,0.0262123707752615,0.00843072816358473
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKCQ,Protein kinase C theta type,42370,0.0120796981324689,0.00459508505707754,0.00307333142059696,0.0210860648443409,0.00857785769029406
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42458,0.00955513110667317,0.00363863260312259,0.0024234112045529,0.0166868510087934,0.00864883186566915
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOLR1,Folate receptor alpha,42600,0.00834716554887256,0.00318009281591063,0.00211418362968772,0.0145801474680574,0.00867935887222362
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TLR1,Toll-like receptor 1,40199,0.00737514208575415,0.00281089496485842,0.00186578795463166,0.0128844962168767,0.0087082480237856
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIAA2013,Uncharacterized protein KIAA2013,40451,0.0147691970853853,0.00563466185041768,0.00372525985856663,0.025813134312204,0.00877559235522987
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMEM25,Transmembrane protein 25,40482,-0.0125227784298156,0.00478636620218182,-0.021904056186092,-0.00314150067353924,0.00889954533575335
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TLR4,Toll-like receptor 4,40199,0.00802905463945819,0.00307677122577478,0.00199858303693961,0.0140595262419768,0.0090778397977137
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMOD4,Tropomodulin-4,40080,-0.0113134206717827,0.00433560687961881,-0.0198112101558356,-0.00281563118772986,0.00908198480439012
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOX9,Transcription factor SOX-9,40182,0.00759342042535254,0.00291152020035912,0.00188684083264867,0.0133000000180564,0.00911800861715965
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLP1R,Glucagon-like peptide 1 receptor,40136,-0.0103928907491358,0.00398543273411228,-0.0182043389079959,-0.00258144259027576,0.00912713787532988
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40302,0.014319371620008,0.00549886302688025,0.00354160008732272,0.0250971431526933,0.00922491297534743
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDKL5,Cyclin-dependent kinase-like 5,40136,-0.0147736586466841,0.00567503119294962,-0.0258967197848654,-0.00365059750850289,0.00924628738209742
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSC1,Hamartin,40199,0.0200523332064781,0.00770666512269005,0.00494726956600559,0.0351573968469506,0.00928203830912975
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NME1,Nucleoside diphosphate kinase A,40199,-0.00601119298139158,0.00231116648104393,-0.0105410792842377,-0.00148130667854548,0.00930945289023994
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGAV,Integrin alpha-V,42721,-0.00445546973520822,0.00171576201252133,-0.00781836327975003,-0.0010925761906664,0.00942018812226001
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42311,0.0137020586154275,0.00532033776373798,0.00327419659850109,0.024129920632354,0.0100229405175515
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL25,Interleukin-25,40036,0.00945291213102711,0.00367454246396768,0.00225080890165045,0.0166550153604038,0.0101086749163518
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TEF,Thyrotroph embryonic factor,40116,0.0116886741052637,0.00456377428856066,0.0027436764996848,0.0206336717108426,0.0104448650175842
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,42311,0.0105839200408802,0.00414403964633544,0.00246160233406277,0.0187062377476977,0.0106602121171512
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40283,0.0100891910301945,0.00395734670875773,0.00233279148102935,0.0178455905793597,0.0108015951294037
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP152,Centrosomal protein of 152 kDa,40080,0.0111641046138286,0.00437991050002638,0.00257948003377691,0.0197487291938803,0.0108188621888747
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42594,0.0231711884651211,0.00909417694168908,0.00534660165941055,0.0409957752708317,0.0108479567996863
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,METAP1,Methionine aminopeptidase 1,42311,0.00778060353249282,0.00305850133581086,0.00178594091430353,0.0137752661506821,0.0109727753402961
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP9,Fatty acid-binding protein 9,42594,0.0151067714259749,0.00595166655566243,0.00344150497687649,0.0267720378750732,0.0111523071766664
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42311,0.0205345740461789,0.00809287178102677,0.00467254535536642,0.0363966027369914,0.0111805061758942
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40136,-0.0163722060086984,0.00647277510494692,-0.0290588452143943,-0.00368556680300242,0.0114398535515031
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PADI2,Protein-arginine deiminase type-2,42370,0.0147703098474829,0.00584233260702316,0.00331933793771755,0.0262212817572483,0.0114780246648565
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40302,0.0120683067456676,0.00477699723561363,0.00270539216386484,0.0214312213274703,0.0115396488835684
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C8B,Complement component C8 beta chain,40539,0.00803682863087459,0.00318366639239522,0.00179684250177996,0.0142768147599692,0.0116033179851869
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP8,Neutrophil collagenase,42681,0.0192502576828694,0.00764186938430391,0.00427219368963379,0.0342283216761051,0.0117786307776669
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXNDC15,Thioredoxin domain-containing protein 15,42679,0.00725740346598777,0.00288461627444513,0.00160355556807531,0.0129112513639002,0.0118844358152292
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDHR1,Cadherin-related family member 1,42311,0.01127393201096,0.00448257834898945,0.00248807844694073,0.0200597855749794,0.0119132309176882
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OPTC,Opticin,42587,-0.0121160492107236,0.00485351190361971,-0.0216289325418182,-0.00260316587962895,0.0125599075552853
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP290,Centrosomal protein of 290 kDa,40302,0.0142832542269362,0.00572953037772385,0.00305337468659748,0.025513133767275,0.0126842269307288
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL36G,Interleukin-36 gamma,40154,0.0179436543723818,0.00722504854450576,0.00378255922515051,0.0321047495196131,0.0130234227969997
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRD3,Bromodomain-containing protein 3,40116,0.0129611731912606,0.00522471180734885,0.00272073804885689,0.0232016083336644,0.0131257884394531
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NGF,Beta-nerve growth factor,42495,0.0031190916937734,0.00125763111420262,0.000654134709936255,0.00558404867761054,0.0131456409349901
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BMP10,Bone morphogenetic protein 10,40283,-0.00746217581388137,0.0030157932500789,-0.013373130584036,-0.00155122104372672,0.0133621427012024
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEPTIN7,Septin-7,40302,0.0141450337534643,0.00571677920745523,0.00294014650685202,0.0253499210000765,0.0133645335830831
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THY1,Thy-1 membrane glycoprotein,42711,0.00779616873185341,0.00315374429003347,0.0016148299233878,0.013977507540319,0.01344682706141
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40451,0.0250664207293621,0.0101418919418372,0.00518831252336119,0.044944528935363,0.0134667123900964
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TERF1,Telomeric repeat-binding factor 1,40199,-0.00767411802446641,0.00310497141859129,-0.0137598620049053,-0.00158837404402748,0.0134675796780372
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REXO2,"Oligoribonuclease, mitochondrial",40116,-0.0124290723338413,0.00503521739914909,-0.0222980984361735,-0.00256004623150909,0.0135859886886102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPM1B,Protein phosphatase 1B,40199,0.0156503906273322,0.00640570706183311,0.00309520478613929,0.0282055764685251,0.0145734812312992
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MBL2,Mannose-binding protein C,40379,-0.0278742819645707,0.0114130958048736,-0.050243949742123,-0.00550461418701842,0.0146091108328297
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,42794,0.0105164222456004,0.00430889840392394,0.00207098137390946,0.0189618631172913,0.0146743817080588
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,40199,-0.015752235759813,0.00645893400491735,-0.0284117464094511,-0.00309272511017504,0.0147506355688012
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFD,Complement factor D,40539,0.00533451115054939,0.00219837058294897,0.0010257048079694,0.00964331749312937,0.0152575737207333
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCDC50,Coiled-coil domain-containing protein 50,40482,0.0191522464686116,0.00792015585920726,0.00362874098456535,0.0346757519526578,0.0156147114386844
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD2,T-cell surface antigen CD2,40116,0.00972336899340972,0.00404736138083319,0.00179054068697667,0.0176561972998428,0.0163046041426314
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGAP30,Rho GTPase-activating protein 30,40302,0.00962210671117032,0.00400553876669491,0.0017712507284483,0.0174729626938923,0.0163130905280795
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUSD5,Sushi domain-containing protein 5,40235,-0.00874207735973277,0.00364997200129813,-0.0158960224822771,-0.00158813223718843,0.0166320266002856
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QL2,Complement C1q-like protein 2,40199,0.0110777648488889,0.00462731689229894,0.00200822373998297,0.0201473059577948,0.0166826975730486
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PALM3,Paralemmin-3,40116,0.0179531924769886,0.00751694888288584,0.00321997266653237,0.0326864122874449,0.0169405611680222
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42346,0.0307035805391312,0.0128751815920373,0.00546822461873797,0.0559389364595244,0.0171066508113879
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,40080,0.0216914296638672,0.0090982733268027,0.00385881394333393,0.0395240453844005,0.0171367698589492
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH3GL3,Endophilin-A3,40250,0.0213051920241858,0.00896839446454252,0.0037271388736825,0.0388832451746892,0.0175380563850476
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK1,Kallikrein-1,42505,-0.032246748188544,0.0135869566584368,-0.0588771832390801,-0.00561631313800784,0.0176411568618692
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DBH,Dopamine beta-hydroxylase,40515,0.0272630042786098,0.0114901728421426,0.00474226550801029,0.0497837430492092,0.0176740796932356
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRR4,Proline-rich protein 4,40198,-0.0173084829074632,0.00730207427033223,-0.0316205484773144,-0.00299641733761208,0.017788316265412
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA9,Carbonic anhydrase 9,42721,-0.0119711798063975,0.00507712960894947,-0.0219223538399385,-0.00202000577285658,0.0183945926504518
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL20RB,Interleukin-20 receptor subunit beta,40199,0.0101279690148252,0.00431420403786309,0.00167212910061358,0.0185838089290369,0.0189130790895401
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,42475,-0.00843324090265899,0.0035952660159386,-0.0154799622938986,-0.00138651951141933,0.0190084912514657
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNGR1,Interferon gamma receptor 1,42676,0.00535913679826253,0.00229381130639651,0.000863266637725369,0.0098550069587997,0.0194877904401995
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40136,0.0151631838374012,0.00649516469932318,0.00243266102672776,0.0278937066480746,0.0195857645469377
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFB118,Beta-defensin 118,40136,0.0139538608330483,0.00599026978293647,0.00221293205849278,0.0256947896076037,0.0198548718275446
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,42676,0.00687026550816577,0.00296782013057627,0.00105333805223628,0.0126871929640953,0.0206322656354572
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NXPH3,Neurexophilin-3,40199,0.00746928012584662,0.00322676587712644,0.00114481900667879,0.0137937412450144,0.0206428259323663
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOLH1,Glutamate carboxypeptidase 2,40199,0.0245933015158221,0.0106676866877343,0.00368463560786284,0.0455019674237814,0.0211626018439368
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTTG1,Securin,40302,0.00991954049947593,0.00430394111684364,0.0014838159104624,0.0183552650884895,0.0211985088499366
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACRV1,Acrosomal protein SP-10,40199,0.0193930486223438,0.00841723507164185,0.00289526788192578,0.0358908293627618,0.0212429219475942
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLAMF1,Signaling lymphocytic activation molecule,42370,0.0146380568603058,0.00635388738173514,0.00218443759210492,0.0270916761285067,0.0212496145439493
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MERTK,Tyrosine-protein kinase Mer,42754,-0.00615670530303217,0.00267445989005272,-0.0113986466875355,-0.000914763918528844,0.0213481700167631
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40302,0.0170766791979729,0.00742860846007575,0.00251660661622441,0.0316367517797213,0.021536348302712
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD86,T-lymphocyte activation antigen CD86,40449,0.00731819125300052,0.00318467601886365,0.00107622625602777,0.0135601562499733,0.0215835111557535
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM3D,Protein FAM3D,40449,0.02066285731118,0.00899492823089545,0.00303279797862496,0.0382929166437351,0.0216274794505572
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPRING1,SREBP regulating gene protein,40080,0.0142729418861365,0.00621848400930264,0.00208471322790337,0.0264611705443697,0.0217380367606154
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FDX1,"Adrenodoxin, mitochondrial",40116,0.0149190322574438,0.00650731970082518,0.00216468564382646,0.0276733788710612,0.0218868546372499
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CYB5A,Cytochrome b5,40080,0.0175841449330643,0.00768207137639621,0.00252728503532775,0.0326410048308009,0.0220992932085341
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PI16,Peptidase inhibitor 16,40532,-0.00600315715270419,0.00263173745232429,-0.0111613625592598,-0.000844951746148589,0.0225632212280278
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP350,Centrosome-associated protein 350,40080,0.00909822168917489,0.00399551569538789,0.00126701092621463,0.0169294324521351,0.0227990760433285
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42586,0.0143961244332479,0.00633840762685225,0.00197284548461751,0.0268194033818783,0.0231474941694496
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42594,0.0358163862774287,0.0158122173662106,0.00482444023965596,0.0668083323152015,0.0235219250149776
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFF1,Trefoil factor 1,42556,0.0196613669148593,0.0086846704818987,0.00263941277033785,0.0366833210593808,0.0235952264288639
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40482,0.0171140773426512,0.00756776972981362,0.00228124867221652,0.0319469060130859,0.0237508052182845
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,42618,0.00897771189151787,0.00397408998503329,0.00118849552085261,0.0167669282621831,0.0238955595098025
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNR,Tenascin-R,42495,-0.0100292658343881,0.00444078872077752,-0.0187332117271121,-0.00132531994166421,0.0239342179797714
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,42587,0.00753797979544143,0.00333842863741479,0.000994659666108444,0.0140812999247744,0.0239652746523738
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,40223,0.00944542739741196,0.00419868162759113,0.00121601140733335,0.0176748433874906,0.0244928786057919
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC39A14,Zinc transporter ZIP14,42311,-0.00811951429979125,0.00361588517603722,-0.0152066492448242,-0.0010323793547583,0.0247518531144415
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC13A1,Solute carrier family 13 member 1,40451,0.0147421932611305,0.00656771600310758,0.00186946989503963,0.0276149166272213,0.0248102499628245
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40223,-0.00928603594292823,0.00415919515738649,-0.0174380584514057,-0.00113401343445072,0.0255918842993796
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DRAXIN,Draxin,42495,0.0102348707101257,0.00459407596105353,0.00123048182646075,0.0192392595937906,0.0259077794744495
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40482,0.0268613341405301,0.0120971565547098,0.00315090729329891,0.0505717609877613,0.0264068778564116
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40483,0.00884868371427845,0.00398742031950993,0.001033339888039,0.0166640275405179,0.0264963265907186
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDHB15,Protocadherin beta-15,40451,-0.00936467216019901,0.0042286240197097,-0.01765277523883,-0.00107656908156801,0.026808111244846
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA3,Carbonic anhydrase 3,42770,0.0138051657938967,0.00623860315554891,0.00157750360902081,0.0260328279787725,0.0269237567510779
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHAD,Chondroadherin,40283,0.0120510664493496,0.00544891902210637,0.00137118516602114,0.0227309477326781,0.0270116207563598
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42611,0.00693425454858974,0.00314713729892257,0.0007658654427015,0.013102643654478,0.027586804885559
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENDOU,Poly(U)-specific endoribonuclease,39633,0.0126517209347663,0.00574676334827923,0.00138806477213905,0.0239153770973936,0.0277197215560325
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LHB,Lutropin subunit beta,42346,0.0193946105744248,0.00883365603299322,0.00208064474975811,0.0367085763990915,0.0281425707711448
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALY,Neuron-specific vesicular protein calcyon,40116,-0.00902198344486398,0.00411502305378113,-0.017087428630275,-0.000956538259452968,0.0283680326066574
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LIFR,Leukemia inhibitory factor receptor,42594,-0.00553224085073225,0.00253078463775566,-0.0104925787407333,-0.000571902960731147,0.0288344207577547
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VASN,Vasorin,42449,-0.00630185405885067,0.00288438770610061,-0.0119552539628079,-0.000648454154893481,0.0289198522874222
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17RA,Interleukin-17 receptor A,42611,0.010060257996186,0.00460681980660177,0.00103089117524658,0.0190896248171255,0.0289960430463312
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL9A1,Collagen alpha-1(IX) chain,42594,0.0111230505935803,0.0050946260523878,0.00113758353090017,0.0211085176562603,0.0290316845099066
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PXDNL,Peroxidasin-like protein,40451,-0.0127647324989456,0.00585075935919153,-0.0242322208429609,-0.00129724415493017,0.0291506413737753
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RALB,Ras-related protein Ral-B,40199,0.00684289274776544,0.00314750725651551,0.000673778524995046,0.0130120069705358,0.0297213168796517
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40511,0.0169753407457667,0.00781360384721778,0.00166067720521983,0.0322900042863135,0.0298358917418622
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRC1,Macrophage mannose receptor 1,40532,0.00664554507314842,0.00306103454028553,0.000645917374188774,0.0126451727721081,0.0299508823957527
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40182,-0.0113883047492322,0.00524611210572867,-0.0216706844764603,-0.00110592502200397,0.0299669891724694
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPN1,Epsin-1,40302,0.0101293555670375,0.00467713207305584,0.000962176703848053,0.0192965344302269,0.0303538466240864
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,40527,-0.00481673907249002,0.00222747441970444,-0.00918258893511072,-0.000450889209869318,0.0306065374344365
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,40482,0.00615853232721623,0.00285252321749417,0.000567586820927662,0.0117494778335048,0.0308729464099875
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBR1,T-box brain protein 1,40182,0.0110074097361964,0.00510201812645554,0.00100745420834353,0.0210073652640492,0.0309912998822015
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MB,Myoglobin,42794,-0.0119019691462109,0.00555941720070248,-0.0227984268595878,-0.00100551143283404,0.0323025438254764
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,42618,0.0662998902006428,0.0310627313018441,0.00541693684902834,0.127182843552257,0.0328291771063663
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA3G,Semaphorin-3G,40283,0.0100063719571116,0.00469561118897315,0.00080297402672418,0.0192097698874989,0.0331106453009827
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOA4,Apolipoprotein A-IV,40539,0.00797625757517427,0.0037828119385054,0.000561946175703689,0.0153905689746449,0.0350050905597083
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH23,Cadherin-23,40483,-0.00577474570816927,0.00274113733028282,-0.0111473748755236,-0.000402116540814948,0.035165862588598
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOH,Beta-2-glycoprotein 1,42611,-0.00802168202943789,0.00381419504363481,-0.0154975043149621,-0.000545859743913663,0.0354744928811765
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGA,Fibrinogen alpha chain,40284,0.00681952559918075,0.00324430523369703,0.000460687341134565,0.0131783638572269,0.0355758763785723
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAT1,Diamine acetyltransferase 1,40116,-0.0113130387505973,0.00539913164721478,-0.0218953367791383,-0.000730740722056344,0.0361633804283529
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL3RA,Interleukin-3 receptor subunit alpha,42370,0.00719422473620936,0.00343400659161167,0.000463571816650478,0.0139248776557682,0.0361905299514889
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTK7,Inactive tyrosine-protein kinase 7,42311,0.00837551721130236,0.0040015112287035,0.000532555203043497,0.0162184792195612,0.0363604133941682
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLITRK1,SLIT and NTRK-like protein 1,40199,-0.00720929690697071,0.00344506194796554,-0.0139616183249832,-0.000456975488958244,0.0364035660220941
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,40136,-0.0112727879345815,0.00539684538312225,-0.0218506048855011,-0.000694970983661884,0.0367511632671437
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40511,0.00704381163149259,0.00337264965911189,0.000433418299633283,0.0136542049633519,0.0367741711325892
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSRP3,Cysteine and glycine-rich protein 3,40116,-0.0219144947176422,0.0105014924138061,-0.0424974198487022,-0.00133156958658213,0.0369295180283938
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40302,0.00814585163064914,0.00390572917439091,0.000490622448842953,0.0158010808124553,0.037036178735197
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40483,-0.00571436317630475,0.00274248932142381,-0.0110896422462954,-0.000339084106314085,0.037215273193349
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL22,Interleukin-22,40451,0.0152937016243748,0.00734792905319175,0.000891760680118968,0.0296956425686306,0.037423311741196
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SULT1A1,Sulfotransferase 1A1,42711,-0.0277345344036081,0.0133410745432356,-0.05388304050835,-0.00158602829886629,0.0376469090347114
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINT1,Kunitz-type protease inhibitor 1,42565,0.00568123151264213,0.00273803849981528,0.000314676053004176,0.0110477869722801,0.0380123294003157
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,40136,0.0108817736557814,0.00524692108812464,0.000597808323057095,0.0211657389885057,0.0381086751873584
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTN5,Contactin-5,42640,-0.0082499572377838,0.00398896610019982,-0.0160683307941754,-0.000431583681392157,0.0386408254092317
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL3A1,Collagen alpha-1(III) chain,40527,0.00505925169927155,0.00245014741254039,0.000256962770692377,0.00986154062785072,0.0389573845881086
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GBP6,Guanylate-binding protein 6,40116,-0.00996367781841987,0.00484769183895287,-0.0194651538227675,-0.000462201814072236,0.0398694456450031
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SELL,L-selectin,40539,0.00512771619788379,0.00250190874566965,0.000223975056371279,0.0100314573393963,0.040434074515709
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNN,Tenascin-N,40527,0.0094343476868293,0.00462398949220718,0.000371328282103216,0.0184973670915554,0.0413431136637012
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42636,-0.00700572514726705,0.00346351727684775,-0.0137942190098886,-0.000217231284645457,0.0431217984108524
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL12,Stromal cell-derived factor 1,42370,0.00851237318822804,0.00421622780246591,0.000248566695394851,0.0167761796810612,0.0435121356126566
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENOPH1,Enolase-phosphatase E1,40451,0.0116470872737955,0.0057718592434487,0.000334243156636034,0.022959931390955,0.0436244072023797
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100G,Protein S100-G,40482,-0.0102164391796723,0.00506322323931003,-0.02014035672872,-0.000292521630624692,0.0436384400892531
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VNN2,Vascular non-inflammatory molecule 2,42587,0.00961900659787398,0.00476860721838926,0.000272536449831025,0.0189654767459169,0.0436995436150664
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,42311,0.0106460015006887,0.00528850642346224,0.000280528910702715,0.0210114740906747,0.0441302854124296
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OBP2B,Odorant-binding protein 2b,42462,-0.0129365807384284,0.00643387570901806,-0.0255469771281038,-0.000326184348753002,0.0443775636082114
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTNNA1,Catenin alpha-1,40136,-0.00741225894244513,0.00369546887028653,-0.0146553779282067,-0.000169139956683525,0.0449054130565946
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42794,0.0146638709516204,0.00735940536235927,0.000239436441396209,0.0290883054618445,0.0463323693878437
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,40482,0.00839801795117091,0.00421477629031237,0.000137056422158669,0.0166589794801832,0.0463382844835935
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ID4,DNA-binding protein inhibitor ID-4,40302,-0.00905596895044411,0.0045634723466581,-0.018000374749894,-0.000111563150994242,0.0472305976369175
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42794,0.00567335139031651,0.00287103088589851,4.61308539554343e-05,0.0113005719266776,0.0481672873969162
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IDS,Iduronate 2-sulfatase,42754,0.00180249302077299,0.000914790227787426,9.50417430963641e-06,0.00359548186723635,0.0488140653173498
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOP56,Nucleolar protein 56,40116,0.023164572995714,0.0117578408578979,0.000119204914234144,0.0462099410771939,0.0488477414753795
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX1B,Syntaxin-1B,40182,0.00839886362094034,0.00426619487446553,3.71216669878965e-05,0.0167606055748928,0.0490124907815977
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DOC2B,Double C2-like domain-containing protein beta,40182,0.00749353965297756,0.00380685458934389,3.21046578635291e-05,0.0149549746480916,0.0490432934646629
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDCL2,Phosducin-like protein 2,40080,0.0108800150905329,0.00557624501280393,-4.94251345628163e-05,0.0218094553156286,0.0510664284785223
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42357,0.00565216479069282,0.00290331060211609,-3.83239894547116e-05,0.0113426535708404,0.0515799712519514
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40136,0.0118530402869279,0.00609771213336499,-9.8475494467452e-05,0.0238045560683233,0.0519390924785779
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TYMP,Thymidine phosphorylase,42563,0.0131930074162476,0.00679761758088315,-0.000130323042283378,0.0265163378747786,0.0523001198297338
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42674,0.0145661872366075,0.00751040307122613,-0.000154202782995692,0.0292865772562107,0.0524652006700754
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGLYRP4,Peptidoglycan recognition protein 4,40116,0.012047125126875,0.00622047664770146,-0.000145009102619827,0.0242392593563699,0.052809201464803
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGLON5,IgLON family member 5,40080,-0.019224352087539,0.00996107661437506,-0.0387480622517141,0.000299358076636159,0.0536393281276097
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42172,0.0134981461847286,0.0069969685755933,-0.000215912223434291,0.0272122045928915,0.0537350092672336
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40136,-0.0110724538976943,0.00576742553118348,-0.0223766079388139,0.000231700143425325,0.0549058435442744
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTRC,Chymotrypsin-C,42626,0.0133086929161927,0.00693297202398742,-0.00027993225082266,0.026897318083208,0.0549266890099789
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUMF1,Formylglycine-generating enzyme,40199,0.0129258148458684,0.00673850242440449,-0.000281649905964375,0.0261332795977012,0.0551111360628289
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MELTF,Melanotransferrin,40511,0.00606148218445392,0.00316641823764824,-0.000144697561336632,0.0122676619302445,0.0556067120694982
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFHD1,EF-hand domain-containing protein D1,40482,0.00724609236890397,0.00378774573886409,-0.000177889279269646,0.0146700740170776,0.0557687708303428
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,40223,0.00673158912763201,0.00351933572749612,-0.000166308898260384,0.0136294871535244,0.0558066741604405
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MANSC4,MANSC domain-containing protein 4,40116,0.0143778492455529,0.00752263623283691,-0.000366517770807429,0.0291222162619133,0.0559950090515798
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40116,-0.00974574204637548,0.00511030387489351,-0.0197619376411668,0.000270453548415801,0.0565368490362685
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42311,0.0133506880171654,0.00700457887574174,-0.000378286579288439,0.0270796626136192,0.0566727695750107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",40059,0.00529104234794937,0.00278320695076957,-0.000164043275558995,0.0107461279714577,0.0573206377590845
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GID8,Glucose-induced degradation protein 8 homolog,40482,0.00682211650424785,0.00359545734328577,-0.00022497988859227,0.013869212897088,0.0577971479392937
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MFAP3,Microfibril-associated glycoprotein 3,42357,0.00964575812840037,0.00508561244514089,-0.000322042264075765,0.0196135585208765,0.0578926089671053
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42346,0.00714871151100821,0.003785319402458,-0.000270514517809465,0.0145679375398259,0.0589760314467078
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAPS,Calcyphosin,40483,0.0204843518106982,0.010867116193229,-0.000815195928030605,0.0417838995494269,0.0594575153773148
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EGFR,Epidermal growth factor receptor,42794,0.0032032787517048,0.00170614662073579,-0.000140768624937359,0.00654732612834696,0.0604719073090835
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC1A,C-type lectin domain family 1 member A,42357,-0.00686157285839509,0.00367658707223402,-0.0140676835199738,0.000344537803183579,0.0620232071450764
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40268,-0.0124205790825507,0.00667721723592271,-0.0255079248649592,0.000666766699857791,0.0628917853021241
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40080,0.010069878394352,0.00541351697558901,-0.000540614877802425,0.0206803716665065,0.0628932216840255
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,42566,0.00588506347911881,0.00316490080191184,-0.000318142092628402,0.012088269050866,0.0629813584180233
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,40136,-0.00662120386197275,0.00357463860784945,-0.0136274955333577,0.000385087809412171,0.0640136536505864
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40116,0.0170123350527542,0.00924500235088133,-0.0011078695549732,0.0351325396604816,0.0657710484958518
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAPPA,Pappalysin-1,42370,0.00900636063942815,0.00490180012647775,-0.000601167608468242,0.0186138888873245,0.0661795999519875
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40116,-0.00836097511168269,0.00455066919897784,-0.0172802867416793,0.000558336518313877,0.0661917792630929
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TP73,Tumor protein p73,40182,0.00665855097158789,0.00363554995109344,-0.000467126932555257,0.013784228875731,0.0670513147110315
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEPTIN3,Neuronal-specific septin-3,40482,-0.0143967956503378,0.00786273376388734,-0.029807753827557,0.00101416252688134,0.0671244179246129
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40199,0.012379910695893,0.00676267942407234,-0.000874940975288827,0.0256347623670748,0.067183988518791
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HCG22,Protein PBMUCL2,40116,-0.0109571560638901,0.00598961790579494,-0.0226968071592481,0.000782495031468005,0.0673732272260917
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICAM3,Intercellular adhesion molecule 3,42794,-0.00513880293589126,0.00281753499190274,-0.0106611715200206,0.00038356564823811,0.0681944471042664
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LY6D,Lymphocyte antigen 6D,42548,0.00780007769317385,0.00427685570735832,-0.000582559493248457,0.0161827148795962,0.0682064834823901
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYH7B,Myosin-7B,40080,-0.00859716579605143,0.00471473493398138,-0.0178380462666549,0.000643714674552067,0.0682600274810485
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARTN,Artemin,42370,0.00855251797588504,0.00469038539828062,-0.00064063740474498,0.0177456733565151,0.0682632413389086
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DUOX2,Dual oxidase 2,42357,0.0136563129312194,0.00749033150627975,-0.00102473682108891,0.0283373626835277,0.0682969769215266
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,42754,0.00912241718630352,0.00501777152260848,-0.000712414998009099,0.0189572493706161,0.0690828808585606
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBM19,Probable RNA-binding protein 19,40116,-0.00917962313279581,0.00507348191842219,-0.0191236476929033,0.000764401427311677,0.0704266169608205
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL33,Interleukin-33,42370,0.00734050543433539,0.00406598666703111,-0.000628828433045579,0.0153098393017164,0.0710436543151686
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPVL,Probable serine carboxypeptidase CPVL,42698,0.00778871928246375,0.00432884150667666,-0.000695810070622515,0.01627324863555,0.0719995898969327
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ODAM,Odontogenic ameloblast-associated protein,42292,0.0105964643896371,0.00589421781907245,-0.000956202535744889,0.0221491313150191,0.0722360434581809
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBP1,Retinol-binding protein 1,40182,0.0128548794619553,0.00718636502001755,-0.00123039597727908,0.0269401549011897,0.0736765927762275
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBM25,RNA-binding protein 25,40080,-0.00891081185901199,0.00498944865249688,-0.0186901312179059,0.000868507499881902,0.0741382293219652
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOX2,Transcription factor SOX-2,40461,0.0044859408785021,0.00251200103014532,-0.000437581140582721,0.00940946289758691,0.0741579240736824
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPT2,Angiopoietin-2,42721,0.00703835262479733,0.00395757958832555,-0.000718503368320743,0.0147952086179154,0.0753526303381318
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40065,-0.00967331707287834,0.0054699929229123,-0.0203945032017864,0.00104786905602977,0.0770165507712346
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,40483,0.00738052989562529,0.00419093803525197,-0.000833708653468583,0.0155947684447192,0.0782538413257646
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42679,-0.0064442134063739,0.00367109671558425,-0.013639562968919,0.000751136156171238,0.079215001768436
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42495,-0.0053021209860863,0.00304035827727076,-0.011261223209537,0.000656981237364384,0.0811973249431031
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFAP,Glial fibrillary acidic protein,42326,0.00892185405580215,0.00512973597192372,-0.00113242844916833,0.0189761365607726,0.0820155747303386
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NINJ1,Ninjurin-1,42346,0.00983496129156719,0.00565989560822674,-0.00125843410055721,0.0209283566836916,0.0822945504193256
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40182,-0.0083955996497238,0.00484647414520765,-0.0178946889743308,0.0011034896748832,0.083246296015048
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42662,-0.00894812408592329,0.00516621451340249,-0.0190739045321922,0.00117765636034559,0.0832881683634022
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTLA,B- and T-lymphocyte attenuator,40080,0.0160224594862575,0.00925686539961407,-0.00212099669698605,0.0341659156695011,0.0835027329321558
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB5,Integrin beta-5,42679,-0.00673429364493551,0.00389630900039284,-0.0143710592857055,0.000902471995834459,0.0839434192063827
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL20RA,Interleukin-20 receptor subunit alpha,42370,0.00814775312223203,0.00471691991039249,-0.00109740990213724,0.0173929161466013,0.0841289625066038
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FBLN2,Fibulin-2,40527,-0.00591812444368936,0.00342707125337866,-0.0126351841003115,0.000798935212932812,0.0842173238326002
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TEX101,Testis-expressed protein 101,40182,0.00958330817138099,0.00556450680208582,-0.00132312516070722,0.0204897415034692,0.0850577078431732
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DOCK9,Dedicator of cytokinesis protein 9,40136,0.0218345046211012,0.012682070356516,-0.00302235327767009,0.0466913625198725,0.0851552264541355
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OTOA,Otoancorin,40136,-0.00986459874603937,0.00574154601312214,-0.0211180289317588,0.00138883143968002,0.0858051256836328
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TJP3,Tight junction protein ZO-3,40136,-0.007566055657471,0.0044209753248257,-0.0162311672941294,0.00109905597918737,0.0870357005841378
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL5A1,Collagen alpha-1(V) chain,40283,0.00741361351185095,0.00433227448991478,-0.001077644488382,0.0159048715120839,0.0870625633087882
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HDDC2,5'-deoxynucleotidase HDDC2,40449,0.00788801924572482,0.00460960133977799,-0.00114679938024003,0.0169228378716897,0.0870689724722158
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMPD1,Sphingomyelin phosphodiesterase,42644,-0.0088132669684322,0.0051661952761454,-0.0189390097096772,0.00131247577281279,0.0880406158234101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40116,-0.00864119769120254,0.00508588036508275,-0.0186095232067647,0.00132712782435964,0.0893370318269709
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMBN,Ameloblastin,42370,-0.00510672462394077,0.00300569002160113,-0.010997877066279,0.00078442781839745,0.0893392000367876
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANPEP,Aminopeptidase N,42666,-0.00493694303929459,0.00290633034009826,-0.0106333505058872,0.000759464427297993,0.0894014281299189
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,40110,0.00612292771978858,0.0036094299133415,-0.000951554910360762,0.0131974103499379,0.0898443907620174
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TUBB3,Tubulin beta-3 chain,40136,-0.00500047217130423,0.00295563809860678,-0.0107935228445735,0.000792578501965063,0.0907046091400513
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSTM4,Glutathione S-transferase Mu 4,40116,-0.0132198003010266,0.00782721909955506,-0.0285611497361545,0.00212154913410135,0.0912571008701631
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB7,Integrin beta-7,42721,0.0081358014195645,0.00482734562350166,-0.00132579600249875,0.0175973988416278,0.0919427525295881
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL15RA,Interleukin-15 receptor subunit alpha,42370,0.0063937929099165,0.00379381063793553,-0.00104207594043714,0.0138296617602701,0.0919501240094543
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40116,0.00985345608920534,0.00586121630013486,-0.00163452785905899,0.0213414400374697,0.0927666052037958
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADA2,Adenosine deaminase 2,42572,0.00780247535405656,0.00464783979916569,-0.00130729065230819,0.0169122413604213,0.0932277267583129
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,40136,-0.0051049786338884,0.0030493622607371,-0.0110817286649331,0.000871771397156314,0.0941368682891273
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40182,-0.0055807060784396,0.00333403416691615,-0.0121154130455952,0.000954000888716045,0.0941865997050888
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,42357,0.0136288940831187,0.00814373145092631,-0.00233281956069686,0.0295906077269343,0.0942439842500244
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HLA_DRA,,42549,-0.00647214858207971,0.00387218040734862,-0.014061622180483,0.00111732501632359,0.0946566303935168
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD58,Lymphocyte function-associated antigen 3,42600,-0.00309720636199401,0.00185849379462864,-0.00673985419946614,0.000545441475478127,0.0956343964613443
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40482,0.00567979399628277,0.00340998261925749,-0.00100377193746191,0.0123633599300274,0.0958134401778462
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42582,-0.0118710038969562,0.00713649925200075,-0.0258585424308777,0.00211653463696524,0.0962515648641506
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,40080,0.0135491181114498,0.00816866575454218,-0.00246146676745286,0.0295597029903525,0.0972111835644867
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRSS53,Serine protease 53,40483,0.00643341031689969,0.00391598073255224,-0.0012419119189027,0.0141087325527021,0.100439635959439
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGBL2,Cytosolic carboxypeptidase 2,40136,0.0156714340757675,0.00954535449176986,-0.0030374607281014,0.0343803288796364,0.100662996964996
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40223,0.00637652561861531,0.00389268898572822,-0.001253144793412,0.0140061960306426,0.101434087312573
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT19,"Keratin, type I cytoskeletal 19",42562,0.01204891118644,0.00739408691009342,-0.00244349915734309,0.0265413215302231,0.103223722778411
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,42370,0.00625855083340002,0.00384228009917276,-0.00127231816097858,0.0137894198277786,0.103365768578434
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNNI3,"Troponin I, cardiac muscle",42357,0.014388007942158,0.00883391219830785,-0.00292645996652543,0.0317024758508413,0.103395315200752
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NTF3,Neurotrophin-3,42594,0.00612110035950874,0.00376132052659684,-0.00125108787262107,0.0134932885916386,0.103679783162448
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHPK,Sedoheptulokinase,40302,-0.00699998480794444,0.00431611792435117,-0.0154595759396727,0.00145960632378385,0.104869360597949
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40539,0.00318437851693406,0.00196438721398473,-0.000665820422476019,0.00703457745634414,0.1050337646411
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,40482,-0.00770299784528259,0.00475737880740978,-0.0170274603078058,0.00162146461724058,0.105438952572255
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,40302,0.00681999826978168,0.0042582414884567,-0.00152615504759346,0.0151661515871568,0.109272593611483
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRC1,Protein regulator of cytokinesis 1,40451,0.00740719706796358,0.00467426181687809,-0.00175435609311747,0.0165687502290446,0.113067738752554
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPNMB,Transmembrane glycoprotein NMB,42315,0.004831018318091,0.00305058487385314,-0.00114812803466115,0.0108101646708431,0.113300506209853
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL21R,Interleukin-21 receptor,40199,0.00929023744885864,0.00587672801858251,-0.00222814946756308,0.0208086243652804,0.113940611736779
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,42611,0.00754055226174388,0.00478058052601564,-0.00182938556924677,0.0169104900927345,0.114743227766907
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40080,0.0105992067572991,0.00672854446285223,-0.00258874038989131,0.0237871539044895,0.115225508334872
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40451,0.0105235758109752,0.00668936035066619,-0.0025875704763305,0.0236347220982809,0.11570497491928
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCGN,Secretagogin,42370,-0.00746279314581973,0.00474399783183809,-0.0167610288962224,0.00183544260458292,0.115719179506505
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PMCH,Pro-MCH,40116,-0.0139729315297973,0.0089045042841299,-0.0314257599266919,0.00347989686709735,0.116630746721187
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,40287,-0.00826587847355265,0.00527369430335795,-0.0186023193081342,0.00207056236102893,0.117054618582366
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INHBB,Inhibin beta B chain,40283,0.00894295897378523,0.00572230282829798,-0.00227275456967881,0.0201586725172493,0.11812225464666
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40136,0.00993855563289954,0.00636261108891009,-0.00253216210136424,0.0224092733671633,0.118311091370277
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,40182,0.00702561985273335,0.00450229602890921,-0.0017988803639287,0.0158501200693954,0.118681745799106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC2L,C-type lectin domain family 2 member L,40182,0.00807995417556334,0.00518084244202401,-0.00207449701080372,0.0182344053619304,0.118887238484254
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,POF1B,Protein POF1B,40199,0.00763139191660027,0.0048985492599439,-0.00196976463288977,0.0172325484660903,0.11928851644746
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DENND2B,DENN domain-containing protein 2B,40116,-0.00817526019236961,0.00524886507320836,-0.018463035735858,0.00211251535111877,0.119373886433618
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPR101,Probable G-protein coupled receptor 101,40136,-0.00988257985758146,0.00634642124201844,-0.0223215654919376,0.00255640577677468,0.119454446235805
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT14,"Keratin, type I cytoskeletal 14",41948,0.00476126455472141,0.00306875350179536,-0.0012534923087975,0.0107760214182403,0.120799423977141
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40482,-0.00385823728053219,0.00249162576723142,-0.00874182378430577,0.00102534922324139,0.121534361967746
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCARE,Photoreceptor cilium actin regulator,40136,0.0136504983185534,0.00883247185900312,-0.0036611465250927,0.0309621431621995,0.122256667453739
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINB5,Serpin B5,42357,0.00785696533588081,0.00509877121015967,-0.00213662623603214,0.0178505569077938,0.123352332824281
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40199,0.00758197254803245,0.00495633453062546,-0.00213244313199345,0.0172963882280583,0.126106374727036
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYO6,Unconventional myosin-VI,40482,0.00582545266884944,0.00381554032235299,-0.00165300636296242,0.0133039117006613,0.126846220464434
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLAUR,Urokinase plasminogen activator surface receptor,42547,0.00446932753806369,0.00294259860442917,-0.00129816572661749,0.0102368208027449,0.128827213630658
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RYR1,Ryanodine receptor 1,40116,-0.00549580485828404,0.00362441446010181,-0.0125996572000836,0.0016080474835155,0.12946511522602
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,40302,0.0101396912731146,0.00668825727265388,-0.00296929298128703,0.0232486755275162,0.129536721281592
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMA1,Laminin subunit alpha-1,40116,-0.0085881708073838,0.00566571866942174,-0.0196929793994504,0.0025166377846828,0.129595547837529
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFL4,Insulin growth factor-like family member 4,40199,0.0116988429471943,0.0077310372534496,-0.0034539900695669,0.0268516759639555,0.130249783814614
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCP2,Non-specific lipid-transfer protein,42346,0.01164700776213,0.00775487175538271,-0.00355254087842012,0.0268465564026801,0.133148080887556
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA11,Carbonic anhydrase-related protein 11,42346,0.00511168457627341,0.00340614251418945,-0.00156435475153792,0.0117877239040847,0.133450606516314
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDNRB,Endothelin receptor type B,40199,0.00701841582389314,0.004682453241957,-0.00215919253034258,0.0161960241781289,0.133934540336919
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYPLA2,Acyl-protein thioesterase 2,40136,0.0176383696815255,0.0117694428854016,-0.0054297383738617,0.0407064777369128,0.133991226981599
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40116,0.00949271527863691,0.00633881821198768,-0.00293136841685894,0.0219167989741328,0.13427836260492
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MUC2,Mucin-2,40527,0.0145879774245782,0.0097558410362658,-0.00453347100650279,0.0337094258556592,0.134862182079654
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42676,0.00661057933004935,0.00442872951440471,-0.00206973051818387,0.0152908891782826,0.135550085454705
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOS2,"Nitric oxide synthase, inducible",40116,-0.0062260088720185,0.00418590871126509,-0.0144303899460981,0.00197837220206108,0.136945111246547
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL5,Interleukin-5,42370,0.0217270889612864,0.0146260070646229,-0.00693988488537452,0.0503940628079473,0.137432534194433
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A3,Protein S100-A3,40451,0.00677164728389261,0.00456861766446807,-0.00218284333846481,0.01572613790625,0.138312622607393
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCARB1,Scavenger receptor class B member 1,42311,0.00900582987754163,0.00609230179266339,-0.00293508163607861,0.0209467413911619,0.139369947823598
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,40116,-0.00755308031160358,0.00510969401975573,-0.0175680805903248,0.00246191996711765,0.139386723894567
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,42611,0.00567443802440279,0.00384742034545414,-0.00186650585268732,0.0132153819014929,0.140271437807943
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF9,Fibroblast growth factor 9,40065,0.00635476522064695,0.00433121060616012,-0.00213440756742688,0.0148439380087208,0.142349767796558
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,42794,0.00480573105825549,0.00329302086745384,-0.00164858984195403,0.011260051958465,0.144486795927844
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,42346,0.00469621617993858,0.00322059946491534,-0.00161615877129549,0.0110085911311727,0.144814603500311
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,42311,-0.00930907172152693,0.00642622651833676,-0.021904475697467,0.00328633225441311,0.147471485879197
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACTA2,"Actin, aortic smooth muscle",42357,-0.00661996488974163,0.0046041251133516,-0.0156440501119108,0.0024041203324275,0.150505100822042
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,40532,0.00410498684254981,0.00285534575173268,-0.00149149083084625,0.00970146451594588,0.150561081247416
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CORO6,Coronin-6,40136,-0.00560332957625393,0.00390990839031865,-0.0132667500212785,0.00206009086877062,0.151854918779559
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42370,0.0171198033827438,0.0119555423863563,-0.00631305969451445,0.0405526664600021,0.152180308875604
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TLR2,Toll-like receptor 2,40302,0.00348679747401986,0.00246088049185818,-0.00133652829002218,0.00831012323806189,0.156543074116416
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD164L2,CD164 sialomucin-like 2 protein,40182,-0.00541062530139962,0.00383305923810952,-0.0129234214080943,0.00210217080529505,0.158105397158352
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40080,0.00397119374172852,0.0028273703784673,-0.00157045220006738,0.00951283968352441,0.160182541247047
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42495,0.0090773481227367,0.00647143675513585,-0.00360666791732957,0.021761364162803,0.160735936587669
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHGB,Secretogranin-1,42664,-0.00631145139522727,0.00450258349297747,-0.0151365150414631,0.00251361225100857,0.161015942160907
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FRMD7,FERM domain-containing protein 7,40182,0.00493293975914135,0.0035199175790632,-0.00196609869582252,0.0118319782141052,0.161111930768171
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTA4H,Leukotriene A-4 hydrolase,42721,-0.0085832942087899,0.00612692250164467,-0.0205920623120135,0.00342547389443365,0.161262599535083
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTNAP2,Contactin-associated protein-like 2,42594,-0.00613965101691494,0.00438711624411251,-0.0147383988553755,0.00245909682154559,0.161694318236552
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40182,0.00585329830720789,0.00419945695583972,-0.00237763732623797,0.0140842339406537,0.163399347654354
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42611,0.00558220142497174,0.00401172603153575,-0.00228078159683833,0.0134451844467818,0.164105642133222
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,40199,0.00783039327915935,0.00563459807449299,-0.00321341894684691,0.0188742055051656,0.164648519807276
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSLNL,Mesothelin-like protein,40182,-0.00575024690613688,0.00413953983326704,-0.0138637449793403,0.00236325116706652,0.164829603851948
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMY2B,Alpha-amylase 2B,41779,-0.00728992120502412,0.00526313710244694,-0.0176056699258201,0.00302582751577188,0.166049346696357
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FBN2,Fibrillin-2,40182,0.00884920937049217,0.00640360497085044,-0.00370185637237468,0.021400275113359,0.167027256056665
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40532,0.00546389031203064,0.00395464983313553,-0.00228722336091499,0.0132150039849763,0.167110427746797
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSLP,Thymic stromal lymphopoietin,42357,0.00881700639466119,0.00639369458874685,-0.00371463499928263,0.021348647788605,0.167913287610063
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB6A,Ras-related protein Rab-6A,42594,0.00661168852888486,0.00480909633841007,-0.00281414029439888,0.0160375173521686,0.169207232349387
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,40136,-0.0107428347544515,0.00781483984781597,-0.0260599208561708,0.0045742513472678,0.169261574470212
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40177,0.00547670434681685,0.00399145518449886,-0.00234654781480091,0.0132999565084346,0.17005809536447
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,42311,0.0094285832437458,0.00687728734078729,-0.00405089994419728,0.0229080664316889,0.17040646676729
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIRREL2,Kin of IRRE-like protein 2,42311,0.00580102577406383,0.00423340575434848,-0.00249644950445918,0.0140985010525868,0.170617470693617
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHH,Sonic hedgehog protein,40199,-0.00607652465051647,0.00443653905784575,-0.0147721412038941,0.0026190919028612,0.170822796757538
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,40116,0.0046842720920343,0.00342268663332286,-0.0020241937092785,0.0113927378933471,0.171154031014169
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,40182,0.00520936872930477,0.0038151123075235,-0.00226825139344129,0.0126869888520508,0.172137664283693
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40116,-0.00853384973183668,0.00630116357598719,-0.0208841303407716,0.00381643087709822,0.175659396554485
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,42587,0.00353640886396568,0.00261637863662737,-0.00159169326382397,0.00866451099175533,0.176512498015225
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZPR1,Zinc finger protein ZPR1,40136,0.0138244112305307,0.0102449779082334,-0.00625574546960676,0.0339045679306682,0.177241514683236
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HRAS,GTPase Hras,40286,0.0141196105424936,0.0104739363835362,-0.00640930476923746,0.0346485258542246,0.1776630564787
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRHR1,Corticotropin-releasing factor receptor 1,42357,0.00845107386408956,0.00627302240826126,-0.0038440500561025,0.0207461977842816,0.177936037571932
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPHS2,Podocin,40199,-0.0148300403162486,0.0110320527906899,-0.0364528637860009,0.00679278315350367,0.178889308459336
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLK,STE20-like serine/threonine-protein kinase,40302,0.0112457223330408,0.00839679535910019,-0.00521199657079555,0.0277034412368772,0.180504527396061
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",40116,-0.00550599507958752,0.00411681876757644,-0.0135749598640373,0.0025629697048623,0.18110714409712
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC7A,C-type lectin domain family 7 member A,42754,0.00851499139347223,0.00636982723287839,-0.00396986998296942,0.0209998527699139,0.181320282378403
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,42521,0.00809653743594643,0.00605894253471941,-0.0037789899321036,0.0199720648039965,0.181475532827983
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZP4,Zona pellucida sperm-binding protein 4,40080,-0.00437112226173947,0.00331574405342227,-0.0108699806064471,0.00212773608296818,0.187433311080632
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FSTL1,Follistatin-related protein 1,40223,-0.00312841402003302,0.00237756639595358,-0.00778844415610203,0.001531616116036,0.188266811987266
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJA1,DnaJ homolog subfamily A member 1,40080,-0.00658902188054594,0.00501083815092576,-0.0164102646563604,0.00323222089526855,0.188553047385751
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTNAP4,Contactin-associated protein-like 4,40182,0.0141467482156109,0.0108195608120766,-0.00705959097605925,0.0353530874072811,0.191064902211019
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHP1,Calcineurin B homologous protein 1,40136,0.0101713007038149,0.00778841844994842,-0.00509399945808402,0.0254366008657138,0.191596332872432
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MFAP4,Microfibril-associated glycoprotein 4,40283,-0.00445842620412812,0.00341421786785289,-0.0111502932251198,0.00223344081686355,0.191633669874788
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUP50,Nuclear pore complex protein Nup50,40116,-0.00475687662888718,0.00364793012118138,-0.0119068196664027,0.00239306640862832,0.19226332993197
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLINT1,Clathrin interactor 1,40080,0.0063291727974553,0.00485568198056807,-0.00318796388445812,0.0158463094793687,0.192446343967777
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42679,-0.00606401174403472,0.00469792535495133,-0.0152719454397393,0.00314392195166988,0.196800357328272
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,42721,-0.00552291030081778,0.00430751291227139,-0.0139656356088697,0.00291981500723414,0.199809348894075
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMPRSS11B,Transmembrane protease serine 11B,40136,0.0104938965336437,0.00818795683609889,-0.00555449886511011,0.0265422919323975,0.200001110598439
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLI2,Zinc finger protein GLI2,40199,-0.00430512861210941,0.00337060201622502,-0.0109115085639105,0.00230125133969163,0.201538098885053
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAPN3,Calpain-3,40451,-0.0051246917727122,0.00401377150983663,-0.012991683931992,0.00274230038656759,0.201707269361503
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDGFRB,Platelet-derived growth factor receptor beta,42794,0.00461093924339564,0.00362114373592967,-0.00248650247902651,0.0117083809658178,0.202919957804671
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL15,Interleukin-15,42594,0.00442420352848281,0.00347852197707603,-0.00239369954658621,0.0112421066035518,0.203443859148245
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFB104A_DEFB104B,Beta-defensin 104,40136,0.00711729164870395,0.00563114109466964,-0.00391974489684855,0.0181543281942565,0.206286955317927
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTF,Ciliary neurotrophic factor,40136,-0.0045492070356348,0.00361152790117278,-0.0116278017219335,0.00252938765066386,0.207827921558055
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC51B,Organic solute transporter subunit beta,40116,-0.0100808915127486,0.00809671631274006,-0.0259504554857191,0.00578867246022195,0.213136685215275
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLAU,Urokinase-type plasminogen activator,42611,-0.00383301710582566,0.00308660404478559,-0.00988276103360542,0.0022167268219541,0.214323437166884
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MFAP3L,Microfibrillar-associated protein 3-like,40182,0.00876587233186655,0.00709777195585801,-0.00514576070161515,0.0226775053653483,0.216850411335487
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYH4,Myosin-4,40116,-0.00587643453452138,0.00476524987422262,-0.0152163242879977,0.00346345521895496,0.217533300582711
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITM2A,Integral membrane protein 2A,42594,-0.00797811714817016,0.00647135838622184,-0.020661979585165,0.00470574528882464,0.21765895627759
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HIP1,Huntingtin-interacting protein 1,40116,0.00432211642015974,0.00351115847434147,-0.00255975418954954,0.011203987029869,0.218362117995336
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCNE1,G1/S-specific cyclin-E1,40199,0.0114538207296392,0.00930754615068191,-0.00678896972569733,0.0296966111849757,0.218500638693814
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSPAN7,Tetraspanin-7,40136,-0.0121654386244174,0.00990437828862517,-0.0315780200701228,0.0072471428212879,0.219364928149598
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RELB,Transcription factor RelB,40199,0.00640245487107515,0.00521841175666745,-0.00382563217199306,0.0166305419141434,0.219887470823737
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MATN3,Matrilin-3,42475,-0.00418936072648766,0.00343126049912848,-0.0109146313047795,0.00253590985180415,0.222130685126655
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40080,0.00750161872341149,0.00617155144435264,-0.00459462210751969,0.0195978595543427,0.224195759406743
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SELENOP,Selenoprotein P,40539,-0.00291988616576761,0.00241380904708579,-0.00765095189805575,0.00181117956652053,0.22643492188118
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRD2,Bromodomain-containing protein 2,40136,0.0045423782340254,0.00375774058950278,-0.00282279332140005,0.0119075497894509,0.226763622638947
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD82,CD82 antigen,40302,-0.00517802038111265,0.00430498790084041,-0.0136157966667598,0.00325975590453454,0.229081075563082
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40302,0.00461886091094955,0.00387174658432781,-0.00296976239433295,0.0122074842162321,0.23290828332379
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",40199,0.00355853256968422,0.00298637525293979,-0.00229476292607777,0.00941182806544622,0.233448049118943
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPTP,Ceramide-1-phosphate transfer protein,40116,-0.00499909900254051,0.00420129917398103,-0.0132336453835433,0.00323544737846232,0.234114078013836
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIRREL1,Kin of IRRE-like protein 1,40136,-0.0071778078668906,0.00604676871128838,-0.0190294745410158,0.00467385880723463,0.235234251457624
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD27,CD27 antigen,42679,0.00550174885592148,0.00463907785237843,-0.00359084373474024,0.0145943414465832,0.235660006427069
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL9,Interleukin-9,40302,0.00697000828929428,0.00591121608002359,-0.00461597522755196,0.0185559918061405,0.238377321812584
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40527,-0.0175527718826452,0.0149048245025307,-0.0467662279076054,0.0116606841423151,0.238958079576568
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40116,-0.00414134997493433,0.00356658795395171,-0.0111318623646797,0.00284916241481101,0.245605554186691
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RTKN2,Rhotekin-2,40116,-0.00629384315895081,0.00542283579874772,-0.0169226013244963,0.00433491500659472,0.245822475129204
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40482,-0.00325697385237586,0.00281203188976043,-0.0087685563563063,0.00225460865155459,0.246795540592986
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGAX,Integrin alpha-X,40302,0.00661054709987794,0.00571996325084518,-0.00460058087177862,0.0178216750715345,0.247829777623948
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NELL1,Protein kinase C-binding protein NELL1,42679,-0.00528820975992996,0.00458172915021415,-0.0142683988943497,0.00369197937448978,0.248440607212556
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYL4,Myosin light chain 4,40223,0.00631967769176264,0.00547838539028281,-0.00441795767319166,0.0170573130567169,0.248703249309098
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UPK3BL1,Uroplakin-3b-like protein 1,40281,-0.00660033234368165,0.00572459675512459,-0.0178205419837259,0.00461987729636256,0.248944398612348
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL31,Interleukin-31,40199,0.00681055674559527,0.00591889225722499,-0.00479047207856571,0.0184115855697562,0.249902411416054
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD70,CD70 antigen,42594,-0.00520461559826418,0.00453900495896178,-0.0141010653178293,0.0036918341213009,0.251549913895269
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,H2AP,Huntingtin-interacting protein M,40080,-0.00634767931458723,0.0055367154047508,-0.0171996415078988,0.00450428287872433,0.251625842454887
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCN1,Transcobalamin-1,40337,0.00409821593972183,0.00358192524331929,-0.00292235753718398,0.0111187894166276,0.252591084978187
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFBR1,TGF-beta receptor type-1,40199,0.00259697283088868,0.00226982400241737,-0.00185188221384935,0.00704582787562672,0.252594777821493
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNPO1,Transportin-1,40302,0.0042595514419133,0.00372401727353016,-0.00303952241420581,0.0115586252980324,0.25272895630429
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MUCL3,Mucin-like protein 3,40080,-0.00510667497541238,0.00447500469294735,-0.0138776841735892,0.00366433422276442,0.253830436977216
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC4C,C-type lectin domain family 4 member C,42594,0.00569060296401088,0.00502820558747181,-0.00416467998743387,0.0155458859154556,0.257765553061768
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL4R,Interleukin-4 receptor subunit alpha,42594,-0.00442098143161473,0.00397601886421108,-0.0122139784054684,0.00337201554223898,0.266196116066687
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASPN,Asporin,40511,0.00325917225370024,0.00294855257392623,-0.00251999079119517,0.00903833529859565,0.269032976348018
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42346,0.0146808853969648,0.0133070173899614,-0.0114008686873596,0.0407626394812892,0.269941459398817
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HBZ,Hemoglobin subunit zeta,40511,0.0122900325268404,0.0111595474532416,-0.00958268048151323,0.0341627455351939,0.270788640037692
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1A,Interleukin-1 alpha,42370,0.00673527746918398,0.00611681217794726,-0.00525367439959266,0.0187242293379606,0.27086929746222
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC123,Cell division cycle protein 123 homolog,40080,0.00726411325427364,0.00663698621483086,-0.00574437972679484,0.0202726062353421,0.273764464774581
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAG,Myelin-associated glycoprotein,40182,0.00564259509020851,0.00515945779116289,-0.00446994218047075,0.0157551323608878,0.2741363908645
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42439,0.00683418924031372,0.00627578198721577,-0.0054663434546292,0.0191347219352566,0.276183349758712
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLMP,CXADR-like membrane protein,42721,0.00248902253094217,0.0023006440441197,-0.00202023979553245,0.00699828485741678,0.279324800187148
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40116,-0.00577209449576899,0.00534915413414926,-0.0162564365987015,0.00471224760716355,0.280581790713563
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,40182,-0.00420215540855183,0.00390246108034677,-0.0118509791260315,0.00344666830892785,0.281594947026453
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40182,-0.00463290640210685,0.00431059665897097,-0.01308167585369,0.00381586304947626,0.282500646594841
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,40136,0.00633294545039767,0.00590479658624122,-0.00524045585863513,0.0179063467594305,0.283515281312992
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,40116,-0.00540533287506303,0.00506744671100154,-0.0153375284286261,0.00452686267849999,0.286140935760527
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40182,-0.00627511402021888,0.00588422233173456,-0.0178081897904186,0.00525796174998086,0.286252522207899
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40116,-0.00670737847104143,0.00629500912855905,-0.0190455963630172,0.0056308394209343,0.286669956501742
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PEPD,Xaa-Pro dipeptidase,40532,0.00294349473288113,0.00277061639152549,-0.00248691339450882,0.00837390286027108,0.288078091702832
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NME3,Nucleoside diphosphate kinase 3,42638,0.00266103776206885,0.00250960392907736,-0.00225778593892277,0.00757986146306047,0.289008211574908
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40302,0.00526952555620094,0.00497564368950976,-0.0044827360752382,0.0150217871876401,0.289593621330123
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH22,Cadherin-22,40302,-0.00311766498328477,0.00295359130781423,-0.00890670394660066,0.00267137398003112,0.291196551808089
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SKIV2L,Helicase SKI2W,40116,-0.00440659387426716,0.00418397372628947,-0.0126071823777945,0.00379399462926021,0.292269051359924
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPT1,Palmitoyl-protein thioesterase 1,40182,0.00850557322497555,0.00810315920196406,-0.007376618810874,0.0243877652608251,0.293896913873899
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH4,Cadherin-4,40136,0.00548036744146984,0.00522739326233388,-0.00476532335270456,0.0157260582356442,0.294480298392036
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRTAC1,Cartilage acidic protein 1,42794,-0.00327021126020409,0.0031290837209472,-0.0094032153532606,0.00286279283285241,0.295994463000767
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL4,Interleukin-4,42370,0.0102137790078669,0.00982776281461067,-0.00904863610876997,0.0294761941245039,0.298694471325368
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40080,-0.00922959377269502,0.00889096352492087,-0.0266558822815399,0.00819669473614989,0.299252603680549
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,42240,0.00438918216640547,0.004230818706296,-0.00390322249793469,0.0126815868307456,0.299554299615141
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CBX2,Chromobox protein homolog 2,40116,-0.0043503491072581,0.00421813557215571,-0.0126178948286833,0.0039171966141671,0.302402335990498
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAP1A,Ras-related protein Rap-1A,40199,0.00763843662185321,0.00745708910967074,-0.00697745803310144,0.0222543312768078,0.305707232407504
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FSHB,Follitropin subunit beta,40223,-0.00581662314642631,0.00568542884869949,-0.0169600636898773,0.0053268173970247,0.306294573730598
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UGDH,UDP-glucose 6-dehydrogenase,40116,0.010276046971599,0.0100517039810207,-0.00942529283120145,0.0299773867743995,0.306652632770836
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42311,0.00486925950018374,0.00477808350697498,-0.00449578417348723,0.0142343031738547,0.308182774176517
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FH,"Fumarate hydratase, mitochondrial",40136,0.00911612780173823,0.00899494127032011,-0.00851395708808919,0.0267462126915657,0.310856818384487
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,40080,0.0152526815963522,0.0150639567852695,-0.014272673702776,0.0447780368954805,0.311308056820856
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA10,Annexin A10,42311,0.00914239304888852,0.00903871475539636,-0.00857348787168835,0.0268582739694654,0.311809965589269
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACTN4,Alpha-actinin-4,42370,0.00346741284267665,0.00343516639765308,-0.0032655132967234,0.0102003389820767,0.312807531239551
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GKN1,Gastrokine-1,42017,0.00296934116535029,0.00294355073565141,-0.00280001827652646,0.00873870060722704,0.313107980413648
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB1,Integrin beta-1,42638,-0.00225635253165928,0.00223853441159746,-0.0066438799783903,0.00213117491507174,0.313491937834685
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPLX2,Complexin-2,40080,-0.00336058014286837,0.00333801072726575,-0.00990308116830923,0.0031819208825725,0.314071855343843
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB6B,Ras-related protein Rab-6B,42311,0.00519048110186985,0.00516309251929282,-0.00492918023594408,0.0153101424396838,0.314768703921197
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RASA1,Ras GTPase-activating protein 1,42311,0.00340586162507341,0.0033938290683564,-0.00324604334890513,0.0100577665990519,0.31561628474656
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17C,Interleukin-17C,42370,-0.00785893575881095,0.00783610169832716,-0.0232176950875322,0.00749982356991028,0.315920795665424
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42346,-0.00334455307743598,0.00334143584134279,-0.00989376732646785,0.00320466117159589,0.316877662762134
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,40116,0.0050464173763561,0.00504718175348003,-0.00484605886046476,0.014938893613177,0.317405955137538
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMY2A,Pancreatic alpha-amylase,42114,-0.00512063354199576,0.0051292804799883,-0.0151740232827728,0.0049327561987813,0.318145720155875
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LY96,Lymphocyte antigen 96,42495,0.00371061100328257,0.00374177905255153,-0.00362327593971843,0.0110444979462836,0.321376442915127
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERCC1,DNA excision repair protein ERCC-1,40080,0.00354727368641058,0.00359185946927125,-0.00349277087336107,0.0105873182461822,0.323376909447909
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAP18,Histone deacetylase complex subunit SAP18,40302,-0.00766634199682236,0.0077827362869062,-0.0229205051191585,0.00758782112551379,0.324623641197842
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DIPK2B,Divergent protein kinase domain 2B,40283,0.00287672836043113,0.00292674697429795,-0.00285969570919286,0.00861315243005511,0.325673265427374
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INSL4,Early placenta insulin-like peptide,40451,-0.00502079249322606,0.00511235159659531,-0.0150410016225529,0.00499941663610076,0.326076317854723
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LMOD2,Leiomodin-2,40136,0.00641504799467596,0.0065550271514083,-0.00643280522208432,0.0192629012114362,0.327776792775537
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17F,Interleukin-17F,42370,0.00772375947782821,0.00792989549760363,-0.00781883569747491,0.0232663546531313,0.330071836387893
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD33,Myeloid cell surface antigen CD33,42679,0.00813198826583842,0.00839866186072762,-0.00832938898118771,0.0245933655128646,0.332937850225189
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP9,Matrix metalloproteinase-9,42594,0.00607289183069215,0.00629077226662936,-0.00625702181190139,0.0184028054732857,0.334379410261872
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAG,S-arrestin,40136,-0.00530329048867868,0.00550625510303424,-0.0160955504906258,0.00548896951326842,0.335498923767973
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA3,Alpha-1-antichymotrypsin,40502,-0.00153457243351307,0.00159368690170525,-0.00465819876085536,0.00158905389382922,0.335614736020254
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC44A4,Choline transporter-like protein 4,40182,-0.00719148626204423,0.00750002614507757,-0.0218915375063963,0.0075085649823078,0.337649623440991
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTSL5,ADAMTS-like protein 5,40511,-0.00396741274636538,0.00414169801557194,-0.0120851408568864,0.00415031536415561,0.338123882245795
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNL2,Interferon lambda-2,40136,0.0062207622680296,0.00650557451558179,-0.00653016378251071,0.0189716883185699,0.33898208281358
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFRC,Transferrin receptor protein 1,42673,0.00378945008153296,0.00396381069392658,-0.00397961887856313,0.0115585190416291,0.339083381935406
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40136,0.00502868316473068,0.00528571275824029,-0.00533131384142029,0.0153886801708817,0.341436194121903
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NENF,Neudesin,40451,0.0109847313621721,0.0115545877697992,-0.0116622606666344,0.0336317233909786,0.341786557026916
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40182,-0.00630468529374078,0.00666818595999356,-0.0193743297753282,0.0067649591878466,0.344430929845939
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL2RG,Cytokine receptor common subunit gamma,40451,0.00363259021785668,0.00384380327160898,-0.00390126419449693,0.0111664446302103,0.344653110827973
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HTR1A,5-hydroxytryptamine receptor 1A,40136,-0.00775385743351059,0.00824398511311369,-0.0239120682552134,0.00840435338819224,0.346957693657008
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,40182,0.00702600518071232,0.00749591214316056,-0.00766598261988237,0.021717992981307,0.348618913905438
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,40199,0.0039442614642593,0.00421451059777254,-0.00431617930737488,0.0122047022358935,0.34935730911028
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,40199,0.00607504458746927,0.00652309495044326,-0.00671022151539953,0.0188603106903381,0.351711993105172
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYL6B,Myosin light chain 6B,40182,0.00890542369023283,0.00956611693055358,-0.00984416549365219,0.0276550128741179,0.351908147643993
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDSN,Corneodesmosin,42710,-0.00434510484658167,0.00466764019698736,-0.0134936796326769,0.00480346993951355,0.35192207751293
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OFD1,Oral-facial-digital syndrome 1 protein,40302,0.0064122186491488,0.00691581104768765,-0.00714277100431899,0.0199672083026166,0.353851956624315
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPP10,Inactive dipeptidyl peptidase 10,42594,0.00347783177371749,0.00376731789130849,-0.00390611129324716,0.0108617748406821,0.355941200807661
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FZD10,Frizzled-10,40182,0.00586047698337255,0.00638161719795039,-0.00664749272461022,0.0183684466913553,0.358462472577807
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGFR4,Fibroblast growth factor receptor 4,40283,0.00510181049153852,0.00557377512501842,-0.00582278875349758,0.0160264097365746,0.360041433787629
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42357,0.00320471881121962,0.00350862991088589,-0.00367219581411672,0.010081633436556,0.361058487199771
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSH1,Chorionic somatomammotropin hormone 1,40532,-0.00271994637583093,0.00298882089308217,-0.00857803532627199,0.00313814257461013,0.362820793962325
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX1,ATP-dependent RNA helicase DDX1,40449,0.00475995018486765,0.00524966109250638,-0.00552938555644485,0.0150492859261802,0.364576564755617
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMIGO1,Amphoterin-induced protein 1,40182,0.00481377279535128,0.00531783387599199,-0.00560918160159301,0.0152367271922956,0.365372359660984
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",40116,0.0037020470950142,0.0041026723381945,-0.00433919068784703,0.0117432848778754,0.366890779633883
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC1A4,Neutral amino acid transporter A,40182,0.00490092094118135,0.00548058283179502,-0.00584102140913689,0.0156428632914996,0.371216541049473
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC4A1,Band 3 anion transport protein,40527,0.00440103900865083,0.00492187878604255,-0.00524584341199256,0.0140479214292942,0.371245293420873
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40136,0.00701502425766706,0.00794570960191416,-0.0085585665620847,0.0225886150774188,0.377326207474044
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,40302,0.00498617362160414,0.00568054295911765,-0.00614769057826645,0.0161200378214747,0.380091026867504
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPR158,Probable G-protein coupled receptor 158,40482,0.00331617560812123,0.00378078248649102,-0.00409415806540116,0.0107265092816436,0.380443623462547
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAGE2A,G antigen 2A,40080,0.00612520076442315,0.00700777024694748,-0.0076100289195939,0.0198604304484402,0.382105707745742
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT17,"Keratin, type I cytoskeletal 17",40116,0.00360886191616895,0.00414275658896588,-0.00451094099820417,0.0117286648305421,0.383704645717599
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICAM2,Intercellular adhesion molecule 2,42794,0.0029487641612559,0.00339660576110619,-0.00370858313051224,0.00960611145302403,0.385327400532089
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEFL,Neurofilament light polypeptide,42262,0.00417034438445089,0.00484641972604638,-0.00532863827860002,0.0136693270475018,0.389529246258104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFNB2,Ephrin-B2,40182,0.00489178302510837,0.00573827273515065,-0.00635523153578691,0.0161387975860037,0.393964354171251
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGS8,Regulator of G-protein signaling 8,42370,0.00576634614595527,0.00676552772825583,-0.00749408820142616,0.0190267804933367,0.394055973458222
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCN,Decorin,42357,-0.00213710658067229,0.00251796813316129,-0.00707232412166842,0.00279811096032385,0.39604002345988
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXK,Tyrosine-protein kinase TXK,40302,0.00668541129267898,0.00788564457088352,-0.00877045206625272,0.0221412746516107,0.396570326494633
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,40136,-0.00370356648687733,0.00440512806233011,-0.0123376174890443,0.00493048451528968,0.400512089955256
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD177,CD177 antigen,42595,-0.0115473403672503,0.0138042777899205,-0.0386037248354946,0.0155090441009939,0.402886066840057
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,40182,0.00323557850770187,0.00387675305628506,-0.00436285748261685,0.0108340144980206,0.403955236446958
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFAP2A,Transcription factor AP-2-alpha,40136,0.00532105997901113,0.00641020829270272,-0.00724294827468619,0.0178850682327085,0.406505112947474
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP4,Caspase-4,40302,0.0150536524696338,0.0181539142804975,-0.0205280195201414,0.050635324459409,0.406995763882012
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOS1,"Nitric oxide synthase, brain",42311,-0.00471069634203392,0.00568352529496584,-0.015850405920167,0.00642901323609913,0.407213692555687
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PYDC1,Pyrin domain-containing protein 1,40223,-0.00370879907844449,0.00449449508693014,-0.0125180094488276,0.00510041129193859,0.409283259864711
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK12,Kallikrein-12,42346,0.0120624775307113,0.0146436973962712,-0.0166391693659802,0.0407641244274028,0.410106968498819
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MN1,Transcriptional activator MN1,40182,-0.00513002111424946,0.00623576873188764,-0.0173521278287492,0.00709208560025031,0.41070976935837
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,40449,0.00255258536105092,0.00311701609096045,-0.00355676617723155,0.0086619368993334,0.412849663773438
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GUCY2C,Heat-stable enterotoxin receptor,40302,-0.00691643399377702,0.00846818004503776,-0.023514066882051,0.009681198894497,0.414085590997629
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERVV_1,,40116,-0.0037382825356925,0.00458628662635633,-0.0127274043233509,0.0052508392519659,0.415032806562635
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,40182,0.00612393020387212,0.0075415289656057,-0.00865746656871506,0.0209053269764593,0.416793344591759
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL13,Interleukin-13,42370,-0.00400363502032872,0.00498206270057232,-0.0137684779134505,0.00576120787279304,0.42163678781433
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IKZF2,Zinc finger protein Helios,42346,0.00739411236955908,0.00922681924188449,-0.0106904533445345,0.0254786780836527,0.422930936486109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,40116,0.00318200672494078,0.00397278824574646,-0.00460465823672228,0.0109686716866038,0.423177726703807
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPSG1,Tryptase gamma,40199,0.00223355371134945,0.00279254406295987,-0.0032398326520519,0.0077069400747508,0.423827975096517
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCAN,Brevican core protein,42495,-0.00289360841946833,0.00362921000427237,-0.0100068600278422,0.00421964318890552,0.42528476797365
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DLL1,Delta-like protein 1,42679,-0.00255504299379346,0.00329704836812897,-0.00901725779532624,0.00390717180773932,0.438383624788027
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP1,"Fatty acid-binding protein, liver",42618,0.0076339848669003,0.00987199352285987,-0.011715122437905,0.0269830921717057,0.439360133775975
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GJA8,Gap junction alpha-8 protein,40080,0.0052997731899229,0.00685988911754853,-0.00814560948047222,0.018745155860318,0.439791204610255
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHA10,Ephrin type-A receptor 10,42311,-0.00538795667723601,0.00701778853840263,-0.0191428222125052,0.00836690885803314,0.442645351342348
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,40136,0.00564233986868021,0.00737368809587734,-0.00881008879923938,0.0200947685365998,0.444169468900562
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,40136,-0.00242668887394795,0.00317149861213112,-0.00864282615372495,0.00378944840582904,0.444195594481869
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL20,Interleukin-20,42370,-0.0039475777995405,0.00515928625901468,-0.0140597788672093,0.00616462326812827,0.444201713050024
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BSND,Barttin,40080,0.0027449637361963,0.00358890949689321,-0.00428929887771438,0.00977922635010698,0.444379722051818
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OSTN,Osteocrin,40182,-0.00336240302625815,0.00439977298618549,-0.0119859580791817,0.00526115202666541,0.444751407172972
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CGN,Cingulin,40182,0.00328219612422861,0.00433420914903258,-0.00521285380787524,0.0117772460563325,0.448900273045164
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42676,0.00454516698282615,0.0060240258242577,-0.00726192363271894,0.0163522575983712,0.450558288197423
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF3,Fibroblast growth factor 3,40199,0.00229575015120978,0.00305602322146788,-0.00369405536286726,0.00828555566528682,0.45253546525812
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCLRE1C,Protein artemis,40080,0.00245835532653085,0.00328511603472322,-0.00398047210152667,0.00889718275458836,0.454276484290491
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PALLD,Palladin,40199,-0.00306311071437793,0.00409348271802991,-0.0110863368417165,0.00496011541296069,0.454301462135379
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,42660,0.00412642274072516,0.00553802509225893,-0.00672810644010234,0.0149809519215527,0.456219880446068
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL11,Interleukin-11,42370,0.00489201958323252,0.00657519248861881,-0.00799535769446035,0.0177793968609254,0.456882715838268
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GDF15,Growth/differentiation factor 15,42794,0.00360504092100371,0.00484542884630579,-0.00589199961775564,0.0131020814597631,0.456884102670439
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GH2,Growth hormone variant,42346,0.0129704001560493,0.0174978692026008,-0.0213254234810483,0.047266223793147,0.458551482567197
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,40527,0.00233659698714769,0.00315431642804402,-0.0038458632118186,0.00851905718611397,0.458853252417034
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF2RB,Cytokine receptor common subunit beta,40199,-0.0033633686345777,0.00457035286406497,-0.012321260248145,0.00559452297898964,0.461801121167083
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",42611,-0.00290393122576923,0.0039508220545822,-0.0106475424527503,0.0048396800012119,0.462340469019851
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCDC2C,Doublecortin domain-containing protein 2C,40080,0.00489260559575884,0.00665716812219723,-0.00815544392374774,0.0179406551152654,0.462393106829659
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP15,Matrix metalloproteinase-15,40511,0.00376414742485546,0.00512552593002,-0.00628188339798374,0.0138101782476947,0.462724816795678
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NECTIN4,Nectin-4,42679,-0.00264044934318284,0.00361789302234078,-0.00973151966697076,0.00445062098060508,0.465506362772326
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PODXL2,Podocalyxin-like protein 2,42679,-0.0021626748704493,0.00296428887916605,-0.00797268107361477,0.00364733133271616,0.465661894112361
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDIA2,Protein disulfide-isomerase A2,40080,-0.00323128095848032,0.00443015869931157,-0.011914392009131,0.00545183009217036,0.465783311241931
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK15,Kallikrein-15,40429,0.00407934937413568,0.00560394747076155,-0.00690438766855696,0.0150630864168283,0.466664191417335
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42357,0.00240740693793879,0.00331400171325777,-0.00408803642004644,0.00890285029592402,0.46758503940179
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40482,-0.0031099469034707,0.00428715441780692,-0.0115127695623723,0.00529287575543087,0.468215260852057
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HDAC8,Histone deacetylase 8,40199,0.00448775269921036,0.00620791740913634,-0.00767976542269686,0.0166552708211176,0.469751816464477
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA6,Corticosteroid-binding globulin,40539,0.00119000694513785,0.00164637277550966,-0.00203688369486108,0.00441689758513678,0.469814419122429
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCND2,G1/S-specific cyclin-D2,40302,0.00280160911931105,0.00387869399992465,-0.00480063112054126,0.0104038493591634,0.47012075095131
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLSPN,Claspin,42292,0.00264363714305074,0.00367422047784794,-0.00455783499353123,0.00984510927963271,0.471839786992653
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRTN3,Myeloblastin,42276,0.0036786146145927,0.00511586187018808,-0.00634847465097593,0.0137057038801613,0.472116436723104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40116,-0.00499152612871597,0.00710336456574662,-0.0189141206775793,0.00893106842014741,0.482258419263992
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,40080,-0.0018543128960977,0.00265082511609027,-0.00704993012363463,0.00334130433143924,0.484240247896357
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCTPP1,dCTP pyrophosphatase 1,42636,0.00230082643921013,0.00331674123995504,-0.00419998639110175,0.00880163926952201,0.487881777781428
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,40116,-0.00264242971457815,0.00381009760422826,-0.0101102210188655,0.00482536158970923,0.487989659272535
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFRA3,GDNF family receptor alpha-3,42474,-0.00207737482217538,0.00301589692663323,-0.00798853279837651,0.00383378315402574,0.490955947607191
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAD2,Glutamate decarboxylase 2,40199,-0.00331340327520918,0.00484316048385958,-0.012805997823574,0.00617919127315559,0.493900719857574
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAYN,Layilin,42476,-0.00270171039396082,0.00396670426612596,-0.0104764507555677,0.00507302996764606,0.495821986243423
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSCA,Prostate stem cell antigen,40449,0.0187518733471006,0.0279336359566146,-0.035998053127864,0.0735017998220653,0.502042675003361
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLHL41,Kelch-like protein 41,40482,-0.00334641615008286,0.00503058697611828,-0.0132063666232747,0.00651353432310896,0.505927311491132
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,40136,0.00283050802095234,0.00426931862009351,-0.00553735647443094,0.0111983725163356,0.507352054083975
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17A,Interleukin-17A,42347,-0.00300030751110124,0.00452875526364883,-0.0118766678278529,0.00587605280565047,0.507661431604474
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZP3,Zona pellucida sperm-binding protein 3,40223,0.0188102923110304,0.0284552561413313,-0.0369620097259789,0.0745825943480398,0.508595291065725
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40302,0.00489481412589109,0.00740998156683014,-0.00962874974509598,0.0194183779968782,0.50890158637215
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KHDC3L,KH domain-containing protein 3,40080,-0.00476411640063442,0.00725582222712004,-0.0189855279657897,0.00945729516452087,0.511457033839665
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGR,Progesterone receptor,40199,0.0067368308505254,0.0102732582082028,-0.013398755237552,0.0268724169386028,0.511989819600115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",40482,-0.00255441116245361,0.00389662559507415,-0.0101917973287989,0.00508297500389172,0.512130657062648
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPB41L5,Band 4.1-like protein 5,40182,0.00420140037010262,0.00644484250173826,-0.00843049093330436,0.0168332916735096,0.514478565018193
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42658,-0.00443958105210697,0.00681502104780558,-0.0177970223058059,0.00891786020159197,0.514773261024352
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCIN,Adseverin,40136,0.00494565721768071,0.00766295283011061,-0.0100737303293361,0.0199650447646975,0.518682596157956
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TAGLN3,Transgelin-3,40080,0.00415813895798559,0.00644383635384989,-0.0084717802955602,0.0167880582115314,0.518753294015972
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAND5,DAN domain family member 5,40199,0.00373511309453423,0.00582179961225095,-0.00767561414547764,0.0151458403345461,0.52116342290747
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMA1,Proteasome subunit alpha type-1,42346,0.00311031934903304,0.00484893548297847,-0.00639359419760476,0.0126142328956708,0.521245595288054
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBQLN3,Ubiquilin-3,40116,0.0036429115392335,0.00570118507924622,-0.0075314112160891,0.0148172342945561,0.522852959765512
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BMP4,Bone morphogenetic protein 4,42475,-0.00311640369479385,0.00488161522936232,-0.012684369544344,0.00645156215475629,0.523226934033147
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPEP2,Dipeptidase 2,42587,-0.00197152950176516,0.00309250885026133,-0.00803284684827736,0.00408978784474705,0.523798504151446
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL4A4,Collagen alpha-4(IV) chain,40284,-0.00358159205323152,0.00562449871893996,-0.0146056095423538,0.0074424254358908,0.524278546864051
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCUN1D2,DCN1-like protein 2,40080,0.00536466816329602,0.00842469481938441,-0.0111477336826974,0.0218770700092895,0.524282241177966
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENPEP,Glutamyl aminopeptidase,40116,-0.00316404482647157,0.00501295541264679,-0.0129894374352593,0.00666134778231615,0.527940267252371
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STEAP4,Metalloreductase STEAP4,40136,0.00481630500169872,0.00765271390448262,-0.0101830142510872,0.0198156242544847,0.529127138856309
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40527,0.00166319082017891,0.00265305756600715,-0.0035368020091951,0.00686318364955292,0.530740125392837
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LCN15,Lipocalin-15,40482,-0.00410749909719097,0.00657139749190638,-0.0169874381813275,0.00877243998694554,0.531946173884804
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARG2,"Arginase-2, mitochondrial",40451,0.00278049154491666,0.00448570095316503,-0.0060114823232868,0.0115724654131201,0.535364717508377
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHD,SH2 domain-containing adapter protein D,40083,-0.00568270461804905,0.00923638392208591,-0.0237860171053374,0.0124206078692393,0.538401102121672
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,40136,-0.00459441089171576,0.00748234660048243,-0.0192598102286613,0.0100709884452298,0.539206007103308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EVI2B,Protein EVI2B,40080,-0.00262704495085452,0.00430410249038379,-0.0110630858320068,0.0058089959302977,0.541637184683641
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40116,0.00456854738533725,0.00753179641694609,-0.0101937735918771,0.0193308683625516,0.544150187928724
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL10,Interleukin-10,42370,0.00528369020191915,0.00891184437274809,-0.0121835247686671,0.0227509051725054,0.553268942149738
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ISM2,Isthmin-2,40527,0.0026948510955767,0.00454863580359784,-0.00622047507947507,0.0116101772706285,0.553559374376695
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ABO,Histo-blood group ABO system transferase,40532,-0.00901814184066496,0.0152320040674543,-0.0388728698128753,0.0208365861315454,0.553827425355176
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MORN4,MORN repeat-containing protein 4,40080,-0.00478475790852652,0.00808288569966676,-0.0206272138798734,0.0110576980628203,0.553888599669821
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,42495,0.00321520024547884,0.00545068672148169,-0.00746814572862527,0.0138985462195829,0.555287376874017
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,40527,-0.00181712609145462,0.00308538445895123,-0.00786447963099903,0.00423022744808979,0.555908963843936
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40449,0.00190860648542702,0.00324328638657006,-0.00444823483225029,0.00826544780310432,0.556222519067057
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLB1,"Phospholipase B1, membrane-associated",40483,-0.00370373366458799,0.00630862689908694,-0.0160686423867984,0.0086611750576224,0.557154801954203
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,40080,-0.00293881590462021,0.00501407848648933,-0.0127664097381393,0.00688877792889888,0.557811823516636
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,40136,-0.00384404837341004,0.00657850087416977,-0.0167379100867828,0.00904981333996271,0.559006988871995
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COPE,Coatomer subunit epsilon,42311,0.00290243027073324,0.00497089772647952,-0.00684052927316661,0.0126453898146331,0.559308043695849
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRNN,Cornulin,42209,0.00422669348363956,0.00724661673577988,-0.00997667531848901,0.0184300622857681,0.559725437567647
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REST,RE1-silencing transcription factor,40080,-0.0020943947355564,0.00360617215051158,-0.00916249215055909,0.00497370267944628,0.561400371163327
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL2RB,Interleukin-2 receptor subunit beta,42370,0.00239106866458338,0.00411918788361815,-0.00568253958730819,0.0104646769164749,0.561607037590304
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PITHD1,PITH domain-containing protein 1,40065,-0.0049140829173134,0.00848683754852478,-0.021548284512422,0.0117201186777952,0.562584952833722
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42611,0.0071308547994594,0.0124299333995046,-0.0172318146635696,0.0314935242624884,0.566191224966678
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADRA2A,Alpha-2A adrenergic receptor,40116,-0.00417824532857294,0.00730968539998972,-0.0185052287125528,0.0101487380554069,0.56760205532871
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCAN,Neurocan core protein,42711,-0.0022541297995966,0.00397890517930579,-0.010052783951036,0.00554452435184275,0.571049672270765
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEB,Nebulin,40116,-0.00228601799221378,0.00403549019431174,-0.0101955787730648,0.00562354278863723,0.571080258178932
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAL,Galanin peptides,42676,-0.00379753307554844,0.00672900183638591,-0.0169863766748648,0.00939131052376793,0.572523235746851
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH17,Cadherin-17,42636,-0.00410872073188193,0.00728252923115931,-0.0183824780249542,0.0101650365611903,0.572635127396894
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUSD4,Sushi domain-containing protein 4,40451,-0.00248476324756636,0.00440675612318854,-0.0111220052490159,0.00615247875388317,0.572865320285855
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALMS1,Alstrom syndrome protein 1,40302,-0.00263989215193223,0.00468709491023101,-0.011826598175985,0.00654681387212056,0.573292596261727
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPTX1,Neuronal pentraxin-1,42611,-0.00235095116895054,0.00419742242612773,-0.0105778991241609,0.00587599678625981,0.575424665226995
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRISP2,Cysteine-rich secretory protein 2,42721,0.00345367172073852,0.00622179475580222,-0.00874104600063383,0.0156483894421109,0.578840558480402
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF6,Fibroblast growth factor 6,40199,-0.00241779053091168,0.00435608725804659,-0.010955721556683,0.00612014049485963,0.578880488035321
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EVPL,Envoplakin,40302,-0.00204866631317227,0.00369923973075804,-0.00929917618545802,0.00520184355911348,0.579721815241409
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UPK3A,Uroplakin-3a,40136,0.00297026802770535,0.00537145434649083,-0.00755778249141668,0.0134983185468274,0.580293347900835
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TET2,Methylcytosine dioxygenase TET2,40286,0.00588348702937236,0.0107568435005678,-0.0151999262317405,0.0269669002904853,0.584422076131973
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A16,Protein S100-A16,42292,-0.00347953558860773,0.00636347729715115,-0.015951951091024,0.00899287991380853,0.584526947744709
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40451,-0.0025708604064876,0.00471371857578746,-0.011809748815031,0.00666802800205582,0.58548949518732
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DHODH,Dihydroorotate dehydrogenase,40116,0.00277724826049885,0.00511110843443575,-0.00724052427099522,0.0127950207919929,0.586882762912689
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40199,0.00165012223286311,0.00307849601108887,-0.00438372994887107,0.00768397441459729,0.591958524417761
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SYT1,Synaptotagmin-1,40483,0.00235918112479518,0.00444804305053084,-0.00635898325424527,0.0110773455038356,0.595854550494939
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RUVBL1,RuvB-like 1,42346,0.00587062473628996,0.0110852307793856,-0.0158564275913058,0.0275976770638858,0.596405332851801
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42357,0.0016930702076659,0.00321695451295616,-0.00461216063772817,0.00799830105305998,0.598691447347463
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLXDC2,Plexin domain-containing protein 2,40483,-0.00149834818158028,0.00286541460968154,-0.0071145608165561,0.00411786445339554,0.60104854945845
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF20,Fibroblast growth factor 20,40199,-0.00246881952053431,0.00474002579362388,-0.0117592700760371,0.0068216310349685,0.602485115805219
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40136,-0.00319792508754524,0.00614473511596302,-0.0152416059148328,0.00884575573974227,0.602772099811253
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MORC3,MORC family CW-type zinc finger protein 3,40483,0.00151355361493991,0.00296988333385082,-0.0043074177194077,0.00733452494928753,0.610317839857193
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42613,-0.00172432912241994,0.00340436420517949,-0.00839688296457175,0.00494822471973187,0.612510166008196
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAMDC2,MAM domain-containing protein 2,40511,-0.00193111219056352,0.003831013764696,-0.00943989916936768,0.00557767478824064,0.61421960075584
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,40302,-0.00423294615077317,0.00852624254136149,-0.0209443815318417,0.0124784892302954,0.619579082426285
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAD1,Glutamate decarboxylase 1,40080,-0.00136253272488641,0.00275133430287643,-0.00675514795852421,0.00403008250875139,0.620450481450556
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42674,-0.00179975006743561,0.00365417359464276,-0.00896193031293542,0.00536243017806419,0.622360487526406
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DIPK1C,Divergent protein kinase domain 1C,40182,0.00216589379041462,0.00441994080000747,-0.00649719017760001,0.0108289777584293,0.624124022773897
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSB,Lupus La protein,42311,0.00297055450075592,0.00610280560043577,-0.00899094447609819,0.01493205347761,0.626442028905524
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRP2BP,LRP2-binding protein,40182,0.00439096314067385,0.00907593485129246,-0.0133978691678594,0.0221797954492071,0.628535434077946
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42737,0.00174826391130431,0.00363489720088165,-0.00537613460242372,0.00887266242503234,0.630548053294015
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42311,-0.00243227829035234,0.0050685563122639,-0.0123666486623896,0.00750209208168491,0.63132360264597
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF7,Fibroblast growth factor 7,40080,-0.00399283996896422,0.00833492000396574,-0.0203292831767371,0.0123436032388086,0.631912976273162
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACAN,Aggrecan core protein,42488,0.00139275463238301,0.00290907213506794,-0.00430902675235015,0.00709453601711618,0.632115475017045
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,40116,0.00552565813001393,0.0115845863372668,-0.0171801310910289,0.0282314473510568,0.633383316484111
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,42611,-0.00171412222811975,0.00360870367110202,-0.00878718142347971,0.00535893696724022,0.634797078204478
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPBGL,Trophoblast glycoprotein-like,40182,-0.00207253510830344,0.0044179934956777,-0.0107318023598317,0.00658673214322486,0.638998672120439
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,40136,-0.00361233637210022,0.00770762226366169,-0.0187192760088771,0.0114946032646767,0.63931440220012
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,42370,0.00146217315125087,0.00312216450519003,-0.0046572692789216,0.00758161558142333,0.639563269904662
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL24,Interleukin-24,42370,0.00247893220695843,0.00530316389210097,-0.00791526902155948,0.0128731334354763,0.640189970427505
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCP11,T-complex protein 11 homolog,40302,0.00289889660643637,0.00622167807081828,-0.00929559241236746,0.0150933856252402,0.641271274444813
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL6ST,Interleukin-6 receptor subunit beta,42636,0.000853272942102425,0.00183269734020827,-0.00273881384470578,0.00444535972891063,0.641521472219242
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMMR,Hyaluronan mediated motility receptor,40059,0.00242800675323685,0.00522340068863829,-0.00780985859649419,0.0126658721029679,0.642060678402881
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL3,Interleukin-3,40080,0.00301811701555893,0.00649604864939041,-0.00971413833724627,0.0157503723683641,0.642221400976587
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL2RA,Interleukin-2 receptor subunit alpha,42517,-0.00202537296777605,0.00436689340607422,-0.0105844840436815,0.00653373810812942,0.642797339769103
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,42636,0.00137719204050943,0.00297365599831573,-0.0044511737161894,0.00720555779720826,0.643278025375413
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KDM3A,Lysine-specific demethylase 3A,40199,-0.0042547385396516,0.00920425873488531,-0.0222950856600268,0.0137856085807236,0.643905741022547
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIPR,Gastric inhibitory polypeptide receptor,40199,0.00235679592393195,0.00514318045227939,-0.00772383776253566,0.0124374296103996,0.646791180439127
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",42311,0.00195693659411143,0.00428735667080812,-0.00644628248067248,0.0103601556688953,0.648078563085734
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPGN,Epigen,40451,0.00217019387565243,0.0047778153146769,-0.0071943241411143,0.0115347118924192,0.649677047208161
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK3,Prostate-specific antigen,40527,0.00468023736841242,0.0103066396604502,-0.0155207763660699,0.0248812511028948,0.649766087181578
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASQ2,Calsequestrin-2,40116,-0.00233543756694316,0.00516075209920188,-0.0124505116813789,0.00777963654749253,0.650890282260643
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGM2,Phosphoglucomutase-2,40182,0.00281928893842492,0.00628839893119328,-0.00950597296671391,0.0151445508435637,0.653922625150521
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSP90B1,Endoplasmin,42247,-0.00313176858884237,0.00699210205040867,-0.0168362886076434,0.0105727514299586,0.654232174162376
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDAN1,Codanin-1,40483,0.00106231709236869,0.00237472543610946,-0.00359214476240585,0.00571677894714323,0.65463591853016
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40116,0.00250665328756496,0.00560964579093806,-0.00848825246267363,0.0135015590378036,0.654994407027319
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,40483,-0.00145813396713728,0.00329221214679545,-0.00791086977485637,0.00499460184058181,0.657843651981802
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CADPS,Calcium-dependent secretion activator 1,40182,0.00198142987922833,0.00450476327715761,-0.00684790614400059,0.0108107659024573,0.660052834312873
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEZ6L,Seizure 6-like protein,42679,-0.00127036399665278,0.00294131620215838,-0.00703534375288321,0.00449461575957764,0.665818645439911
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,40429,0.00178917015232401,0.00414268352238399,-0.00633048955154862,0.00990882985619664,0.66583200804972
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40482,-0.00132578626432811,0.00309287899282198,-0.00738782909025919,0.00473625656160297,0.668180558630991
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCNA,Proliferating cell nuclear antigen,40080,0.00280138458505569,0.00657499165277118,-0.0100855990543758,0.0156883682244872,0.670067713549718
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRN1,Neuritin,40482,0.00161271249055896,0.0038191593346439,-0.00587283980534309,0.009098264786461,0.672836744684081
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC25A,M-phase inducer phosphatase 1,40080,-0.0017184250377921,0.00409817646290786,-0.0097508509050915,0.0063140008295073,0.674994534923922
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAEP,Glycodelin,42495,0.00394392367886691,0.00944074154931699,-0.0145599297577944,0.0224477771155282,0.676132480141083
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HTR1B,5-hydroxytryptamine receptor 1B,40136,-0.00189699707703735,0.00454414974381191,-0.0108035305749087,0.00700953642083399,0.676350758238659
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40136,0.00247111709370011,0.00598539815505237,-0.00926026329020255,0.0142024974776028,0.679719039677248
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TP53BP1,TP53-binding protein 1,40199,0.00375955548617003,0.00911764089675281,-0.0141110206714655,0.0216301316438055,0.680099275531949
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MORF4L2,Mortality factor 4-like protein 2,40080,0.00158980726631262,0.00386415058250881,-0.00598392787540465,0.00916354240802989,0.680769193209609
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40182,0.00219021717242853,0.00535772323425226,-0.00831092036670589,0.012691354711563,0.682697158206702
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL18RAP,Interleukin-18 receptor accessory protein,42425,-0.00721293832946716,0.0180495140539371,-0.0425899858751838,0.0281641092162495,0.689443219851725
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40116,-0.0015721199758044,0.00396562136160709,-0.00934473784455429,0.00620049789294549,0.691790245212738
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPT1,Translationally-controlled tumor protein,42370,-0.00271489973420976,0.00685780324816377,-0.0161561941006108,0.0107263946321912,0.692196460629475
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PEAR1,Platelet endothelial aggregation receptor 1,42794,0.000943163930798256,0.00238330366254528,-0.00372811124779048,0.005614439109387,0.692304494048277
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPHA2,Glycoprotein hormone alpha-2,40449,-0.00189161841445083,0.00488759297067637,-0.0114713006369765,0.00768806380807485,0.698745359105115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,40080,0.00205270742389,0.00531442521448723,-0.00836356599650497,0.012468980844285,0.699317586614714
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB2,Integrin beta-2,42569,0.00115302527487973,0.00299975178845904,-0.00472648823049999,0.00703253878025946,0.700707704852808
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSMB,Beta-microseminoprotein,42559,0.00290840932036293,0.00758920804233389,-0.0119664384426115,0.0177832570833374,0.70155561239904
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42711,-0.00188794827871665,0.00498677552156274,-0.0116620283009796,0.00788613174354632,0.704997560192457
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40116,-0.0010049925567286,0.0027182594937137,-0.00633278116440745,0.00432279605095024,0.711598938755479
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL2,Interleukin-2,42370,-0.00124386524558664,0.003366390393664,-0.00784199041716808,0.00535425992599479,0.711764554161195
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZNF75D,Zinc finger protein 75D,40302,0.00236945742765368,0.00644810067235543,-0.010268819890163,0.0150077347454703,0.713278487987652
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,42591,0.00166494133893736,0.00458548587049939,-0.00732261096724143,0.0106524936451162,0.716543826952966
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC11A,C-type lectin domain family 11 member A,42592,0.00185325595970534,0.00513891254141723,-0.00821901262147243,0.0119255245408831,0.718380300336507
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,40182,0.00296570033249628,0.00826394591771762,-0.0132316336662303,0.0191630343312228,0.719697603344733
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MLLT1,Protein ENL,40080,0.00248971321038607,0.00697879364466562,-0.0111887223331585,0.0161681487539307,0.721282819331727
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HLA_A,,40482,-0.00120405858132008,0.00348277732034636,-0.00803030212919895,0.00562218496655878,0.729561147260142
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40136,-0.00114473092973057,0.00332622842060974,-0.00766413863412567,0.00537467677466453,0.730737966224373
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PFDN6,Prefoldin subunit 6,40182,0.00233673110575742,0.00681352957707046,-0.0110177868653007,0.0156912490768155,0.731639198243751
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDDM3B,Epididymal secretory protein E3-beta,40451,-0.00189432210316294,0.00553216045243111,-0.0127373565899279,0.00894871238360203,0.732041270280266
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DLGAP5,Disks large-associated protein 5,40482,0.00181824471092003,0.00533427052894884,-0.0086369255258197,0.0122734149476598,0.733214580310866
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,40302,0.00239152089579266,0.00704510784837479,-0.0114168904870219,0.0161999322786073,0.734270863260332
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMCN2,Hemicentin-2,40269,-0.00207454424894073,0.00613708093501876,-0.0141032228815775,0.00995413438369604,0.735343699145493
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCN3B,Sodium channel subunit beta-3,40136,0.0016873212760492,0.0050598242142827,-0.00822993418394489,0.0116045767360433,0.738782684980938
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRL5,Fc receptor-like protein 5,42611,-0.00205039201065468,0.006175613410425,-0.0141545942950877,0.0100538102737783,0.739883641584141
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BEX3,Protein BEX3,40080,0.0016581563782212,0.00502584661094151,-0.00819250297922415,0.0115088157356665,0.741462389614514
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40449,0.00606269875076611,0.0183835427807919,-0.029969045099586,0.0420944426011182,0.741565185104713
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPTXR,Neuronal pentraxin receptor,42636,0.00114941566897428,0.00355934123719917,-0.0058268931559361,0.00812572449388467,0.746753788661324
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OMP,Olfactory marker protein,40136,-0.00169817310109018,0.00528842816537229,-0.0120634923052199,0.00866714610303952,0.748132315093728
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTNL10,Butyrophilin-like protein 10,40080,-0.00142854751698883,0.00448338500968294,-0.0102159821359674,0.00735888710198973,0.750012106198608
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PFDN4,Prefoldin subunit 4,40080,0.00173215139500636,0.00552027739267196,-0.00908759229463069,0.0125518950846434,0.7536943190325
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZNF830,Zinc finger protein 830,40451,-0.00253877176517397,0.00814116059425349,-0.0184954465299108,0.0134179029995629,0.755164888204979
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NLGN1,Neuroligin-1,40182,-0.00225428592446115,0.00734939781736693,-0.0166591056465003,0.012150533797578,0.759054173646906
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA5,Annexin A5,42261,0.000982220879046044,0.00321455054474513,-0.00531829818865441,0.0072827399467465,0.759948618239563
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,40199,-0.0013360547517046,0.00437937377734271,-0.00991962735529632,0.00724751785188712,0.760311792727404
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CBLN1,Cerebellin-1,40136,0.00302223846324165,0.0099726816582417,-0.0165242175869121,0.0225686945133954,0.76185619777629
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40302,0.00200357387407012,0.00661399089515685,-0.0109598482804373,0.0149669960285775,0.761949155939412
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40136,-0.0020155941863302,0.00670281827150281,-0.0151531179984757,0.0111219296258153,0.763642527341781
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM171A2,Protein FAM171A2,40482,0.0050395942894351,0.0167898797926565,-0.0278685701041716,0.0379477586830418,0.764063186983964
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DUSP29,Dual specificity phosphatase 29,40182,-0.00211576025673586,0.00708281464838119,-0.015998076967563,0.0117665564540913,0.765161298284858
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,40080,0.0018065399593408,0.00606262889534073,-0.010076212675527,0.0136892925942086,0.765724391785882
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOLR3,Folate receptor gamma,42629,-0.00576999422745863,0.0194400629775021,-0.0438725176633628,0.0323325292084456,0.766616585468165
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPRR1B,Cornifin-B,40302,-0.00257647602633605,0.00872948040416891,-0.0196862576185071,0.014533305565835,0.767887446934976
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA8,Carbonic anhydrase-related protein,40199,0.000881558869152914,0.00300802450850841,-0.00501416916752357,0.0067772869058294,0.769474902917918
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40136,0.00164662527044878,0.00565905477462196,-0.00944512208781025,0.0127383726287078,0.771078413378653
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENG,Endoglin,42794,-0.000529957810455586,0.00182143579855906,-0.00409997197563133,0.00304005635472016,0.771089350852886
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMC3,Structural maintenance of chromosomes protein 3,40080,0.00165383282274562,0.00584049286945718,-0.00979353320139045,0.0131011988468817,0.777054473371983
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42711,-0.00136751657028741,0.00487437614766129,-0.0109212938197035,0.00818626067912872,0.779058236523398
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CYTH3,Cytohesin-3,40080,-0.0021577770897667,0.00785215654772968,-0.0175480039233169,0.0132324497437835,0.783474675533188
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40283,-0.00123896760760435,0.00454135199278308,-0.0101400175134592,0.00766208229825048,0.784997349286726
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MORF4L1,Mortality factor 4-like protein 1,40302,0.00114456584714014,0.00419697661433072,-0.00708150831694807,0.00937064001122835,0.785079686078062
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFB116,Beta-defensin 116,40136,-0.00220413488315259,0.00809204188442351,-0.0180645369766227,0.0136562672103175,0.78533265968904
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCUN1D1,DCN1-like protein 1,40136,-0.00214424620651708,0.00787517722324798,-0.0175795935640831,0.013291101151049,0.785412558769965
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42113,-0.00107063852982074,0.00394049903763146,-0.00879401664357841,0.00665273958393693,0.785856078524772
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COMP,Cartilage oligomeric matrix protein,42511,-0.000948297319800297,0.00352418315949681,-0.00785569631241405,0.00595910167281346,0.787870080636328
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RANGAP1,Ran GTPase-activating protein 1,42346,0.00134869208730762,0.00506601160394897,-0.00858069065643236,0.0112780748310476,0.790071145238183
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NXPE4,NXPE family member 4,40116,-0.000926208123566979,0.00354275931143225,-0.00787001637397418,0.00601760012684022,0.793760509399328
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40080,0.00152551580761832,0.00583731670117387,-0.00991562492668246,0.0129666565419191,0.79383639442902
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,40199,-0.00148579999830239,0.00575795130439613,-0.0127713845549188,0.00979978455831404,0.796378416646365
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPA33,Cell surface A33 antigen,42587,-0.00373788533791942,0.0145530159164274,-0.0322617965341171,0.0247860258582783,0.797301528561996
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HEBP1,Heme-binding protein 1,42357,0.00139172499662402,0.00552498750898734,-0.00943725052099117,0.0122207005142392,0.801125000317393
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AXL,Tyrosine-protein kinase receptor UFO,42689,0.000729986479956353,0.00290112761680389,-0.00495622364897928,0.00641619660889198,0.80133736419654
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,40302,-0.00115029253924458,0.00461302690830876,-0.0101918252795298,0.00789124020104058,0.803088920959651
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLXDC1,Plexin domain-containing protein 1,42346,0.000801113313509198,0.00330716425812146,-0.00568092863240887,0.00728315525942727,0.808601295900613
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42346,-0.00203481476760194,0.00844201072606325,-0.0185811557906859,0.014511526255482,0.809532232730351
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40451,0.00134008247965372,0.00556175079765178,-0.00956094908374377,0.0122411140430512,0.809601235887698
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42711,-0.00071284801815683,0.00298154012022034,-0.00655666665378869,0.00513097061747503,0.811041607521308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,40136,-0.00124935324501086,0.00542092802775914,-0.0118743721794188,0.00937566568939706,0.817732033165952
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OMG,Oligodendrocyte-myelin glycoprotein,42587,0.00156775085984364,0.00693486907039272,-0.0120245925181261,0.0151600942378134,0.821152108110805
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRND,Prion-like protein doppel,40483,0.00124204751717908,0.00549534147108095,-0.00952882176613957,0.0120129168004977,0.821191310116584
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASE10,Inactive ribonuclease-like protein 10,40223,0.00116889350286255,0.00519443617563334,-0.00901220140137879,0.0113499884071039,0.821961673083676
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40080,0.00135384485554598,0.00608742555963509,-0.0105775092413388,0.0132851989524307,0.824006503613671
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40136,-0.00101865349858368,0.00468701526032152,-0.0102052034088139,0.00816789641164649,0.827951162673058
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL36A,Interleukin-36 alpha,40199,-0.00130907300825516,0.00604667995539373,-0.0131605657208269,0.0105424197043165,0.828606317625923
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42653,-0.00106564902280654,0.0051531799080422,-0.0111658816425693,0.00903458359695618,0.836173516257786
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40451,-0.00190530533173337,0.00951125392675442,-0.020547363028172,0.0167367523647053,0.841233040578158
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ART5,Ecto-ADP-ribosyltransferase 5,40136,-0.00135114861726015,0.00676288593603322,-0.0146064050518853,0.011904107817365,0.841649502388746
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HBQ1,Hemoglobin subunit theta-1,42721,0.00124887804683382,0.00631331131179721,-0.0111252121242887,0.0136229682179564,0.843191497052921
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HYAL1,Hyaluronidase-1,42544,0.000469642658112691,0.00242976348928388,-0.00429269378088372,0.00523197909710911,0.846736837078814
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRRT3,Proline-rich transmembrane protein 3,40223,-0.000797663856491782,0.00420055353330353,-0.00903074878176671,0.00743542106878314,0.849394953171582
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTN2,Contactin-2,42721,0.000886735067647542,0.00467196434062725,-0.00827031503998188,0.010043785175277,0.849469335119298
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD34,Hematopoietic progenitor cell antigen CD34,42674,0.000470433710859182,0.00254126791210226,-0.00451045139686125,0.00545131881857961,0.853139491640444
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCLN,Nicalin,42370,0.00100302137258656,0.00543999946069404,-0.00965937757037377,0.0116654203155469,0.853719022015438
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,40136,-0.0011446765108168,0.00622266697730295,-0.0133411037863306,0.011051750764697,0.854053955222154
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40182,0.00150610918693692,0.00828969911829955,-0.0147417010849302,0.017753919458804,0.855833743779593
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FZD8,Frizzled-8,40136,0.000872409062659902,0.00480836658868142,-0.00855198945115569,0.0102968075764755,0.856029008112917
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40182,-0.000977391451286591,0.00544820673254411,-0.011655876647073,0.00970109374449986,0.857629365523043
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF12,Fibroblast growth factor 12,40199,-0.000865784146945136,0.00491815803815106,-0.0105053739017212,0.00877380560783095,0.860267097573155
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,40199,0.000893784221353136,0.00514187406241818,-0.00918428894098649,0.0109718573836928,0.862006504907568
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRYBB2,Beta-crystallin B2,40483,0.00145912337120722,0.00857270536932868,-0.015343379152677,0.0182616258950914,0.864851414363245
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ESPL1,Separin,40080,0.00102395971254023,0.00604700296180736,-0.0108281660926022,0.0128760855176827,0.865537533843063
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHEK2,Serine/threonine-protein kinase Chk2,42357,0.000586970842634084,0.00348413054640518,-0.00624192502832006,0.00741586671358823,0.866216273637513
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPTN,Neuroplastin,42346,-0.00138925606186013,0.00824955589193026,-0.0175583856100434,0.0147798734863232,0.866268255921476
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPSD1,Tryptase delta,40482,-0.00067164070159572,0.00403171620514701,-0.00857380446368387,0.00723052306049243,0.867696212576005
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAMT,Guanidinoacetate N-methyltransferase,40116,0.000639278059695719,0.00398210802934781,-0.00716565367782599,0.00844420979721743,0.872460575388398
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,40511,0.000489443828987051,0.00310395146282239,-0.00559430103814484,0.00657318869611894,0.874708534117218
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WFDC12,WAP four-disulfide core domain protein 12,42698,0.00105710977097333,0.00685790109850784,-0.012384376382102,0.0144985959240487,0.877497871106102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSPAN15,Tetraspanin-15,40116,0.000832309489594802,0.00547671073309645,-0.00990204354727423,0.0115666625264638,0.87921142273539
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40199,0.000649270745421285,0.0044595584187113,-0.00809146375525287,0.00939000524609544,0.884247085566888
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LPO,Lactoperoxidase,42134,0.000894511421082537,0.00637679757191491,-0.0116040118198707,0.0133930346620358,0.888444138479796
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40451,0.00111553452425975,0.00804506518185073,-0.0146527932321677,0.0168838622806872,0.889720739976968
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLSTN1,Calsyntenin-1,42311,-0.000754690035198456,0.00556834688988356,-0.0116686499393702,0.0101592698689733,0.892193225116255
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REG1B,Lithostathine-1-beta,42794,0.000830997025986017,0.00613481542091324,-0.0111932411990039,0.012855235250976,0.89225342367677
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNLZ,DNL-type zinc finger protein,40136,0.00127589102964718,0.0095668514304079,-0.0174751377739523,0.0200269198332467,0.893906524508054
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40302,0.000954947241669564,0.00734094695760243,-0.0134333087952312,0.0153432032785703,0.896501516135128
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RLN1,Prorelaxin H1,40482,-0.000638075716625505,0.00508324590991114,-0.0106012377000513,0.00932508626680034,0.900109971467748
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40116,0.000635355886181425,0.00520679620498553,-0.00956996467559021,0.0108406764479531,0.902881984325527
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42794,-0.000349341137395436,0.00288332522311069,-0.00600065857469239,0.00530197629990152,0.903566795511378
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOS,Proto-oncogene c-Fos,40065,0.000450586141205368,0.00375630589273904,-0.00691177340856314,0.00781294569097388,0.904521335066965
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39845,-0.000637326024052897,0.00540126078777401,-0.01122379716809,0.00994914511998416,0.906073220094784
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFF3,Trefoil factor 3,42613,0.000530575124684738,0.00451223031467655,-0.00831339629208129,0.00937454654145077,0.90639745628776
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGLC2,Immunoglobulin lambda constant 2,40519,0.000304876472843186,0.00265699322143002,-0.00490283024115965,0.00551258318684602,0.908649342763542
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40116,-0.000719068895182249,0.00644118003356025,-0.0133437817609603,0.0119056439705958,0.911113915340382
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EXOSC10,Exosome component 10,40116,0.000661664026403564,0.00634735293483297,-0.0117791477258691,0.0131024757786762,0.916978810577638
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40116,0.000498138851324274,0.00500043488603728,-0.00930271352530879,0.0102989912279573,0.9206485534519
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHIT1,Chitotriosidase-1,42699,0.00147760349062657,0.0161714098291833,-0.0302183597745727,0.0331735667558259,0.927198883839305
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",40080,-0.000468948990186339,0.00514678017465825,-0.0105566381325165,0.00961874015214382,0.927402872683255
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40080,-0.000322096018238538,0.00363629124820585,-0.007449226864722,0.00680503482824493,0.92941878841472
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINT3,Kunitz-type protease inhibitor 3,40449,0.00138013540816515,0.0155958478191982,-0.0291877263174634,0.0319479971337937,0.929485808235458
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KCNIP4,Kv channel-interacting protein 4,42311,-0.000438039865012193,0.00516808046746857,-0.0105674775812506,0.0096913978512262,0.932454508704183
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40116,0.000622174247672505,0.00734687297189685,-0.0137776967772453,0.0150220452725903,0.932512907118875
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANK2,Ankyrin-2,40116,0.000612026260991416,0.00773777936944155,-0.014554021303114,0.0157780738250969,0.936957830887067
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,40080,-0.000537904784545227,0.00693787127078061,-0.0141361324752752,0.0130603229061848,0.938202018536345
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HDAC9,Histone deacetylase 9,40136,-0.000504331881937586,0.00689644520894969,-0.014021364491479,0.0130127007276038,0.941704600642012
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HK2,Hexokinase-2,42357,-0.000208728524940839,0.00289103420560623,-0.00587515556792905,0.00545769851804737,0.942444982999325
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",40482,0.000337526342783345,0.00470087691335779,-0.00887619240739793,0.00955124509296462,0.94276177257965
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,L1CAM,Neural cell adhesion molecule L1,42679,0.000203036026260919,0.00306740899884897,-0.00580908561148306,0.0062151576640049,0.947226442905022
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ESR1,Estrogen receptor,40199,-0.000378554953255923,0.00580932669162487,-0.0117648352688407,0.0110077253623288,0.948045157386193
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAPT,Microtubule-associated protein tau,42311,-0.000349411220080185,0.00557802026893174,-0.0112823309471864,0.010583508507026,0.950053555599258
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,40080,0.000622420424602493,0.0101211229449392,-0.0192149805474784,0.0204598213966834,0.950964396625948
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40080,-0.000284478111476662,0.00475420841018414,-0.00960272659543758,0.00903377037248426,0.952286464059695
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAGEA3,Melanoma-associated antigen 3,40302,0.00052379892921489,0.00912482779018301,-0.0173608635395438,0.0184084613979736,0.954224643639725
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WNT9A,Protein Wnt-9a,42370,0.000177947222262308,0.00311445544873744,-0.00592638545726308,0.00628227990178769,0.954437803596719
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TAP1,Antigen peptide transporter 1,40302,0.000356736430500035,0.00647545839157848,-0.0123351620169938,0.0130486348779939,0.956067331951955
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GHRHR,Growth hormone-releasing hormone receptor,42311,-0.000317580407863106,0.00589210704951572,-0.0118661102249139,0.0112309494091877,0.95701622029489
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRX,Cone-rod homeobox protein,42357,0.000597909181808579,0.0111354418063247,-0.0212275567585878,0.0224233751222049,0.957179579901999
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHC1,SHC-transforming protein 1,40080,-0.000643696096211725,0.0124192643656369,-0.02498545425286,0.0236980620604365,0.958664741269703
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,40199,-0.000433634724169607,0.00951296831152795,-0.0190790526147644,0.0182117831664252,0.963643019753009
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40116,0.00024623943665349,0.00546198333089416,-0.0104592478918991,0.010951726765206,0.964042436685811
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TEX33,Testis-expressed protein 33,40302,-0.000153749092960228,0.00400984953529762,-0.00801305418214357,0.00770555599622311,0.969415008864272
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMC3,26S proteasome regulatory subunit 6A,40080,-0.000121875616502935,0.00321957212508495,-0.00643223698166945,0.00618848574866358,0.969804304775749
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMEM132A,Transmembrane protein 132A,40223,-0.000241152334787873,0.00658123155624165,-0.0131403661850215,0.0126580615154458,0.970770772935513
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40302,-0.000233683762860482,0.00666092303707227,-0.0132890929155221,0.0128217253898012,0.972014355082139
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,40116,-6.80711905035548e-05,0.00353698762938267,-0.00700056694409358,0.00686442456308647,0.984645590664514
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40136,-6.66535935430484e-05,0.00349558523636023,-0.00691800065680909,0.006784693469723,0.984787258270493
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,40116,-0.000113961165640974,0.0060224238237468,-0.0119179118601847,0.0116899895289027,0.98490303083336
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UNC5D,Netrin receptor UNC5D,40199,3.49306456724226e-05,0.00274789894715698,-0.00535095129075525,0.0054208125821001,0.989857982532081
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANKRA2,Ankyrin repeat family A protein 2,40080,-4.61968665721444e-05,0.00603500065038513,-0.011874798141327,0.0117824044081827,0.993892534193531
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZNF174,Zinc finger protein 174,40199,2.12671809117994e-05,0.00393217362512592,-0.007685793124335,0.0077283274861586,0.995684756393878
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYBPC2,"Myosin-binding protein C, fast-type",40223,4.60468013476212e-05,0.00890545818577656,-0.0174086512427744,0.0175007448454697,0.995874548553569
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40199,2.52208978468917e-06,0.00298411174583219,-0.00584633693204641,0.00585138111161579,0.999325665149852
